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Executive Summary 
This is the final report of the Nanocomput project, the main aims of which were to review 
the current status of computational methods that are potentially useful for predicting the 
properties of engineered nanomaterials, and to assess their applicability in order to provide 
advice on the use of these approaches for the purposes of the REACH regulation. Since 
computational methods cover a broad range of models and tools, emphasis was placed on 
Quantitative Structure-Property Relationship (QSPR) and Quantitative Structure-Activity 
Relationship (QSAR) models, and their potential role in predicting NM properties. In 
addition, the status of a diverse array of compartment-based mathematical models was 
assessed. These models comprised toxicokinetic (TK), toxicodynamic (TD), in vitro and in vivo 
dosimetry, and environmental fate models. Finally, based on systematic reviews of the 
scientific literature, as well as the outputs of the EU-funded research projects, 
recommendations for further research and development were also made.  
The Nanocomput project was carried out by the European Commission’s Joint Research 
Centre (JRC) for the Directorate-General (DG) for Internal Market, Industry, 
Entrepreneurship and SMEs (DG GROW) under the terms of an Administrative Arrangement 
between JRC and DG GROW. The project lasted 39 months, from January 2014 to March 
2017, and was supported by a steering group with representatives from DG GROW, DG 
Environment and the European Chemicals Agency (ECHA). 
 
Background information 
The first part of this report (Chapters 0-2) provides background information.  
Chapter 0 provides the terms of reference of Nanocomput, and is intended to orient the 
reader, linking the project objectives to different chapters in this report.  
Chapter 1 provides the scientific background and regulatory context to the rest of the 
report. It identifies the properties that drive the toxicity and fate of NMs, gives an overview 
of standard test methods for measuring physicochemical properties and toxicity, and 
explains the different kinds of alternative (non-animal) approaches that are being developed 
for regulatory purposes. In addition, an overview of the EU regulatory framework for NMs 
(REACH and other pieces of legislation) is provided. 
Chapter 2 presents an overview of software tools (including models and databases) that are 
available for predicting the toxicity and fate of NMs. The emphasis is on the different kinds 
of (mathematical) modelling approaches being used. Practical considerations and 
opportunities for developing computational models are also discussed. The chapter also 
includes experience in the grouping of NMs for the purpose of read-across, and proposals 
for NM categorisation schemes. 
 
Assessment of the availability and applicability of computational methods for NMs 
Chapter 3 provides a systematic review of the model landscape, based on a detailed and 
systematic survey of the scientific literature. This includes an analysis of current status of 
QSPR and QSAR models. A quantitative structure-property relationship (QSPR) is a 
mathematical model that uses key descriptors (chemical features or physicochemical 
properties) to make predictions of other physicochemical properties, whereas a QSAR is a 
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similar type of model except that the descriptors are used to make predictions of a biological 
activity (such as a toxicological endpoint).  In this report, QSPRs and QSARs are treated in the 
same way, since they both employ statistical learning methods to identify useful descriptors 
and/or establish the form of the correlative model between descriptors and predicted 
property/activity. 
The development of QSPRs and QSARs for NMs is still in its infancy, and been a challenge for 
a number of reasons. Traditionally, QSPR and QSAR modelling has applied to substances in 
solution, typically undissociated molecules, rather than particles. At present, relatively few 
theoretical descriptors are available for particles, although experimental descriptors may be 
useful (provided they can be measured reliably). A further complication is that particles do 
not typically form a homogeneous collection of species – they may undergo 
aggregation/agglomeration processes, adsorb and desorb macromolecules present in the 
surrounding medium, and may (partially) dissolve as well, leading to a distribution of 
masses/sizes/shapes (i.e. polydispersity). Rather than modelling a single species, it may 
therefore be necessary to model a distribution / mixture of species, which is increasingly 
difficult the more the material deviates from monodispersity. Furthermore, as with most 
'classical' chemicals, the mode of toxicological action is often unknown, making it difficult to 
identify, a priori, the most relevant and predictive descriptors. Finally, in the case of QSARs, a 
lack of reliable biological data has also hindered model development.   
In spite of these challenges, the development of QSPRs and QSARs for NMs has been a 
growing area of research. The analysis of QSPR/QSAR landscape identifies the properties and 
endpoints that are most often predicted, the availability of datasets for modelling, the 
descriptors (properties) that are most often used as predictors, as well as the statistical 
techniques most often applied. A detailed review of the literature identified 44 QSPRs (with 
solubility being the most frequently modelled endpoint) and 78 QSARs (with in vitro 
cytotoxicity endpoints being the most frequently modelled). It is concluded that while many 
of the QSPRs may be relevant for filling data gaps under REACH, very few QSARs directly 
predict a REACH endpoint. Some QSARs predict generic biological "endpoints", for example 
based on the integration of readouts from multiple in vitro methods. Thus, in general, QSARs 
are more likely to be useful for prioritising chemicals of concern, and for supporting read-
across arguments, rather than for directly filling data gaps. 
The QSAR Model Reporting Format (QMRF), as a tool for documenting and reporting 
QSPR/QSARs, was found to be useful, but requires a few additional fields to capture relevant 
particle properties. 
 
Chapter 3 also includes an analysis of the current status of compartment-based models, 
including TK and TD models, in vitro and in vivo dosimetry models, and environmental fate 
models. 
TK models simulate the time-dependent concentration of particles (including NMs) in one or 
more biological compartments of an organism. These include physiologically based kinetic 
(PBK) models that are based on physiologically relevant compartments and processes, as 
well as classical toxicokinetic (CTK) models that simulate key ADME properties by 
aggregating compartments into simpler model structures.  In the context of regulatory risk 
assessment, these models could be used to reduce uncertainties in extrapolating toxicity 
data (e.g. acute-to-chronic, within and between species, route-to-route), and therefore 
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modify the assessment factors applied in the determination of Derived No Effect Levels 
(DNELs). The literature review revealed the availability of 19 TK models, including 13 PBK 
models and 6 CTK models. These models are applicable to a total of 15 different NMs 
including metals, metal oxides, polymeric and carbon-based nanomaterials, with metal NMs 
being the most commonly modelled materials (10 out of 19 models).  The PBK models are of 
varying complexity (from 3 to 20 compartments), with blood, liver, spleen, kidneys and the 
reticuloendothelial system (RES) being the most represented compartments among the 
different models. Since NMs are captured and retained by the RES these cells (monocytes in 
the blood, reticular cells in the spleen, and Kupffer cells in the liver), these models could 
provide a means of predicting the potential for bioaccumulation, which is a property of 
concern. 
TD models simulate the intensity and time-course of substance-induced effects on a 
biological system (e.g. prediction of the inflammatory response of macrophages under 
exposure to NMs). While these models are still very much in their infancy, they can be used 
to provide mechanistic insights and to support the experimental design of toxicological 
studies. The literature review revealed the availability of just four such models.  
Dosimetry models simulate the local concentration or dose of particles (including NMs) in a 
defined in vitro or in vivo system. These include respiratory tract dosimetry models, which 
simulate the fate of inhaled NMs in the respiratory tract based on the physical and 
physiological factors that influence the deposition, clearance, and retention of inhaled 
particles. These models can be used to extrapolate toxicologically effective doses from 
animal studies to humans. The literature review revealed the availability of 7 respiratory 
tract models. 
Dosimetry models also include in vitro dosimetry models that simulate the fate of particle 
(including NMs) within in vitro test systems, based on kinetic processes such as diffusion, 
sedimentation and advection. By simulating the fraction of administered particles that 
deposit on cells as a function of time, these models can be used to support in vitro test 
design and the interpretation of toxicologically relevant in vitro effects for a given applied 
concentration. The literature review revealed the availability of 5 in vitro dosimetry models. 
Environmental fate models, developed to predict environmental concentrations in the 
environment or consumer exposure via the environment, were categorised into two types of 
models – material flow (MF) models and process-based environmental fate models. MF 
models typically track the materials from production to use and further to end-of-life stages 
and identify at each stage how much of a material is released into a technical (e.g. waste 
water treament plant) or environmental (e.g. air, soil, water) compartment. Process-based 
fate models determine the transport (e.g. advection and deposition) and fate (partitioning 
between compartments) of a material in an environmental system by modelling 
physicochemical processes, such as aggregation and sedimentation. Based on a systematic 
literature review, a total of 27 publications for MF models and 54 publications for process-
based fate models (out of 100) were characterised. 
The MF models were found to differ widely in terms of the NMs modelled, the types of NM-
containing product categories considered (e.g. cosmetics, biocides, paints, textiles), the 
number of compartments and life cycle stages, scale (e.g. local, national) and modelling 
approach (static, dynamic, deterministic, stochastic).  The MF models are applicable to a 
limited range of NMs, these being metals (mostly Ag), metal oxides (mostly TiO2, ZnO and 
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CeO) and carbon-based NMs (mostly MWCNT).  On the whole, MF models are based on the 
mass of NMs and transfer / release factors between compartments. The physicochemical 
properties of NMs, their environmental transformations (e.g. oxidation, reduction, 
aggregation, agglomeration) and detailed transfer and fate processes (e.g. sedimentation, 
resuspension, partitioning) are not generally taken into account. In predicting environmental 
concentrations of a NM, background levels are not generally taken into account. Major 
sources of uncertainty in these models relate to the amounts of a NM produced and 
allocated to different product categories, and the quantification of use patterns. 
Process-based environmental fate models were also found to be a diverse range of models, 
but could be broadly categorized into two groups depending on whether they describe fate 
and transport in aquatic (including multimedia box models) or soil media. These models vary 
considerably in terms of temporal and spatial scales, but tend to take physicochemical 
properties, transformations, and other fate and transport processes (e.g. agglomeration, 
aggregation, sedimentation, dissolution) into account.  They also differ in terms of the 
modeling approach (static vs dynamic), and the level of mechanistic detail considered. For 
example, some models apply colloidal chemistry kinetic equations to describe particle 
aggregation and sedimentation. Aquatic media models are applied to a restricted number of 
NMs, mostly metals and metal oxides. Models describing the fate and transport of NMs in 
soil media can be considered a special class of models in the sense that they attempt to 
account for the transport and retention of colloids in porous media. Many of these models 
are based on colloidal filtration theory (CFT), which include advection-diffusion equations as 
well as a sink term for (reversible or irreversible) colloid-collector interactions. Again, a 
major source of uncertainty in these models concerns the input parameters (mass loadings) 
which are sometimes derived from the outputs of MF models. 
In terms of applicability under REACH, MF models provide approximate estimates of releases 
to major environmental compartments, which could be used in low-tier risk assessments. In 
contrast, process-based models are not generally intended for reliable PEC estimation, but 
rather to take into account the mechanistic processes underlying transport and fate, and to 
evaluate the influence of natural variability in the environmental fate and transport of NMs 
in aquatic and soil environments. 
In addition, a few models were identified that predict the bioaccumulation of NMs in aquatic 
species (Daphnia magna and Chlamydomonas reinhardtii). These are generally single 
compartment models based on uptake and depuration (elimination) processes, and could be 
used to identify concerns for toxicity to environmental species. 
The detailed results of the literature review supporting Chapter 3 are provided as 
supplementary materials (Excel-based inventories of models and their characteristics using 
standardised reporting templates; S1 for QSAR and QSPR models, and S2 for PBK, dosimetry 
and environmental fate models). In order to systematically capture the characteristics of 
QSPR and QSAR models, a modified version of the QMRF was developed. In contrast to QSPR 
and QSAR models, there is no international (e.g. OECD) standard for reporting kinetic, 
dynamic, dosimetry and fate models. Therefore, in order to systematically capture the 
characteristics of these types of models, a reporting template had to be developed from 
scratch. 
Chapter 4 reports the results and conclusions of two case studies on grouping and read-
across, which were carried out to explore the practicalities of reading across toxicological 
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properties between different physical forms (analogues) of the same substance. The two 
case studies focus on the genotoxicity of TiO2 and carbon nanotubes (CNT), respectively. The 
aim was to explore the practical process of grouping and read-across between analogues, 
the applicability of the ECHA Read Across Assessment Framework (RAAF), with a view to 
sharing the lessons learned about the overall process. Thus, the conclusions obtained for 
specific substances should not be regarded as recommendations for regulatory action. 
 
In the TiO2 genotoxicity case study, the result of in vitro comet assay was selected as the 
endpoint to be predicted for two targetTiO2 NMs based on a set of 6 source NMs. This 
endpoint was selected for practical reasons, being the most data rich endpoint based on 
extensive literature search. The source TiO2 NMs had sizes from 5-93 nm, crystal types of 
anatase and rutile, some were coated and others uncoated, and were mostly spherical. 
More than 150 physicochemical properties for each of these NMs were gathered and used 
to inform the read-across.  
The grouping hypothesis was based on the observation that coated nano TiO2 produced 
negative results in the in vitro comet assay while the uncoated forms were positive. The 
mechanism through which the coating prevents genotoxicity of TiO2 is not well understood 
and the literature points to a possible combination of effects. The conduction band of TiO2 
falls in the cellular redox region and therefore shows that TiO2 has the potential to damage 
DNA and other cellular components. Some studies show that PEG-coated nano-TiO2 is 
negative in the comet assay, while uncoated forms are positive. This can be explained by two 
different phenomena. The first is that the coating can act as a "bumper" preventing the 
physical contact between the NM and cellular target (e.g DNA) that is needed to cause 
genotoxicity; the second is the fact that coated NMs show better dispersibility, lower 
cytotoxicity and sedimentation rates than uncoated NMs. Some studies have shown that 
dispersions of nano-TiO2 with agglomerates of more than 200nm were positive in the comet 
assay, while the smaller agglomerates were negative. It is difficult to identify a single 
mechanism of action for the genotoxicity of some nano-TiO2 and probably multiple 
mechanisms are contributing to the toxicity. Both of the identified mechanisms have the 
consequence that coating prevents the genotoxicity of nano-TiO2 as determined by the in 
vitro comet assay.  
The grouping hypothesis was supported by the use of chemoinformatic techniques such as 
hierarchical clustering, principal components analysis (PCA), and random forest (RF). 
Hierarchical clustering showed two clear clusters of NMs: the coated ones and the rest. The 
PCA indicated that the main differences between NMs are due to particle size, crystal type, 
and the presence of coating. All the other properties were shown to be less relevant. Finally, 
the RF methodology showed that the most important properties for predicting the 
genotoxicity of nano-TiO2 are all related to the presence or absence of coating.  
In the CNT case study, physicochemical, in vitro genotoxicity and in vivo genotoxicity data 
were compiled for 19 MWCNT and 2 reference materials (carbon black and asbestos). The 
physicochemical data were not reported consistently in the source publications which made 
it difficult to compare analogues in terms of their physicochemical properties. The 
genotoxicity data were selected by applying a number of data quality considerations. While 
a range of genotoxicity endpoints were available, the case study focused on five endpoints 
which were the most data rich: in vitro gene mutation in mammalian cells, in vitro DNA 
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damage (Comet assay), in vivo DNA damage (Comet assay), in vitro chromosome aberration 
(micronucleus assay), and in vivo chromosomal aberrations (micronucleus assay). Based on a 
weight of evidence across all reliable studies, the 19 MWCNT were all considered non-
genotoxic. It was therefore hypothesised that this conclusion may be extrapolated to other 
MWCNTs within the assessed ranges of size (length and width), surface coating, and content 
of oxidising impurities. Target substances were those analogues having a data gap for at 
least one of the five genotoxicity study types.  
Since all analogues were treated as non-genotoxic, supervised learning could not be applied 
to identify properties that may distinguish between genotoxic and non-genotoxic 
nanoforms. However, unsupervised learning (hierarchical clustering and principal 
component analysis [PCA]) could be applied to explore structural similarities between the 
nanoforms. Hierarchical clustering showed that clusters were mainly driven by the size 
(length and diameter) and surface area of the MWCNT, but not by the presence of impurities 
or type of functionalization. PCA revealed that the analogues could be clustered according to 
length, surface area, ROS generation, and combustion elemental analysis (CEA) of H and N. 
Again, the type of functionalization did not play a role in clustering. These results suggest 
that genotoxicity does not seem to be (solely) responsible for the initiation of carcinogenicity 
following MWCNT inhalation. To the extent that in vivo studies reveal the potential for 
carcinogenicity following MWCNT exposure, this is likely to be due to the persistence of the 
fibres, resulting in persistent release of reactive oxygen species and inflammation. 
Accordingly, the presence of genotoxicity in vivo may be a secondary effect, resulting from 
ROS generation and inflammation. There is evidence that the persistence of CNTs in 
biological compartments is related to their morphological (size and shape) and mechanical 
(rigidity) characteristics (as with larger fibres). 
The two case studies show how data from different sources can be gathered, interpreted 
and combined, and how the ECHA guidance on the grouping and read-across can be applied 
at a practical level. The case studies also illustrate how chemoinformatic techniques could be 
applied to support a grouping hypothesis. A detailed analysis of different physicochemical 
properties like zeta potential, polydispersibility index and particle size distribution measured 
in different media and with different sonication treatments is provided in the annexes. 
The two read-across case studies were also analysed in terms of their underlying 
uncertainties with a view to evaluating the applicability of ECHA's Read-Across Assessment 
Framework (RAAF) for NMs. The RAAF was developed as a structured approach to promote 
consistency in the evaluation of read-across arguments. Out of the six RAAF scenarios 
defined by ECHA, scenario 6 best reflects the NM case studies. Both the TiO2 and MWCNT 
case studies are based on category approaches (reading-across from a group of substances 
to a target), different compounds (in this case nanoforms) having the same type of effect, 
and no variations in effect (e.g. Comet assay result either positive or negative).  It was found 
that the RAAF is useful and applicable for evaluating read-across of NM properties, although 
some of the considerations ("assessment elements") need to be interpreted more broadly to 
capture nan-specific issues. In particular, the following uncertainties need to be considered 
for NMs: a) the high variability of measurements used in the physicochemical 
characterisation of NMs (e.g. zeta potential); b) the fact that similarity cannot be based on 
chemical (e.g. molecular) structure alone, as for conventional chemicals, but should also 
consider physical form and relevant physicochemical properties; c) experimental artefacts 
affecting the interpretation of in vivo and in vitro toxicity studies (in particular those relating 
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to kinetics, e.g. sedimentation of particles onto cellular monolayers); d) transformation 
processes (e.g. metal ion speciation, dissolution, agglomeration/ aggregation) which may 
also vary over time; and e) effects of coatings, which may be intentionally added, or 
adsorbed from the environment (coronas). 
The detailed results supporting Chapter 4 are provided as supplementary materials (Excel-
based datasets for the grouping and read-across case studies). 
 
Recommendations for further research and development 
Based on the content of previous chapters, and a detailed review of unpublished 
deliverables requested from EU-funded research projects (Framework Programmes, Horizon 
2020), Chapter 5 summarises the scientific and technical state of the art, and makes 
recommendations for further research and development, with a view to increasing the 
availability and uptake of computational methods. The systematic review of the recent EU 
project research into nanosafety assessment showed that considerable progress has been 
made towards addressing the challenges of modelling nanomaterials. However there is still a 
fragmentation in the scientific results and a lack of coordination, and the lack of public 
access to the results and tools is preventing their uptake and use in regulatory decision 
making. 
 
Overall conclusions and recommendations 
Chapter 6 presents the overall conclusions from the Nanocomput project, including lessons 
learned in conducting literature reviews and research-based case studies on grouping and 
read-across. A number of recommendations are also offered with a view to overcoming 
current shortcomings in our knowledge of NM behaviour, and in the availability of tools 
(such as databases and predictive models) and practical guidance to use such tools in the 
regulatory assessment of NMs. The overall conclusions and recommendations are structured 
according to 6 main themes which are related to: 1) the inherent scientific uncertainties in 
our understanding of NM behaviour, 2) data quality and availability; 3) the availability of 
predictive models (the "model landscape"); 4) the practicality of applying the REACH 
guidance on grouping and read-across; 5) the utility of the ECHA Read-Across Assessment 
Framework (RAAF) in evaluating and documenting uncertainties in the read-across of NM 
properties; and 6) the need for infrastructures and a one-stop hub to support the application 
of predictive models in nanosafety assessment. 
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0 Terms of Reference and report overview  
 
The Nanocomput project was carried out by the European Commission’s Joint Research 
Centre (JRC) for the Directorate-General (DG) for Internal Market, Industry, 
Entrepreneurship and SMEs (DG GROW) under the terms of an Administrative Arrangement 
(No 33269) between JRC and DG GROW. Some of the work, aimed at compiling inventories 
of computational models, was carried out under the terms of a JRC subcontract with Leitat 
Technological Centre (Spain). 
The project lasted 39 months, from January 2014 to March 2017, and was supported by a 
steering group with representatives from DG GROW, DG Environment and the European 
Chemicals Agency (ECHA). 
The main aims of Nanocomput were to review the current status of computational methods 
that are potentially useful for predicting the properties of engineered nanomaterials, and to 
assess their applicability in order to provide advice on the use of these approaches for the 
purposes of the REACH regulation. The technical terms of reference in Administrative 
Arrangement defined four main tasks: 
Task 1: Current status of computational methods for estimating the intrinsic properties 
and toxicological effects of manufactured nanomaterials (NMs);  
Task 2: Assessment of the applicability of available models/approaches in meeting the 
data requirements of REACH;  
Task 3: Recommendations on the use of computational methods;  
Task 4: Recommendations for further research and development activities. 
 
A brief explanation of these tasks, and associated subtasks, with links to parts of this report 
is given in the following Table: 
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Table 0.1. Relationship between Nanocomput tasks (defined in the project terms of reference) and parts of this report 
Tasks Chapter  Appendices and supplementary 
materials1 
T1 
1.1 Review on grouping, QSAR, 
QSPR and TK models applied to 
NMs  
The conceptual basis of the different modelling approaches 
is explained in Chapter 1, whereas practical considerations 
that need to be considered when developing such models is 
discussed in Chapter 2. 
Chapter 2 also includes a list of relevant NM databases, and 
describes efforts at developing database ontologies. 
Approaches for grouping NMs for various purposes 
(including read-across) are also reviewed in Chapter 2. This 
includes research proposals as well as experience gained in 
regulatory assessments. 
An extensive and systematic review of the modelling 
literature is summarised in Chapter 3. 
Information on (as yet unpublished) models under 
development in EU funded research projects is summarised 
in Chapter 5. 
 
 
 
 
 
 
 
 
 
 
 
 
Appendices IV and V gives a list of EU 
(IV) and other (V) funded research 
projects having a stated aim to develop 
computational models or grouping 
approaches. 
1.2 Compile model inventories  Templates for the structured reporting of QSPR/QSAR and 
PBK/fate/dosimetry models were developed, and used to 
systematically capture information on model characteristics 
from the scientific literature.  
The QPSR/QSAR and PBK/fate/dosimetry model templates 
are described in Chapter 3. 
The model inventories for QSPR/QSAR 
and TK/TD/dosimetry/fate models are 
provided as supplementary materials S1 
and S2 (Excel workbooks). 
 
The individual QSPR/QSAR model 
descriptions in document format are 
also provided as supplementary material 
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Tasks Chapter  Appendices and supplementary 
materials1 
S3.  
1.3 QMRF evaluation The suitability of the QMRF for NM-relevant models is 
evaluated in Chapter 3. 
Appendix VI outlines a proposal for 
extending the QMRF to capture NM-
relevant properties. 
T2 
2.1 Practicality and applicability 
of the different identified 
approaches according to REACH
The status of REACH information requirements and 
guidance documentation is reviewed in Chapter 1. 
Existing grouping proposals are reviewed in Chapter 2, 
including comments on their practicality and applicability 
for the purposes of REACH. 
Based on the results of a detailed literature review, Chapter 
3 provides an assessment of the practicality and 
applicability of QSPR/QSAR models as well as 
TK/TD/dosimetry/fate models. 
 
Appendix III  gives an overview of the 
Standard Information Requirements 
(REACH Annexes VI-X)  
 
Appendix VII illustrates the reporting 
format developed to systematically 
information on TK/TD/dosimetry/fate 
models 
2.2 Evaluate computational 
methods and models for the 
purposes of grouping NMs  
Building on the conclusions of Chapters 2 and 3 (Task 2.1), 
the practicality and applicability of grouping approaches, 
including the use of  supervised and unsupervised machine 
learning techniques, is explored through two read-across 
case studies (nano TiO2 and MWCNTs) in Chapter 4.   
 
The details of the computational 
machine learning techniques (clustering 
and PCA) for the nano TiO2 case study 
are provided in Appendix X. 
 
T3 
3.1 Grouping NMs according to 
similarity 
In Chapter 4, practical recommendations on how to group 
NMs considering compositional, physicochemical and in 
vitro descriptors, in accordance with draft ECHA guidance, 
are provided. These recommendations are based on the 
experience gained in carrying out two read-across case 
studies (nano TiO2 and MWCNTs). 
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Tasks Chapter  Appendices and supplementary 
materials1 
3.2 QSAR and read across in 
integrated assessment 
approaches 
Background information on integrated assessment 
approaches, such as Integrated Testing Strategies (ITS) and 
Weight of Evidence (WoE) is provided in Chapter 1. 
The use of WoE as an integral part of the grouping and read-
across approach is illustrated in Chapter 4. 
Research gaps, in terms of the need for new QSPRs and 
QSARs, are identified in Chapter 5. 
 
The dataset for the MWCNT case study 
is given in Supplementary Material S4. 
3.3 Use of models and 
approaches to predict NM 
physicochemical properties 
Existing models and approaches to predict NM 
physicochemical properties are described in Chapter 3. 
Ongoing research developments are reported in Chapter 5. 
 
T4 
4.1 R&D on approaches 
assessed under Task 2 
 
 
 
4.2 Public dissemination and 
update of the models 
inventories developed under 
Task 1 
The challenges in developing and applying predictive 
approaches for NMs are described in Chapter 1.  
Based on the literature reviews (Chapter 3), the lessons 
learned in the case studies (Chapter 4), and review of EU 
project deliverables, recommendations for further research 
and development activities are made in Chapter 5.  
A proposal for public dissemination and future updating of 
the model inventories is provided in Chapter 5. 
 
Overall conclusions are presented in Chapter 6. 
 
Appendices IV and V give a list of EU 
funded (IV) and other (V) research 
projects having a stated aim to develop 
computational models or grouping 
approaches. 
 
 
1) Supplementary materials S1-S4 are available upon request 
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1 Background information 
1.1 Introduction  
Manufactured nanomaterials (NMs) are being increasingly included in a variety of goods and 
products, because of their novel physical and chemical characteristics (European 
Commission, 2012). There are concerns, however, that the very same characteristics may 
also lead to environmental and human health risks. 
In the EU nanomaterials have been defined by some legal pieces. Legally binding definitions 
are included in the Cosmetic Products Regulation (EC) 1223/2009, the Biocidal Products 
Regulation (EU) 528/2012/EC and Regulation (EU) 1169/2011 on Provisions of Food 
Information to the Consumers (FIC Regulation). In addition in 2011 the EC adopted a 
Recommendation (2011/696/EU) on the definition of the term 'nanomaterial' with the goal 
to promote consistency in the interpretation of the term nanomaterial for legislative and 
policy purposes in the EU (EC, 2011a). This definition is broadly applicable across different 
regulatory sectors, however not legally binding. The EC Definition applies to all particulate 
NMs regardless of their origin, i.e. natural, incidental or manufactured. It refers to a size 
range of 1 – 100 nm and established also a threshold of 50% or more particles <100 nm in 
the number size distribution which in specific cases can be lowered to 1% (Appendix II). This 
size range has been proposed in several definitions, including ISO/TS 12805:2011 by the 
International Organization for Standardization (ISO). 
The NM definition in the Biocidal Products Regulation is based on the EC Definition, while 
the definitions for cosmetic products and food were implemented previously and contain 
some relevant differences. Although comprising a comparable size range (<100 nm) the main 
difference is the restriction to intentionally manufactures (or produced) materials, which is 
further restricted for cosmetic products to insoluble or biopersistent material. This size 
range has been proposed in several definitions, including ISO/TS 12805:2011 by the 
international Organization for Standardization (ISO). 
The revision of the EC definition and an alignments of the definitions of NM in cosmetic 
products and food with the EC definition are currently are under discussion (JRC internal 
information; Rauscher et al., 2014; Roebben et al., 2014). 
To evaluate and manage the environmental and health impacts of chemicals, risk 
assessment (RA) is considered a pertinent approach that can be adapted to assess the 
potential risks caused by NMs. RA is a process by which scientific and regulatory principles 
are applied in a systematic approach to address qualitatively and/or quantitatively the 
likelihood that humans or environmental species may be harmed due to potential exposure 
to chemicals.  
Regulation 1907/2006 concerning the Registration, Authorisation and Restriction of 
Chemicals (REACH) (EU, 2007; European Parliament and Council, 2006a), requests 
registrants to demonstrate the safe use of chemicals including NMs. REACH is intended to 
ensure chemical safety while promoting innovation and competitiveness as well as reducing 
the use of in vivo testing through the use of non-animal alternatives such as in silico, in vitro 
methods and in chemico methods, read across and weight of evidence.  
This chapter provides background information on the information requirements for NMs 
with special focus on REACH, as well as the scientific and technical basis for understanding 
their behaviour (fate and effects). The REACH regulation (section 1.2) and risk assessment 
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approach (section 1.3) are briefly introduced, and an overview is given (section 1.4) of key 
physicochemical (PC) properties that are relevant for characterising and understanding the 
behaviour (fate and biological effects) of NMs. This chapter also touches on the scientific 
basis of NM behaviour (section 1.5), since this understanding is important in the 
development and application of standard (section 1.6) and alternative approaches to animal 
testing (section 1.7). 
 
1.2 Information requirements for risk assessment - legal provisions and guidance 
In the EU, substance and sector-specific pieces of legislation provide a binding framework to 
ensure the safety of substances and products on the market (manufactured or imported). 
NMs are implicitly covered or explicitly addressed (e.g. cosmetics and biocidal products), 
depending on the applications and its legislative framework. The 'substance' definition of 
REACH applies to chemicals irrespective of size, shape and physical state, and thus its 
provisions apply also for NMs, even if there are currently no provisions that explicitly refer to 
NMs (EC, 2008; European Parliament and Council, 2006a).  
 
1.2.1 Chemical substances under REACH 
According to the (second) Regulatory Review on Nanomaterials (EC, 2012c), REACH sets the 
best possible framework for the risk management of NMs when they occur as substances or 
mixtures. More specific requirements may be introduced through the possible revision of 
some of the REACH Annexes. In addition further ECHA guidance for REACH registrants is 
needed.  
The provisions of REACH contain extensive obligations for manufacturers to generate and 
assess data on chemicals (including PC properties, manufacture, uses and hazardous 
properties) and to demonstrate that risks can be adequately controlled during their use. All 
chemicals manufactured or imported in quantities higher than 1 t/y have to be registered 
with basic information requirements (for overview, see Appendix III). In addition, for all 
chemicals manufactured or imported in quantities higher than 10 t/y, a chemical safety 
assessment (CSA) has to be performed and documented in the chemical safety report (CSR).  
Under REACH, different forms of one substance (e.g. solids, suspensions, powders, 
nanomaterials, etc.) are considered within a single registration of a substance (EC, 2012c). 
However, the registrant must ensure the safety of all included forms and provide adequate 
information to address the different forms in the registration. This means that more than 
one endpoint study for different forms may be required, or different forms within one 
registration may have a different hazard classification. 
The REACH approach to hazard assessment and risk characterisation, with its built-in 
flexibility, makes it suitable for NMs (EC, 2012c). Based on RIPoN (REACH Implementation 
Project on Nanomaterials) Reports (Hankin et al., 2011), ECHA has published specific 
guidance for NMs (ECHA, 2012b, 2012c, 2012d). In addition, ECHA has set up a 
Nanomaterials Working group to give advice on scientific and technical issues in relation to 
NM under REACH. 
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The information collected or generated under REACH is used e.g. for priority setting, 
classification and labelling, chemical safety assessment and PBT/vPvB1 assessment. It needs 
to be adequate for both classification & labelling and for chemical safety assessment if the 
latter is required (triggered by classification or PBT assessment). REACH Article 10 defines 
the information requirements to be submitted for registration and Annex I outlines the 
general provisions for assessing substances and preparing chemical safety reports. Annexes 
VII to X more specifically detail the standard information requirements. Information on 
intrinsic properties is mainly dependent on the tonnage at which the substance is brought 
on the market (see overview in Appendix III). Column 2 of each of these Annexes (VII to X) 
defines the specific rules for adaptation of the standard information requirements as 
defined in column 1, i.e. when a specific step (test) does not need to be conducted, or 
further studies may be considered in case of positive results. Guidance notes on fulfilling the 
requirements of Annexes VII to X are presented in REACH Annex VI. This Annex contains also 
the information requirements which are independent from the tonnage, i.e. general 
registration information, identification of the substance, manufacture and use, classification 
and labelling, and guidance on the safe use. REACH Annex XI defines the 'General rules for 
adaptation of the standard testing regime set out in Annexes VII to X'. The basis for the use 
of alternative approaches under these rules are laid down by Article 13 and 25.  
Article 25(1) states that testing on vertebrate animals shall be undertaken only as a last 
resort. According to Article 13(1):  
"information on intrinsic properties of substances may be generated by means other 
than tests, provided that the conditions set out in Annex XI are met. In particular for 
human toxicity, information shall be generated whenever possible by means other 
than vertebrate animal tests, through the use of alternative methods, for example, in 
vitro methods or qualitative or quantitative structure-activity relationship models or 
from information from structurally related substances (grouping or read-across)." 
As described in Annex XI, testing can be waived or replaced by other information and 
methods when: i) testing is not scientifically necessary; ii) testing is technically not possible, 
or iii) Substance-tailored exposure–driven testing (i.e. exposure-based waiving) is 
appropriate. The types of test that can be waived or replaced by alternative tests are 
dependent on the tonnage and the requirements of the respective Annex (see Appendix III). 
Guidance is provided in Chapter R.5: 'Adaptation of information requirements' of the ECHA 
'Guidance on information requirements and chemical safety assessment' (ECHA 2011). 
REACH Annex XI also explains when alternative approaches such as (Q)SAR, grouping and 
read-across, in vitro methods and weight of evidence can be used instead of testing to 
indicate the presence or absence of a certain dangerous property (see section 1.7).  
Results obtained from valid qualitative or quantitative structure relationship models ― 
(Q)SARs ― may be used to indicate the presence or absence of a certain dangerous 
property, if: i) the scientific validity of the (Q)SAR model has been established, ii) the 
substance falls within the applicability domain of the (Q)SAR model, iii) the results are 
adequate for the purpose of classification and labelling and/or risk assessment and iv) the 
                                                      
1 Persistent, Bioaccumulative and Toxic (PBT), very Persistent and very Bioaccumulative 
(vPvB) 
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adequate and reliable documentation of the applied method is provided (REACH Annex XI, 
1.3).  
Substances whose physicochemical, toxicological and ecotoxicological properties are likely 
to be similar or follow a regular pattern as a result of structural similarity may be considered 
as a group, or 'category' of substances and PC, human health effects and environmental 
effects or environmental fate may be predicted from data for reference substance(s) within 
the group by interpolation to other substances in the group (read across approach) (REACH 
Annex XI, 1.5) (see also section 1.7.4) 
Guidance on how to assess (Q)SARs if conditions are met and on the technically and 
scientifically justified methodology for the grouping of substances is provided in 'Chapter 
R.6: QSARs and grouping of chemicals' of the 'ECHA Guidance on information requirements 
and chemical safety assessment' (ECHA 2008).  
The current minimum standard information requirements as described in the REACH 
Annexes may not address all NM-specific PC properties and characteristics; especially the 
physicochemical properties may not be sufficient to adequately characterise the 
nanomaterial and discriminate it from other forms. However, it is already possible to 
document relevant information in IUCLID (International Uniform Chemical Database), which 
is the electronic tool used for submissions of REACH dossiers to ECHA. IUCLID included in 
September 2013 the 13 OECD Harmonised Templates (OHTs) which cover NM-specific 
endpoints (http://www.oecd.org/ehs/templates/). 
The impact assessment on the possible amendment of the REACH Annexes to more 
specifically address NMs has been finalised and the potential elements were presented as 
'Informal Considerations' (non-paper) at the May 2014, March 2016 and March 2017 
meetings of the 'Subgroup of the REACH and CLP Competent Authorities on Nanomaterials' 
(CASG Nano). The proposed amendments include for example more detailed information on 
substance identity and highlight the existence of nanoforms of the same substance. The 
proposal also includes a definition of nanoform which is in accordance with the European 
Commission Recommendation of 18 October 2011 (EC, 2011a) on the definition of 
nanomaterial.  
 
1.2.2  Cosmetic products 
Certain ingredients of cosmetics require an authorisation based on a scientific risk 
assessment and an inclusion in Annexes IV (colorants), V (preservatives) and VI (UV filters) to 
Regulation (EC) No 1223/2009 (European Parliament & Council, 2009). Some of these 
substances may be particles at the nanoscale. The Cosmetic Products Regulation provides a 
definition of nanomaterial (insoluble/partially soluble or biopersistent and intentionally 
manufactured) as well as mechanisms for notification, labelling and safety evaluation of 
cosmetic products containing nanomaterials. It also imposed bans on testing finished 
products and ingredients on animals as well as on marketing of such products and 
ingredients (from March 2013).  
The EU Scientific Committee for Consumer Safety (SCCS) released a guidance on the 'Safety 
Assessment of Nanomaterials in Cosmetics' (SCCS, 2012) where it is recommended that the 
nanospecific physicochemical properties are considered in the safety assessment. It 
highlights the need for special considerations in relation to the safety of NMs, in view of the 
 9 
 
possible distinct properties, interactions, and/or effects that may differ from conventional 
forms of the same materials. It covers and gives recommendations addressing the main 
elements of risk assessment, i.e. material (physicochemical) characterisation, exposure 
assessment (e.g. likelihood and extent of translocation of NMs across biological barriers), 
and toxicological evaluation (e.g. consideration of nano-related aspects such as particulate 
form or possible interaction with biological entities). The guidance presents an overview of 
available methods of toxicological evaluation of nanomaterials for each endpoint and 
concludes that at present in view of current limitations an approach using in vitro assays 
only is too premature to be applied for risk assessment. Concerning read-across, the SCCS 
considers that in the absence of a sufficient knowledge base on nanomaterial properties, 
behaviour, and effects, a category approach to risk assessment is currently not feasible for 
NMs, and risk assessment of each nanomaterial needs to be carried out on a case-by-case 
basis. The SCCS is, however, open to consider the application of read-across and 
mathematical models that enable a category approach to conduct risk assessment of NMs in 
the future, when new knowledge will increase the understanding of the key parameters that 
drive the properties, biological interactions and toxicological effects of NMs (SCCS, 2012).  
Further guidance on NMs data submission is provided in the SCCS 'Notes of guidance for the 
testing of cosmetic ingredients and their safety evaluation'  it is stressed again that specific 
properties should be taken into consideration in safety assessment (SCCS, 2015) and in the 
Memorandum on 'Relevance, Adequacy and Quality of Data in Safety Dossiers on 
Nanomaterials' (SCCS, 2014), SCCS highlights the importance of submitting data that are 
relevant, adequate and of good quality in support of risk assessment and also highlights that 
when NMs are submitted under the same dossier, the possibility to read-across should be 
justified. 
 
1.2.3  Biocidal products 
The risk assessment and authorisation of NMs in biocidal products is addressed by the 
Biocidal Products Regulation (EU) No 528/2012 (European Parliament and Council, 2012). It 
states that for the approval of NMs as active substances and for subsequent product 
authorisation, the test methods applied to the NMs shall be accompanied by an explanation 
addressing their scientific appropriateness, taking into consideration the specific 
characteristics of each NM. The information requirements for active substances are outlined 
in Annex II of the Regulation, whereas those for the biocidal product are given in Annex III. 
The general rules for the adaptation of the data requirements for biocides are presented in 
Annex IV of Biocidal Products Regulation (EU) No 528/2012. These are in accordance with 
Annex XI of REACH regulation. Specific guidance for nanomaterials is in preparation. 
 
1.2.4  Plant protection products 
The Plant Protection Products Regulation (EC) 1107/2009 (European Parliament and Council, 
2009) does not make any explicit reference to NMs. The data requirements for active 
substances and plant protection products are set out in Annexes II and III to Directive 
91/414/EEC (Union & Council of the European Union, 1991). Guidance on how to assess the 
risk of NMs in plant protection products is provided by the EFSA Guidance on the Risk 
Assessment of the Application of Nanoscience and Nanotechnologies in the Food and Feed 
Chain (EFSA, 2011). 
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1.2.5 Food production 
The use of nanotechnology and nanomaterials in food production is currently covered by EC 
Regulation No 258/97 concerning 'novel foods' and 'novel food ingredients' (European 
Parliament and Council, 1997) which addresses food not consumed to any significant degree 
in the EU prior to May 1997. The proposal for the revised regulation (European Commission, 
2013) addresses NM and nanotechnology more explicitly by covering 'foods modified by new 
production processes such as nanotechnology and nanoscience and food or vitamins, 
minerals and other substances containing or consisting of 'engineered nanomaterials'. A pre-
market approval (safety assessment and authorisation) is required for novel food as well as 
for food additives.  
In 2011 EFSA issued a 'Guidance on the risk assessment of the application of nanoscience 
and nanotechnologies in the food and feed chain' (EFSA, 2011) providing a practical 
approach for assessing potential risks arising from applications of nanoscience and 
nanotechnologies in food additives, enzymes, flavourings, food contact materials, novel 
foods, feed additives and pesticides. This guidance is now being updated. 
This document provides guidance to applicants for data generation on the PC 
characterisation and on testing approaches to identify and characterise hazards arising from 
the properties of NMs. It describes 6 exposure scenarios, depending on the possible 
transformations of the NM before and after ingestion of the food/feed and for each of these 
scenarios the type of data needed to conduct a risk assessment is specified. When no 
exposure to NM is verified for example by data indicating no migration2 from food contact 
materials or by demonstration of complete degradation/dissolution with no possible 
absorption of NM, the information requirements can be reduced. Direct use of NM in food 
or feed which are transformed to non-nanoforms in a food/feed matrix and before ingestion 
can be treated as and follow the guidance for non-nanoforms. For such NMs only local 
effects in the gastrointestinal tract and possible absorption before transformation should be 
considered. A comparison should indicate whether the nanoform has increased, less or 
similar hazard as compared to the non-nanoform. 
 
1.3 Risk assessment  
The three major steps in a risk assessment (or to prepare a CSA under REACH) include (a) 
hazard assessment, (b) exposure assessment and (c) risk characterisation (REACH Annex I ; 
ECHA, 2009; European Parliament and Council, 2006a). 
The hazard assessment has the objective to identify the hazards of the substance, assess 
their potential effects on human health and the environment, and determine, where 
possible, the no-effect levels (threshold levels). If a substance meets the criteria for 
classification as dangerous, or is identified as PBT or vPvB, it will undergo the exposure 
assessment and risk characterisation.  
                                                      
2 The guidance document does not include details on analytical or mathematical methods 
for detecting migration of NMs to food and feed; the analytical approach should be well 
justified by the applicant. 
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The exposure assessment serves to measure or estimate the dose or concentration of the 
substance to which humans and the environment are, or may be, exposed in specific 
exposure scenarios which cover all identified uses and life stages of the substance. An 
exposure assessment is required only for hazardous substances in REACH. 
For the risk characterisation, Derived No Effect Levels (DNELs) extrapolated from the in vivo 
no-effect levels are compared with the levels of exposure to assess whether the risk is 
controlled. When a no-effect level cannot be quantitatively determined, a qualitative or 
semi-quantitative approach is used.  
 
 
Figure 1.1 Overview of the Chemical Safety Assessment process under REACH (ECHA, 2009). 
 
Although the necessity of an exposure assessment and risk characterisation is dependent on 
the results of the hazard assessment, exposure information may play an important role in 
influencing it. In situations where human or environmental exposure is absent or so low that 
additional effects information is not requested to improve the risk management, exposure-
based waiving of hazard information can be considered (Annex XI of REACH, section 3 on 
substance tailored exposure-driven testing, European Parliament and Council 2006). 
Reducing/minimising exposure is therefore an important risk management option in the 
development and production of NMs and NM-containing products, especially when there 
are still scientific uncertainties in the hazard assessment. 
In contrast to exposure-based waiving, additional (targeted) testing can be triggered if the 
risk characterization indicates a need to investigate further the effects on humans or the 
environment for certain exposure situations. The exposure assessment also informs the 
hazard assessment in terms of which routes of exposure (e.g. inhalation) and which 
concentrations are the most relevant to test. Exposure-based adaptations are an integral 
part of the ECHA Guidance on Information Requirements and Chemical Safety Assessment, 
Chapter R5: Adaptation of Information requirements (ECHA, 2011). According to this 
guidance, exposure based adaptations (EBA) can be considered when they can be justified 
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based on no release, strictly controlled conditions, absence of exposure, or no significant 
exposure. In practice, exposure based adaptations of the standard hazard testing regime 
under REACH require reliable information on use and exposure, which is often not available 
for NMs. 
The applicability of current risk assessment methodologies for NMs has been assessed by 
the EC scientific committees including the Scientific Committee on Emerging and Newly 
Identified Health Risks (SCENIHR), the Scientific Committee on Consumer Safety (SCCS), the 
European Food Safety Authority (EFSA) and the European Medicines Agency (EMA). SCENIHR 
(SCENIHR, 2009) concluded that 'risk assessment methodologies for the evaluation of 
potential risks of substances and conventional materials to man and the environment are 
widely used and are generally applicable to nanomaterials. However, specific aspects related 
to nanomaterials still require further development. As there is not yet a generally applicable 
paradigm for nanomaterial hazard identification, a case-by-case approach for the risk 
assessment of nanomaterials is still warranted.' Similar conclusions were made by the 
scientific committee of EFSA for NM applications in food and feed (EFSA Scientific 
Committee, 2009).  
 
The Scientific Committees as well as OECD have identified that for NMs further development 
of some standardised and validated methods are required, for example for sample 
preparation and characterisation, exposure data and models and some endpoints in 
toxicological test guidelines (section 1.6). Harmonisation and standardisation of 
measurement and test methods in support or risk assessment of NM is being promoted 
through the OECD and by a Commission Mandate to the European Standards Organisation 
(EC, 2012c).  
Several (regulatory) risk assessments on NM-containing products have been completed and 
various products in different sectors have been authorised (Second regulatory review 2012: 
20 medicines, 3 food contact materials, 4 cosmetic products) (EC, 2012c). The SCCS (and its 
predecessor committees) has performed a number of risk assessments on nanomaterials 
used as cosmetic ingredients (Table 1.1) 
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Table 1.1. SCCS risk assessments on nanomaterials used as cosmetics 
 
Nanomaterial Document1  
Titanium dioxide as UV-Filter, as pigment SCCNFP/0005/98 
Zinc oxide in suncream( SCCP/1147/07 
TiO2  SCCS/1516/13 + SCCS/1539/14 
ZnO SCCS/1489/12 + SCCS/1518/13 
ETH 50 (nano and non-nano) SCCS/1429/11 
MBBT SCCS/1460/11 
Silica   SCCS/1545/15 
Carbon Black  SCCS/1515/13 
Hydroxyapatite SCCS/1566/15 
Additional coatings for TiO2 (nano form) as UV filter in 
dermally applied cosmetic products 
SCCS/1580/16 
Titanium Dioxide (nano form) as UV-Filter in sprays –  SCCS/1583/17 (in finalization) 
1 Documents available at: https://ec.europa.eu/health/scientific_committees/consumer_safety/opinions_es 
 
1.4 Properties that drive NM behaviour (fate and toxicity) 
Table 1.1 provides a list of properties that have been identified as relevant for understanding 
fate and effects of NMs. These properties have been identified from the discussions of the 
OECD Working Party on Manufactured Nanomaterials (WPMN) (OECD, 2014g), Member 
States for REACH implementation, the Scientific Committee on Emerging and Newly 
Identified Health Risks (SCENIHR, 2009), the Scientific Committee on Consumer Safety (SSCS, 
2012) as well as the scientific literature. Information requirements for NMs under REACH is 
at the moment not yet finalised: inclusion of relevant properties in REACH submissions is 
under discussion; such properties include crystalline phase, dustiness, crystallite size, zeta 
potential, pore density, radical formation potential, surface chemistry and functionalization, 
specific surface area, dispersability, (photo)catalytic activity, particle size distribution, 
agglomeration/aggregation states (OECD, 2010, 2014g).  
Properties in Table 1.2 have been organised following the scheme proposed by Sellers et al. 
(2015) into chemical identity, particle characteristics, fundamental transport and behaviour, 
reactivity/activity, which is consistent with the properties suggested in ECHA's voluntary 
Practical Guide on grouping NMs for read-across (ECHA, 2017b). In the Sellers proposal, the 
chemical identity group comprises a NM including impurities and surface coating, and 
information on crystal structure. The particle characteristics group may include shape, size 
related properties and porosity. The transport and behaviour group covers properties that 
influence the movement of a NM in the environment or within the organism, and may 
depend on the NM or on the environment, like water solubility, dispersibility, zeta potential. 
The reactivity/activity group comprises properties that are exclusively related to the 
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reactivity of the NM as a whole, like radical formation potential, catalytic activity, protein 
binding properties, hydrolysis, dissociation constant.  
There is a distinction to be made between intrinsic and extrinsic properties. Intrinsic 
properties are characteristics of the material itself that do not account for interactions with 
other components (OECD, 2010a). Extrinsic properties are characteristics resulting from 
interactions occurring at the interface (i.e. boundary) and the surrounding medium (which 
may be an environmental or biological matrix or medium in an experimental test system). 
This distinction is important in the development of in silico models for PC properties. With 
regard to this distinction, physicochemical properties listed in Table 1.2 are to be considered 
as intrinsic properties that aim at defining the nature of the pristine NMs. Any property that 
may be modified by the interaction of the NM with the environment can be considered as an 
extrinsic property, and may be then defined according to the environment (e.g. behaviour 
properties may be considered also extrinsic properties). 
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Table 1.2. Physicochemical properties and their relevance in (eco)toxicological assessment. The table shows the list of parameters that can be 
submitted following the voluntary ECHA Practical Guide, and those that are under discussion by the OECD (WPMN). Physicochemical properties 
that are considered relevant in the literature are also added to the table. 
Category
Term Definition [u.m.] Relevance in (eco)toxicological assessment 
REACH 
requirement or 
OECD 
recommendation 
C
h
e
m
i
c
a
l
 
i
d
e
n
t
i
t
y
 
Chemical 
composition 
This refers to the chemical identity and atomic 
arrangement of the nanomaterial; it shall consider 
also impurities and additives [purity is expressed 
as the percentage of the intended NM present]. 
The type of elements involved in the core 
as well as the form or valence of those 
elements are relevant in toxicology.  
Definition is 
applicable to NMs 
(ECHA, 2014a; 
OECD, 2010). 
Crystal type3 The specific arrangement of a chemical group 
(crystallite) in the three dimensional space. In 
some cases more crystal types of the same NM 
may observed: in this case the relevant 
information is the fraction of the different 
crystalline forms that are present (OECD, 2010). 
This is a recognized indicator of the 
biological impact of NMs (Aitken et al., 
2011; Landsiedel et al., 2010). 
Definition is under 
discussion (OECD, 
2010). 
Crystallite size  Size of the crystal or grain. Important for ensuring comparability 
between tests and for interpreting data 
from the tests. 
Definition is under 
discussion (OECD, 
2010). 
Surface chemistry  Chemical nature, including composition, of the 
outermost layers of the nano-object. 
It allows the recognition of the various 
modifications of the surfaces of 
nanomaterials that will lead to numerous 
potential interactions and will play a key 
role in determining: i) fate in natural 
aqueous systems; ii) colloidal stability 
and iii) exposure (OECD, 2010, 2014g). 
Definition is under 
discussion (OECD, 
2010). 
                                                      
3 Crystalline phase in OECD (2010) 
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Category
Term Definition [u.m.] Relevance in (eco)toxicological assessment 
REACH 
requirement or 
OECD 
recommendation 
 Surface 
functionalization, 
coating  
Functionalization is mainly related to the 
introduction at a surface of chemical groups which 
are intended to subsequently react with other 
species (Rivolo, 2012). Surface modification, 
functionalization and coating are considered in 
RIP-oN 1 (European Commission, EC, & IHCP JRC, 
2011) as synonymous with surface treatment. 
Surface treatment is considered to affect 
environmental fate and health safety of 
NMs (OECD, 2014g). 
Definition is under 
discussion (OECD, 
2010). 
P
a
r
t
i
c
l
e
s
 
c
h
a
r
a
c
t
e
r
i
s
t
i
c
s
 
Basic morphology  NMs with the same composition may have 
different shape (i.e. spheres, rods, tubes, fibres 
and plates), which may be related to different 
physical, chemical, and biological properties. 
Shape is defined by OECD (2010) as the (semi-) 
qualitative geometrical description or 
dimensionless term of the extremities of the 
particle or collections of particles, their 
agglomerates or aggregates, of the material under 
investigation. Recognised shape descriptors are 
sphericity, circularity, aspect ratio, convexity and 
fractal dimension. ISO (2012d) defines three levels 
of detail in describing the shape, described by the 
geometric form of the external boundary of the 
particle and refer to convexity, perimeter, 
circularity at different scale levels (macro-, meso-, 
and micro-shape descriptors, u.m. m/m)4. 
The elongation (or aspect) ratio (together 
with rigidity) is an important determinant 
of the potential health effects of fibrous 
materials, including NMs. 
Considered as 
shape, definition is 
under discussion 
(ECHA, 2012b; 
OECD, 2010). 
                                                      
4 Macrodescriptors are defined from size measurements made on the particle silhouette; mesodescriptors are morphological mathematical descriptors, 
computing robustness and largest concavity index, a concavity tree, providing general insight into the organization of concavities and their complexity and 
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Category
Term Definition [u.m.] Relevance in (eco)toxicological assessment 
REACH 
requirement or 
OECD 
recommendation 
Particle size The physical dimension of the smallest discrete 
form of a substance under specified measurement 
conditions. If a group of particles are of differing 
sizes they may be described by a particle size 
distribution (OECD, 2010). 
Once internalised, particle size may also 
affect the distribution within the body, 
and the toxicity at both the point of entry 
and distally. Size distribution is not a 
static parameter; it may also change 
during the course of (environmental) 
toxicity testing (as well as during the life 
cycle of the material) due to e.g. partial 
dissolution, interaction with test media 
or preferential absorption of smaller 
particles (ECHA, 2017b). 
 
Pore density Pore density is defined measure of the void (i.e. 
'empty') spaces in a material, and is a fraction of 
the volume of voids over the total volume [g/cm3]. 
Pore density has relevance in the fate of 
NMs as it influence their kinetics (i.e. 
sedimentation rate and size distribution 
as suspended material) in different 
media (J. Meesters, Koelmans, Quik, 
Hendriks, & van de Meent, 2014; Antonia 
Praetorius, Scheringer, & Hungerbühler, 
2012). 
Definition is under 
discussion (OECD, 
2010). 
                                                                                                                                                                                                                                                                    
angularity descriptors, fractal dimension, Fourier descriptors, bending energy; microdescriptors determines the roughness of shape boundaries using fractal 
dimension and higher-order Fourier descriptors/coefficients for surface and textural analysis (ISO, 2012d). 
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Category
Term Definition [u.m.] Relevance in (eco)toxicological assessment 
REACH 
requirement or 
OECD 
recommendation 
 Specific surface area 
(SSA) 
SSA is the surface area of the particle SA [m2] per 
unit mass m [g] SSA=SA/m [m2/g] (Wolfgang G. 
Kreyling, Semmler-Behnke, & Chaudhry, 2010). It is 
an intensive property and hence allows expressing 
the information related to the surface area in a 
comparable way, independent on the quantity of 
the available material. The area of the exposed 
surface of a single particle plays an important role 
in influencing the physical and chemical 
interactions of the particle in the media. SCENIHR 
(SCENIHR, 2009) and ECHA (2012b) consider also 
the concept of volume specific surface area (VSSA) 
[m2/cm3] 
 
 
(1) 
Where ρ is material density and V [cm3] is the 
volume of the material. VSSA is proposed as a 
measurement that can be used to distinguish dry 
solid nanostructured material from non-
nanostructured material at VSSA≥60 m2/cm3 
(Wolfgang G. Kreyling et al., 2010). 
Chemical reactions take place at 
surfaces, hence high SSA represents high 
reactivity. SSA is relevant for a number of 
parameters for (eco)toxicological and risk 
assessment. It will dictate the surface 
charge density in cases where 
nanomaterials are surface functionalised. 
This in turn has direct consequences on 
(a) nanomaterial interactions (i.e., 
agglomeration) with other naturally 
occurring particulate matter (i.e., 
contaminant vectors); (b) route of 
exposure as a function of surface ligand-
biological interface (i.e., bioaccumulation 
pathway, bioavailability); and (c) 
mechanisms of toxicity (e.g., dose 
response curves normalised for surface 
area may indicate different results 
compared to results presented on a per 
mass basis). 
Definition is under 
discussion (ECHA, 
2012b; OECD, 
2010). 
F
u
n
d
a
m
e
n
t
a
l
 
t
r
a
n
s
p
o
r
t
/
b
e
h
a
v
i
o
u
r
 
Dispersibility Dispersibility is the degree to which a particulate 
material can be uniformly distributed in another 
material (the dispersing medium or continuous 
phase). A dispersion is a suspension of discrete 
insoluble particles in a fluid, which may falsely 
have the visible appearance of a solution (i.e. the 
It may influence the ability of the NMs to 
reach and enter the cell (OECD, 2010). 
Definition is under 
discussion (OECD, 
2010). 
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Category
Term Definition [u.m.] Relevance in (eco)toxicological assessment 
REACH 
requirement or 
OECD 
recommendation 
product of the conversion of a solid substance to 
liquid form by mixture with a solvent). A dispersion 
of an insoluble material may elicit a different 
response from that anticipated from the classical 
molecular or elemental toxicity expected from the 
chemical composition. Dispersion stability is an 
important parameter to assess in the context of 
sample preparation (Hankin et al., 2011). 
 
Water solubility Water Solubility/Dispersibility refers to the mass 
proportion of a given sample of nanomaterial 
which is held in water solution or as a colloidal 
suspension in water as a function of time or where 
the sample of nanomaterial loses its particulate 
character as it changes from a particle form to a 
molecular form (OECD, 2010).  
[u.m.: µg/L; mg/L; g/L; g/cm³; kg/m³; ppb; vol%] 
 
If a nanomaterial is soluble, it is likely to 
be presented to the in vitro/in vivo test 
system in a molecular or ionic form and 
can be expected to elicit the same 
response as more usual chemical forms 
of the material (with different dissolution 
rate compared to the bulk substance). If 
the nanomaterial under investigation is 
insoluble in biological or environmental 
media then it will be presented to the 
test system in particulate form and might 
elicit a different response from that 
expected based on the chemical 
composition. 
Already required 
in REACH (ECHA, 
2012b; European 
Parliament and 
Council, 2006a).  
Dissolution rate According to experimental evidence, the rate of 
dissolution of soluble materials increases with 
decreasing particle size and differs in different 
media; dissolution rate is relevant as a process 
Dissolution rate is considered in several 
studies as a measure for NMs 
biodurability; it is then related to NMs 
(bio)persistence (K. A. Jensen, 
Not required in 
REACH. 
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Category
Term Definition [u.m.] Relevance in (eco)toxicological assessment 
REACH 
requirement or 
OECD 
recommendation 
when dealing with NMs behaviour (Utembe, 
Potgieter, Stefaniak, & Gulumian, 2015). 
Kembouche, & Nielsen, 2013; Utembe et 
al., 2015) 
Hydrophobicity/ 
Hydrophilicity  
Hydrophobicity refers to the 'water-avoiding' 
behaviour of a nonpolar molecule or group that 
has low affinity for water molecules. 
Hydrophilicity refers to the 'water-liking' behaviour 
of a polar molecule or group that has high affinity 
for water molecules 
Influences protein binding to NM 
(Aggarwal, Hall, McLeland, 
Dobrovolskaia, & McNeil, 2009; 
Landsiedel et al., 2012), and 
characterizes inhibitory activity towards 
various enzymes (Gallegos, Burello, & 
Worth, 2009). Hydrophilicity is one of the 
most relevant descriptors in uptake 
models (V Chandana Epa et al., 2012). 
Not required in 
REACH. 
Dustiness This is the propensity of a material to generate 
airborne dust during its handling. The measure of 
interest is the degree to which a given 
nanomaterial can remain in the air column before 
settling. Interactions of NMs with other common 
airborne particulate matter should be studied. 
It provides a basis for estimating the 
potential for inhalation exposure (Lidén, 
2006). 
 
Definition is under 
discussion (OECD, 
2010). 
Zeta potential 
(surface charge) 
Defined as the charge at the particles interfaces. It 
is a repulsive inter-particle force, because a 
colloidal, charged system is a stable system 
(Fermin & Riley, 2010): therefore, ionization 
enhances the particles stability. In fact, a charged 
surface attracts counter-ions in its vicinity. 
Therefore, when two particles approach each 
other, their diffuse layers will overlap and the 
resultant repulsive force may outweigh the 
attractive Van der Waals attraction, rendering the 
Zeta potential can be related to the 
stability of colloidal dispersions. The zeta 
potential indicates the degree of 
repulsion between adjacent, similarly 
charged particles in dispersion. For 
molecules and particles that are small 
enough, a high zeta potential will confer 
stability, i.e., the solution or dispersion 
will resist aggregation. When the 
potential is low, attraction exceeds 
Definition is under 
discussion (OECD, 
2010). 
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Category
Term Definition [u.m.] Relevance in (eco)toxicological assessment 
REACH 
requirement or 
OECD 
recommendation 
suspension stable [mV]. Van der Waals forces are 
expressed by the Hamaker constant, which is 
related only to the properties of the interacting 
bodies and the medium and consists of the 
summation of intermolecular interactions 
(Hamaker, 1937). This constant could be useful in 
determining the degree of agglomeration and 
sorption (Sellers et al., 2015). 
repulsion and the dispersion will break 
and flocculate. In nanotoxicology, zeta 
potential (surface charge) plays a key 
role in determining the (1) degree of 
colloidal interaction which is itself a 
function of the pH and ionic strength of 
the bulk solution; and (2) bioavailability 
when considering mass transport 
through charged membranes. 
Steric hindrance Repulsion short-range effects rising from surface 
characteristics (e.g. presence of polymers) 
(Elimelech, Gregory, Jia, & Williams, 1995b). 
It influences agglomeration (SCENIHR, 
2010) and protein binding (Landsiedel et 
al., 2012) of NMs. It is considered 
relevant as a property driving toxicity of 
NMs (Tomasz Puzyn et al., 2011a). 
Not required in 
REACH. 
R
e
a
c
t
i
v
i
t
y
 
Protein binding Mechanism of chemical interaction with proteins. 
It can be covalent (irreversible; common with 
electrophilic toxicants such as nonionic and 
cationic electrophiles and radical cations) or non-
covalent (apolar interactions or the formation of 
hydrogen and ionic bonds and is typically involved 
in the interaction of toxicants with targets such as 
membrane receptors, intracellular receptors, ion 
channels, and some enzymes) (Casarett & Doull, 
2008). 
Protein binding results in increased 
stability of NMs (Vandebriel & De Jong, 
2012) and affects biodistribution of NMs 
throughout the body (Aggarwal et al., 
2009). 
Not required in 
REACH. 
Hydrolysis Cleavage of chemical bonds by the addition of 
water. 
Uptake is a modulated by hydrolysis, and 
hence may influence exposure to a 
Already required 
in REACH 
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Category
Term Definition [u.m.] Relevance in (eco)toxicological assessment 
REACH 
requirement or 
OECD 
recommendation 
Catalytic activity  This is the ability of some NMs to speed up  certain 
reaction as a catalyst [mol/(g*s); mol/(g*h)]. 
It causes ionization events leading to free 
radical production (WHO, 2012). 
Definition is under 
discussion (OECD, 
2010). 
Photocatalytic 
activity  
This is the ability of some NMs to speed up a 
certain photoreactions as a catalyst, eventually in 
combination with light (sunlight, ultraviolet light) 
[mol/(g*s); mol/(g*h)].  
It is recognized as a relevant PC property 
in toxicity testing (SCENIHR, 2010). 
Photocatalytic activity may drive 
oxidative stress under UV light (Ken 
Donaldson et al., 2013). 
Definition is under 
discussion (OECD, 
2010). 
Conduction band 
(valence band, band 
gap) 
Energy required to free an electron from its bond 
to an atom [eV]. 
Substances with conduction band in the 
range of cellular membrane redox 
potential (-4.12 to -4.84 eV) are possibly 
causing oxidative stress (Burello & 
Worth, 2011a; Haiyuan Zhang et al., 
2012a). 
Not required in 
REACH and not 
considered in 
OECD 
recommendations. 
Electrophilicity and 
Nucleophilicity 
(acidity and basicity) 
Electrophilicity is the attraction to electrons; 
electrophiles tend to accept electrons. 
Nucleophilicity is the tendency to donate an 
electron pair to an electrophile in a reaction. 
Electrophilicity/Nucleophilicity is related 
to reactivity of NMs (Burello, 2013; 
Albert Poater, Gallegos Saliner, Solà, 
Cavallo, & Worth, 2010) 
Not considered in 
REACH and not 
considered in 
OECD 
recommendations. 
Radical formation 
potential 
This is the ability of a substance to produce 
reactive oxygen species (ROS), including for 
instance superoxide radical O2·, hydrogen 
peroxide H2O2, and hydroxyl radical OH·. 
These ROS compounds exert severe 
cellular damage such as oxidations of 
DNA, proteins or lipids that may cause 
cell death (Rivolo et al., 2012). 
Definition is under 
discussion (OECD, 
2010). 
Redox potential Measure of the tendency of a chemical species to 
acquire electrons and thereby be reduced [mV]. 
Oxidizing substances may interact with 
cells thus altering their redox balance 
and causing oxidative stress (Burello & 
Already required 
in REACH 
(European 
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Category
Term Definition [u.m.] Relevance in (eco)toxicological assessment 
REACH 
requirement or 
OECD 
recommendation 
Worth, 2013). This is related to the 
conduction band. 
Parliament and 
Council, 2006a). 
Dissociation 
constant 
It is the reversible reaction of a substance resulting 
into two or more chemical species, which may be 
ionic; the process may be represented as 
RX↔R+X. he dissociation constant K is expressed 
as the ratio of concentrations of the species on 
either side of the equation at equilibrium: 
 
Where the cation R+ is hydrogen, the substance 
can be considered an acid, and so this constant 
becomes an acid dissociation constant (Ka) (ECHA, 
2014a). 
It is related to protein binding (Vilaseca, 
Dawson, & Franzese, 2013; S.-T. Yang, 
Liu, Wang, & Cao, 2013) and may be 
important for interpreting the 
agglomeration of NMs (Bruinink, Wang, 
& Wick, 2015). 
Already required 
in REACH 
(European 
Parliament and 
Council, 2006a). 
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1.4.1 Theories underlying environmental and biological fate  
The OECD published 118 guidelines for the testing of chemicals, and the WPMN evaluated 
which of these is applicable to NMs (OECD, 2009b). This review concluded that 4 out of 22 
test guidelines for physical chemical properties are applicable to NM. 16 guidelines might be 
applicable under some circumstances, or to some classes of NM. Two guidelines are not 
applicable to NM or, if applicable, provide no useful information.  
Standard methods are needed in order to fulfil the information requirements listed in Table 
1.3. Measurement methods and protocols for providing information listed in the previous 
table are not yet identified, although several projects are developing measurement 
protocols (see Appendixes IV and V). In particular, NanoReg developed several SOPs on 
particle size distribution (Mast & De Temmerman, 2016; Gottardo et al, 2017). 
The OECD WPMN is also aiming at providing test guidance for the determination of PC 
properties for NMs to support the submission of information on substances within IUCLID.  
Table 1.3 lists the methods for relevant PC and environmental fate properties according to 
the OECD WPMN discussions (OECD, 2014b, 2014g). Characteristics that are not reported in 
the OECD guidelines are not listed here. When an OECD guidance is available for the 
identified PC property, its applicability as addressed in OECD (2009b) is reported in a 
dedicated column. When OECD guideline is not available, other relevant guidelines are 
reported (OECD, 2009b, 2014g). 
 
Table 1.3. List of the existing methods supporting the measurement of NM properties  
PC property OECD guideline5 Applicability for 
NMs testing  
ISO standards Other available 
methods 
Dispersion/ 
agglomeration/ 
aggregation 
None available 
(OECD, 2014g) 
- Centrifugal 
liquid 
sedimentation, 
dynamic light 
scattering, 
small- angle x-
ray scattering; 
single-particle 
ICPMS, particle 
tracking analysis 
and field flow 
fractionation; 
TEM and x-ray 
diffraction (ISO, 
2013a) 
- 
                                                      
5  More about OECD’s Test Guidelines Programme, see 
http://www.oecd.org/env/testguidelines.  
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PC property OECD guideline5 Applicability for 
NMs testing  
ISO standards Other available 
methods 
Water solubility 105 Existing 
guidance needs 
to be revised 
(OECD, 2014g) 
- Solubility of 
particles of size 
below 4 mm are 
considered in CEN 
(2002) 
Zeta potential None available 
(OECD, 2014g) 
- Electrophoretic 
and electro-
acoustic 
methods are 
available (ISO, 
2012c, 2013b, 
2102) 
- 
Composition of 
nanomaterial 
None available 
(OECD, 2009b) 
- ISO documents 
are also 
available (ISO, 
2011a, 2011b, 
2011c, 2012a, 
2012b); One is 
specific for NMs 
(ISO, 2011d) 
Bulk: Elemental 
Analysis, ICPMS, 
EDX, EELS, 
dynamic-SIMS, 3D 
– Atom Probe 
(OECD, 2009b).  
Particle size 
distribution – dry 
and in relevant 
media  
110 Might be 
applicable to 
NMs under 
certain 
circumstances 
(OECD, 2009b) 
Many 
techniques are 
available from 
ISO, many of 
them were 
recently revised 
(ISO, 1996, 
2004, 2007a, 
2007b, 2007c, 
2009b, 2010b) 
On TEM analyses 
(ASTM, 2009a, 
2009b, 2010) 
Basic morphology None available 
(OECD, 2009b) 
- SEM and TEM 
(ISO, 2011a, 
2012a, 2012b) 
Specific 
guidelines for 
carbon 
nanotubes (ISO, 
2012a) 
- 
Crystallite type - - - Crystalline phase 
guidance is 
available from 
Japanese 
Industrial 
Standards (JIS, 
2007) 
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PC property OECD guideline5 Applicability for 
NMs testing  
ISO standards Other available 
methods 
Crystallite size  - - Grain size is 
determined via 
SEM and TEM 
(ISO, 2004, 
2012b); a 
guideline is 
available for 
aerosols (ISO, 
2009a) 
Powder XRD, HR-
TEM, Raman 
spectroscopy (JIS, 
2005; OECD, 
2009b) 
 
Surface 
chemistry  
None available 
(OECD, 2014g) 
- Available 
guidelines for 
single walled 
carbon 
nanotubes are 
given by ISO 
(ISO, 2010a, 
2011b); plus 
other guideline 
on other 
methods (ISO, 
2002, 2006b, 
2010c) 
Fourier-transform 
infrared 
spectroscopy, 
time-of-flight 
secondary-ion 
mass 
spectrometry, 
matrix-assisted 
laser desorption 
time-of-flight mass 
spectrometry, 
auger electron 
spectroscopy, XPS, 
electron energy 
loss spectroscopy, 
UV-vis, molecular 
spectroscopy; ICP-
MS, ICP-AAS, LC-
MS, GC-MS, TGA 
(OECD, 2014g) 
Other guidance 
(Stefaniak et al., 
2005) 
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PC property OECD guideline5 Applicability for 
NMs testing  
ISO standards Other available 
methods 
Specific surface 
area (SSA) 
None available 
(OECD, 2014g) 
- BET (ISO, 2010b) Brunauer Emmett 
Teller (BET) 
method and 
transmission 
electron 
microscopy (TEM) 
methods (ISO, 
2003; OECD, 
2009b, 2014g)6; 
small-angle X-ray 
scattering (SAXS) 
Form metal 
powders 
(American Society 
for Testing and 
Materials, 2010) 
Photocatalytic 
activity  
None available 
(OECD, 2014g) 
- - DCFH – 
fluorescence 
based analysis for 
reactive oxygen 
species(possible 
nanoparticle 
interference with 
the assay). 
Colorimetric 
methods (possible 
nanoparticle 
interference with 
the assay).  
Electron spin 
resonance. Quartz 
crystal 
microbalance. 
Gas-phase 
techniques such as 
gas-
chromatography 
Hydrolysis 111 Might be 
applicable to 
NMs under 
certain 
circumstances 
(OECD 2009a) 
- - 
                                                      
6 ISO methods are not defined specifically for NMs. 
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PC property OECD guideline5 Applicability for 
NMs testing  
ISO standards Other available 
methods 
Dustiness - - - Relevant guideline 
on airborne dust 
(not specific to 
NMs) (ASTM, 
1990; CEN, 2006) 
Pore density None available 
(OECD, 2014g) 
- BET (OECD, 
2014g); methods 
are available 
from ISO but 
these are not 
specific to NMs 
(ISO, 2005, 
2006a, 2007d) 
- 
Octanol-water 
partition 
coefficient, 
where relevant  
107, 117, 123 Non suitable for 
NMs (exception: 
fullerene) 
 Other kinetics 
shall be 
considered for 
NMs; methods are 
not sufficiently 
developed to 
become 
standardised 
(OECD, 2014g) 
Hydrophobicity  116 Applicable to 
NMs (OECD, 
2009b) 
- Hyrophobicity 
characterisation 
method developed 
by JRC (Desmet et 
al, 2017) 
 
1.5 Understanding the fate and toxicity of NMs 
Exposure of humans and the environment to NMs can occur throughout their life cycle, from 
their production, manufacture (incorporation into products), use and disposal. The different 
phases in life cycle may affect NM properties and hence their interactions with 
environmental and biological media (Gottschalk et al.) 
Once humans are exposed to NMs, the particles can travel throughout the body and deposit 
in target organs, where they may penetrate cell membranes and even enter organelles such 
as mitochondria. They can therefore affect biology at different levels (Günter Oberdörster, 
Oberdörster, & Oberdörster, 2005), which may result in injurious responses. 
This section is aimed at: 1) introducing well-established theories that have been applied in 
investigating the fate of NMs in environmental and biological systems; 2) summarising the 
available information on the kinetics of NMs; and 3) reporting evidence on their 
toxicodynamics.  
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1.5.1 Theories underlying environmental and biological fate  
The fate of NMs in environmental media and biological systems is partly determined by 
particle-particle and particle-surface7 interactions leading to agglomeration/aggregation 
processes that may result in colloidal instability and gravitational sedimentation. These 
processes are relevant in both aqueous and gaseous compartments. 
Agglomeration and aggregation kinetics in fluid media 
The behaviour of NMs in fluids is dependent on particle-specific properties, the chemistry of 
the surrounding medium (e.g. pH, ionic strength, ionic composition, presence of proteins or 
colloids) and hydrodynamic conditions (Ilinskaya & Dobrovolskaia, 2013a, 2013b; Petosa, 
Jaisi, Quevedo, Elimelech, Tufenkji, et al., 2010).  
The transport of NMs in fluids follows Brownian diffusion, a random and chaotic motion of 
particles resulting in collisions between the particles and fluid molecules surrounding them. 
The trajectory of a given particle is of self-similar nature, meaning that any magnified 
portion of the trajectory would look qualitatively similar to the original one (Elimelech, 
Gregory, Jia, & Williams, 1995a).  
Depending on the environmental conditions and on intrinsic PC properties, NMs can 
agglomerate or aggregate in fluid media (see Table 0.1 for definitions). Agglomerates can de-
agglomerate in presence of stabilizing agents such as proteins (Rivolo et al., 2012). Changes 
in particle size resulting from agglomeration or aggregation may influence the interactions of 
NMs with natural colloids (e.g. humic and fulvic acids) and macromolecules (e.g. proteins, 
peptides) (Klaine et al., 2008), as well as their reactivity and toxicity. Although the processes 
of agglomeration and aggregation are relevant in predicting the fate of NMs, there are no 
theoretical models capable of distinguishing between the two processes. Ongoing research 
is focusing on identifying which environmental parameters influence particle coalescence 
(Yanjie Li et al., 2015; Joris T K Quik et al., 2012) and on the parameters that can be used to 
model and predict the fate of NMs (Cornelis, Pang, Doolette, Kirby, & McLaughlin, 2013; J. T. 
K. Quik, Velzeboer, Wouterse, Koelmans, & van de Meent, 2014). In these models,  
aggregate formation is assumed to be irreversible, and aggregation and agglomeration 
processes are not distinguished (Elimelech, Gregory, Jia, & Williams, 1995c; Pippa, 
Dokoumetzidis, Demetzos, & Macheras, 2013).  
In the following paragraphs the main theories considered in modelling 
aggregation/agglomeration processes are presented. 
 
DLVO theory  
The classical DLVO (Derjaguin, Landau, Verwey and Overbeek) theory of colloidal stability 
has been proposed to address the kinetics of agglomeration processes. DVLO theory 
combines the opposing effects of the van der Waals attractive force and the electrostatic 
repulsive force due to the so called 'double layer' of counterions, i.e. zeta potential for NMs. 
The repulsive force depends on the double layer potential and thickness, the particle radius 
                                                      
7 A surface is conceptualized by an infinite flat plate and is relevant in studying the 
deposition of NMs (S. Lin & Wiesner, 2012). In some instances a natural colloid interacting 
with a NM is assumed as a surface because of the big difference in dimension (J. Meesters et 
al., 2014). 
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and the dielectric constant of the medium. The potential energy curve as a function of the 
separation distance between particles has an energy barrier and two minima, as shown in 
Figure 1.2.  
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Figure 1.2. Potential energy curve for the interaction between colloidal particles. The interaction 
depends on a balance between attractive van der Waals forces and repulsive electrostatic forces. 
General rules can be used to determine colloidal stability. For example, the thicker the 
double layer around the particles, the greater the repulsion between them. Repulsive forces 
between particles decrease when the pH of the medium is close to the isoelectric point (IEP) 
value of the particle. An increased concentration of an inert electrolyte causes the electrical 
double layer potential to decrease, and the same effect is observed when an organic, water 
miscible, solvent, is present, which causes the dielectric constant of the medium to 
decrease. Repulsive forces between particles can be caused by adsorption of polymers, 
proteins, non-ionic detergents and polyelectrolytes. The intentional coating of particles with 
polymers causes steric stabilization, although partial coverage can lead to agglomeration. 
Van der Waals forces are expressed by the Hamaker constant, which is related only to the 
properties of the interacting bodies and the medium and consists of the summation of 
intermolecular interactions (Hamaker, 1937). In aqueous environments, when particles 
approach each other (coalescence) or a surface (deposition), the overlap of the diffuse 
electric double layers results in electrostatic double layer interactions.  
Non-DLVO interactions that are relevant for the agglomeration/aggregation and deposition 
of NMs in an aqueous environment include steric interactions, magnetic forces (for iron-
based NMs), and hydration forces (Petosa, Jaisi, Quevedo, Elimelech, Tufenkji, et al., 2010). 
Expressions describing the extent of steric forces have been derived for particles with 
adsorbed layers of polymers or surfactants that might lead to steric repulsion. Magnetic 
materials exhibit dipole behaviour that overcomes the particle-particle interactions. Finally, 
particles that carry hydrophilic material such as proteins at their surfaces may attract water 
molecules and hence have a hydrated surface. Such particles will exert a repulsive 
 31 
 
interaction thus influencing NMs stability (Healy, Homola, James, & Hunter, 1978). 
Parameters for calculation of non-DLVO interactions are not available and this is the reason 
why this theory is not extensively applied (Haiyuan Zhang et al., 2012a). 
DLVO is taken into consideration in environmental fate models in absence of measurements 
for calculating the attachment efficiency α (J. Meesters et al., 2014). According to the DLVO 
theory, the total interaction energy between suspended particles can be evaluated as the 
sum of the attractive van der Waals and the repulsive electrical double-layer energies. The 
aggregation efficiency α is defined as (Equation 2): 
 
 
(2) 
Where Vmax(i,j) is the total interaction energy between particles i and j; kb is the Boltzmann 
constant; T is the temperature; kDebye is a parameter related to the length of the double layer 
(Pashley & Karaman, 2005), ri is the radius of the particle i. Other authors have proposed 
different calculations of α, for instance by taking into consideration the relevance of both 
interaction energy and Brownian diffusion in the transport of NMs (Wen Zhang, Crittenden, 
Li, & Chen, 2012; Wen Zhang, Rittmann, & Chen, 2011). The DLVO theory is also taken into 
consideration in biological environments in predicting protein binding to NMs (Vilanova, 
Franzese, & Barnabei, 2014), where it is applied in simulating NM-protein interactions8.  
 
Smoluchowski-Friedlander theory  
Smoluchowski (1917) and Friedlander (1977) calculated the kinetics of spherical dispersed 
particles in fluids, and this theory is sometimes considered to represent the kinetics involved 
in aggregation and coagulation processes such as flocculation and Ostwald ripening. 
Simplified versions of the Smoluchowski equation are considered for instance in the 
calculation of aggregation constants (Jiang, Oberdörster, & Biswas, 2008; J. T. K. Quik et al., 
2014), as a theory at the base of model development (Arvidsson, Molander, Sandén, & 
Hassellöv, 2011). 
This approach considers three types of kinetic process: Brownian diffusion (perikinetic 
aggregation, due only to particle diffusion, equation 3), fluid motion (orthokinetic 
aggregation, that happens in presence of flow, equation 4), and differential settling 
(equation 5) (Elimelech et al., 1995c):  
 
 
(3) 
 
 
(4) 
 
 
(5) 
 
                                                      
8 The software is available online at http://ovilanova.github.io/BUBBLES/ and is an output of 
the NanoTranskinetic FP7 project. Publications are not available yet. 
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Where kij are the different collision rate constants of particles (or aggregates) i and j, k is the 
Boltzmann constant, T is the absolute temperature, ai,aj are the particle radii, µ is the 
viscosity of the fluid, G is the shear rate, g is the acceleration due to gravity, ρ is the density 
of the fluid and ρs is the density of the particle. The diffusion coefficient of a spherical 
particle undergoing Brownian motion is expressed by the Einstein Stokes equation (Equation 
6), from which Smoluchowski derived the definition for the perikinetic rate constant 
(Equation 3): 
 
 
 
(6) 
 
Assuming each collision is effective in forming an aggregate, it is possible to write the rate of 
change of concentration of aggregates as equation 7:  
 
 
(7) 
Where the first term on the right-hand side represents the rate of formation of k-fold9 
aggregates by collision of any pair of aggregates, i and j, such that i+j=k. The second term 
accounts for the loss of k-fold aggregates by aggregation with any other particles or 
aggregates. The terms kij and kik are the appropriate rate constants (equations 3 to 5), ni and 
nj are number concentrations of different aggregates - ni particles of size i, nj particles of size 
j. 
These equations have been combined in several applications aimed at studying the 
behaviour of NMs in environmental media (Arvidsson, Molander, Sandén, et al., 2011; 
Buffle, Wilkinson, Stoll, Filella, & Zhang, 1998; Petosa, Jaisi, Quevedo, Elimelech, Tufenkji, et 
al., 2010; J. T. K. Quik et al., 2014) and in human exposure (EC, 2012b). For instance, 
Arvidsson et al. apply Equation 7 in defining an environmental fate kinetic model where the 
number of particles of k-fold aggregates varies in time as a function of aggregation 
efficiencies10 αi,j (see definition in Table 1.3), adding a term for sedimentation and one term 
for advection in the system. In the field of human exposure this equation was applied in the 
ENPRA EU FP7 project for the estimation of coagulation kinetics of particles in the aerosol, 
where particles of any size can coagulate to form aggregates (EC, 2012b). 
Considering the low environmental concentrations of NMs and the corresponding lower 
probability of interaction of two NMs in real fluids, scientists in the field identified 
heteroagglomeration/aggregation rather than homoagglomeration as a relevant process to 
                                                      
9 Equations are defined assuming an initial dispersion of identical particles that after a period 
during which aggregation occurs, contains aggregates of various sizes and different 
concentrations: ni particles of size i, etc. where ni refers to the number concentrations of 
different aggregates and 'size' implies the number of primary particles comprising the 
aggregate; we can speak of 'i-fold' and 'j-fold' aggregates (Elimelech et al., 1995c) 
10 Arvidsson et al. (2011) refers to αi,j as collision efficiency; since it is defined as irreversible 
collision, it corresponds to aggregation efficieny (Elimelech et al., 1995c) 
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be considered when addressing the environmental fate and transport of NMs (J. Meesters et 
al., 2014), but the inherent challenges in the prediction are still high as there is no clear 
measurement technique nor recognised protocol for the measurement of attachment 
efficiencies that is so far only possible though the application of semi-empirical models (Wen 
Zhang et al., 2012).  
Following these approaches, and in order to express the kinetics of interactions of different 
nature, different authors defined homo- and hetero- attachment efficiencies αhomo and 
αhetero (definitions in Table 1.4) (Arvidsson, Molander, Sandén, et al., 2011; J. Meesters et al., 
2014; Antonia Praetorius, Scheringer, & Hungerbühler, 2012).  
 
Table 1.4. Relevant parameters taken into account by multimedia modelling (MMM) 
approaches. The table reports definitions of the identified parameters that are used as input 
values in MMMs.  
Parameter relevant for 
environmental fate models 
Definition
Collision (or attachment, or 
aggregation) efficiency, also 
referred to as 'sticking 
probability' or 'stickiness 
coefficient', α 
It is defined as the fraction of collisions that are effective in 
agglomeration in Elimelech et al. (Elimelech et al., 1995c). It is 
recalled by Praetorius et al. (Antonia Praetorius, Scheringer, & 
Hungerbühler, 2012) and by Quik et al. (J. T. K. Quik et al., 2014) 
as attachment efficiency. If there is strong repulsion between 
particles then practically no collision gives an aggregate and α=0. 
When there is no significant net repulsion or when there is an 
attraction between particles, then the collision efficiency can 
approach unity. Zhang et al. (Wen Zhang et al., 2012) reports that 
aggregation kinetics of various ENMs have been extensively 
studied using attachment efficiency (α), commonly determined by 
normalizing the hydrodynamic size growth rate in initial 
aggregation curves to the growth rate under the favourable (or 
fast) aggregation condition in which the ionic strength is equal to 
or greater than the critical coagulation concentration. 
Homo- and Hetero-
agglomeration / aggregation 
rate constants (also defined as 
coagulation or flocculation rate 
constants according to 
Elimelech et al. 1995b). 
It is the rate constant governing agglomeration/aggregation 
processes in kinetic models (Arvidsson, Molander, Sandén, et al., 
2011). The homo-agglomeration rate constant is referred to as 
the interactions between NMs of the same type and is defined as 
khom-agg=αhom kcolli,j where αhom is attachment efficiency for homo-
agglomeration and kcolli,j is the collision rate constant. Hetero-
agglomeration/aggregation is the interaction of natural colloids or 
of suspended particulate matter with ENMs. Praetorius et al. 
(Antonia Praetorius, Scheringer, & Hungerbühler, 2012) defines it 
as khet-agg=αhet∙kcolli,j where αhet is the attachment (or collision) 
efficiency for hetero-agglomeration.  
Collision rate constant for 
particles of type i and j 
It depends on factors such as particle size and transport 
mechanism. It is usual to assume that the collision rate is 
independent of colloid interactions and depends only on particle 
transport (see equations 3-5). 
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Brownian motion applies also in the gas medium and diffusion is considered the main 
mechanism for collision of NM particulates in aerosols. Reflecting this, some authors have 
defined the polydisperse coagulation coefficient as a function of particle size and diffusivity 
in air (J. Meesters et al., 2014). Polydisperse particles are particles of different sizes (i.e. 
particles and their agglomerates or aggregates).  
Agglomeration kinetics are also taken into account in the kinetics of NMs in in vitro systems, 
where the process is considered to be affected by NM concentration, surface chemistry and 
zeta potential (Teeguarden, Hinderliter, Orr, Thrall, & Pounds, 2007), where the concepts of 
gravitational settling and diffusion are also taken into account.  
 
Fractal approaches  
The Einstein Stokes equation (6) is also applied in the analytical technique of Dynamic Light 
Scattering (DLS) assuming well-dispersed primary spherical particles (Landsiedel et al., 2010). 
When agglomerates or aggregates are formed, their loose packing can be accounted for by 
considering the aggregate/agglomerate fractal dimension (Wendel Wohlleben, 2012).  
The term 'fractal' comes from the Latin adjective fractus, that means 'to break', intended as 
creating irregular fragments (Mandelbrot, 1982). Fractal geometry is an extension of 
conventional Euclidean geometry that allows size-dependent measures to change in a non-
integer or fractional way when the scale changes. This characteristic can be described by 
assigning a fractional number – a fractal dimension – to the dimension of the object. The 
relationship between the mass M of an agglomerate/aggregate and its size L can be 
expressed in terms of a fractal dimension: 
  (8) 
Where M is the mass of the particles L is a linear measure of size11 and df is the mass fractal 
dimension (Elimelech et al., 1995c). Aggregates and agglomerates are considered fractal 
objects with fractal dimension df < 3. When equation 8 is valid at different scales, then 
aggregates have a self-similar structure, independent of the scale of observation. 
Fractal approaches have been applied so far in a series of studies that have demonstrated 
that scale invariance is a common characteristic of biological systems, ranging from tissues 
to cultured cells, nucleus and chromatin (Metze, 2013; Moreno et al., 2011). In colloidal 
chemistry, fractal distribution is assumed in diffusion-limited agglomeration leading to 
fractal morphology characterised by a df ≈2.1 (M. Y. Lin et al., 1990). Being fractal, the 
structure of the colloidal aggregates can be studied in more detail in terms of the 
relationship of the cluster structure and its aggregation kinetics.  
Fractal dimension df is mentioned in the ECHA guidance on information requirements and 
chemical safety assessment regulatory requirements (Appendix R7-1) in relation to the 
definition of NM shape (ECHA, 2012b). It is also considered as a structural descriptor in QSAR 
applications (T. Le, Epa, Burden, & Winkler, 2012) as well as environmental fate models 
(Arvidsson, Molander, Sandén, et al., 2011; Haoyang Haven Liu & Cohen, 2014b; Antonia 
                                                      
11 L is a measure of length of a particle or aggregate/agglomerate. It may be the gyration 
radius of the aggregate or the largest diameter of an irregular aggregate.  
 35 
 
Praetorius, Scheringer, & Hungerbühler, 2012) where it is used as a rough estimate of the 
density of the aggregates . 
 
1.5.2 Human kinetics  
Pre-absorption processes 
Human biokinetics/toxicokinetics/pharmacokinetics (all synonymous but from now on 
named toxicokinetics or TK) is the science that studies the concentration-time course of a 
chemical substance in blood, tissues and excreta. It is dependent on the rates and extents of 
absorption, distribution, metabolism and excretion (ADME). Distribution, metabolism and 
excretion together are sometimes called 'disposition' where metabolism and excretion may 
be lumped to the term 'elimination'.  
TK for classical substances starts with absorption. Absorption is usually defined as the 
passage across an outer lining (membrane) such as the gastrointestinal (GI) tract epithelium, 
the skin or the epithelium covering the airways. For soluble chemicals, the rate of absorption 
is not considered to be limited by the dissolution process. Thus absorption is considered to 
occur directly from the mucus layer (produced by mucous membranes) in which the 
substance is dissolved, from the GI fluid, or from a very thin aqueous layer covering the skin.  
For NMs, the situation may be different. Some NMs are relatively soluble and once 
dissolved, the resulting ions behave like the soluble chemicals. Other NMs are poorly soluble 
but may still undergo various kinds of transformation (e.g. change in speciation and/or 
attachment of organic molecules (Schultz et al., 2014) h taken from a paper on aquatic and 
terrestrial organisms in the environment (C. Schultz et al., 2014). This may occur in humans 
following airborne exposure that results in deposition in the aqueous lung lining phase, oral 
exposure that might result in release from the food matrix in the aqueous contents of the GI 
tract or dermal exposure that might result in migration a consumer product or direct 
deposition (following airborne exposure or skin contact with contaminated surfaces in 
occupational settings) towards the thin aqueous layer on the epidermis.  
The above implies that 'pre-absorption' processes can be influential on the systemic 
bioavailability of NMs (the amount that becomes available in the systemic circulation 
relative to the total exposure). The low or absence of solubility implies that there is 'time' for 
other processes: to occur; for example, local clearance (i.e. removal) may occur at the same 
time and leave less NM for absorption. In other words, unlike soluble chemicals, NMs can be 
cleared to a varying extent already before absorption. 
 
Inhalation exposure. Considering the inhalation pathway, it is recognised that particles 
smaller than 10 µm can enter the lung. Particle deposition in the lung depends on particle 
size, density, and hygroscopicity (ability of a substance to attract and hold water molecules 
from the surrounding environment), and is influenced by the local anatomy and airflow as 
reviewed recently by Braakhuis et al. (Braakhuis, Park, Gosens, De Jong, & Cassee, 2014). 
They report that NMs with diameters in the range 10-100 nm enter preferentially the 
alveolar areas. For particles in the mentioned diameter range, the deposition of NMs is 
mainly governed by diffusion of the NMs in the inhaled air (Brownian motion) and the 
density is less relevant; whereas for particles (or agglomerates) larger than 100 nm diffusion 
is less likely but the density more and more is determining the deposition. Probably, shape 
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and the extent of absorption contribute as well. Once deposited in the lung, (partially) 
soluble NMs dissolve (partially) in the lining fluid (mucus layer) of the epithelium where inert 
NMs might form non-dissolved but colloidal suspensions. Local clearance from the airways 
occurs as macrophages transport non-dissolved NMs (single and agglomerated but still 
relatively small NMs) by mucociliary transport up to the laryngopharynx (W. Yang, Peters, & 
Williams, 2008). This can be followed by swallowing after which absorption in the GIT may 
occur via the so-called 'mucociliary escalator'. This is the transport by macrophages from the 
lower lung compartments 'upwards' to the bronchioles where it can be followed by coughing 
and swallowing. As an example, for agglomerates of 7 and 20 nm gold nanoparticles, 
macrophage mediated escalation followed by fecal excretion is the major pathway of 
clearing the inhaled NPs from the lungs in rat (Balasubramanian et al., 2013).  
Local clearance may also result from the solubility of the NM, as suggested by Konduru et al. 
(2014) in a study on the biokinetics and effects of barium sulfate nanoparticles following 
inhalation and instillation in rats. Pulmonary exposure to instilled BaSO4 NPs caused dose-
dependent lung injury and inflammation. Four-week and 13-week inhalation exposures to a 
high concentration (50 mg/m3) of BaSO4 NPs elicited minimal pulmonary response and no 
systemic effects. Instilled and inhaled BaSO4 NPs were cleared quickly yet resulted in higher 
tissue retention than when ingested. Injected BaSO4 NPs localized in the reticuloendothelial 
organs and redistributed to the bone over time. BaSO4 NP exhibited lower toxicity and 
biopersistence in the lungs compared to other poorly soluble NPs such as CeO2 and TiO2. 
Based on these observatiosn, particle dissolution was regarded as a likely mechanism. 
Oral exposure. NMs can reach the GI tract via intake of food or water, or accidental 
ingestion, or following inhalation and clearance by the mucociliary escalator. Once ingested, 
NMs face different environments while passing through the GI tract. An important factor is 
the pH value as it affects the net surface charge of the NM (Burello, 2013). In the stomach, it 
ranges from 1.5-2.0 in the fasting state and might rise up to 7.0 after ingestion of a meal. 
Upon increasing motility of the stomach, the contents are transported to the small intestine, 
where pancreatic bicarbonate secretion leads to neutralisation of the chyme to a pH ranging 
from 6.4 to 7.5, depending on the intestinal section. The surface area of the small intestine is 
amplified immensely towards the more distal part, due to the presence of crypts (the crypts 
of Lieberkühn) and projections (microvilli), thereby facilitating nutrient absorption 
(altogether, the intestine features a surface area of 200-300 m2). In addition to the wide pH 
range a NM has to face while passing the GI tract, a series of proteins is secreted, such as 
mucins, lactoferrin, albumin and other factors which are capable of mineral chelation. These 
proteins have the potential to influence the absorption of a NM by affecting corona 
formation, solubility, agglomeration and aggregation.  
Dermal exposure. Personal care products such as sun screens may contain nano-TiO2 or 
nano-ZnO, due to their efficiency in filtering UV light and their transparency (Nohynek & 
Dufour, 2012). 
 
Absorption 
NMs may enter the body via different routes, including inhalation, ingestion and penetration 
of the skin).  
Upon inhalation exposure. Soluble NMs that dissolve in the lining fluid of the lung 
epithelium can be transferred to the blood and distributed to the whole body (Günter 
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Oberdörster et al., 2005). Solubility (rate and extent of dissolution) depends on chemical 
composition, size, coating, stability and on the biological environment (Braakhuis et al., 
2014). In the respiratory tract, less soluble NMs may be absorbed via cell-mediated active 
translocation from the site of deposition through the lung epithelium to interstitial sites. 
From there NMs may be directed to the local lymph nodes and as lymph nodes are drained 
by blood they may ultimately reach the systemic blood circulation. Uptake from the site of 
deposition into systemic blood may also happen directly by crossing the lung barrier in the 
alveoli (Borm et al., 2006). Once less soluble NMs are deposited in the alveoli, there is a 
competition between alveolar macrophages and lung endocytes for cellular uptake. Cellular 
uptake by alveolar macrophages may result in local clearance via the mucociliary transport 
before absorption to the systemic circulation can occur (as mentioned above). Once taken 
up by endocytes, cell-mediated transport across the epithelial membrane results in 
absorption.  
Upon oral exposure. The level of NM uptake within the GI tract appears to be relatively low, 
albeit dependent on properties such as size, surface structure, chemical composition and 
charge (Landsiedel et al., 2012). Various uptake routes are relevant for various size 
distributions: endocytosis through 'regular' epithelial cells, uptake by M-cells (phagocytising 
enterocytes in the Peyer’s Patches) and possibly also persorption (via gaps at the villous tip 
when enterocytes are lost to the gut lumen) and  paracellular uptake (Powell, Faria, Thomas-
McKay, & Pele, 2010; Stern & McNeil, 2008). Interspecies differences occur, for example 
because there are more M-cells in rodents compared to humans (Hagens, Oomen, de Jong, 
Cassee, & Sips, 2007).  
Upon dermal exposure.  The number of studies on skin penetration of NMs is limited. When  
Zn was applied topically as labelled ZnO-nano (Osmond-McLeod et al., 2014), most of 
healthy and intact skin surface area seemed impermeable to the NM. Only the hair follicles 
and the openings of the sweat glands be available for some particle penetration. Also, the 
effect of damaged skin needs further investigation (EASAC & JRC, 2011). Furthermore, most 
studies seem to be performed under static conditions where flexing of the skin during 
exposure might enhance penetration (Günter Oberdörster et al., 2005).  
The SCCS has evaluated the dermal penetration potential of several NM ingredients in 
cosmetics, including TiO2 (SCCS/1516/13 and SCCS/1539/14), ZnO (SCCS/1489/12 and 
SCCS/1518/13) and Carbon Black (SCCS/1515/13). In its Opinion on TiO2 (nano form)” the 
SCCS concluded: “From the limited relevant information provided in the submission, and the 
information from open literature, the SCCS considers that TiO2 nanomaterials in a sunscreen 
formulation are unlikely to lead to: systemic exposure to nanoparticles through human skin 
to reach viable cells of the epidermis, dermis, or other organs.” (SCCS/1539/14). However, 
the SCCS also state that: “Although there is no conclusive evidence at present to indicate 
penetration of TiO2 nanoparticles through the skin to viable cells of the epidermis, a number 
of studies have shown that they can penetrate into the outer layers of the stratum corneum, 
and can also enter hair follicles and sweat glands.” For ZnO NPs the SCCS stated that there is 
no indication for dermal penetration of ZnO NPs based on the available scientific literature. 
However, a very small proportion of Zn ions that are released from the ZnO NPs may be 
available for systemic exposure after dermal application (SCCS/1489/12). The SCCS also 
found an “overall lack of dermal absorption of carbon black nanoparticles“ (SCCS/1515/13). 
A study funded by the Danish EPA used in vitro (EpiDermTM) and in vivo (mouse, human skin 
graft) models to investigate whether the size or surface coating of TiO2 NPs and ZnO NPs has 
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an effect on the dermal penetration/absorption of the nanoparticles (DK EPA, 2015). Based 
on their results, it was concluded that “dermal penetration of TiO2 and ZnO NPs did not 
occur at or above the limit of detection of the used experimental methods. Should 
absorption of TiO2 and ZnO nanoparticles occur at levels below the detection limit of the 
assays used herein, the systemic dose would be very small (far lower than the doses used in 
the studies discussed above) and so highly unlikely to cause systemic toxicity based on 
toxicological evidence in rodents.”  
 
Distribution 
Once systemically available (following absorption), poorly soluble NMs typically distribute 
via the systemic circulation or within phagocytising cells via the lymph drainage to various 
parts of the body. Distribution via blood is followed by rapid uptake by organs and tissues 
containing significant phagocytising capacity. Thus distribution is mainly to the liver and 
spleen although distribution to heart, kidneys and immune-modulating organs has been 
reported as well (Landsiedel et al., 2012; Günter Oberdörster et al., 2005; van Kesteren et 
al., 2014). General characteristics such as rate of dissolution, surface treatment, chemical 
composition, shape, agglomeration, aggregation all may have an impact on distribution 
(where and how much). In whatever tissue (including blood), NMs can bind with different 
affinities to biological targets such as peptides, proteins, lipids and DNA to form a corona 
(Iseult Lynch, Feitshans, & Kendall, 2015). NMs are reported to be able to distribute to the 
central nervous system via sensory neurons in the nose (Oberdörster et al., 2005). A recent 
paper argues that nanomaterials have the right size and shape for interacting with transport 
proteins such as apolipoproteins, offering them access to all cells via the low-density 
lipoprotein receptor (Iseult Lynch et al., 2015). 
 
Metabolism  / Dissolution / Transformation / Bio-Nano interaction 
Metabolism, defined as the enzyme-mediated conversion from one chemical species to 
another (a metabolite), is probably not relevant for NMs, not least because they are 
generally too large to fit into the active site of the well-known biotransformation enzymes. 
However, some abiotic oxidation may occur at the outer surface of NMs. Two other 
transformation processes are more relevant for NMs: dissolution into ions, and corona 
formation through bio-nano interactions (Iseult Lynch et al., 2015). These processes will 
depend on the physicochemical characteristics of the NM as well as those of the 
environment (e.g. pH, the presence of salts and proteins). 
Once the NM is exposed to a protein rich environment, a protein corona is formed. This is 
the biomolecule coating that forms around nanoparticles upon contact with biological 
molecules. It is formed because of the high surface reactivity of the NMs resulting in 
adsorption of various molecules (mainly proteins). Desorption also occurs at different time 
scales depending on the binding energy of the nanoparticle-protein interaction. 
Characteristic binding forces are van der Waals interactions, hydrogen bonds, hydrophobic 
interactions, electrostatic interactions and π - π stacking (Wolfram et al., 2014). There is 
evidence that the corona is stratified into two layers, one of which is 'soft' (loosely 
associated macromolecules, characterised by short exchange times) and the other 'hard' 
(tightly bound, characterised by long exchange times) (Monopoli et al., 2011; Monopoli, 
Aberg, Salvati, & Dawson, 2012).  
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The corona is continuously exchanging with the proteins in the environment and its 
composition varies in time and depending on the environmental conditions (Cedervall et al., 
2007). The corona is stable for a longer time than the typical time scale of cellular uptake, 
thus acting as cell 'mediator' in the interaction of the NM with cell receptors (F. Wang et al., 
2013). Wang also found that after entering the cell, the nanoparticle and the corona reach 
the lysosomes where peptides are degraded by lysosomal enzymes. Subsequently, 
membrane damage may occur following release of the lysosomal content into the cytosol 
and subsequent cell death due to apoptosis.  
Qualitatively, the composition of the protein corona on a given NM, at a given time, depends 
on the concentration and type of the proteins in the surrounding medium (e.g. plasma) and 
their affinity for the NM surface. It is generally assumed that proteins with high 
concentrations in plasma and high association rates will initially cover the surface of the 
NMs. Over time, however, these proteins will dissociate and will be replaced by proteins of 
lower concentration, slower exchange rates but higher affinities (Vroman & Adams, 1969). 
Therefore, as NMs distribute from the blood to various locations or between different cell 
compartments, the evolution of the protein corona will change the surface properties of the 
NMs, changing also their toxicological profiles (Burello, 2013; Iseult Lynch et al., 2015). 
The plasma membrane is a highly selective and effective barrier that limits the entry and exit 
of large macromolecular substances and materials. Neverthless, NMs are capable of 
enntering cells, either through one of the several endocytic pathways, or by passive 
penetration of the plasma membrane. Folloing endocytosis, NMS are enclosed within the 
early endocytic vesicles and are thus not directly carried into the cytosol. In contrast, the 
nanomaterials internalized via membrane penetration enter the cytoplasm directly. The 
term ‘endocytosis’ can be broadly divided into pinocytosis (“cell drinking”) and phagocytosis 
(“cell eating”). Pinocytosis is commonly involved in the internalization of fluids and 
molecules by small vesicles, whereas phagocytosis is the process by which the cells such as 
monocytes/macrophages, neutrophils and dendritic cells engulf large particulate matter and 
are form intracellular phagosomes. The mechanisms of cellular uptake by endocytosis have 
been reviewed elsewhere (Salatin and Khosroushahi, 2017). 
 
Excretion  
Excretion via the usual routes (biliary, urinary, via mammal glands, via saliva) is generally 
unknown. The few studies available, however, suggest that excretion is very slow. The longer 
the half-life, the longer (and more expensive) the study needed for a reliable assessment of 
the rate of excretion. This is however highly relevant information, since the longer the half-
life, the higher the risk for bioaccumulation (Savolainen et al., 2013). 
Generally, the largest proportion of ingested NMs in food appears to be excreted directly via 
the feces, the excretion rate is usually above 90% (Hillery, Jan, & Florence, 1994; Landsiedel 
et al., 2012; van Kesteren et al., 2014). Only upon intravenous administration, limited biliary 
secretion into the faeces was found for polystyrene NMs (Landsiedel et al., 2012). 
For very small quantum dots (up to approximately 20 nm which is dependent on the coating) 
as well as for carbon nanotubes, urinary excretion seems relevant (Landsiedel et al., 2012).  
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Elimination (sum of solubilisation and excretion) 
Once absorbed and phagocytised, insoluble NMs are eliminated (cleared) from the body to a 
minor extent. For many NMs, the whole-body elimination half-lives are significantly longer 
than the absorption half-lives, which means that the rate of appearance in the body is larger 
than the rate of disappearance. Persistency is an early indication of accumulation upon 
repeated exposure. As far as the authors are aware, however, no studies have been 
reported that investigate the time-course of tissue concentrations of NMs upon repeated 
exposure. What has been investigated is the time-course after a single exposure or after the 
last exposure in recovery studies. This has been recognised as a data gap and need for 
further investigation in the EU (Savolainen et al., 2013). The results of a recent preliminary 
risk assessment based on computer modelling of human intake and clearance of nano silica 
showed that the concentration of Si in the liver is expected to keep on increasing for about 2 
years (more than 500 days) before a steady-state is reached between uptake and 
elimination (van Kesteren et al., 2014).   
 
1.5.3 Toxicodynamics  
Once a NM reaches an organ or a cell following exposure, it may exert different toxicological 
effects (Alarifi et al., 2013; E.-J. Park et al., 2008; Vandebriel & De Jong, 2012).  
NMs have been implicated in a range of cellular interactions that may result in cytotoxicity 
and other cellular responses (Lai, 2012). These include: 1) interaction with the plasma 
membrane that physically disrupts membrane processes (ion transport, signal transduction) 
and may lead to cell death; 2) biochemical interaction with membrane receptors, leading to 
activation of signal transduction pathways; 3) uptake into the cell via endocytosis with 
subsequent effects on intracellular macromolecules and organelles; 4) interaction with 
mitochondria leading to alterations in metabolism, ROS production and interference with 
the anti-oxidant defence (E.-J. Park et al., 2008; X.-R. Xia, Monteiro-Riviere, & Riviere, 2010); 
5) DNA binding and damage, leading to the arrest of cell cycle division and protein synthesis; 
6) interaction with the cytoskeleton, halting vesicular trafficking and causing mechanical 
instability and cell death; and 7) interaction with proteins, lipids, and other biomolecules 
leading to different types of corona and biological effects. Depending on the nanomaterial, 
oxidative stress results in inflammation, DNA adduct formation and apoptosis (Cheng, Jiang, 
Wang, Chen, & Liu, 2013; Ken Donaldson & Poland, 2012).  
The reticuloendothelial system (RES) primarily consists of monocytes and macrophages 
which are accumulated in lymph nodes, spleen and liver. Once NMs reach the liver, they may 
induce systemic DNA damage and mutagenesis because of uptake and subsequent induction 
of systemic inflammation. Macrophages in the RES of the liver and the spleen are known to 
take up particles bound with serum proteins, which can trigger autoimmune responses (A. 
Nel, Xia, Mädler, & Li, 2006). Once NMs reach liver and spleen, they have the potential to 
induce acute toxicity associated with histological changes in terms of focal infiltration with 
phagocytic and inflammatory cells, loss of neurons, microgliosis, astrogliosis and apoptosis 
(Knudsen et al., 2014).  
Once taken up by macrophages NMs can interfere with their physiological function. 
Autophagy is an active uptake mechanism during which a portion of the cytoplasm or old 
and damaged organelles is engulfed by double or multi membrane structures 
(autophagosomes). These organelles later fuse with lysosomes, so that their contents can be 
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digested by lysosomal enzymes. Autophagy can be activated by cells as a pro-survival 
mechanism in response to cellular stress, and to sustain energy production via alternative 
routes, but it can also be involved in a cell death program, depending on the stimuli and the 
cell type (F. Wang et al., 2013). This protective mechanism could be disturbed by NM uptake 
and may lead to the enhancement of NM-induced toxicity. Moreover, the NM may directly 
interact with the lysosomal membrane of the macrophage, inducing oxidative stress, cell 
death and inflammation (Ho, Wu, Chein, Chen, & Cheng, 2011; W G Kreyling, 1992; 
Wolfgang Koch, 2008).  
As a consequence of inflammation, the NLRP-3 inflammasome is activated, a process that 
has been described for both crystalline and amorphous SiO2, but also for TiO2 (Hornung et 
al., 2008; Tschopp & Schroder, 2010; Winter et al., 2011). Particles of low solubility and 
toxicity (LSLTP) may cause inflammation in proportion to their specific surface area and their 
zeta potential (Duffin, Tran, Brown, Stone, & Donaldson, 2007; Tran, Buchanan, Cullen, Searl, 
& Jones, 2000), and their adverse effects have been demonstrated to be associated with 
their intrinsic inflammatory potency (Bakand, Hayes, & Dechsakulthorn, 2012; Günter 
Oberdörster et al., 2005). As it has been shown that these LSLTP induce rat lung overload at 
a certain threshold level, Donaldson and co-workers considered dosimetry, rather than 
particle number or size, as the driving factor for inflammatory responses in vivo (Donaldson 
et al., 2008). In fact, the determined threshold value for TiO2 and BaSO4 was found to be 
1 cm2/cm2 of the proximal alveolar region (PAR, site of high particle retention in the lung), as 
calculated using previously published results (Tran et al., 2000), below which the 
inflammatory response would not be triggered. This was found true not only for 
nanoparticles, but also for their micron-sized counterparts. Equal results could be found in in 
vitro studies using A549 lung epithelial type II cells and IL-8 as the relevant readout for pro-
inflammatory effects (K Donaldson et al., 2008). In a later publication, Donaldson and Poland 
underpinned the comparability of mechanisms of toxicity for nano- and micron-sized 
particles and state that the dose is the main trigger for adverse effects (Donaldson and 
Poland, 2013). Taking into account above considerations, surface area was recommended as  
the most appropriate metric in particle toxicity testing.  
Inhaled particles are known to play an important role not only in fibrosis or cancer 
development, but also in chronic obstructive pulmonary disease (COPD) and asthma (Borm 
et al., 2006; Geiser et al., 2014). An important player in the relationship between 
inflammation and carcinogenesis is the formation of ROS during inflammatory phagocyte 
respiratory burst. Also macrophages are known to play a significant role in inflammatory 
processes induced by NMs in the lungs: they are a key player in the uptake and removal of 
inhaled NMs (Ken Donaldson et al., 2013). Vandebriel and De Jong (2012) report that the 
toxic effect of ZnO NMs is due to its solubility resulting in increased intracellular 
concentration of Zn2+. A correlation exists between particle size, surface charge and 
pulmonary inflammation, as indicated by neutrophil influx and the induction of 
proinflammatory mediators: the smaller the particles, the greater the inflammatory 
response(Ken Donaldson et al., 2013; Mura et al., 2011).  
Chronic inflammation in the liver may occur when biopersistent NMs cannot be removed, 
and inflammatory cells are continuously recruited. In vivo experiments with injected 
(intraperitoneal or intravenously) TiO2 have reported increases in general markers for liver 
damage (such as ALT or AST) (Duan et al., 2010; Huiting Liu et al., 2009), inflammation 
(increase in pro-inflammatory cytokines and/or infiltration of inflammatory cells) (Cui et al., 
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2011; Ma et al., 2009), oxidative stress (Huiting Liu et al., 2010; Soliman, Attia, Hussein, 
Mohamed, & Ismail, 2013), apoptosis , necrosis as well as fibrosis (Alarifi et al., 2013; J. 
Chen, Dong, Zhao, & Tang, 2009). Upon treatment via oral gavage, similar findings were 
reported: apoptosis, necrosis or inflammation (Cui et al., 2011), as well as general liver 
damage after treatment with higher concentrations of TiO2 (starting from 125 mg/kg BW, as 
detected via above-mentioned markers) (Duan et al., 2010) were found usually above 
subacute exposure (60 and 30 days, respectively). Also, specific DNA damage has been 
reported after oral gavage (Sycheva et al., 2011) and administration via the drinking water 
(Trouiller, Reliene, Westbrook, Solaimani, & Schiestl, 2009), respectively. It must be noted 
however that the reported effects were only found at the highest concentration groups (200 
mg/kg BW and 500 mg/kg BW, respectively).  ZnO and SiO2 NMs are also reported to induce 
liver damage and inflammation. Vandebriel and De Jong (2012) report that intravenous 
instillation and oral administration of ZnO nanoparticles result in accumulation to the liver 
(but also to the spleen, lungs and kidney); oral exposure of nanoparticulate SiO2 also leads to 
accumulation to the liver (van der Zande et al., 2014). Intravenous administration of SiO2 
nanoparticles cause DNA damage in the liver (Downs et al., 2012). When lower doses induce 
an adverse effect, such as influx of inflammatory cells, a recovery to normal levels is 
sometimes reported (Ali Kermanizadeh, 2013). 
In the blood, NMs can mechanically obstruct the vasculature which leads to congestion in 
multiple vital organs and subsequent organ failure. For example, there are reports of 
nanoparticle-induced coagulopathies (i.e. coagulation disorders caused by perturbation of 
the blood coagulation system), dependent on the size and charge of the NM, which 
determines if a NM has pro- or anti-coagulant properties. A consequence can be 
disseminated intravascular coagulation (DIC), which can be either acute or chronic and, if 
untreated, may lead to multiple organ failure and death (Ilinskaya & Dobrovolskaia, 2013a, 
2013b).  
Moreover, NMs such as TiO2 have been found to cause an imbalance in haemostasis and 
thus a disturbance of the immune system. For example, in vivo studies in mice reported 
decreased proliferation of T and B lymphocytes as well as natural killer cells has been (Duan 
et al., 2010); exposure was occurring through intragastric administration. A disturbance of 
the cell cycle can result from interactions of TiO2 with proteins, as reported in in vitro studies 
on human lung epithelial cells (Prasad et al., 2013). 
Thus, NMs can cause adverse effects through their interactions with cells in target organs 
and with proteins in the blood and tissue fluids. An increasing number of studies are 
investigating these effects and their relationships with the PC properties of NMs.  
 
1.6 Standard Test Guideline methods for toxicity testing 
The OECD provides test guidelines (TGs) which contain of internationally harmonised test 
methods for Mutual Acceptance of Data, used by government, industry and independent 
and certified laboratories. Originally, they were developed to determine the safety of 
chemicals and chemical preparations. Their use for safety assessment of NMs has been 
evaluated and published in the OECD's 'Preliminary Review of OECD Test Guidelines for their 
Applicability to Manufactured Nanomaterials' (OECD, 2009a). A number of toxicity endpoints 
are listed as well as the respective test guidelines and their possible implementation for 
nanotoxicity testing.  
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More recently, results from expert workshop recommendations have been published, such 
as on genotoxicity (OECD, 2014d) or inhalation toxicity testing (OECD, 2011). Inhalation 
toxicity testing has been further discussed by an expert group (OECD, 2012b). This group has 
considered issues such as the NM size range and the analysis of the broncho alveolar lavage 
(BAL) fluids. The links between the toxicity test results and these parameters are considered 
essential, as is knowledge on toxicokinetics, to determine for example lung burden and 
biokinetics. The TG 417 on toxicokinetics was discussed for its applicability for NM toxicity 
testing, as discussed at the OECD expert meeting on the Toxicokinetics of Manufactured 
Nanomaterials in 2014 where challenges for its application to NMs toxicological assessment 
were identified (OECD, 2016d). A guidance document on a tiered testing approach for 
preliminary assessment of NMs hazard using in vitro methods is foreseen to be available in 
2017. Table 1.5 lists the discussed endpoints, the respective OECD test guideline(s) and their 
current applicability status. 
Furthermore, the OECD has published a living document on NM sample preparation and 
dosimetry, with the latest update being made available in 2012 (OECD, 2012a). The issue on 
the right dosimetry is discussed equally to previous publications by Donaldson and 
colleagues (K Donaldson et al., 2008; Ken Donaldson & Poland, 2013), stating that the mass 
metric appears not always to be the most appropriate or relevant one. Indeed for some 
nanomaterials the results may be better expressed as a function of surface area or particle 
number because particle size and specific area may play a main role in determining the 
toxicity of nanomaterials. However, it is also acknowledged that this is -currently- often still 
a challenging task. Other issues raised in this document are on storage and stability of NM or 
the appropriate test media, making the point that it is key to know and report the exact 
composition of the prepared sample. Furthermore, the document points out the 
fundamental importance of proper PC characterisation of the materials and lists the relevant 
properties. 
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Table 1.5. Endpoints, the discussed method, the respective OECD test guideline(s) and their 
current applicability status. This status is under regular review. In vitro test methods are in 
bold. 
Endpoint Method OECD Test Guideline 
Applicability for nanotoxicity 
testing 
Acute toxicity oral exposure 420, 423, 425 Appropriate for initial investigation (OECD, 2009a) 
Repeated dose 
toxicity (28 and 
90 days) in 
rodents 
oral exposure, to detect 
neurotoxic and immunotoxic 
effects, effects on the 
reproductive and endocrine 
system 
407, 409 
Applicable; enhancement of 
methods to detect NM-specific 
effects (e.g. cardiovascular effects) 
needs to be considered (OECD, 
2009a) 
inhalation 412, 413 Not specifically intended for the testing of NMs (OECD, 2009a) 
Skin and Eye 
irritation in vivo application 404, 405 Applicable (OECD, 2009a) 
Skin corrosion  
Transcutaneous Electrical 
Resistance Test (TER), 
Reconstructed Human 
Epidermis (Rhe) Test Method, 
In vitro Membrane Barrier 
Test Method 
430, 431, 435 
Applicable; however some assays 
(e.g. MTT assay or other assays 
using metabolically converted vital 
dyes) may not be appropriate 
(OECD, 2009a) 
Skin sensitization local lymph node assay 429 
Most appropriate method, permits 
estimation of the potency of the 
sensitization reaction (OECD, 2009a) 
Genotoxicity 
Bacterial reverse mutation 
assay 471 Not applicable (OECD, 2014d) 
In vitro mammalian cell gene 
mutation assay 473, 476 Applicable (OECD, 2014d) 
In vitro micronucleus assay 487 Applicable after modification (OECD, 2014d) 
Reproductive and 
developmental 
toxicity 
oral exposure 421, 422, 414, 415, 416 
Applicable for oral exposure 
(inhalation exposure would require 
additional considerations) (OECD, 
2009a) 
Toxicokinetics 
oral exposure, Intravenous 
(IV) administration, dermal or 
inhalation exposure (as 
applicable) 
417 Not applicable (OECD, 2009a) 
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In additional to these TGs, several different working groups are currently dealing with the 
fate of NMs in aquatic media as discussed in a rolling work plan. Here, new TGs/ guidance 
documents for determining different PC properties, on their ecotoxicological and 
environmental effects (OECD, 2014c) or aquatic and algal toxicity are being discussed or 
developed further. 
 
1.7 Alternative methods 
The risk assessment of chemicals has traditionally been based on toxicity studies on animals, 
mainly rodents like rats and guinea pigs, which have served as surrogates for humans. With a 
growing concern about animal welfare and technological advances, new possibilities to 
determine the toxic properties of substances that do not require the use of animals are 
increasingly available. Alternative (non-animal) methods can be used as exploratory (e.g. to 
better understand mechanisms of action) or predictive tools (to extrapolate observations to 
the whole organism level). 
In vitro experiments provide an important source of information on possible (toxic) effects of 
chemicals at the cellular level, however for many endpoints, they still don't represent a full 
replacement for in vivo tests, with the exception of some validated and accepted methods 
(for example for eye irritation/corrosion) that can be found in the designated database DB-
ALM: http://ecvam-dbalm.jrc.ec.europa.eu/.  
Another alternative to in vivo testing is the use of computer-based techniques commonly 
referred to as in silico tools. When little is known about the activity of substances, in silico 
tools are usually used to cluster and group those that are 'similar', i.e. have common 
structural features, metabolites, or PC properties and are thus expected to have similar 
biological activity (ECHA, 2008; OECD, 2012c, 2012d). This is the basis of the read-across 
approach in which the unknown toxic effects of a chemical of interest are deduced from the 
known effects of its analogues. 
Differently from read-across, quantitative structure-activity relationship (QSAR) models are 
in silico tools that correlate specific activities (toxicity endpoint) of a series of substances 
with structural features. QSARs can thus be used to predict the activities of substances from 
their own properties, without the need to know the activities of analogues. 
Physiologically based toxicokinetic (PBTK) models are another set of tools that at least in 
theory have in vivo predictive potential based on an understanding of anatomy and 
physiology, and on the application of mathematical modelling to data derived from in silico 
and in vitro models. In this case, predictions are not of a toxicological endpoint, but of the 
kinetics of absorption, distribution, metabolism and excretion resulting in an overall time-
course of a chemical in blood plasma or organs.  
Given their reductionist nature and uncertainties in their applicability, alternative methods 
do not usually represent stand-alone alternatives to classical test methods. However, it is 
expected that approaches based on the integrated use of multiple alternative methods, 
commonly called Integrated Testing Strategies (ITS) or Integrated Approaches to Testing and 
Assessment (IATA), will help to minimise or avoid animal testing. 
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1.7.1 Adverse Outcome Pathways (AOPs) 
An Adverse Outcome Pathway (AOP) is a conceptual construction that portrays existing 
knowledge concerning the link between a molecular initiating event (MIE) and an adverse 
outcome (AO), by capturing the sequential chain of causally-linked events at different levels 
of biological organisation (Ankley et al., 2010). AOPs provide a means of systematically 
organising mechanistic knowledge on the biological and toxicological effects of chemicals, 
they can guide the further development of alternative methods, facilitate the integration 
and use of newer 'non-standard' data such as HTS and 'omics, and support the identification 
of knowledge gaps to inform intelligent testing strategies. 
An AOP programme was launched by the OECD in 2012 
(http://www.oecd.org/chemicalsafety/testing/adverse-outcome-pathways-molecular-
screening-and-toxicogenomics.htm). Specific rules are applied to AOP development. For 
example, one AOP always consists of a single MIE and a single AO, but can have multiple key 
events (KEs) which are causally linked by the so-called key event relationships (KERs). This 
leads to a simplified and 'linear' representation of a mechanism of toxicity. The AO can be 
defined at various levels: in humans, an AO can relate to the whole population, but also to 
individual organ damage, for example liver fibrosis or skin sensitisation; in environmental 
science, the AO relates to the death or reproductive impairment of an individual (e.g. a fish) 
which ultimately has consequences for the whole population. To promote the harmonised 
development of AOPs, an AOP-wiki was launched in September 2014 (https://aopkb.org/). 
So far, AOPs have been developed on the basis of chemical-induced MIEs (Gerloff et al., 
2017). However, due to the unique properties of NMs, their mechanisms of toxicity might 
not be directly comparable to those of chemicals in solution. In particular, NM-triggered 
MIEs could be different, and the toxicokinetics of NMs plays a major role in determining this 
(for example, solubility might vary depending on the biological environment of toxicological 
action).  
 
1.7.2 In silico methods 
In silico methods comprise a diverse range of techniques that solely use a computer to 
obtain an outcome. They are used to extract patterns and knowledge from large amounts of 
data (i.e. perform data mining) and to use this knowledge to build models (i.e. machine 
learning) that are able to predict the outcome of an experimental test thereby avoiding the 
need to carry it out. The terms 'data mining' and 'machine learning' are often confused as 
they employ the same methods but with different goals.  
Supervised and unsupervised methods  
Data mining methods may be categorized as either supervised or unsupervised. In 
unsupervised methods, no target variable is identified as such. They can be used during the 
early stages of an investigation to detect patterns, find features that can be useful for 
categorization, and gain insight into the nature or structure of the data. In contrast, 
supervised methods are mostly applied to reproduce and/or predict patterns found in the 
data.  
The most common unsupervised data mining method is clustering, which is the grouping of 
objects into meaningful categories. Given a representation of N objects, a clustering exercise 
will assign the N objects to k clusters with respect to a similarity measure. There are various 
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clustering algorithms. Here we briefly describe two of the most common ones: hierarchical 
clustering and k-means clustering. 
Hierarchical clustering assigns each object (e.g. NM) to a cluster. Initially, N objects are 
assigned to N clusters, each containing just one object. The distances (similarities) between 
the clusters are therefore the same as the distances (similarities) between the items they 
contain. In a second step, the most similar pair of clusters is identified and these are merged 
into a parent cluster so that there is one cluster less. The distances between this new cluster 
and all the other clusters are recalculated in the third step. Then, steps 2 and 3 are repeated 
until the whole dataset has been merged into a single cluster.  
An example of hierarchical clustering is shown in Figure 1.3. In the ENPRA project 
(www.enpra.eu), various NMs (ZnO, TiO2, Ag, and CNTs) were tested with different coatings, 
crystalline structures and sizes. The NMs were clustered with respect to their lowest 
observed effect concentrations obtained for a series of cytotoxicity, genotoxicity, 
inflammation, and oxidative stress tests (Asturiol & Worth 2012 unpublised results).   
 
Figure 1.3. Hierarchical clustering of a set of NMs based on their toxicological profiles 
 
The way in which the distance between the clusters is calculated (single-linkage, complete-
linkage, average-linkage, etc.) determines the hierarchy of the cluster. If a pre-determined 
number of clusters is desired, the dendrogram is cut across the appropriate number of 
branches/links.  
K-means clustering is an iterative algorithm that groups data into a pre-set number of 
clusters (K) which is defined by the user. In a first step, the algorithm randomly guesses the 
centre locations of the clusters. In a second step, each data point is assigned to its closest 
centre. In a third step, each cluster finds the centroid of the points that they are assigned to, 
i.e. the clusters find their centre. Steps 2 and 3 are then repeated until convergence is 
achieved, i.e. there is no variation in the position of the centroids. 
Supervised learning consists of finding a model/rule that relates the data associated with 
objects (e.g. NMs descriptors or properties) to a pre-defined class (e.g. carcinogen/non-
carcinogen, sensitiser/non-sensitiser, etc.). Datasets of objects with known classes are 
defined as training sets and are used to train the model. The trained model will be applied to 
a test set of compounds for its validation. If the training sets are sufficiently diverse 
(general), the model will be applicable to a wide variety of compounds (large applicability 
domain). Otherwise, its applicability domain will be specific to a small family of compounds 
(small applicability domain). For example, given a database that consists of a list of chemicals 
with their structural features (e.g. presence of heteroatoms, presence of rings, number of 
conjugated bonds, etc.) and their toxic activity (e.g. carcinogen or non-carcinogen), a 
supervised machine learning algorithm will find a function or pattern that differentiates 
carcinogens from non-carcinogens. The function or model could be as simple as this: 
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compounds containing aromatic nitro groups and with MW<1000Da are indicators of 
carcinogens (Benigni & Bossa, 2006). Given the database of carcinogens and non-
carcinogens, the model 'learns' that aromatic nitro groups are characteristic of carcinogens. 
There are many types of machine learning algorithms. Decision trees like the one explained 
previously are probably the most simple and intuitive models. More sophisticated 
supervised learning approaches include support vector machines (Denis Fourches et al., 
2010), Bayesian networks(Rong Liu et al., 2013a), and artificial neural networks (Mehdi 
Ghorbanzadeh, Fatemi, & Karimpour, 2012). See Table 1.6 for other methods.  
 
Table 1.6. Supervised methods that are used to derive predictive models. 
Method Short description 
Linear discriminant analysis (LDA) Uses a linear combination of continuous 
descriptors to discriminate between two or more 
categorical variables 
Classification algorithms and regression trees 
(CART) 
Recursive process to partition the dataset in 
different subsets with respect to attributes 
values. The data is partitioned on the 'nodes' of a 
tree creating branches (subsets of data). Each 
branch is recursively partitioned until no added 
value in predicting a category is observed. Then, 
a leave corresponding to a category is created. 
This approach can use either continuous or 
categorical data in both, descriptors and 
category.  
K-nearest neighbours (K-NN) Local regression or classification method that 
uses the average of the K nearest neighbours to 
the test chemical in order to classify or predict 
the category or property of interest. 
Support vector machines (SVM) Model that represents the dataset as points in a 
space that maximises the separation between 
the different classes of the category. The test 
chemical is categorised or predicted with respect 
to the points in the space that are within a given 
threshold. 
Bayesian networks (BN) Graphical model that encodes probabilistic 
relationships (arcs) among random variables 
(nodes). The distribution of these variables with 
respect to the categories is used to assign a 
probability of pertinence to each category. The 
accumulated pertinence probability across all 
nodes, which are presumed independent, is used 
for categorisation. One of the advantages of this 
method is that not all descriptors (variables) are 
needed in order to have a prediction and that 
the influence of having additional data on the 
final classification can be tested beforehand.  
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Method Short description 
Artificial neural networks (ANN) Set of interconnected nodes (neurons) that 
resemble biological neuronal networks. The 
neurons can compute values from inputs, and a 
hidden layer of neurons establishes self-adapted 
relations that derive in an output. Depending on 
the inputs values, different neurons are activated 
and outcome a result.  
 
QSAR/QSPR 
Quantitative structure-activity relationships (QSARs) are a specific type of in silico method. 
These methods are based on the assumption that the activity of the substances is related to 
its structure. The concept is well established (the first QSAR for biological activity can be 
dated back to 1868 (Fraser & Crum-Brown 1868) but in the past few decades it has been 
applied more efficiently and extensively due the availability of computational methods. The 
term structure-activity relationship (SAR) is sometimes used to express a simple qualitative 
association between an activity and the presence of a structural feature. 
Quantitative structure-property relationships (QSPRs) are conceptually the same as QSARs 
but they relate structure to physicochemical properties (rather than biological activities) of 
the chemicals.  
There are different ways to encode structural information in a QSAR/QSPR. The simplest way 
is identifying the presence or absence of certain chemical groups, i.e. fingerprints. These 
chemically-based encodings are usually not quantitative but discrete, giving rise to SAR. 
Alternatively, quantitative representations of chemical structures are used, which giving rise 
to QSAR. One of the most famous QSARs is the Hansch equation (Hansch & Fujita, 1964), 
which relates general bioactivity of compounds with their hydrophilicity. The extended 
Hansch (Hansch, 1969) equation 9) shows the curvilinear relationship between log1/C50 and 
hydrophobicity normally found in single dose tests: 
  (9) 
Where C is the molar toxicant concentration producing a standard response (e.g. 50% 
mortality or effect) in a constant time interval, logP is the water-octanol partition coefficient, 
σ is the Hammett electronic parameter(Hammett, 1937), Es is Taft's steric factor (Taft, 1956), 
and ρ and δ are constants related to the sensitivity of the reaction to electron density.  
A descriptor is a mathematical representation of chemical structure, (Todeschini & Consonni 
Viviana, 2009) and has been defined as  
The molecular descriptor is the final result of a logic and mathematical procedure which 
transforms chemical information encoded within a symbolic representation of a molecule 
into a useful number or the result of some standardized experiment. 
There are thousands of descriptors that can represent a chemical structure. The main 
families are presented in Table 1.7. 
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Table 1.7. List of chemical descriptors usually used in QSARs. 
Descriptor family Description 
Zero-dimensional (0-D) / constitutional / 
information 
These are derived from just the structural 
formula and only describe the composition, e.g. 
number of N atoms, number of double bonds, 
etc. 
1-D / fingerprints  These describe the composition in terms of 
structural fragments, e.g. number of benzene 
rings.   
2-D / topological  These include information on the connectivity of 
atoms and structural fragments. They are 
obtained from molecular graph theory (2D 
representations of chemical structure) and can 
differentiate molecules according to their size, 
degree of branching, flexibility, etc. Examples 
include atom connectivity indexes (Hall & Kier, 
1977; Randic, 1975) which are derived from the 
bonds present in the molecule. 
3-D / geometric  These are properties that depend on a three-
dimensional representation of the chemical 
structures. They include size, shape, surface and 
volume-related descriptors, as well as electronic 
(quantum chemical) descriptors. They are 
typically derived from the coordinates of an 
energy-minimised conformation of the molecule.
They may also take conformational flexibility into 
account, e.g. using molecular dynamic 
simulations (Hopfinger et al., 1997).  
4-D These are similar to 3-D descriptors but they also 
capture interaction energies. These energies are 
calculated in terms of the interaction of the 
molecule with a steric, electronic or hydrophobic 
probe (depending on the type of interaction 
energy). 
They are derived by various methods including 
Comparative Molecular Field Analysis 
(ComFA)(Cramer, Patterson, & Bunce, 1988). 
CoMFA is based on the rational that differences 
in a target property, e.g. biological activity, are 
often closely related to changes in shapes and 
strengths of non-covalent interaction fields 
surrounding the molecules. In CoMFA, field 
values are systematically calculated for ligands at 
each grid point of a regularly sampled 3-D grid 
box that extends 4 Å beyond the dimension of all 
molecules in the data set, using a sp3 carbon 
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Descriptor family Description 
atom with +1 charge as probe molecules. Other 
3-D programs are CoMSIA (Klebe, Abraham, & 
Mietzner, 1994), and GOLPE (Cruciani & Watson, 
1994). 
Physicochemical properties These can also be used as 'descriptors' or more 
accurately as predictor variables. The property 
may be calculated from chemical structure or an 
experimental measurement may be used 
directly. A common example is logP. 
 
Descriptors that have been found useful in the QPSR/QSAR modelling of particles (including 
NMs) are identified in Chapter 3. 
 
Validation of QSARs for regulatory purposes 
The first condition for using QSARs in regulatory decision making is the demonstration of 
model validity. Since the concept of validation is incorporated into legal texts and regulatory 
guidelines, it is important to clearly define what this means and to describe what the 
practical validation process might entail. According to the OECD Guidance Document on the 
Validation and International Acceptance of New or Updated Test Methods for Hazard 
Assessment (OECD, 2007a), the term validation is defined as follows: … the process by which 
the reliability and relevance of a particular approach, method, process or assessment is 
established for a defined purpose.  
This wide-ranging definition is intended to cover all kinds of traditional and alternative 
testing methods. In the context of QSARs, this definition is rather abstract and difficult to 
apply. However, in the case of QSARs, a set of five validation principles has been established 
by the OECD report (OECD, 2004). Thus, for a QSAR to be valid it must have: 
• a defined endpoint 
• an unambiguous algorithm 
• a defined domain of applicability 
• appropriate measures of goodness-of-fit, robustness and predictivity 
• a mechanistic interpretation, if possible. 
The 'appropriate documentation' for demonstrating model validity is recognised in the QSAR 
Model Reporting Format (QMRF), which is structured according to the OECD principles for 
QSAR validation. Information on QSAR model validity, including peer-reviewed 
documentation, is available from various sources, including the JRC QSAR Model Database 
(http://qsardb.jrc.it).  
 
Expert systems 
Expert systems have traditionally been associated with tools that capture and reproduce the 
knowledge of an 'expert'. One of the best known expert systems is Derek (Lhasa Ltd.), a 
knowledge-based expert system that predicts the toxicity of a chemical from its structure. Its 
predictions are based in part on structural alerts that describe structural features or 
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toxicophores associated with toxicity. These alerts are usually derived by human expert 
interpretation of toxicity data for known compounds within the same chemical class and an 
understanding of toxicological mechanisms.  
A broader definition of the term 'expert system' was recommended during an ECVAM 
workshop (Dearden et al., 1997): any formalized system, not necessarily computer-based, 
which enables a user to obtain rational predictions about the toxicity of chemicals. According 
to this definition, any available software tool for toxicity prediction is considered an expert 
system, including those based entirely on statistical models (statistically-based systems), 
those based entirely on expert knowledge (knowledge-based systems), and those based on a 
combination of expert knowledge and statistical induction (hybrid systems). Widely used 
examples include Toxtree, TIMES-SS, TOPKAT, EPISuite, PASS, and Vega. A recent review of 
expert systems and their regulatory applicability (in the cosmetics sector) has been 
published by the International Cooperation on Cosmetics Regulation (ICCR; 
http://www.iccrnet.org/topics). 
 
Applicability of QSAR/QSPR approaches to NMs 
The challenge of developing QSARs for NMs has been discussed in the literature (Hristozov 
et al., 2014; Rong Liu et al., 2013a; Ratna Tantra et al., 2014; H. Zhou et al., 2008). Due to the 
novelty of applying the QSAR approach to NMs, the resulting models have sometimes been 
called quantitative nano-structure-activity relationships (QNARs) and the underlying 
descriptors nanodescriptors (Denis Fourches et al., 2010; Tomasz Puzyn, Leszczynska, & 
Leszczynski, 2009).  
However, these terms are misleading since the main modelling challenges are not nano-
specific, but rather they relate to the difference between modelling the behaviour of 
chemicals in solution ('classical' or 'bulk form') and in particulate form. Traditionally, QSPR 
and QSAR modelling has applied to substances in solution, typically undissociated molecules, 
but in principle, ionised molecules and soluble metal ions can be modelled too. This is 
sometimes complicated by the fact that the substance of interest can undergo abiotic or 
biotic (metabolic) conversions (in the case of molecules) or speciation (in the case of metal 
ions), creating a mixture whose composition can vary in time and space.  
The modelling of particles, including nanoparticles, has been a challenge since relatively few 
theoretical descriptors are available for particles. In some cases, the particles have an 
amorphous (e.g. certain clays) rather than a crystalline structure, making it difficult to 
establish theoretical descriptors. Nevertheless, experimental descriptors (Table 1.1) may be 
available. In the case of NMs, it will be necessary to develop descriptors that are genuinely 
'nanodescriptors' in the sense that they express the novel and size-dependent characteristics 
of NMs. A further complication is that a nano-sized (or micro-sized) particle does not form a 
homogeneous collection of species - it may undergo aggregration/agglomeration processes, 
adsorb and desorb macromolecules present in the surrounding medium, and may (partially) 
dissolve as well, leading to a distribution of masses/sizes/shapes (i.e. polydispersity). Rather 
than modelling a single species, it may therefore be necessary to model a distribution / 
mixture of species, which is increasingly difficult the more the material deviates from 
monodispersity. Furthermore, as with most 'classical' chemicals, the mode of toxicological 
action is often unknown, making it difficult to identify, a priori, the most relevant and 
predictive descriptors (Rallo et al., 2011; Shao et al., 2013).     
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As a consequence of these challenges, as well as the currently limited availability of 
systematic collections of physicochemical, in vitro and in vivo data (Oksel, Ma & Wang, 
2015), there are relatively few QSARs for NMs in the scientific literature. 
In principle, it should be easier to develop QSPRs (Martin, Maran, Sild, & Karelson, 2007) for 
NMs, since physicochemical (including magnetic and optical) properties are more closely 
linked to nanostructure than biological activity, and the property data is more likely to be 
generated in a systematic way (using standardised protocols). A few reviews of QSPRs and 
QSARs for NMs have been published elsewhere (Gallegos et al. 2009; Burello & Worth 2011; 
Gajewicz et al. 2012; Puzyn et al. 2010; Oksel, Ma, Liu et al,  2015) and a review on QSAR and 
QSPRs is reported in Chapter 3.  
 
Physiologically Based Kinetic (PBK) modelling 
Kinetics (sometimes referred to as toxicokinetics [TK] or pharmacokinetics [PK]) is the 
science that studies the fate of a substance (including NMs) in the body, whereas dynamics 
(sometimes referred to as toxicodynamics [TD] or pharmacodynamics [PD]) studies what a 
substance does to the body once it contacts the body (local toxicity) or enters the body 
(systemic toxicity). The usual OECD Test Guidelines for investigating TK are OECD TG 417 
(toxicokinetics), TG 427 (in vivo skin absorption) and TG 428 (in vitro skin absorption). When 
studying TK using TG 417, separate studies are usually carried out and reported to study 
some 'ADME' parameters in isolation: one to determine relative (%) absorption and 
excretion (faeces, urine and sometimes exhaled air), one to establish organ distribution and 
one to establish metabolism. They are usually performed at two dose levels and with single 
and repeated (usually seven days, once per day) dosing. Indications of accumulation might 
be obtained when comparing tissue levels after seven days of exposure compared to a single 
exposure. Increasingly, concrete TK parameters like AUC, Cmax, Tmax and half-life (t1/2) are also 
being investigated. In order to establish half-life (t1/2), follow-up TK (tissue depletion) during 
a wash-out (no exposure) period following single or repeated dosing is needed. 
Irrespective of whether a test substance is a NM or not, the TK is studied separately from the 
TD. It is therefore a challenge to evaluate whether data gathered in TK studies are relevant 
to the hazard characterisation information obtained from TD studies. One way of addressing 
this is to include some preliminary TK sampling in the TD studies. This is currently under 
discussion by the OECD Expert Group on the inhalation test guidelines 412 and 413 (28 and 
90 days inhalation). 
Traditionally, TK has been studied empirically in living organisms. In this approach, whole 
body parameters like absorption rate constant (ka or kin) and elimination rate constant (ke or 
kout) can be obtained using classical toxicokinetic (CTK) computer approaches to fit the 
empirical data (Figure 1.4A). CTK modelling can be used for interpolation between dose 
levels if measurements at these dose levels exist. However, it can be used for extrapolation 
only to a limited extent and care should be taken due to the possibility of non-linear 
relationships. Once ka and ke are established, CTK modelling can be used to assess the 
potential for ka > ke and to determine the level of accumulation at given exposure levels.  
A more recent approach, physiologically-based toxicokinetic (PBTK) modelling, is based on 
physiologically relevant compartments and processes (including bioavailability in the 
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relevant organs and the systemic blood flow). In contrast to CTK, PBTK allows various kinds 
of extrapolation, e.g. interspecies extrapolation, high-to-low dose extrapolation, route-to-
route extrapolation and can take inter-individual variation into account. This has been used 
for non-NM substances. In addition, as shown in Figure 1.4B, PBTK modelling has been 
applied to simulate TK profiles by integrating independently obtained information from in 
silico (QSAR) and in vitro methods for absorption, distribution, metabolism and excretion 
(ADME). In that respect, it has more characteristics of a predictive modelling than the CTK 
modelling approach.  
Although CTK modelling can be used to perform interpolation and assessment of 
accumulation based on at least some experimental in vivo data, it is generally considered as 
an empirical rather than predictive approach. Multi-compartmental classical empirical 
modelling (i.e. CTK) has provided some initial insights into the NM-specific (Ag and SiO2) 
rates of absorption from the GI tract to the systemic circulation and into the distribution 
from the systemic circulation to specific organs (Bachler, von Goetz, & Hungerbuhler, 2014; 
D. Li et al., 2014; van Kesteren et al., 2014). 
PBTK modelling approaches have greater potential to simulate the concentration-time 
profile. This is the especially the case for relatively simple chemicals for which the TK is 
(mainly) driven by passive diffusion across biological membranes. Incorporation of active 
processes such as active transport across external and internal membranes (Hagenbuch & 
Meier, 2004) is more demanding. Although for very small NMs, like quantum dots (<10 nm), 
diffusion might still be relevant, for NMs in general most processes that drive the 
absorption, tissue distribution and excretion (if any) are probably active processes such as 
macrophage uptake. These processes have not been mimicked in vitro nor modelled in silico 
in any detail. 
An issue that is relevant not only for kinetic modelling but also for assessing the suitability of 
analogues for read-across (e.g. between bulk particles and nanoforms) is solubility (the 
amount that dissolves and the rate of dissolution) under physiologically relevant conditions. 
Typically, a considerable proportion of a NM does not dissolve12 to a large extent (the NM is 
"durable"). With respect to kinetic modelling, it is much easier to model the behaviour of a 
NM that readily dissolves, i.e. becomes a 'classical readily soluble chemical' for which many 
of the usual assumptions hold. However, when it comes to insoluble particles, uptake by 
phagocytising cells needs to be considered, which is not trivial from a modelling point of 
view.   
 
                                                      
12 Dissociation is to go from salt to dissociated ions (e.g. from AgCl to Ag+ and Cl-). To dissolve is to 
change from solid into ‘dissolved in solution’ (solute) status. For some chemicals, dissolving requires 
dissociation at the same time (from NaCl crystal into Na+ and Cl-. For other chemicals, dissociation 
does not occur when going into solution (e.g. from glucose crystals to glucose monomers in solution).  
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A     B
Figure 1.4. (A) Empirical classical toxicokinetic (CTK) modelling to fit the model to an experimental 
C,t-curve for humans or an environmental species a posteriori; (B) Physiologically-based 
toxicokinetic (PBTK) modelling to simulate a C,t-curve a priori. Papp = Apparent permeability, Ps,app = 
apparent skin permeability, Kba = blood:air partitioning coefficient, Ktb = tissue:blood partitioning 
coefficient, fu = fraction unbound to protein, CLint = intrinsic clearance, Km = Michaelis-Menten 
constant, Vmax = maximum rate of metabolic conversion, GFR = glomerular filtration rate 
 
The computational modelling of this type of biodistribution is more demanding than 
simulating simple diffusion using differential equations. As such, the development and use of 
PBTK modelling has not kept pace with experimental TKs and TDs. The number of papers 
covering PBTK modelling of NMs is currently very low, i.e. around 10-20. These are all hybrid 
PBTK models that simulate whole-body kinetics of NMs but rely heavily on calibration to 
experimental concentration-time course data, i.e. they have a strong empirical grounding 
(Bachler et al., 2014; Bachler, von Goetz, & Hungerbühler, 2013; D. Li et al., 2014; van 
Kesteren et al., 2014). This means that the physiological parameters such as blood flow and 
organ weights are measured data, but chemical-dependent parameters such as absorption 
rate are not known and are set by fitting to existing blood concentration-time course data.  
Nevertheless, interesting results have been found from PBTK studies of NMs. For example, 
at dietary exposure to TiO2 NMs between 15 to 150 nm, the size and crystalline structure of 
the particles had a minor influence on the biodistribution and at high internal exposure the 
particles agglomerate in vivo and are taken up by macrophages (Bachler et al., 2013; 
Bruinink et al., 2015). Agglomeration and de-agglomeration are very relevant processes for 
the exposure assessment as well as the hazard characterisation of NMs. High concentrations 
in an animal study might cause agglomeration, exposure to larger (maybe micron-sized) 
particles, and a blurred dose-response.  
The future power of applying PBTK modelling to NMs lies in the possibility of simulating TK 
profiles a priori rather than fitting them a posteriori. In other words, the parameterisation of 
the equations in the model (e.g. giving values to absorption rates and transfer rates from 
blood to tissues) can be done by using QSPR predictions or in vitro measurements. This will 
require the further development of QSPR models and in vitro models for kinetic parameters. 
For example, the development of in vitro assays to measure active uptake by different types 
of phagocytising cells in different tissues may greatly enhance PBTK modelling approaches.  
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1.7.3 In vitro methods 
In 2009, Stone et al. provided a first critical overview of in vitro test systems in 
nanotoxicology (V. Stone, Johnston, & Schins, 2009). They identified some general 
limitations of in vitro test systems, one of them being the fact that these test systems are 
limited to one or only a few different cell types and thus cannot fully represent the biological 
responses in a whole organism. Furthermore, these cell systems are usually derived from 
cancer or other long-lived cell lines, which can result in different outcomes when compared 
to in vivo tests (Joris et al., 2013). Single exposures are typically used in in vitro work which 
usually lasts from a few minutes up to a few days, depending on the tested endpoint. 
Therefore, chronic NM exposure cannot be tested sufficiently. Defining a suitable dose-
range is a challenge for both in vitro and in vivo tests, as often unrealistically high doses are 
chosen in order to observe the effect of interest. In vitro studies often aim to acquire mainly 
mechanistic information, which are difficult or impossible to conduct in a whole body 
system. 
The in vitro testing of NMs poses some specific technical challenges. The exposure medium 
plays an important role as it can affect the agglomeration or aggregation state of a NM and 
subsequently its uptake and toxicity (Joris et al., 2013). NMs can also interfere with the test 
system. For example, when using colorimetric assays such as the MTT assay (Table 1.8), one 
has to consider that a NM may generate an absorbance at the same wavelength as that used 
to quantify the coloured product, which will lead to an overestimation of the cell viability (V. 
Stone et al., 2009). Also, the NM might adsorb the coloured reagent due to its high specific 
surface area. When using fluorescent endpoints, one needs to consider the interference of 
the NM by for example physical blocking of the light emitted (e.g. carbon), reflection of the 
excitation light (e.g. TiO2), and autofluorescence of the particle. Therefore, thorough care 
needs to be taken to choose the right systems, conduct appropriate pre-tests and include 
suitable controls (V. Stone et al., 2009). 
Despite these technical challenges, in vitro models offer a number of advantages for 
nanotoxicity testing (Hirsch, Roesslein, Krug, & Wick, 2011). They can be used in mechanistic 
studies to investigate the potential of NMs to cross barriers, to enter cells, to influence 
cellular morphology and viability, to cause genotoxicity, to trigger cell signalling, gene 
expression and protein production. Table 1.8 lists in vitro systems that have been found 
useful for detecting cytotoxicity or cellular membrane damage. These assays can support the 
derivation of values for regulatory toxicity (e.g. LC50 or no observable adverse effect level - 
NOAEL), but also to determine sublethal concentrations for the assessment of mechanistic 
endpoints such as apoptosis, formation of ROS and oxidative stress, markers of pro-
inflammatory enzymes and general gene-regulation assays.  
High content imaging (HCI) systems, such as Cellomics, provide a means to upgrade 
traditional in vitro analyses to high throughput screening and offer a way to avoid 
interference of NM with colorimetric products, as in-cell fluorescence is analysed via an 
inverted microscope. Another advantage is the fact that it allows for live- and fixed-cell 
imaging, and multiple endpoints can be analysed in parallel in the whole-cell system. High 
throughput screening (HTS) is being an increasingly important means of detecting 
mechanistically relevant endpoints which can then serve for in vivo toxicity prediction (A. Nel 
et al., 2013).  
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At present, multiple efforts are ongoing to develop standardised in vitro methods for NM 
testing, but as yet, none have been formally validated by validation bodies such as the 
European Union Reference Laboratory for alternatives to animal testing (EURL-ECVAM), 
which is hosted by the JRC. In the meantime, available and potentially useful methods have 
been summarised by the SCCS in their Guidance on the Safety Assessment of Nanomaterials 
in Cosmetics (SCCS 1484/12: SCCS 2012) and in the 9th revision of the Notes of Guidance for 
the Testing of Cosmetic Ingredients and their Safety Evaluation (SCCS 1564/15; SCCS 2015). 
 
Table 1.8 Overview of the most commonly used in vitro test methods to detect nanoparticle-
induced adverse effects in vitro.  
General 
effect Read-out Assay 
Cell viability 
Determination of mitochondrial 
function by measuring the 
activity of mitochondrial 
enzymes; quantified by light 
absorbance 
MTT ((3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay 
MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium) assay
XTT (2,3-bis-(2-methoxy-4-nitro-5-
sulfophenyl)-2H-tetrazolium-5-carboxanilide) 
assay
WST (Water soluble Tetrazolium salts) assay 
ATP levels are an indicator of 
metabolically active, viable cells; 
quantified by luminescence
cellular ATP (adenosine triphosphate) 
content 
Cell death via 
necrosis 
Increase in the leakiness of the 
plasma membrane; quantified by 
light absorbance 
LDH (lactate dehydrogenase) assay 
Cells with an intact cell 
membrane are able to prevent 
uptake of the dye; compromised 
cells however are colored blue 
within seconds of exposure; 
quantified by manual counting
Trypan Blue exclusion 
(PI) propidium iodide staining 
Apoptosis 
Staining of cleaved caspase 3/7, 
analysed by immunofluorescence 
staining or luminescence
caspase 3/7 staining 
Annexin V binds to phosphatidyl 
serine on the surface of apoptotic 
cells; quantified by flow 
cytometry 
annexin V–FITC (fluorescein isothiocyanate) 
staining 
ROS 
production 
Cell-free or in the presence of 
cells, The presence of ROS 
converts DCFH to 2,7-
dichlorofluorescein; analysis by 
fluorimetry or flow-cytometry
DCF(D)H (2,7-dichlorofluorescin) assay 
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General 
effect Read-out Assay 
Specific spin traps or probes 
allow for the quantification and 
specific identification of free 
radical species generated
EPR (Electroparamagnetic resonance) 
spectrometry 
Unwinding and linearization of a 
coiled bacterial DNA plasmid is 
used to estimate free radical 
and/or ROS exposure
plasmid assay 
For detection of superoxide, it 
exhibits blue-fluorescence in the 
cytosol until it's oxidized, where it 
intercalates within the cell's DNA, 
staining its nucleus a bright 
fluorescent red 
DHE (dihydroethidium) assay 
Oxidative 
stress 
Its reduced form acts as an 
antioxidant by reacting 
directly with ROS to neutralize 
them, the oxidized 
glutathione (GSSG) is formed and 
accumulated; protein contents 
are analysed 
GSH (glutathione) assay 
TBARS are formed as a byproduct 
of lipid peroxidation; 
colorimetrical quantification
lipid peroxidation (e.g thiobarbituric acid 
reactive substances (TBARS) assay) 
Quantification of mRNA 
expression changes of oxidative 
stress-dependent genes
e.g. HO-1 (heme oxygenase-1) 
Inflammation 
Detection of cytokine and/or 
chemokine protein production; 
colorimetrical quantification
ELISA (enzyme linked immunosorbent assay ) 
Quantification of mRNA 
expression changes of cytokine 
regulating genes 
e.g. TGFβ (tumor growth factor beta), IL-8 
(Interleukin 8) 
Genotoxicity 
Evaluation of clastogenic 
(chromosome breaking) effects; 
microscopical analysis 
alkaline comet assay 
micronucleus assay 
Specific comet assay: specific 
quantification of DNA double 
strand lesions  
neutral comet assay 
Specific comet assay: 
quantification of oxidative DNA 
adducts 
8-OHdG (8-hydroxydeoxyguanosine) 
formation 
Salmonella reverse mutation 
assay; quantification by counting 
of the mutants 
Ames test* 
*The Ames test has recently been described as not recommended for NMs by an OECD workshop 
(OECD, 2014d). 
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1.7.4 Grouping and read-across 
The concept of chemical category has been defined within the REACH technical guidance 
(ECHA, 2008) and the OECD grouping guidance (OECD, 2007c, 2014e) as follows:  
A chemical category is a group of chemicals whose physicochemical and human health 
and/or environmental toxicological properties and/or environmental fate properties are 
likely to be similar or follow a regular pattern as a result of structural similarity.  
In practical terms, this involves treating a group of similar substances as a category. Missing 
data on endpoints or properties within a category are predicted by read-across from data-
rich analogues within the category. 
The way in which similarity is defined within a group is essential to read-across. However, 
there is not a single way to measure/define it, and it can actually be endpoint-dependent. 
According to REACH and OECD guidance, similarities may be based on:  
• common functional group(s) e.g. aldehyde 
• common constituents or chemical classes, similar carbon range numbers e.g. UVCB 
substances (substance of Unknown or Variable composition, Complex reaction products or 
Biological materials) 
• an incremental and constant change across the category e.g. a chain-length category for 
boiling point range;  
• the likelihood of common precursors and/or breakdown products, via physical or biological 
processes, which result in structurally similar chemicals. 
The terms ‘category approach’ and ‘analogue approach’ are used to describe techniques for 
grouping chemicals. An analogue approach is often used when a chemical grouping is based 
on a very limited number of chemicals, typically two substances. A chemical category is used 
to describe a grouping of three or more chemicals.  The term read-across applies to both the 
category and analogue approaches. 
One of the key considerations in grouping and read across is to demonstrate that the 
grouping method is not invalidated by 'extrinsic' factors such as bioavailability, metabolism, 
or reactivity. This is especially relevant for NMs. Although the development of chemical 
categories and QSARs are underpinned by the same principles of chemical similarity, there is 
no formal process for validating a category, i.e. there is no official body like EURL-ECVAM to 
determine the validity of chemical categories. Nevertheless, a robust justification to 
demonstrate the scientific robustness of the data gap filling approach needs to be 
presented. In other words, there is a need to justify the read-across argument. This should 
be done using a standard document known as the Reporting Formats for the Analogue and 
Category Approaches (section 6.2.6 in ECHA 2008b).  
There is a preference for the use of interpolation within grouping approaches under REACH, 
presumably because this gives rise to less uncertainty than extrapolation. Extrapolation is 
therefore considered as less reliable due to this higher level of uncertainty associated with 
predictions. The exception to this is where an extrapolation from one substance to another 
leads to an equally severe or more severe hazard assessment for the target substance. 
Although it may seem logical to assume that interpolation is subject to less uncertainty than 
extrapolation, in reality the degree of uncertainty is not due to the interpolation or 
extrapolation of data, but rather the strength of the relationship forming the basis of the 
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category/analogue approach itself. This in turn is dependent on the size of the category and 
the amount and quality of the experimental data for the category members themselves. If 
the relationship underpinning the category is poorly defined then interpolation or 
extrapolation can result in significant uncertainty. 
In addition to the available regulatory guidance, practical guiding principles and 
considerations for developing analogue and category approaches are described in several 
papers (ECETOC, 2012; Patlewicz, Roberts, Aptula, Blackburn, & Hubesch, 2013; Wu, 
Blackburn, Amburgey, Jaworska, & Federle, 2010).  
It is important to bear in mind that there are no officially accepted chemical categories in the 
EU, so read-across arguments are presented (by the registrant) and evaluated (by the 
regulatory assessor) on a case-by-case basis. In order to ensure consistency in the 
evaluations of different assessors, ECHA is developing a Read-Across Assessment Framework 
(RAAF) for both human health and ecotoxicological effects. This is an attempt to identify the 
different kinds of arguments/hypotheses that can be made and the importance of 
confounding factors (e.g. differences in metabolism or mode of action between source and 
target chemicals). It also applies a scoring scheme to determine the validity of the read-
across argument. Further information can be found at: 
http://echa.europa.eu/en/support/grouping-of-substances-and-read-across 
While there is still considerable experience to be gained in the application of read-across to 
NMs, one can anticipate that the RAAF will need to be adapted at some point in order to 
better define and apply the concept of particle similarity. 
 
Read across and categories of nanomaterials 
In principle the development of categories of NMs should provide a valuable means of filling 
data gaps for the hazardous effects of NMs, especially in the absence of reliable QSARs. For 
the prediction of NM properties, three main kinds of read-across can be foreseen (even 
though strictly speaking the REACH legal text only refers to read-across  between different 
substances): 1) from bulk to all nanoforms, 2) from bulk to specific nanoforms, 3) from one 
or more nanoforms to one or more other nanoforms (nanoforms of different chemical 
identity, or the same chemical identity but with differences in physicochemical 
characteristics). 
As mentioned above, any grouping and read-across approach must be based on a robust 
scientific justification and the use of toxicologically relevant properties. It has been shown 
that the drivers for the toxicological effects of NMs include parameters such as composition 
(including the presence of impurities, coatings and surface treatment), shape and size, 
charge, surface reactivity, solubility, biological persistence, dispersibility, and the ability to 
translocate across biological barriers (Ken Donaldson & Poland, 2013). These properties are 
covered in Section 1.3.. 
1.7.5 Weight of evidence  
According to the REACH legal text, weight-of-evidence (WoE) is one of the options for 
meeting the information requirements while arguing that testing is not scientifically 
necessary. In particular, according to REACH Annex XI:  
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"There may be sufficient weight of evidence from several independent sources of 
information leading to the assumption/conclusion that a substance has or has not a 
particular dangerous property, while the information from each single source alone is 
regarded insufficient to support this notion. 
 
There may be sufficient weight of evidence from the use of newly developed test methods, 
not yet included in the test methods referred to in Article 13(3) or from an international 
test method recognised by the Commission or the Agency as being equivalent, leading to 
the conclusion that a substance has or has not a particular dangerous property. 
Where sufficient weight of evidence for the presence or absence of a particular dangerous 
property is available: 
- further testing on vertebrate animals for that property shall be omitted, 
- further testing not involving vertebrate animals may be omitted. 
In all cases adequate and reliable documentation shall be provided." 
 
While weight-of-evidence is a widely used scientific concept, the way in which it is applied is 
very heterogeneous. According to a review carried out by Linkov et al (2011), the term WoE 
can be found in the scientific literature with a variety of meanings, ranging from the purely 
colloquial use of the word to structured approaches to data integration and interpretation. 
Focusing on the structured approaches, and building on previous work (Chapman, 
McDonald, & Lawrence, 2010; Weed, 2005), Linkov et al. proposed a taxonomy of WoE 
methods, ranging from mainly qualitative approaches to increasingly more quantitative ones 
(Table 1.9). 
Table 1.9. Taxonomy of WoE methods (adapted from Linkov et al, 2012). The methods are 
listed in order of increasing quantitative rigour.  
Method Nature Description
Listing evidence Qualitative Presentation of individual lines of evidence 
without attempt to integrate them 
Best Professional 
Judgement 
Qualitative Qualitative integration of multiple lines of 
evidence, usually invoking a professional opinion 
Causal Criteria Semi-quantitative Use of a consistent set of criteria for determining 
cause and effect 
Logic Semi-quantitative Use of a systematic framework for evaluating 
multiple lines of evidence 
Scoring Quantitative Quantitative integration of multiple lines of 
evidence by applying (different) weights and 
ranking them 
Indexing Quantitative Weighting of multiple lines of evidence and 
integration into a single score (numerical value) 
Quantification Quantitative Use of formal decision analytic methods, such as 
Bayesian statistics or Multi-Criteria Decision 
Analysis (MCDA)  
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Guidance on how to apply WoE in REACH is given in an ECHA practical guide (ECHA, 2010b). 
The guide recommends that WoE arguments should take into account the reliability, 
relevance, adequacy and quantity of the individual lines of evidence. While the ECHA 
guidance does not make reference to the Linkov taxonomy, from the examples presented, it 
would appear to fall under the Best Professional Judgement Category, although more 
quantitative approaches are not excluded. 
EFSA has also developed guidance on "The Use of the Weight of Evidence Approach in 
Scientific Assessments", which at the time of writing (March 2017) was under public 
consultation (https://www.efsa.europa.eu/en/consultations/call/170306-0). 
 
1.7.6 Integrated Approaches to Testing and Assessment (IATA)  
Integrated assessment approaches are based on data generated by multiple alternative 
methods combined with other types of information (e.g. exposure considerations). These 
approaches have been developed to effectively and efficiently support decision making 
while reducing the reliance on animal testing. An IATA may include both formalised (e.g. in 
vitro prediction models and QSARs) and non-formalised methods (e.g. WoE and read-
across). 
The OECD (OECD, 2016c) defines an IATA as  
"An approach based on multiple information sources used for the hazard 
identification, hazard characterisation and/or safety assessment of chemicals. An 
IATA integrates and weights all relevant existing evidence and guides the targeted 
generation of new data, where required, to inform regulatory decision-making 
regarding potential hazard and/or risk. Within an IATA, data from various information 
sources (i.e. physicochemical properties, in silico models, grouping and read-across 
approaches, in vitro methods, in vivo tests and human data) are evaluated and 
integrated to draw conclusions on the hazard and/or risk of chemicals. " 
Formalised methods within an IATA are referred to as "defined approaches", which consist 
of a defined set of information sources and data interpretation procedure that converts the 
results of the information sources into a prediction of the property of interest. 
One of the first published IATA corresponds to skin corrosion and irritation (OECD, 2014f) 
and consists of three steps:  
1) Existing information (in vivo & in vitro data, PC properties, and non-testing 
methods like QSAR and read-across);   
2) WoE analysis;  
3) Additional testing.  
The WoE analysis (step 2) is carried out with the data obtained in step 1, which will mainly 
be obtained from literature, databases and other reliable sources of data. If the WoE is 
found conclusive, no more testing is needed. However, if it is found inconclusive step 3 will 
be used in order to obtain further data and re-evaluate step 2.  
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Essentially the same sequential strategy for skin irritation and/or corrosion is proposed in 
ECHA’s guidance on information requirements and Chemical Safety Assessment (ECHA, 
2014a), which also includes ITS for other human health and environmental effects. 
More recently, with the advent of the AOP approach, there have been discussions on the 
development and evaluation of AOP-informed IATA (OECD, 2016b). It has been concluded 
that the degree to which an IATA needs to be populated by a full complement of methods 
addressing each of the key events will be dependent on the ultimate purpose it is being used 
for. For chemical categorisation purposes, e.g. to facilitate read-across, it is conceivable that 
using approaches to address the first key event, the molecular initiating event, might suffice. 
Whereas, if a risk assessment decision is being made where uncertainty needs to be 
minimized as far as possible, generating information to address a number of other key 
events and their quantitative relationship with the adverse outcome as well as information 
on the expected exposure may be necessary. Thus flexibility is foreseen in the choice of the 
various information sources depending on the purpose of the IATA and the substance under 
investigation.  
 
1.8 Concluding remarks 
 
In this chapter, we have summarised the REACH information requirements for NMs, with 
reference to the state-of-play in terms of possible amendment of the Annexes to the REACH 
Regulation and respective guidance. In addition, we have given an overview of the scientific 
basis for understanding the behaviour (fate and effects) of NMs, as well the different types 
of non-animal methods and approaches that are under development to determine the 
properties of NMs. This information provides the context and background information for 
the work presented in the rest of this report. 
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2 Review of computational tools and grouping approaches for nanomaterials 
 
2.1 Introduction 
This chapter discusses the practical considerations and opportunities in developing 
predictive models for the toxicity and fate of NMs. The first part presents an overview of 
software tools that are available, or under development, with emphasis on the different 
kinds of modelling approaches adopted. An in depth description of the literature-based 
models is given in Chapter 3. The second part of the chapter includes experience in the 
grouping of NMs for the purpose of read-across, and proposals for NM categorisation 
schemes. 
 
2.2 Practical considerations in developing and applying predictive tools 
Developing a predictive model consists of finding a (mathematical) relation between an 
endpoint (e.g. biological activity) and a more fundamental property (or set of properties) for 
a given group of substances. There are three key points that will determine the quality of the 
prediction tool: unequivocal identification of the substance, high quality data at both ends of 
the mathematical equation and “well behaved” data trends.  
 
2.2.1 Unique identification 
In order to have robust relationships between properties and activities, it must be assured 
that the property and activity that we are trying to relate, e.g. cytotoxicity and conduction 
band of nanomaterials, correspond to exactly the same substance. This is a relatively simple 
task in the chemicals world as the chemical structure uniquely defines a chemical identity. In 
addition, the IUPAC nomenclature provides chemical names that unequivocally define 
chemical structures and from which structural variations can be understood, e.g. methyl-, 
ethyl-, propyl-, etc. Even the smallest variations in structure can imply different activities as 
may occur between enantiomeric forms, which are compounds that have identical 
composition but different positioning of substituents. The most famous case is probably the 
different biological activities of the R and S forms of thalidomide(Lenz, 1988). Thus, it is clear 
that the identification of substances is crucial. In the case of NM there is not (yet) a 
nomenclature that unequivocally defines a NM entity of a given composition, i.e. a 
nanoform. In fact, the generation of such a nomenclature is a big challenge given that (in 
addition to composition) small variations in size, coating, impurities, synthetic route, or 
crystalline structure can lead to completely diverse biological activities. The main use of such 
a nomenclature will correspond to the distinction between bulk material and nanoforms, 
although the distinctions between nanoforms may also become crucial if different 
nanoforms show different activities (Gerloff et al., 2012a; Uboldi et al., 2016). 
At present, and probably in the short- and mid-term future, the only way to determine 
whether two nanoforms are the same is to carry out an extensive characterization process. 
Characterization of nanoforms and/or nanomaterials is a complex issue. The NanoDefine FP7 
project (NanoDefine, 2013) will produce guidance on the nanomaterial characterization 
process to identify/classify any substance or mixture in accordance with the EC 
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recommendation for the definition of nanomaterial (2011/696/EU). NanoDefine focuses on 
the following characteristics in order to identify a nanomaterial: 
• Type of matrix (only for consumer products containing NMs) 
• Chemical composition 
• Nanoscaled dimensions and shape 
• Presence of different sized particles 
• Trade form and dispersibility 
• Stability of particles during testing 
• Specific properties 
 
Each of these properties is further subdivided into more specific ones like the types of 
composite (core/shell, multiple coatings, mix of two or more materials) or whether the 
material can be dispersed in specific media. The reader is referred to the original source for 
further details (Gaillard, Mech, & Rauscher, 2015). 
One of the main contributions to a nano-specific nomenclature that can allow for a unique 
identification of NMs is the one proposed in 2009 by Gentleman & Chan. It consists of a 
hierarchical codification system reminiscent of library classification taxonomies. In practice, 
it is a string of fields with typographic codes addressing composition, size, shape, and 
physicochemical properties. An example is shown below: 
"Chemical Class"-"Size and shape"-"Core chemistry"-"Ligand chemistry"-"Solubility" 
The full codification system is shown in Table 2.1. Such a format is designed to facilitate 
digital archiving and searching. The identity of the nanostructures can be directly read from 
the code, and the codes are relatively short compared to the complexity of the structures 
they define. It is reminiscent of the IUPAC chemical nomenclature. For instance, alcohols are 
indicated as –ol and a number indicates its position in a chain (i.e. 2-butanol). With Gentle 
and Chapman nomenclature, numbers can indicate the type of substance (i.e. organic or 
inorganic NM), as well as size, depending on the field in which the number belongs to. For 
instance, 2-90H(6)-(Pb,S) corresponds to:  
 
• 2 indicates inorganic 
• 90H(6) indicates size 90 nm of a polyhedron with 6 faces (a cube) 
• (Pb,S) indicates the composition of the NM  
 
This nomenclature allows the easy comparison of NMs by stripping its names. For instance, 
the third field (Core chemistry) can be used to group NMs that have a core that contains Au, 
or the last field (Solubility) can be used to group NMs by a measure of solubility (e.g. logD). 
More details and examples can be found in Table 2.2.. 
Another nomenclature presented for annotating NMs formulations and its material parts or 
entities based on computable string expressions was proposed by Thomas et al. (2012). The 
string expression also consists of numbered labels separated by hyphens, e.g. F1-N1-M1, F1-
N2-M1, or F1-N2-S1 (see Table 2.2). The labels correspond to unique material parts and in 
practice indicate whether it is the whole nanoparticle formulation itself or one of its parts. 
The numbers are key in this nomenclature as they ultimately differentiate each of the parts, 
i.e. F1 corresponds to the first formulation of a database (e.g. Au NP), F2 to the second (e.g. 
 81 
 
SiO2 NM), and so on. Similarly, D1 would correspond to a specific medium like deionised 
water, D2 to another specific medium like glycerin, and so forth (see Table 2.3 for more 
examples). These numbers are predefined and follow the NanoParticle Ontology (NPO), 
which can be accessed at http://purl.bioontology.org/ontology/npo.  
Another nomenclature that has a more atomistic character was proposed by Toropov and 
Leszczynski (2006). Most of their examples correspond to bulk material, but it can be applied 
to any NM. They proposed a SMILES-like nomenclature for nanomaterials that contain data 
on atom composition and technological conditions of the synthesis of the nanomaterials. 
The SMILES-like codes were used to define descriptors that were ultimately used to predict 
Young's modulus (elasticity) of NMs.  
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Table 2.1. Codification protocols of the nanomaterial nomenclature proposed by Gentleman and Chan. 
Chemical class Size and shape core chemistry ligand chemistry Solubility 
XT1T2 r(re)M1M1b(m2)M3M4M5 (Z1,Z2,...,Zn) [(fi,fe)1;(fi,fe)2;...;(fi,fe)n] S[log D(pH)] 
X 
1 if organic/ fullerene 
(contains no metals) r 
smallest defining dimension 
in nm 0 if no core 0 if no ligands S  
2 if inorganic/ 
organometallic re 
other defining size (if 
applicable) 
Z1, 
Z2,..Z
n 
list core elements in conventional 
order; dopants can be included if 
known 
fi (see functional group code) on inside/adsorbed to core O if logD>1 
T1 
1=outermost chemistry 
M1 
B=ball  / indicates inter-core boundary, for example (CD,Se/Zn,S) is a core/shell fe 
(see functional group code) outer 
functional group W if logD<-1 
D=dendrimer  H=polyhedron/faceted 
    
/  
indicates multilayer structures, for 
example [(fi,fe)/(fi,fe)] is a bilayer for 
nested structures, only indicate 
outermost shell 
OW if -1<logD<1 
F=fullerene R=rod/wire     
bioconjugation[(fi,fe/Bio)] or [(fi,Bio)] 
sheet structure, list twice, for example 
CNT [(Ful,Ful)] 
  
indicate logD and 
pH of measurement 
(if known) 
L=liposome  P=plate/disc/well   
P=polymer M1b (M1 
value not 
necessary) 
A=astral(not after B) 
 
T2 N=nested I=irregular 
  
m2 (omit if 
unknown) 
B(b),b=# radii: 1- spheroid 
2-ellipsoid 
H(h), h=# faces 
R(r), r=# barrel faces, 0= 
cilinder 
P(p),p=# sides, 0=circle 
A(a),a=# arms 
M3 L if elongated 
M4 T if teethed/ jagged edges 
M5 C if coiled/helical/twisted 
 
Some examples are:  
NM Code NM Code
~90nm wide PbS nanocubes aminoalkane cap 2-90H(6)-(Pb,S)-[(Amn,Alk)]-O 20-nm thick ZnO nanohelices, no cap 2-20P(4)LT-(Zn,O)-0-W 
20-nm thick ZnO nanohelices, no cap 2-20P(4)LT-(Zn,O)-0-W 7-nm diameter fullerene MWNT 1FN-7RL-0-[(Ful,Ful)]-O 
Gd atom inside hydroxylated buckyball [Gd@C82(OH)16]
7-nm 2F-1B(1)-(Gd)-[(Ful,Ful);(Ful,Alc)]-O 
4-nm diameter CdSe NC capped with PAMAM 
dendrimer 2D-4H-(Cd,Se)-[(Amn,Amn)-O 
57-nm diameter silica-coated Au NPs; poly(DMAEMA) cap biofunctionalized 2-57B(1)-(Au/Si,O)-P[(Amn,Acr/Bio)]-W r-nm diameter star polymer 50% alkyl, 50% hydroxyl 1P-rA-(C)-[(Bnz,Alk);(Bnz,Alc)]-O 
Abbreviations for functional groups used in ligand chemistry field
Functional 
Group Abbrev         
acyl halide Ach haloalkane Hak phehyl/benzyl Bnz phosphine oxide Pox leucine Leu 
alanine Ala hydroxyperoxide Hoo carbonate Cba phosphodiester Pde lysine Lys 
acrylic Acr imine Imn cyanide Cyd phosphate Pha methionine Met 
arginine Arg imide Imd isocyanide Icy phosphonic acid Poa phenylalanin Phe 
alcohol Alc ketone Ket cyanate Cya pyridine Pyr proline Pro 
aldehyde Ald nitrate Nta isocyanate Ica sulphide Sde serine Ser 
alkyl Alk nitrile Ntl thiocyanate Tca sulphone Soo threonine Thr 
amide Amd nitro Nto isothiocyanate Itc sulphonic acid Soa tryptophan Try 
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Table 2.2. Definition of the labels proposed by Thomas et al.  
Label Definition 
F Nanoparticle formulation (NPO_868)Error! Bookmark not defined.* 
N Nanoparticle component (NPO_1496) or nanoparticle (NPO_707) 
D Medium (NPO_1853) 
S 
Structural parts of a nanoparticle like coat (NPO_1367), core (NPO_1617), 
and shell (NPO_760); structural parts of complex organic molecules (e.g., 
the core and branches of a dendrimer); other structural parts like a spacer 
molecule (NPO_485) 
M 
All chemical component parts other than the nanoparticle (N): molecular 
components of the nanoparticle (N), of the medium (D), and of any 
structural part (S) 
L Linkages (NPO_195) of a nanoparticle formulation: covalent linkage (NPO_563), encapsulation (NPO_138), and entrapment (NPO_471) 
*NPO codes correspond to the labels of the Nanoparticle Ontology (http://www.nano-
ontology.org/documentation/codes-for-npo-terms) 
Table 2.3. Examples of strings annotating NMs. 
Label 
pairs String examples String interpretation 
F#-N# F1-N1, F1-N2 
F1-N1 and F1-N2 are two types of 
nanoparticles in the nanoparticle formulation, 
F1. 
N#-M# F1-N1-M1, F1-N1-M2 F1-N1-M1 and F1-N1-M2 are molecular components of the nanoparticle, F1-N1 
N#-S# F1-N2-S1 F1-N2-S1 is a structural part of the nanoparticle, F1-N2 
M#-S# F1-M1-S1, F1-M1-S2, F1-M1-S3 
F1-M1-S1, F1-M1-S2, F1-M1-S3 are structural 
parts of a molecular component (e.g., a 
complex organic molecule), F1-M1. 
S#-M# F1-N2-S1-M1, F1-N2-M1-S1-M1 
F1-N2-S1-M1 is a molecular component of the 
structural part F1- N2-S1. F1-N2-M1-S1-M1 is a 
molecular component of the structural part 
F1-N2-M1-S1 
F#-D# F1-D1 F1-D1 is a medium of the nanoparticle formulation, F1. 
D#-M# F1-D1-M1,F1D1-M2 F1-D1-M1 and F1-D1-M2 are molecular components of the medium, F1-D1. 
F#-M# F1-M1,F1-M2 
F1-M1 and F1-M2 are chemical component 
parts (other than the nanoparticle) of the 
nanoparticle formulation, F1. 
M#-M# F1-N2-S1-M1-M1, F1-N2-S1-M1-M2 
F1-N2-S1-M1-M1 and F1-N2-S1-M1-M2 are 
molecular components of F1-N2-S1-M1. 
F#-
L#[...;...] 
F1-L1[F1-N1;F1-N2], 
F1-L2[F1-N1-M2; F1-
M2] 
There is a linkage, F1-L1, existing between the 
two nanoparticles, F1-N1 and F1-N2. There is a 
linkage, F1-L2, existing between the molecular 
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Label 
pairs String examples String interpretation 
components, F1-N1-M2 and F1-M2. 
 
The SMILES-like nomenclature contains information on atom composition (Al, Ti, Zr, O, … ), 
type of substance (bulk or not), and the temperature of synthesis (coded by labels, i.e. 
a=20ºC, A=22ºC, B=25ºC, C=400ºC, …M=1500ºC)  
For instance a ceramic nanomaterial composed of ZrO2 synthesised at 1200 ºC would be 
coded as Zr,O,O,CER,%H. One of the shortcomings of this nomenclature is that it is 
restricted to encoding the available information on the synthesis of the NMs. 
Another proposal for the nomenclature of nanomaterials is the Curly-braces enhanced 
Smart Material Input Line Entry Specification (CurlySMILES) (Drefahl, 2011). CurlySMILES is a 
chemical language for the specification of chemical materials and supramolecular 
structures. It provides a format to encode molecular details and extra-molecular features 
such as non-covalent interactions and attachment to a biomolecule as well as the surface of 
a substrate material or nanoparticle.  
The CurlySmiles notation is a string of dot-separated component notations. For instance, 
NaAlH4 would be represented as: 
[Na+].[AlH4-] 
A component notation can consist of a plain SMILES, an annotated SMILES, or a special 
format notation. A plain notation maintains the grammar and rules of the known SMILES 
language and is modified by introducing attributes (e.g. structural variations, details and 
decorations) enclosed in curly braces. An annotation can be anchored to a particular atomic 
node or placed at the end of a SMILES component. For instance, oleic acid (cis form) would 
be represented as: 
O=C(O)CCCCCCCC=C{Z}CCCCCCCC 
A special format notation begins with an opening ({) and ends with a closing curly brace (}) 
and includes an alias or a notation for a structure that defies molecular-graph encoding. 
There are different types of special format notations. The most relevant for nanomaterials 
are the shape and state annotation markers (SSAM). These, correspond to a series of codes 
accounting for information like nanocrystal (nc), nanodisk (nd), nanoparticle (np), or 
nanowire (nw). They also encode information such as the crystal state (cr), allotrop name, or 
phase name (phn) (see http://www.axeleratio.com/csm/proj/stateshapeann.htm for a list of 
SSAM and definitions. For instance, diamond would be represented as: 
[C]{crall=diamond} 
Materials with known atomic or substructural stoichiometry, but without a discrete pattern 
of finite atom connectivity (molecular structure), e.g. such as minerals are defined by 
stoichiometric formula notation (SFN), which is a variation of the special format notation as 
it begins with ({*) and ends with a curly brace (}). For instance, titanium dioxide (anatase) 
would be represented as:  
{*TiO2}{crphn=anatase} 
 85 
 
Unfortunately, besides the efforts put into developing nomenclatures, none of the ones 
presented here have been considered for the databases available today. However, not all 
the areas of nanochemistry are missing nomenclatures, for instance fullerenes and 
dendrimers have well-established nomenclatures (Friedhofen & Vögtle, 2006; Godly & 
Taylor, 1997; Goodson, Gladys, & Worst, 1995) and there is an ongoing IUPAC project 
dedicated to the nomenclature of CNTs and related substances (Project No.:2013-056-1-
800).   
Nomenclatures are implicitly linked to ontologies and databases since an ontology is a 
formalised system that captures the relationships between different concepts / terms (i.e. 
database objects). Ontologies are further discussed in chapter 2.2 together with databases 
for NMs.  
2.2.2 High quality data at both ends of the mathematical model 
One of the main problems that were encountered with the first data generated for 
nanomaterial was the variability. For instance, it was observed in the ENPRA project that 
some cell lines showed very high cytotoxicity for all NMs, while others showed no cytotoxic 
effects at all. Coefficient variations of >30% were not rare in ENPRA and NanoTest, and the 
Nanogenotox project showed some between laboratory variability when measuring particle 
size for the very same particles with a precise technique like TEM (c.a. 20nm).  
The quality of a predictive model depends on the underlying quality (reliability and 
relevance) of the data from which the model is built. Any QSAR model, for example, is based 
on two sets of data: a) properties and b) activities. In relation to data reliability, it must be 
taken into account that all experimental measurements are subject to experimental 
variability, which is the consequence of the presence of systematic and/or random errors in 
the measurements. High quality data is thus data that is obtained by minimising this 
variability as far as practically possible. Assuming that it is impossible to remove all sources 
of variability, the practices listed below help to minimise them: 
• Use data obtained with the same experimental protocol and preferably a standardised 
guideline 
• Use data measured in the same laboratory and by the same personnel, if possible 
• Use data on the very same endpoint 
• Use data from compounds that are suitable for the test system, e.g. solubility, volatility, etc.  
 
The reader is referred to the list of existing methods for the measurement of NM 
physicochemical (PC) properties (Table 1.2), and the list of endpoints and related methods 
(Table 1.3) that were presented in chapter 1. ISO standards and OECD TG for the specific 
methods are also included in the tables. Moreover, a detailed review of test methods to 
determine composition, size, shape, dissolvability, dispersibility, and stability including with 
performances, applicability domains is provided by Gaillard et al. (2015). The use of 
standardised tests should assure that the procedures used by two different persons in two 
different laboratories to measure the same property/endpoint are in fact the same and that 
the variability that arises from technicalities like time of exposure, bath temperature, or 
dispersion protocols, are minimised. These steps are important since NMs are suspensions 
of solids that are subject to many effects such as surface charge, 
aggregation/agglomeration, adsorption, or temperature that can have huge impact in final 
measurements. Only by using data that has been obtained with the same experimental 
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techniques on the very same endpoint increases the quality of the model, but it tends to 
reduce the number of data available for the model development (or for category 
formation). Therefore, it is necessary to decide on a suitable trade-off between the amount 
of data used and the overall data quality needed. It is not recommended to use data for 
modelling that has been generated with methods not suitable for testing the specific 
compounds. This is a problem with NMs as many of the testing methods are well stablished 
for chemicals and have just been adopted for NMs. The applicability or interference of the 
methods is not assured for all NMs as many of them are metals that may interfere with the 
test read-out. Due to the lack of standards it is not easy to identify such interferences. For 
example, in spectrophotometry based tests like MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) (Mosmann, 1983), the NM can mask the read-out (Kroll, 
Pillukat, Hahn, & Schnekenburger, 2009, 2012), or Ag NPs can interfere with the Griess 
reaction (Kaempfer et al., 2017).  
Evaluation criteria to determine the quality of published experimental data, similar to the 
Klimisch classification (1997), has been proposed (Lubinski et al., 2013). It consists of a two-
dimensional classification indicating the quality of the data and the usefulness for 
nanoQSAR modelling. The categories are shown in Table 2.4. Each category is determined 
based on a series of characteristics such as number of data points, data obtained from a 
single source, experiments carried out according to GLP, degree of characterisation of NPs, 
etc. The list of properties that determine each category can be found in the original work.  
 
Table 2.4. Lubinski et al. categories to determine data quality and usefulness for QSPR and 
QSPR 
Data quality Data usefulness 
1+ 1+ Reliable with additional information A+ 
A+ useful for constructing a 
single nano-QSPR/nano-QSAR 
1 1 Reliable A A Useful 
2 2 Reliable with restrictions B B Useful with restrictions 
3 3 Unreliable C C Limited use 
4 4 Not assignable D D Not assignable 
 
Test Guidelines will need to be more detailed for NMs as some of the aspects mentioned 
above are often not included in guidelines addressed for chemicals and even many details 
are often overlooked in NM publications. The OECD Working Party on Manufactured 
Nanomaterials (WPMN) has focused on developing appropriate methods and strategies to 
address potential safety concerns of NMs. Among others, OECD has been evaluating the 
guidelines for their adequacy to appropriately address the characterisation of NMs and the 
assessment of their toxicological properties. The guidance on sample preparation and 
dosimetry for the safety testing of manufactured nanomaterials (ENV/JM/MONO(2012)40) 
(OECD, 2012a) refers specifically to water-insoluble manufactured nanomaterials, including 
those that can release soluble species, e.g. silver, as it is considered that soluble 
nanomaterials are unlikely to need different sample preparation techniques than other 
chemicals, apart from precautions dictated by the specific reactivity of each material. This 
document provides guidance relevant to sample preparation and dosimetry for 
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physicochemical characterisation, ecotoxicity studies, degradation, transformation and 
accumulation studies, and health effects. For example, concerning OECD TG 413 (Subchronic 
Inhalation Toxicity: 90-day Study), the OECD WPMN recommended modifications addressing 
the inclusion of BAL (broncho-alveolar lavage) studies for particles and NPs, the 
development of better guidance criteria for establishing a no observed adverse effect level 
(NOAEL) or benchmark dose (BMD) and consideration of cell proliferation (BrdU) of various 
components of the respiratory tract.  
 
2.2.3 Well behaved data trends 
"Well behaved" data translates into gradual behaviour (activity) with respect to specific 
properties or combination of properties (descriptors). When the activity of a test substance 
gradually increases with the gradual increase of another property, its behaviour is in general 
easier to predict than when there are sudden changes in activity. Well behaved data is often 
compared to a smooth mountain landscape, where the height is the activity and the space 
coordinates are a set of given properties. Unfortunately the real world, e.g. toxicology, drug 
discovery, or environmental toxicology is usually not similar to a smooth landscape but 
rather a harsh landscape plenty of cliffs. This implies that linear models, like regression 
QSARs, or models that are continuous have big difficulties in predicting landscapes that are 
not linear or continuous (Maggiora, 2006). Thus, trying to predict activities that do not show 
a gradual behaviour with rather simple linear equations is difficult and subject to a number 
of pitfalls. Some possibilities consist of defining smaller applicability domains for which the 
trends are kept, or transforming the continuous variables into discrete bins that allow for 
classification algorithm. Some authors have transformed specific dependent variables (e.g. 
cytotoxicity, membrane permeability, ROS) into more generic variables such as "toxicity", 
which turned out to be easier to model (Rong Liu et al., 2013b). Other possibilities include 
the use of different modelling techniques such as neural networks or support vector 
machines, which are usually considered to be "black boxes" as they are difficult to interpret, 
but that result more appropriate to deal with activity cliffs. 
 
2.2.4 Lack of data and/or knowledge 
In addition to uncertainties arising from data reliability (variability) described above, there is 
also uncertainty that results from lack of data and/or knowledge. In principle, data 
variability cannot be completely avoided, even though it can be minimised and 
characterised. In contrast, uncertainty can be reduced by obtaining more data and by better 
understanding its predictive relevance (WHO, 2014).  
Thus, an important consideration in any predictive approach, including QSAR/QSPR, 
grouping for read-across, is the lack of knowledge on the specific modes of action that 
determine the ultimate outcome/activity. When dealing with chemicals, very specific 
chemical or atomic properties, usually computationally derived such as logP, 
electronegativity (Hansch, 1969), or the simple presence or absence of reactive groups, are 
used to predict toxicological outcomes. Due to the relative novelty of nanotechnology and 
the big challenge that NMs represent for computational scientists – nanomaterials do not 
have a well-defined structure and are too big to be easily calculated with traditional 
computational models that are meant for structures of less than 3000 atoms – are the main 
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causes for which there is not (yet) a well-established set of computational properties that 
can determine toxicological outcomes. The lack of computational properties does not 
preclude the modelling activity as measured PC properties can be used as model 
descriptors, although the availability of data is then significantly limited. In fact, there are a 
number of PC properties that can be experimentally measured on NMs (see Table 1.2 of 
chapter 1), however it is common practice in the literature to limit the PC characterization 
to measures of size, size distribution, zeta potential, and crystalline structure (Lubinski et al., 
2013). Thus, in practice there is a lack of computationally derived descriptors and of 
experimental properties measured consistently for a diverse enough group of NMs. 
However, some advances are being made. For instance, heat of formation, which is a 
surrogate of redox activity (Burello & Worth, 2011a), seems to be one of the few properties 
that can be used to predict cellular effects like cytotoxicity (Tomasz Puzyn et al., 2011b). Its 
extrapolation to in vivo effects is more complex, although it has been shown that together 
with solubility it relates to pulmonary inflammation (Haiyuan Zhang et al., 2012a).  
 
2.3 Models and tools for environmental behaviour and toxicity prediction 
The different databases, tools, and models like QSARs, QSPRs, or PBTK that are available for 
NMs and that could be used in a modelling context are presented in this section.  
2.3.1 Databases 
The list of databases related to NMs is presented in the table below together with a short 
description and the links where they can be found. In general, most databases have fully or 
partially restricted access to data except for eNanomapper, NBI, and Nanomaterial registry, 
which can be accessed directly. Some of them offer free registration procedures that in 
principle allow access to data, but in practice, we encountered a number of difficulties 
(Table 2.5). Overall, the information that is readily available is scarce.  
 
Table 2.5. Existing databases for NM properties 
Name & Link Description and comments on utility 
NanoHub/Nano
material registry 
 
https://nanohub.
org/  
 
https://www.nan
omaterialregistry
.org 
 
https://www.nan
omaterialregistry
.org/Search.aspx 
 
The Nanomaterial Registry, sponsored by NIH, is a central registry and 
growing repository of publicly-available nanomaterial data which are fully 
curated based upon a set of Minimal Information about Nanomaterials 
(MIAN). Each nanomaterial curated into the Registry will provide the following 
information from a data source, when available: 
 
• Physical characteristics – values, protocols, metadata 
• Information on the related biological and/or environmental studies 
• Instance of Characterization information – preparation, synthesis, and 
time frame leading up to the nanomaterial characterization 
• Validation back to the Data Source – scholarly article  
Comments: 
• The system allows searches based on size, agglomeration states, size 
distribution, surface area, shape, composition, purity, surface charge, 
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Name & Link Description and comments on utility 
surface chemistry and reactivity, solubility, stability, type of biological 
or environmental study, data source, and degree of compliance level.  
• Biological and environmental data present in the database cannot be 
downloaded, only physicochemical properties can be exported.  
• The data on physicochemical properties can be exported as an xls file. 
• The interface of the webpage is well designed but it is slow at showing 
the filtered data or browsing across pages. Only 3 nanoforms can be 
compared simultaneously. 
NHECD 
 
http://www.nhec
d-fp7.eu/ 
 
 
 
NHECD is a free access, robust and sustainable web based information system 
including a knowledge repository on the impact of nanoparticles on health, 
safety and the environment. It includes unstructured data (e.g., scientific 
papers and other relevant publications) and a mechanism for updating its 
knowledge repository, thus enabling the creation of a large and developing 
collection of published data on environmental and health effects following 
exposure to nanoparticles. 
The system allows for basic, advanced, intelligent and taxonomic level search 
features, depending on the specifics required during the retrieval process. 
This provides a comprehensive solution to wading through copious amounts 
of information, and provides the user with an option to make either a general 
or specialised search.  
 
Comments: 
• The system allows to search by model, experiment or nanoparticle 
attributes among others fields. 
• The database is not accessible (December '15) 
caNanoLab 
 
https://caNanoLa
b.nci.nih.gov 
 
caNanoLab is a data sharing portal that contains: 
• Nanotechnology protocols in biomedicine 
• Composition of nanomaterials 
• Functions of nanomaterials (for example, therapeutic, targeting, 
diagnostic imaging) 
• Physico-chemical characterizations including size, molecular weight, 
shape, physical state, surface chemistry, purity, solubility, and 
relaxivity 
• In Vitro characterizations such as cytotoxicity, blood contact 
properties, oxidative stress, and immune cell functions 
• Publications and reports from nanotechnology studies in biomedicine 
 
Comments: 
• The webportal is very comprehensive with a dedicated wiki 
• Some data is publicly available but most of it has restricted access 
• Data cannot be downloaded, only presence of data is shown on the 
record  
• Any person can ask for a user account that allows access to a personal 
restricted space and to upload data. Groups can also be created 
• The search queries are rather slow  
PaFTox 
 
http://fraunhofer
-repdose.de/ 
This is an extension of the already existing data for chemicals RepDose. In 
general, data on application route, nanoscale dimension, reliability, species 
and study duration are included in the database. In addition, each entry is 
given a quality criteria (Bitsch et al., 2006).  
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Name & Link Description and comments on utility 
 Membership is needed in order to access the database. The membership is 
free and can be obtained directly on the website, although it is not 
immediate, a couple of days may be necessary to obtain the login details. 
The dataset was filled with data preferentially obtained from inhalation 
studies. Regarding the data contained in the database:  
• Particle data contains: Specifications of primary object by 
producer/supplier and authors, and secondary object by authors. Size 
/ distribution, aggregation/agglomeration state in the exposure 
media, shape, specific surface area, composition / purity, surface 
chemistry, solubility / dispersibility, and surface charge. 
• Study part contains: application type, exposure, instillation (number, 
frequency), post-exposure duration, species/strain/sex, number of 
animals, particle and fibre characteristic as administered (secondary 
object), reference, reliability, scope of study. 
• Toxicological data is aimed at in vivo studies, therefore the database 
is designed to accommodate organ related data. A complete review of 
the database can be found in Schröder et al. 2014 (Schröder et al., 
2014). 
 
Comments: 
• Not accessible.  
NBI 
 
http://nbi.oregon
state.edu/ 
 
The NBI Knowledgebase is intended to offer industry, academia, the general 
public, and regulatory agencies a mechanism to rationally inquire for unbiased 
interpretation of nanomaterial exposure effects in biological systems. 
The knowledgebase serves as a repository for annotated data on 
nanomaterial characterization (purity, size, shape, charge, composition, 
functionalization, agglomeration state), synthesis methods, and 
nanomaterial-biological interactions (beneficial, benign or deleterious) defined 
at multiple levels of biological organization (molecular, cellular, organismal) 
 
Comments: 
• NMs can be searched by their composition, core, decorations, size, 
and other parameters. Concentration of NM in zebrafish after 
exposure is the main biological data found on the database.  
• The database is easily searchable, and the data is easily 
downloadable. The data is more abundant on dendrimers and 
nanocellulose than on metal and metal oxides.  
NanoDatabank 
 
http://nanoinfo.o
rg/nanodatabank
/ 
 
NanoDatabank consists of a repository and database system of engineered 
nanomaterial (ENM) properties, experimental and simulation datasets of ENM 
fate and transport (F&T), as well as toxicity data. Login can be done as guest, 
lab administrator or system administrator. NanoDatabank contains a number 
of databases that include: 
• Physiocochemical properties 
• Toxicological properties 
• Experimental datasets of ENM toxicity 
• Experimental datasets of ENM fate and transport behaviour 
• Results of simulation predictions and estimation of ENM toxicity and 
fate behaviour 
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Name & Link Description and comments on utility 
Comments: 
• Membership is required to access the data, and such a procedure is 
not completed after one week. 
Nanotechnology 
Information 
Library 
 
http://nanoparticl
elibrary.net/ 
 
The goal of the NIL is to help occupational health professionals, industrial 
users, worker groups, and researchers organize and share information on 
nanomaterials, including their health and safety-associated properties. NIOSH 
has released the NIL web resource in draft form for public review and 
feedback.  
 
Comments: 
• The database can be browsed and it mainly consists of summaries of 
publications indicating composition, size, and a link to the original 
source.  
• No activity/toxicity data is currently included in the database 
Enanomapper 
 
https://apps.idea
consult.net/enan
omapper/ 
 
It is a public database hosting nanomaterials characterization data and 
biological and toxicological information. The database provides various 
possibilities to search and explore information, and to download data in 
various standard formats. The database supports data upload through 
configurable Excel templates. It currently contains data from MARINA and 
MODENA FP7 projects as well as from other sources such as the JRC 
repository or an inventory of Sigma-Aldrich nanomaterials.  
 
Comments: 
• The webpage allows searches of nanomaterials by identifier, citation, 
physicochemical properties, biological effects, composition, study 
purpose, protocol, guideline, or by free text.  
• The data can be browsed and viewed on the web without need of 
downloading it. The browsing experience is smooth and the data can 
be downloaded in different formats, i.e. xls, csv, json.  
• The dataset is fully open source and can be found on 
http://ambit.sourceforge.net/. A tool to download IUCLID 5 data is also 
available on the website. 
• At the moment the database content on biological data is a bit scarce, 
although probably projects of the Nanosafety cluster will upload their 
data once finished. 
Modern Project 
 
http://modern-
fp7.biocenit.cat/ 
 
• The modern project has set up a database in ISA-TAB-Nano standard 
format (Robinson, Cronin, Richarz, & Rallo, 2015) which can 
accommodate all types of data, e.g. toxicity, physicochemical 
properties. It is intended to accommodate non-structured data from 
various projects like PreNanoTox, QualityNano, MARINA, NanoFATE, 
and MODENA action COST.  
 
Comments: 
• The database is only accessible to members of the consortium.  
Nanopuzzles  
http://nanopuzzl
es.eu/ 
A database on ISA-TAB-Nano format with data obtained from the literature 
including physicochemical properties of NMs and activities such as 
cytotoxicity or zebra fish mortality was collected by the different partners of 
the Nanopuzzles project and can be downloaded freely at: 
http://zenodo.org/record/35493#.Vp5z10YXzw0 
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Name & Link Description and comments on utility 
 
BAM 
http://www.nano
.bam.de 
 
https://www.we
bshop.bam.de/de
fault.php?cPath=
2282 
The web portal holds a registry of reference nanomaterials with data on 
composition, size, and data found on the safety data sheets.  
 
Comments: 
• The webportal is not a database per se, but includes a list of products 
with some properties.  
• No biological data is included in the list. 
• Some information is found in German, only. 
Nanohub JRC 
http://www.nano
hub.eu/ 
 
Nanohub JRC is a respository of all the data generated in a number of 
European and OECD projects on nanotechnology, i.e. ENPRA, MARINA, 
NANoREG, OECD-WPMN Gold, OECD-PROSPECT, etc.  
 
Comments: 
• The database is not web-based. It is necessary to run a java based 
client that requires the installation of Java Runtime Environment. 
• The address does not exist anymore (March 2017)  
Nanomaterials 
registry 
 
https://www.hea
lthdata.gov/datas
et/nanomaterial-
registry  
 
This nanomaterial registry aims at providing consistent information on the 
biological and environmental interactions of NMs, as well as links to 
associated publications, modelling tools, computational results.  
Beyond the possibility to search for NMs on physicochemical properties and 
categories of NMs, it gives the possibility to identify similar NMs based on 
physicochemical properties. 
Nano 
 
http://nano.natur
e.com/ 
Nano reports information extracted by indexed papers NMs and nanodevices. 
Each entry is linked to the source paper and the information is structured as 
follows: structure, size, composition, properties, characterisation methods, 
toxicity and biological effects, preparation/synthesis methods, applications, 
patents claims. 
Comments: 
• data present in the database cannot be downloaded 
 
 
2.3.2 Database ontologies 
An ontology can be defined as a framework of concepts related to a specific domain (e.g. 
nanotechnology). The main advantage of ontologies is that they facilitate the exchange of 
information between communities as they provide limited sets of terms (jargon) to refer to 
specific entities. Its main function is found in databases as clear and unique terms or 
concepts are needed in order to store data in a structured manner, and to deliver it in when 
needed. Concepts are usually called classes and have associated and unique IDs and labels, 
and may have synonym(s), definitions, and other associated "properties". For instance, 
some classes of the eNanomapper FP7 project (www.enanomapper.net) ontology are 
"material entity", "process", "quality", or "disposition".  
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Classes can also have subclasses such as "cell line" and "chemical substance" to "material 
entity"; or "adverse event" and "synthesis part" to "process" in the case of enanomapper. 
Subclasses can also have further sub-subclasses, and so on. The relation between classes 
and subclasses determines the structure of the ontology. In addition to properties, classes 
can have "mappings" to other ontologies, which indicate the classes of one ontology that 
correspond to the same class(es) of other ontologies. For instance the enanomapper class 
"nanoemulsion", which is a subclass of "material entity", is mapped to "Nanoemulsion" and 
"nanoemulsion" of the National Cancer Institute Thesaurus and the Nanoparticle Ontology, 
respectively. In fact, enanomapper is developing ontology for NMs by reusing and extending 
existing ontologies of relevance for the nanosafety domain. This exercise (Hastings et al., 
2015) is intended to harmonise data from different fields and enable data sharing. This 
ontology covers among other areas NM classes, NMs physicochemical properties, biological 
characterisation of NMs, and environmental characterisation..  
Thus, the way in which the ontology is built will determine the way entities or objects, 
nanoparticles in our case, are defined. The ontologies from which enanomapper ontology 
are derived are listed in Table 2.6.  
Table 2.6. List of ontologies, acronyms and links included in the enanomapper ontology. 
Acronym Ontology Link 
NPO NanoParticle Ontology http://bioportal.bioontology.org/ontologies/NPO 
ENM eNanoMapper Ontology http://purl.enanomapper.net/onto/enanomapper.owl 
ENVO Environmental Ontology http://purl.bioontology.org/ontology/ENVO 
IAO Information Artifact Ontology http://purl.bioontology.org/ontology/IAO 
CHEMINF Chemical Information Ontology http://code.google.com/p/semanticchemistry/ 
OBI Ontology for Biomedical Investigations http://obi-ontology.org/ 
BAO BioAssay Ontology http://bioassayontology.org/ 
ChEBI Chemical Entities of Biological Interest http://www.ebi.ac.uk/chebi/ 
UO Unit Ontology http://code.google.com/p/unit-ontology/ 
OAE Ontology of Adverse Events http://purl.bioontology.org/ontology/OAE 
PATO Phenotype and Quality Ontology https://code.google.com/p/pato/ 
 
Ontologies are not fixed and that they evolve in time by adopting new terms, properties and 
mappings. For instance, a nanoparticle in the nanoparticle ontology (NPO) is represented as 
shown in Figure 2.1 by properties accounting for particle size, shape, mass, chemical 
composition of coating(s), and surface related properties such as surface area, chemical 
composition, surface charge, and zeta potential. 
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Figure 2.1. Representation of a NP in the NPO ontology. Adapted from http://www.nano-
ontology.org/ 
 
2.4 Existing (proposals for) grouping approaches 
The objective of this section is to report the state-of-the-art on grouping approaches for 
NMs. Various schemes for the categorisation of NMs have been proposed covering a variety 
of assessment goals, including: a) priority setting of NMs for further evaluation (including 
ranking based on level of concern) (e.g. Nel et al. 2013; Cockburn et al. 2012), b) guiding the 
choice of relevant endpoints and methods in testing strategies (Stone et al. 2013; Godwin et 
al. 2015) and c) grouping and read-across for the purpose of filling data gaps in regulatory 
submissions (e.g. Sellers et al. 2015), which is the application of particular interest in this 
report. It should be noted that terminology is not used consistently in different sources, so 
that "grouping" does not always correspond with the use of this term under REACH 
(European Parliament and Council, 2006b), where it is defined as follows:  
“Substances whose physicochemical, toxicological and ecotoxicological properties are 
likely to be similar or follow a regular pattern as a result of structural similarity may be 
considered as a group, or "category" of substances. Application of the group concept 
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requires that physicochemical properties, human health effects and environmental 
effects or environmental fate may be predicted from data for reference substance(s) 
within the group by interpolation to other substances in the group (read-across 
approach). “ 
 
2.4.1 Review of  grouping approaches: search strategy 
We have reviewed all published categorisation schemes and grouping for read-across 
approaches from literature and FP7 projects. Relevant approaches proposed by various FP7 
projects are summarised in Appendix 5. The relevant contents on categorisation and 
grouping that are available are already taken into consideration. Other outputs are expected 
to be released from different projects in the coming months.  
We performed a literature search in Scopus with the criteria presented in Table 2.7. Of the 
293 papers resulting from the search, 28 were identified as relevant based on abstracts 
contents as relevant for categorisation and grouping approaches. Results considered of 
possible interest for  NanoComput were also highlighted (23 results). From the selected 28 
papers, 8 were proposing an original framework for categorisation of NMs, or approaches 
that may be useful for grouping or ranking (including a predictive approach). These papers 
are reported in the next paragraphs. The others are cited in the text, when relevant. 
 
Table 2.7 Literature search strategy for grouping approaches 
Keywords for nano-objects Search for approaches 
Nanopart* 
Nanomat* 
Grouping 
Read-across 
Categorisation* 
Prioritisation* 
Ranking 
Search results: 293 papers (last search: 30/11/2015) 
First selection on abstracts: 28 
papers on categorisation or grouping 
approaches; 27 papers containing 
relevant information for NanoComput
Selection criteria: "categor", "group", "rank" or 
"predict" approaches were mentioned in the 
abstract, and abstract contents were relevant to 
our field of interest 
Second selection of papers: of the 27 
papers on categorisation and 
grouping, 3 were presenting 
categorisation frameworks and 5 are 
considered relevant as grouping for 
read-across (one is on read-across) 
and are reported in the respective 
tables (Table 2.8 and Table 2.10) 
Selection criteria: the paper proposes a 
categorisation or grouping approach; ranking 
approaches considering similarities or relevant for 
our aim were also included 
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The papers identified as containing information on categorisation and grouping are 
presented next. 
 
2.4.2 Grouping approaches for filling hazard data gaps by read-across 
ECHA released in May 2016 the first draft of its guidance for REACH registrants on how to 
justify the use of hazard data between nanoforms of the same substance as an Appendix to 
Chapter R.6.7 of the Guidance on IR&CSA on QSARs and Grouping (ECHA, 2017b). This 
document proposes a revised version of the strategy for grouping of nanoforms presented 
earlier in a joint publication with RIVM and JRC (RIVM, JRC, & ECHA, 2016). Before the 
release of the draft ECHA guidance, the ECHA Group Assessing Already Registered 
Nanomaterials (GAARN) and the ECHA Nanomaterials working group (NMWG) had 
identified some key concepts and considerations related to NM grouping and read-across. It 
included the need to consider properties beyond chemical composition (e.g. aspect ratio, 
particle size, shape, or solubility), the reaffirmation of the similarity rules from REACH Annex 
XI for NMs, the relevance of toxicokinetic studies (and toxicokinetic proxies), in grouping, 
read-across, and for in vitro to in vivo tests extrapolation (ECHA, 2013, 2014b). The OECD 
(2014e) had acknowledged the need to develop frameworks for grouping of NMs. The 
European Food and Safety Agency identifies the relevance for read-across in risk assessment 
of NMs (EFSA Scientific Committee, 2011). Guidance on how to consider and integrate 
weight of evidence in scientific assessments is being finalised by EFSA, also taking into read-
across (public consultation closed in May 2017). 
An extensive review of the current concepts and approaches for grouping of NMs is given by 
Arts et al. (Arts et al., 2014) and in a report by the Dutch National Institute for Public Health 
and The Environment (RIVM) (Sellers et al., 2015).  
The FP7 project ITS Nano has suggested that any approach adopted for grouping should take 
into account the changes occurring during the lifecycle (LC) of NMs (U. K. V. Stone, Balharry, 
Fernandes, Johnston, Munro, & Hartl, 2013). Key aspects are physicochemical (PC) 
characteristics of NMs (chemical composition, size, SSA, etc.), their behaviour and effects 
(ROS generation, electron transfer, photoreactivity, etc.) and their fate (e.g. hydrophobicity, 
agglomeration, zeta potential). The FP7 research project MARINA goes further in 
recommending that grouping be supported by information on kinetics (uptake, distribution, 
biopersistence) and early and apical biological effects (A. G. Oomen et al., 2014). 
NANOSOLUTIONS does a step forward in proposing a toxicity classifier to categorise NMs 
according to their toxicity, as presented in the next paragraph. 
The US-Canada Regulatory Cooperation Council (RCC) has developed an approach based on 
chemical composition. In this approach, seven classes of NMs are defined: CNTs; inorganic 
carbon; metal and metalloid oxides; metals, metal salts and metalloids; semiconductor 
quantum dots; organics and other classes. In addition, toxicologically relevant PC properties 
are identified for each of the classes to support (sub-)classification (RCC, 2013a, 2013b). The 
Nanomaterial registry by the US National Institute of Health has defined similarity rules to 
support matching of NMs entries in the registry. Such rules determine similarity in the range 
10%-85% depending on surface chemical composition, surface charge, shape and size. If the 
NMs were characterised in the same environment (defined taking into consideration both 
the kinetic and thermodynamic aspects) for size, then the NMs are in a 22.5-30% match; if 
the size values are within 10%, those two nanomaterials are an additional 15% match. If 
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both NMs have the same material type for their most outward chemistry, they are an 
additional 25% similar, and if the isoelectric point value is within 10% and the NMs were 
characterized in the same way, another 15% similarity can be added (NIH, 2014). 
The German environment agency (UBA, BfR, & BAuA, 2011) has recommended that 
grouping be based on PC properties like primary particle size, surface properties, and water 
solubility. In addition to solubility, crystal structure, surface charge and coatings, conduction 
band energies are recommended as useful PC properties in grouping of NMs. They also 
recognise that one group should be identified by multiple types of parameters related to 
e.g. shape, biopersistence and toxicity; and that grouping could be based on the potential of 
NMs to cause inflammation. It was also admitted that nanotubes should be considered as a 
separate group (Schröder et al., 2014).  
The International Cooperation on Cosmetics Regulation (ICCR) supports the application of 
the "bridging toxicity approach" in test waiving, which can be considered as implicit read-
across. This consists in extrapolating (long term) toxicity data between nanoforms or from a 
non-nanoform to a nanoform when the properties of the (non)-nanoforms and the results 
of the (short term) toxicity studies are similar (Araki, Bose, Chaudhry, Dewan, & Dufour, 
2013).  
In occupational safety, the inhalation route is the exposure pathway of most concern. Some 
grouping schemes group NMs according to their PC properties. For example Gebel et al 
(2014) consider three categories according to the mode of action and exposure route: 
chemically mediated toxicity (e.g. soluble NMs), granular biodurable particles  and fibrous 
NMs: Similarly, the German Bundesanstalt für Arbeitsschutz und Arbeitsmedizinsuch (BAuA) 
distinguishes (BAuA 2013): 
• soluble 
• granular biopersistent particles with specific toxicological properties  
• granular biopersistent particles without specific toxicological properties, and  
• biopersistent fibrous material.  
The US National Institute on Occupational Safety and Health (NIOSH) has also followed this 
grouping approach and in addition has proposed a framework based on the mechanism 
causing the toxic effect: NMs are classified as (Kuempel, Castranova, Geraci, & Schulte, 
2012) 
• higher solubility particles that can reach systemic tissues (toxic ions reach systemic 
tissue)  
• poorly soluble, low toxicity particles (toxicity is related to total deposited or retained 
particle dose in target respiratory tract region based on particle size)  
• poorly soluble, high toxicity particles (same as above but with reactive surface)  
• fibrous particles for which the toxicity is related to bioperistence and genotoxicity 
The identification of these four classes of hazardous NMs is taken into account also by the 
British Standard Institute (https://nanohub.org/groups/gng/guidelines). The ECETOC task 
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force on Nanomaterials (Arts et al., 2015) defines a three-tier approach (DF4nanoGrouping) 
to group NMs for inhalation exposure in one of four main hazard classes following the 
above-mentioned categories (BAuA, 2013; BSI, 2007; Kuempel et al., 2012): 
• soluble NMs 
• biopersistent with high aspect ratio NMs 
• passive NMs 
• active NMs 
This is done through a three-tier approach. Tier 0 precedes the DF4NanoGrouping by 
collecting intrinsic material properties to identify a NM. Tier 1 involves the assignment of a 
NM to the group of soluble NMs or to one of the other groups by means of its intrinsic 
properties. Tier 2 provides assignment of the NM to one of the three groups (i.e. 
biopersistent high aspect ratio, passive, or active NMs) depending on system-dependent 
properties. Toxicological information is used in Tier 3 to corroborate the assignment of the 
NM to a class and to support sub-grouping of active NMs depending on the outcome of 
short term in vivo studies. Applicability of the framework is addressed in Arts et al. (Arts et 
al., 2016). DF4NanoGrouping foresees read-across within the identified categories, which 
groups NMs with similar physicochemical and activity properties. For instance, group 1 may 
allow read-across between soluble NMs (even from bulk), group 2 for biopersistent and high 
aspect ratio NMs like CNTs, group 3 for non-fibrous passive NMs, and group 4 between 
reactive NMs. The case studies consist of 24 NMs of different classes of composition 
(carbonaceous, metal oxides and sulphates, amorphous silica, organic pigments). Each 
identified NM was assigned to one of the four pre-defined groups following the 3-tier 
approach. Assignment of NMs to groups i. to iii. does not need animal testing whereas 
group iv. represents specific hazards that are addressed with in vivo experiments. Although 
DF4nanoGrouping's framework defines qualifiers for grouping related to the use, release, 
and route of exposure, these considerations are missing in the practical example.  
Other authors apply high throughput screening platforms together with computational 
methods for data evaluation to rank NMs and to guide in vivo testing. For example, Nel et al. 
(2013) have identified a set of in vitro assays reflecting toxicity pathways of NMs. The tests 
provide information about ROS, dissolution and release of toxic metal ions, cationic injury to 
surface membrane and organelles, pro-fibrogenic responses to CNTs, inflammasome 
activation by long aspect ratio materials, Photoactivation and influence of bandgap, 
Zebrafish embryo hatching interference, or cell membrane lysis by surface reactivity. The 
resulting data is claimed to support clustering based on similar biological responses or 
linkage to PC properties (e.g. shape, size, crystal structure, band gap, dissolution, surface 
chemistry, surface charge, and surface functionalization), but this is not translated into 
practical guidance.  
The RIVM approach consists of different steps that aim at substantiate a hypothesis on the 
behaviour of the NM of interest depending on known information. A tiered testing strategy 
is presented where data are collected at different levels of complexity (tiers 0 to 2; some 
pieces of information are not required by REACH but are considered necessary for the 
assessment) and read-across is considered for each endpoint according to similarities 
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identified depending on collected information (mainly on PC properties and behaviour in 
environmental or biological media) (Sellers et al., 2015). The proposed strategy consists of a 
4-step framework and on a 3-tiers data collection to evaluate NMs and decide on the 
applicability of read-across. The 4 steps comprise:  
• collection of existing information (including NM characterisation and behaviour of 
the NM in different media) 
• hypothesis formulation  
• testing (3 tiers: PC properties, reactivity and in vitro toxicity, and in vivo toxicity)  
• assessment (do data support the hypothesis, or is there need of new data?) 
Step 1 is used to collect data to form a hypothesis (step 2) that eventually leads to 
experimental testing, which is used to issue a final assessment. The framework is illustrated 
by its application to two NM case studies. This approach does not aim primarily at assigning 
a NM to a predefined category, as hazard groups are eventually defined in a flexible manner 
after collection of information on PC properties and toxicological endpoints. In this 
approach, the LC of products containing NMs is considered as a step for identifying 
exposure routes when addressing specific case studies. 
The proposals for hazard- and risk-based grouping approaches that propose a framework 
are presented in Table 2.8. Documents that merely provide or reiterate principles for 
grouping are not included in the table, and are only cited in the text. These documents focus 
on the testing of NMs and make reference to grouping approaches, identifying some key 
aspects a grouping approach should focus on, but do not propose a strategy or a framework. 
The aim of Table 2.8 is to systematically report the existing frameworks for grouping that 
are captured in the column "Approach", in order to easily compare the different 
approaches. To make this possible, the table captures information on the "assessment goal" 
of the approach, we extract the basic principle applied for grouping ("Basis for grouping ") 
and identify "predefined groups" when they are defined. If a "testing strategy" is supported, 
this is pinpointed in a dedicated column. We also report if the approach identifies the 
availability of standard methods like OECD test guidance or other standard operating 
procedures, based on the considerations made by the authors ("Practicality") and if 
applications to case studies are presented ("Applicability") and we comment on the 
applicability of the proposed method for REACH purposes. 
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Table 2.8. List of frameworks proposed for NM grouping.  
Approach 
(reference)
Assessment 
goal(s) 
Basis for grouping Predefined 
groups 
Testing 
strategy 
supported 
Practicality 
(standard 
methods 
identified) 
Applicability Comments on 
applicability 
within REACH 
RIVM 
grouping 
approach 
(Sellers et 
al., 2015) 
Human health 
and 
environmental 
hazard and risk  
assessment  
Similarity may be supported 
by information about chemical 
identity, particle 
characteristics, fundamental 
transport and behaviour, 
activity and reactivity (the so 
called Tier 0 testing) 
No threshold to determine 
similarity has been developed 
No Yes, read-
across is 
considered for 
each endpoint 
to waive tests 
on animals  
Standard 
methods are 
mostly not 
available 
The approach 
is applied to 
TiO2 and Ag 
NMs 
Read-across is 
supported when PC 
properties of the 
NM under 
evaluation are 
similar to the ones 
reported in the 
reference studies 
(then test waiving 
is accepted)  
DF4nanoGr
ouping 
(Arts et al., 
2015) 
Human health 
hazard 
assessment 
(inhalation 
exposure)  
Assignment to one of the four 
pre-defined categories is 
based on water solubility, 
particle morphology and 
composition, dissolution rate, 
surface reactivity, 
dispersability. Confirmation of 
the categorisation of a NM 
comes through information 
from in vivo studies 
(biopersistence, 
biodistribution, genotoxicity). 
Use release and exposure 
information are applied as 
qualifiers to support grouping 
or appropriate testing  
4 categories are 
identified: 1. 
Soluble NMs, 2. 
biopersistent high 
aspect ratio NMs, 
3. Passive NMs, 4. 
Active NMs 
Exposure-
based test 
waiving is 
supported; 
toxicological 
tests are 
identified for 
the inhalation 
route 
Preferred 
methods, 
protocols and 
existing test 
guidelines are 
identified   
The approach 
is applied to 
carbonaceous, 
metal sulphate 
NMs, 
amorphous 
silica and 
pigments. 
Belonging of a 
NM to a pre-
defined class 
determined 
testing 
strategy and 
risk 
management 
The approach is 
based on REACH 
requirements. The 
proposed testing 
strategy is based 
on inhalation route 
of exposure (the 
other routes are 
only mentioned) 
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Approach 
(reference)
Assessment 
goal(s) 
Basis for grouping Predefined 
groups 
Testing 
strategy 
supported 
Practicality 
(standard 
methods 
identified) 
Applicability Comments on 
applicability 
within REACH 
US 
National 
Institute 
for 
Occupation
al Safety 
and Health 
(NIOSH) 
(Kuempel 
et al., 
2012) 
Human health 
risk assessment in 
occupational 
settings 
(Inhalation) 
Particle size, shape and 
density, surface area, 
reactivity, solubility 
4 categories are 
identified: higher 
solubility particles 
that can reach 
systemic tissues; 
(ii) poorly soluble 
particles for 
which toxicity is 
related to the 
SSA, (iii) poorly 
soluble toxic NMs 
where reactive 
particle specific 
surface area dose 
determines 
toxicity and to the 
(iv) fibrous 
particles for 
which the toxicity 
is related to 
bioperistence and 
genotoxicity 
A testing 
strategy is 
supported but 
not proposed 
Specific 
standard 
methods are 
not identified 
The approach 
is applied to 
fine and 
ultrafine 
particles 
(diesel exhaust 
particulate, 
carbon black 
in the ultrafine 
range). One 
NM falling in a 
predefined 
class would be 
compared to 
the identified 
reference 
materials and 
the risk 
estimate 
would be 
made 
according to 
identified PC 
properties  
Occupational 
inhalation 
exposure is 
considered; the 
approach may 
support the 
selection of PC 
properties for 
hazard grouping 
but is not 
developed for 
REACH application 
 
US-Canada 
Regulatory 
Cooperatio
n Council 
Human health 
and 
environmental 
NMs are classified on their 
chemical composition in order 
to identify (dis)similarities 
with bulk chemicals and for 
Seven classes are 
identified: CNTs; 
inorganic carbon; 
metal and 
Yes. A 
flowchart is 
provided 
where, 
Lack of 
standard 
methods 
No case 
studies  
A testing strategy is 
identified 
according to the 
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Approach 
(reference)
Assessment 
goal(s) 
Basis for grouping Predefined 
groups 
Testing 
strategy 
supported 
Practicality 
(standard 
methods 
identified) 
Applicability Comments on 
applicability 
within REACH 
(RCC, 
2013a, 
2013b)  
safety  
 
supporting future read-across. 
PC properties for each group 
are identified to support 
grouping and read-across. 
Size, shape, surface chemistry, 
solubility, composition, crystal 
structure 
metalloid oxides; 
metals, metal 
salts and 
metalloids; 
semiconductor 
quantum dots; 
organics and 
other classes 
according to 
available 
information 
on exposure 
and PC 
properties, 
testing is 
suggested 
exposure route  
PC properties for 
the definition of 
similarity for read-
across are 
identified for each 
class 
MARINA 
framework 
(A. Oomen 
et al., 
2015) 
Human health 
and 
environmental 
hazard and risk  
assessment  
A group includes NMs with 
low variability in PC, exposure, 
(eco)toxicological kinetic or 
fate properties   
Suggested 
predefined 
categories: 
quickly dissolving 
NMs, passive and 
active NMs, NMs 
with high aspect 
ratio 
Yes: the 
Marina Risk 
Assessment 
Strategy is 
supported  
Lack of 
standard 
methods 
No case 
studies 
presented 
Generic framework 
suitable for 
application within 
REACH   
 
 103 
 
2.4.3. Hazard classes in control banding tools  
Control Banding (CB) is a pragmatic approach that can be used for the control of the 
workplace exposure to agents with unknown or uncertain toxicological properties and for 
which there is a lack of quantitative exposure estimations. CB tools identify a range of 
control measures (such as general ventilation, and containment) according to the estimated 
range or “band” of hazard and of exposure based on combined hazard and exposure 
ranking. 
For the purposes of this review, we were interested in investigating which PC properties or 
which toxicological endpoints are applied to rank the hazard of NMs in various nano-specific 
control banding tools, as this may in some cases also support the grouping NMs for read-
across of hazardous (toxicological) properties. 
Liguori et al. (2016) published an extensive review on all the available CB tools applicable to 
NMs, and comparing them in terms of the required inputs of PC properties, toxicology and 
exposure. Based on the information in this review, Table 2.9 summarises key features of the 
available CB tools specific to NMs. The aim of each CB tool is reported under “assessment 
goal”, whereas “Information relevant for hazard classification” contains detail on the PC 
properties considered in the hazard banding (in case toxicological information is taken into 
account or required by the tool this is also reported in this column). Under the column 
“hazard classes” details on the number and type of hazard bands is reported and finally 
under “availability of case study” reference to any applications is reported. From the table it 
is evident that solubility, together with shape, are considered relevant PC properties for 
identifying the hazard group in all the tools except the Swiss precautionary matrix, where it 
was excluded because of lack of data (Höck et al. 2013). Solubility is taken into account in 
most tools as a screening property: the biological effects of highly soluble materials are 
considered similar to coarser particles and traditional risk assessment tools are considered 
suitable in these cases. For instance, in Stoffenmanager hazard banding is based on 
solubility and persistence (highly  soluble particles are considered lower priority substances) 
(Van Duuren-Stuurman et al., 2012). On the other hand, the ANSES CB Tool requires 
solubility rate as an input and in case of low solubility rate, the assigned hazard band is 
higher (Liguori et al., 2016). Surface coating is a required input for hazard banding only in 
Nanosafer, and an optional input in the Swiss precautionary matrix. In some tools, 
(bio)persistence is considered as well  (Liguori et al., 2016). 
Interestingly, both NanoSafer and the ANSES CB tool consider the possibility to take into 
account data from the corresponding bulk material or analogous material. In the ANSES CB 
Tool an analogous material is defined as "a substance or material with a similar composition 
and/or crystalline phase from the same chemical category and with similar documented 
physico-chemical properties (metal oxides, graphite, ceramics, etc.) as the substance of 
interest" (Riediker et al. 2010).  
NANOSOLUTIONS developed a classifier for of NM toxicity (ENM safety classifier) based on 
multiple data sources (intrinsic properties, omics data and in vitro toxicity data). Although 
the classifier is not developed as a control banding tool, it is reported in table 2.9 because it 
identifies three hazard classes that are defined according to physicochemical properties and 
toxicological tests (Fortino & Grevo, 2017). 
In a data-poor context, Bayesian networks have been proposed by Marvin et al. (2017) for 
human hazard ranking of NMs. This approach consists in the selection of physicochemical 
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parameters relevant for hazard assessment of NMs by expert elicitation, and in the 
construction of a Bayesian network to classify NMs according to the information on 
exposure and hazard. A validation exercise shows that the ranking of hazard potential of 
NMs was satisfactory. As the authors state, the limit of this approach is that, there is no 
mechanistic evidence in hazard identification. Since this model is not applied as a control 
banding approach, it is not reported in Table 2.9. 
 
Table 2.9. List of occupational banding tools containing a hazard module. 
Approach 
(reference) 
Assessment 
goal(s) 
PC properties considered for 
hazard classification 
Hazard classes Availability of 
a case study 
CB 
Nanotool 
(Zalk, Paik, 
& Swuste, 
2009) 
Oriented for 
nanotechnology 
researchers risk 
assessment and 
management 
Chemical form, size, shape, 
surface reactivity, solubility; 
Information on parent 
material or NM: Toxicity 
(lowest OEL), LD50, 
mutagenicity, carcinogenicity, 
reproductive toxicology, 
dermal toxicity, asthmagen 
4 bands for 
identified as 
severity scores 
(taking into 
account both 
exposure and 
hazard 
information by 
summing the 
identified factors) 
The tool was 
applied to 
several 
activities and 
NMs (Paik, 
Zalk, & 
Swuste, 2008) 
IVAM 
guidance 
(Cornelisse
n, 
Jongeneele
n, 
Broekhuize
n, & 
Broekhuize
n, 2011) 
Workers and 
occupational 
exposure 
Shape (fibrous particle) and 
water solubility 
Three hazard 
categories: 
(Water) soluble 
nanoparticles, 
Synthetic, 
persistent 
nanomaterials 
(non-fibrous) 
Fibrous, 
nonsoluble 
nanomaterials 
NA 
Swiss 
precaution
ary matrix 
(Höck et 
al., 2013) 
Employers and 
employees 
prioritise health 
risks and 
implement 
control measures 
Stability, redox activity, 
catalytic activity, ROS 
formation potential; induction 
potential for inflammation 
Three classes of 
potential effects 
(low medium and 
high) 
No 
Stoffenma
nager (Van 
Duuren-
Stuurman 
et al., 
2012) 
Human health 
risk assessment in 
occupational 
settings 
(Inhalation) 
Shape (fibre length). 
Inhalation hazard; water 
solubility; biopersistence 
5 classes are 
identified 
Fe powder. 
Falling in a risk 
band identifies 
the level of 
hazard priority 
ANSES CB 
tool 
(Riediker 
et al., 
2010) 
Exposure 
prevention; for 
small to large 
enterprises 
Reactivity, solubility rate, 
shape and biopersistence. 
Preliminary hazard band of 
the bulk material; is the 
material already classified ? 
5 hazard bands 
are identified 
(from very low to 
very high) 
No case study 
available in 
the guidance 
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Approach 
(reference) 
Assessment 
goal(s) 
PC properties considered for 
hazard classification 
Hazard classes Availability of 
a case study 
NanoSafer 
(K. a 
Jensen et 
al., 2014) 
SMEs; 
precautionary risk 
assessment 
PC properties: size, shape, 
solubility, surface coating. 
Materials OEL; Risk  
4 control banding 
classes are 
identified based 
on toxicity 
No case study 
available 
ENM 
safety 
Classifier 
(Fortino 
and Greco, 
2017) 
Group NMs 
according to 
toxicity 
Intrinsic properties 
(nanospecific properties are 
not mentioned) 
Three classes are 
identified as low, 
medium and high 
toxicity 
The tool is 
developed for 
31 NMs 
starting from 
the 
NANOSOLUTI
ONS dataset t 
and it is 
validated with 
data from  
MARINA 
 
2.5 Experience in grouping for read-across of NMs 
The research studies selected from the literature review consider different datasets and 
different methods to derive their conclusions. The only published study showing a example 
of read-across application for NMs for filling data gaps is presented by Gajewicz et al. 
(2015). They consider two case studies based on in vitro cytotoxic endpoints, and they 
calculated descriptors for activity (enthalpy of formation of a gaseous cation having the 
same oxidation state as that in the metal oxide structure and Mulliken’s electronegativity). 
Euclidean distance was the similarity metric applied for the identification of groups of NMs 
with similar toxicity. Data was split into training and validation sets to perform read-across. 
The "prediction" was successful from both sets except for a few oxides for which toxicity is 
under predicted (SnO2, Mn2O3 and V2O3) in the HaCaT cell line for TiO2.  
Zhang et al. (2012b) identify different hazard groups of NMs according to dissolution and 
energy (band gap) profiles. The band-gap prediction was successful in confirming the 
toxicity of the metal oxides whose band gap was overlapping with the cellular redox 
potential. Other metal oxides were exhibiting toxic effects but were outside the band gap 
range identified by the model (false negative predictions), and to solve this, a regression 
tree analysis taking into account both the effect of band gap and dissolution was 
successfully identifying three groups of NMs: non-toxic NMs, NMs toxic because of their 
solubility and NMs toxic because of their band gap energy.  
Since there are only a few examples of grouping of NMs in the literature, in our analysis also 
other relevant approaches are included and summarised in Table 2.10. In particular, 
approaches that result in the ranking of NMs are potentially useful since a rank ordering of 
chemicals (or NMs) can be regarded as a group, and interpolation (i.e. read-across) of 
properties can be carried out between NMs of known toxicity and different rank order.   
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Table 2.10. Grouping for read-across: approaches identified in the literature and computational applications that aim at ranking NMs 
Approach Objective of 
the study 
Methods Dataset Properties for 
grouping 
Results Comments 
Gajewicz 
et al. 
(2015) 
Read-across in 
dataset of NMs 
to fill data gaps 
for the 
cytotoxicity 
endpoint 
(reduction of 
cells viability, 
EC50) for E. coli 
and HaCaT cell 
line (human 
keratinocytes) 
One calculated molecular 
descriptor is identified in 
each case study (endpoint) 
and is used to group NMs in 
the Euclidean space; NMs 
from the validation set are 
(qualitatively) predicted 
according to the euclidean 
distance 
 
Two 
datasets 
with 17 and 
18 metal 
oxide NMs  
 
Euclidean distance is 
the similarity metric; 
properties that are 
considered are 
enthalpy of formation 
of a gaseous cation 
having the same 
oxidation state as 
that in the metal 
oxide structure 
(ΔHMe+) and 
Mulliken’s 
electronegativity (χC) 
3 groups of NMs with 
increasing toxicity 
properties were identified 
in both case studies 
 
 
This study represents an 
application of a qualitative 
read-across that could be 
relevant according to 
REACH Annex XI but the 
endpoint is not required 
by REACH  
Zhang et 
al. (2012b) 
Validate hazard 
ranking based on 
HTS output and 
on in vivo tests 
Regression tree analysis for 
the effect of band gap and 
dissolution on metal oxides 
NMs toxicity (cell viability) 
24 metal 
oxides 
Cellular toxic NMs 
were identified 
depending on band 
gap. Dissolution was 
then addressed to 
assess the 
toxicological impact 
of NMs 
Dissolution and band gap 
could predict the toxicity 
of 7 out of 8 NMs that 
were predicted (and 
tested) as toxic 
This application identifies 
a group of non-toxic NMs 
and two groups of toxic 
NMs depending on 
dissolution and band gap. 
The authors show 
correlation between in 
vitro results and in vivo 
acute pulmonary 
inflammation 
George et 
al. (2011) 
Hazard ranking 
of a set of metal 
oxide NMs 
Information on NM type, 
dose, duration of exposure, 
cellular targets, cytotoxicity 
events were extracted from 
2 cell lines 
and 4 
cytotoxicity 
responses 
NMs were ranked 
according to (a) 
similarity between 
their lethal response 
NMs were ranked in 4 
groups according to the 
cytotoxicity endpoints. 
They were ranked in 5 
Hazard-based ranking of 
NMs. A more extensive 
dataset on PC properties 
may help to identify a 
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Approach Objective of 
the study 
Methods Dataset Properties for 
grouping 
Results Comments 
HTS data and visualised in 
self organising maps and 4 
groups of NMs were 
identified according to the 
observed effect 
for 7 metal 
oxide NMs 
outcome or (b) the 
cytotoxic response 
profile of each cell 
line (HTS data) 
groups according to the in 
vivo tests  
group of similar NMs 
(structural similarity) 
Liu et al., 
(2015) 
Consider 
dosimetry 
modelling in in 
vitro toxicity 
ranking 
Hazard ranking was based 
on the EC50 and slope of 
the dose-response curves. 
Sedimentation of NMs was 
calculated via a fate model 
considering Brownian 
motion and gravitational 
settling 
7 metal 
oxide NMs 
Hazard ranking 
considering delivered 
dose was based on 
dose-response 
analyses and 
compared with 
administered dose 
ranking 
The comparative ranking 
between administered 
and delivered dose did not 
show any difference  
The approach would be 
useful if there was an 
extrapolation to in vivo 
studies 
Chen et 
al., (2014) 
Prediction of 
biological 
surface 
adsorption 
index(BSAI) 
Calculation of the 
adsorption coefficient k as a 
function of 5 variables 
(describing molecular 
interactions); PCA for 
clustering  
23 NMs 
(metal 
oxides, Ag, 
organic 
NMs) 
Clustering using the 5 
identified variables   
The prediction of the 
adsorption index was 
improved compared to 
the previous model  
The approach could be 
applied by using the five 
variables as the basis for 
ranking and read-across 
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2.5.1 Experience and activities of the European Commission on grouping of NMs 
The EC launched the REACH Implementation Project on Nanomaterials (RIP-oN) in 2009 (EC, 
2011b) with the aim of providing advice on key aspects of the implementation of REACH 
concerning Information Requirements (RIP-oN2) and Chemical Safety Assessment (RIP-oN3) 
of nanomaterials (Aitken et al., 2011; Hankin et al., 2011). The project recommended to 
invest in the extrapolation of information from studies conducted with bulk forms of the 
substance or modifications of the respective nanoforms to reduce further (in vivo) testing, 
taking into account particle size and surface area so that potential hazards are not 
underestimated. Read-across (nano-to-nano) on certain forms of NM such as low toxicity, 
low solubility particles was considered possible but still requiring further study and 
validation. The reports were finalised in July 2011 and are available from the DG ENV 
website: http://ec.europa.eu/environment/chemicals/nanotech/reach-clp/ripon_en.htm 
The Nanosupport project (2010-2013) aimed to provide a scientific assessment of the 
information on nanomaterials contained in 2010 REACH registration dossiers, i.e. substances 
registered as nanomaterials or which based on their size could be considered nanomaterials 
or (may) contain a fraction in the nanosize range. The analysis showed that read-across was 
applied/claimed in almost half of the assessed dossiers for some (eco)toxicological 
endpoints based on the common parent compound or metal ion. The particle nature and/or 
different particle sizes as well as different solubility of such salts/oxides were usually not 
given special attention. Furthermore, read-across was not explicitly applied on a form-to-
form basis in dossiers containing multiple forms of the substance. In general no 
argumentation was given for the robustness of the read-across. 
The project recommended that 
“A justification should be explicitly required when data from one form of a substance is 
used to cover the properties/hazards/risks associated with another form, especially for 
endpoints where particle size is known to have a significant impact on the outcome of 
the test. […] Read-across from one form to another should follow the same 
requirements as from one substance to another. The same is recommended for other 
non-testing approaches, […] e.g. QSAR models should only be used for nanomaterials if 
the materials are within the applicability range. […]  
For NMs surface treated/functionalized or capped with (in)organic compounds (e.g. 
one or more (in)organic layers to prevent ion leaching and control dispersability), it 
should be taken into consideration that the properties and behaviour of the 
nanoparticle would be highly dependent on the properties (including biocompatibility 
etc.) of the surface treatment material (EC & ECHA, 2012).” 
Since then, the Scientific Committee on Consumer Safety (SCCS) released an opinion on TiO2 
(SCCS, 2013b) where grouping was considered feasible for different forms of the same 
nanomaterial (NM with the same chemical identify). In the case of TiO2 15 NMs were 
submitted for evaluation and three groups were distinguished according to crystallinity and 
photocatalytic activity.  
Twenty three different materials were submitted for SCCS opinion on SiO2. The applicants 
presented the 23 NMs in the following four groups: a. hydrophilic precipitated silica, b. 
hydrophilic pyrogenic silica, c. hydrophobic pyrogenic silica, and d. colloidal silica. The large 
variations in PC properties (VSSA, solubility and density) is not scientifically justified and 
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hence the proposal to apply data from one material to other materials within the same 
group is not accepted (Scientific Committee on Consumer Safety, 2015). 
Other activities are being carried out within the ECHA NMWG which was established in 2012 
as an informal advisory group consisting of experts from Member States, the European 
Commission, ECHA and accredited stakeholders organisations, with the mandate to "provide 
informal advice on any scientific and technical issues regarding the implementation of 
REACH and CLP legislation in relation to nanomaterials." 
The following case studies for read-across have been presented (mainly by Industry) and 
discussed. 
Zinc Oxide (Subgroup discussion CC 2013) 
The presentation by the International Zinc Association illustrated that ZnO toxicity is driven 
by the Zn2+ ion, which is the same for the bulk, and the assessment of the bio-elution will 
therefore predict the overall toxicity. Nano sized and micro sized particles including coated 
materials gave comparable results in various simulated bio-fluids; however, the release of 
ions was dependent on pH.  
Concerning penetration through (damaged) skin further information was requested about a 
new study presented within the OECD WPMN showing a bigger dermal uptake compared to 
previous studies.  
ECHA informed the applicant that depending on the endpoint, bio-elution (alone) may not 
be sufficient to justify read across. 
Calcium carbonate (Subgroup discussion CC 2013) 
The presentation by the Industrial Minerals Association (IMA) explained that the nanoform 
of CaCO3 did not have any new properties/functionalities but only an enhancement of 
already existing properties (fillers). No significant differences are expected in the phys-chem 
test results; Ca++ and CO32– are the «biological agent » and these are physiologically 
abundant. A possible impact on the toxicity and hence on the difficulty to read across 
(between materials from different suppliers) may be due to impurities, which can be present 
in concentrations up to 20%.  
Silver (Subgroup discussion CC 2013) 
The presentation given by the European Precious Metals Federation (EPMF) concluded that 
all forms of Ag are essentially the same chemical with regard to the manufacturing process, 
uses and exposure control. Their effect is driven by the Ag ion; NanoAg, irrespective of 
particle size and coating type, was found less toxic or of equivalent toxicity to ionic Ag. 
Therefore, read-across from ionic Ag or nanoAg to non-nano Ag is suggested to be valid and 
conservative. New testing is therefore carried out with nano-Ag and read-across from the 
bulk form, as this is considered the more conservative. 
Carbon based NM, Pigments and Me-oxides (5th NMWG 2014) 
A presentation given by BASF showed different attempts to grouping nanomaterials based 
on the chemistry of carbon-based. Materials, covering: MWCNT, graphene, graphite 
nanoplatelets and carbon black, organic Diketopyrrololpyrrol-Pigments (DPP-Pigments) in 
bulk and nanoforms (DPP Orange 1 (bulk), DPP Orange 2 (nano), DPP Orange 3, Pigment Red 
254-1 (bulk), Pigment Red 254-2 (nano), Pigment Yellow 74; Pigment Blue 15) and toxicity 
for metal oxides and silica using short term inhalation studies (STIS). A ranking of 
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nanomaterials according to their toxic potency in the STIS showed that chemistry and size 
did not correlate with toxicity for most of the tested materials and most were of low (NOAEC 
10- 50 mg/m3) or medium (NOAEC ~10 mg/m3) toxicity. Higher toxicity (≤ 0.5 mg/m3) was 
shown for some coated (CeO2, ZnO, TiO2) and uncoated nano-oxides (CeO2, TiO2) and 
MWCNTs. They concluded that various criteria need to be taken into consideration for the 
grouping of NMs, including exposure, release, solubility, uptake and these factors need to be 
considered in a testing strategy which should be concern-driven. 
Pigments (5th NMWG 2014) 
A presentation by Lanxess/Eurocolour outlined the close correlation between particle 
size/particle size distribution and characteristics such as colour, tinting strength and 
dispersibility, which are all dependent on the production process. These parameters are 
often used for production control and allow a reduction of the efforts employing electron 
microscopy. No correlation to toxicological effects were presented. 
 
2.5.2 Pre-REACH experience on grouping and read-across 
Before REACH entered into force, chemicals were regulated by a number of different 
regulations and directives including the Existing Substances Regulation No 793/93 (ESR)13. 
The risks of 141 priority ("existing") substances were assessed and the results were 
published as risk assessment reports (RAR). Some of these RARs covered several forms of a 
substance or groups of substances between which some of the endpoint data were read 
across. Read across and grouping approaches were also applied for classification and 
labelling. Lessons can be learned from such substances which exist as different salts and 
oxides, although at that time nanoforms were not dealt with. RARs of the substances listed 
below may therefore provide relevant examples for read across.  
In general it may be concluded that for (inorganic) compounds the most relevant 
determinants for read across were based on solubility, bioaccessibility and absorption 
(measured as blood levels). However, it was also found that solubility was not always 
directly related to absorption. Usually the cation was considered responsible for the toxic 
effects, although this was not always the only determining factor.  
Based on the particle size distribution in dustiness testing (mass median aerodynamic 
diameter: MMAD) the deposition pattern in human lungs of solids/metal powders was 
modelled by applying MPPI (Multiple-Path Particle Dosimetry Model Anjilvel 1995), e.g. for 
copper and lead. 
Zinc: Zinc oxide, Zinc chloride, Zinc sulphate, Zinc stearate, Zinc phosphate 
Large parts of the hazard section are identical in the risk assessment reports for the six zinc 
compounds. The grouping approach is based on the assumption that the zinc cation (for 
dissolved zinc species) is the determining factor for systemic toxicity. The RAR however also 
acknowledges that the bioavailability is affected by various physico-chemical parameters 
(ionic behaviour, solubility, pH, alkalinity etc.).  
                                                      
13  http://echa.europa.eu/information-on-chemicals/information-from-existing-substances-
regulation 
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Although there was some information on the solubility of the six zinc compounds (they are 
soluble in water (sulphate, chloride) or in diluted acids (phosphate, distearate and oxide) 
and elemental zinc is attacked by HCl to yield Zn2+, adequate information was lacking how to 
quantitatively determine or estimate the bioavailable fraction of all the different zinc 
compounds in either laboratory animals or humans.  
 
Cadmium 
Data with other cadmium compounds (Cd chloride, Cd sulphide, other Cd compounds) were 
used as supporting data when no (or not enough) information on the effects of CdO/Cd 
metal was available and when the studies using cadmium compounds were mechanistically 
relevant.  
Read-across was applied for oral, dermal, inhalation absorption, acute and repeated dose 
inhalation toxicity, mutagenicity, carcinogenicity, reproductive toxicity, developmental 
toxicity, bone and kidney. 
The acute pulmonary toxicity of cadmium was considered to depend on the chemical and 
physical form of the administered compound, and therefore the question of the validity of 
an extrapolation to other CdO compounds was considered in the Cd RA. 
The authors concluded that acute effects of Cd compounds in the lung cannot be predicted 
from their water solubility alone (G Oberdörster, Cox, & Baggs, 1987): small (insoluble) CdO 
particles and water soluble CdCl2 for example were equally toxic in rats exposed by 
inhalation (G Oberdörster et al., 1987)– in another study CdO was even more toxic (Grose et 
al., 1987). The in vivo solubility in the lung after inhalation exposure is very high for CdO (G. 
Oberdörster & Cox, 1990). 
 
Nickel: Nickel dinitrate, nickel sulfate, nickel carbonate, nickel dichloride 
RARs were made separately for all 5 nickel compounds, however general conclusions on 
nickel compounds were drawn in a "Background document in support of the individual Risk 
Assessment Reports" which explains when results from other nickel compounds can be used 
(Larsen & Tyle, 2008). 
The category approach was agreed for a large number of nickel compounds to fill data gaps. 
Depending on the endpoints nickel/nickel compounds were “source chemical” and/or 
“target chemical”. 
The determinants of nickel toxicity were considered to be: water solubility, bioaccessibility 
and bioavailability. The relationship between water solubility and bioavailability of nickel (II) 
at target sites was found to be more complex for nickel, with compounds of intermediate 
solubility having the highest bioavailability. The basic assumption was that after intake, 
nickel compounds (and metallic nickel) are changed and the nickel ion is the determining 
factor for toxicity. However, the potential release and absorption of nickel from metallic 
nickel is substantially lower than from the soluble compounds via all routes, which is why 
metallic nickel was not classified for the same endpoints as Nickel compounds (e.g. 
developmental toxicity). 
The bioavailability depends on various characteristics of the individual nickel compounds, of 
which solubility is considered as being particularly important for the release of nickel ion and 
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thus the systemic bioavailability of the nickel ion. Ideally, data on the solubility of the nickel 
compounds in biological fluids are preferable; however, no data were available regarding the 
solubility of any of the five prioritised nickel compounds in biological fluids. For the purpose 
of risk characterisation the water solubility was used as a prediction of the solubility in 
biological fluids although it was acknowledged that such a prediction might not be correct as 
some data indicate that compounds insoluble or slightly soluble in water might be more 
soluble in biological fluids. 
It was also recognised that with respect to local effects, the nickel ion may not be 
responsible for the toxic effects in all situations. Therefore, data on other nickel compounds 
in evaluations of local effects of an individual nickel compound were considered on a case-
by-case basis. 
Nickel, nickel sulphate, nickel dichloride, nickel carbonate and nickel nitrate were all 
classified for skin sensitisation (H317) and STOT Re1 (H372 Inhalation).  
Metallic nickel was not classified (as the others) for Repr. 1B (H360) and mutagenicity (H341) 
and for carcinogenicity "only" in Cat 2 (H351), whereas the other compounds were Cat 1A 
(H350). It was agreed that metallic nickel should not be classified for this effect as the 
potential release and absorption of nickel from metallic nickel was substantially lower than 
from the soluble compounds via all routes. The nickel compounds were additionally 
classified for respiratory sensitisation (H334), skin irritation (H315) and only nickel dinitrate 
for serious eye damage (H318). The nickel compounds differed from each other with respect 
to acute toxicity via oral and inhalation exposure. Nickel dichloride was classified as toxic via 
these routes (H301, H331) while the others were classified as harmful (H302, H332).  
 
Chromate sodium chromate, sodium dichromate, potassium dichromate, ammonium 
dichromate, chromium trioxide 
All chromate compounds were covered in one RAR. They had the same proposal for 
classification and labelling, except chromium(IV)trioxide which was more toxic to skin (the 
others were harmful) and less toxic for reproductive effects (cat 3 instead of cat 2). Further 
differences concern the physical-chemical hazards such as explosion and fire. In relation to 
the potential for tumour induction after inhalation, it was noticed that the water solubility of 
Cr (VI) is inversely related to its bioavailability. 
 
Lead 
The voluntary RAR covered [Phthalato(2-)]dioxotrilead, basic lead carbonate, basic lead 
sulphate, basic lead sulphite, dioxobis(stearato)trilead, lead metal, lead monoxide (lead 
oxide), lead stabiliser compounds, neutral lead stearate, orange lead (lead tetroxide), 
pentalead tetraoxide sulphate, polybasic lead fumarate, trilead dioxide phosphonate.  
Read-across has been based upon evaluation of physical properties (e.g. particle size in 
dustiness testing) and water solubility. This strategic approach has been made possible by a 
set of circumstances that include:  
• all compounds under evaluation were sparingly soluble in water 
• acute oral toxicity data were available for a number of compounds under evaluation 
• indicated absence of toxicity up to the upper limit of ranges tested 
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• direct effects upon the skin or the lung (e.g. sensitization) were absent 
• the particle size distribution of compounds was such that upper airway deposition was 
predicted to be followed by translocation to the gastrointestinal tract ― systemic effects 
following acute inhalation exposure would thus largely be dictated by the oral exposure 
route. 
Prediction of the toxic potential of different lead compounds based solely upon physical or 
chemical properties of individual lead compounds proved difficult due to discrepancies 
between parameters such as water solubility and the relative bioavailability of different lead 
compounds following the more common routes of exposure (e.g. ingestion). While 
extremely water insoluble lead compounds can have low bioavailability, some can exhibit 
bioavailability close to that of lead acetate. The failure of the water solubility of compounds 
to correlate with relative bioavailability is due to the complex acidic conditions within the 
stomach and variability of bioavailability of as a function of decreasing particle size. As 
particle size decreases, the resistance of otherwise stable lead compounds in the 
gastrointestinal tract will be diminished. Relatively oral bioavailability will further be 
modulated by “matrix” effects that can be exerted by lead-containing foods or soils that may 
be ingested.  
 
Copper 
The voluntary RAR covered copper (metal), copper (I) oxide, copper(II) oxide, copper 
sulphate pentahydrate, copper oxychloride. For the purposes of testing derogation and 
classification, read across was based upon evaluation of physical properties (e.g. particle size 
in dustiness testing), water solubility and oral absorption. 
Read-across for classification and risk assessment was applied for: 
1. acute inhalation toxicity for Cu(II)O, Cu-powder and CuS04.5H2O 
2. acute oral toxicity for Cu-powder 
3. mutagenicity 
4. carcinogenicity 
5. reproductive toxicity 
6. repeated dose toxicity 
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3 Availability and regulatory relevance of literature-based models for NMs  
 
3.1 Summary  
This chapter describes the availability, and assesses the REACH relevance, of literature-based 
QSPR and QSAR models, as well as toxicokinetic (TK), toxicodynamic (TD), in vitro and in vivo 
dosimetry, and environmental fate models. The aim of the chapter is to identify models 
potentially useful for the fulfilment of REACH information requirements (Appendix III).  
TK/TD/dosimetry/fate models are all kinetic models, i.e. they provide information on the 
(time-dependent) concentration or amount of NMs in a biological, technical or 
environmental compartment. TK models include relatively simple, classical toxicokinetic 
(CTK) models, as well as physiologically-based kinetic (PBK) models. Environmental fate 
models include material flow (MF) models, process-based fate models, and bioaccumulation 
models. TD models, including physiologically based dynamic (PBD) models, simulate the 
intensity and time-course of substance-induced effects on a biological system. These models 
are still in their infancy (only four such models were identified). 
For each model domain (QSPR/QSAR, TK/TD/dosimetry/fate models), details of the paper 
search and selection strategy to compile the model inventory are first presented. To 
systematically capture information on TK and TD models, a structured template was 
developed (Appendix VII) Model inventories are stored as separate Excel files 
(Supplementary Materials S1 and S2). Secondly, a detailed analysis on the characteristics of 
available models is reported: emphasis is given to the nanomaterials covered by the models, 
the predicted endpoints, descriptors used and the statistical methods applied. In the third 
part of each section, we evaluate the extent to which available models are potentially useful 
for predicting REACH-required physicochemical properties, ecotoxicological and toxicological 
endpoints, or how available models could be applied supporting REACH submissions.  
Some QSPR and QSAR models are indeed predicting REACH-relevant information. Under the 
physicochemical characterisation, models predicting water solubility, octanol-water partition 
coefficient, stability in organic solvents are available. For toxicological endpoints, there are 
some models for the Ames test, although the relevance of such models for mutagenicity 
assessment is questionable, as the OECD TG on the Ames test is not considered applicable to 
NMs. The majority of QSAR models are for cytotoxicity endpoints, which are not directly 
predictive of a REACH endpoint, but may be useful for screening purposes, or as the basis of 
grouping NMs for read across. For ecotoxicity endpoints, models are available on growth 
inhibition study, short term toxicity to fish and to invertebrates. Many other models have 
been developed using composite endpoints, which while related to REACH endpoints, are 
not directly predictive of them. Such models are therefore of limited utility for directly filling 
data gaps, but are potentially useful for screening purposes, or as the basis of grouping 
similar NMs for read across. Even where a model is directly predictive of a REACH endpoint, 
it does not necessarily follow that the prediction is adequate for filling a data gap. As with all 
QSPR and QSAR predictions, this needs to be evaluated on a case by case basis, in 
accordance with REACH guidance. 
The utility of the established QSPR/QSAR model reporting format (QMRF) is evaluated by 
applying it to a QSAR model. On this basis, it is proposed to make minor adaptations to the 
QMRF in order to capture some NM-relevant physicochemical properties (Appendix VI). 
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The kinetic predictions provided by TK/dosimetry/fate models can be used for various 
purposes, which depending on the model type, include: a) the better interpretation of 
toxicity data; b) the design of toxicity studies; c) various types of extrapolation that support 
risk assessment (in vitro to in vivo, high dose to low dose, interspecies) and d) the prediction 
of toxicologically relevant internal concentrations at target organ/tissue level.  The latter 
type of information could in principle be used to reduce uncertainty in read-across 
predictions for systemic endpoints. 
 
3.2 QSPR/QSAR model inventory 
A compilation of QSPRs and QSARs has been based on a comprehensive and systematic 
analysis of existing literature on computational models for nanomaterials. The aim of this 
compilation was to determine the models that are currently available and that could be used 
in a regulatory context (e.g. REACH) for the assessment of the hazardous properties of 
manufactured NMs. The models have been documented in a searchable Excel file (hereafter 
inventory). Parameters such as endpoint predicted, NMs modelled, descriptors used in the 
model, data source, algorithm, performance statistics, have been collected for each model. 
The detailed model information in the inventory was used to construct the “landscape” of 
available QSPR/QSARs, including the endpoints and NPs modelled, the descriptors that were 
mostly used in the models as well as the type of models and data sources used. 
As explained in Chapter 1 (section 1.7.2), QSPRs and QSARs are models that mathematically 
relate a property (in the case of QSPRs) or (biological) activity (in the case of QSARs) of a 
given substance with its chemical structure (or other physicochemical properties). Such 
models are based on the assumption that the property/activity of a substance is related to 
its (chemical) structure. Independently of the method used to derive the QSPR/QSAR, the 
same 5 principles apply for their validation (OECD, 2007b), namely: 1) defined endpoint; 2) 
unambiguous algorithm; 3) defined domain of applicability; 4) appropriate measures of 
goodness-of-fit, robustness and predictivity; and 5) mechanistic interpretation. 
In the following sections, the search strategy used to compile the QSPR/QSAR models is first 
described, followed by a detailed description of the parameters used to categorise the 
models and the methodology applied for the literature review. Finally, the current 
QSPR/QSAR model landscape will be described by analysing the endpoints, NPs, descriptors, 
statistical method, etc. of the QSAR-QSPR models that are included in the inventory. 
 
3.2.1 Search and selection strategy 
The steps followed from the selection of relevant papers to their inclusion in the inventory 
are summarized below:  
1. Selection of papers by means of database websites 
2. First selection of relevant publications 
3. Removal of duplicates 
4. Prioritisation of relevant papers based on the abstract 
5. In-depth reading of the articles  
6. Inclusion or exclusion of the model from the inventory 
In order to select the initial set of publications, Scopus and WoS (Web of Science) database 
websites were used as search engine tools and the relevant terms included for the initial 
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screening were chosen. Specifically, the main terms were: the model itself (i.e. QSAR*14, 
SAR*, “structure activity”, QSPR*, “structure property”, nano-QSAR and QNAR), the 
nanomaterial term (nanomaterial*, nanoparticle*, nanotube*, fullerene*), the desired 
endpoint to which the mathematical model is aiming to give answer (e.g. toxicity, 
ecotoxicity, cytotoxicity, solubility, adsorption, ROS production), and finally the species or 
human cell lines which are usually used in the experimental procedures for toxicity 
assessment (e.g. Daphnia, lung cells). In addition, due to sometimes the term QSAR is not 
used to define the models but the type of algorithm (e.g. decision tree, SVM, neural 
network, machine learning, random forest, linear regression and PCA), these terms were 
also included in the search parameters. 
Different combinations of the terms included above led to the compilation of almost 1150 
publications, which were included in the reference manager Mendeley program. After 
removal of duplicates, the set of publications was reduced down to a number close to 600. 
Then, a detailed evaluation of titles and abstracts further reduced the number of the final 
set, resulting in a total of 122 publications, from which 78 were assigned to QSAR and 44 to 
QSPR models. The screening performed to remove non-relevant papers in the last step was 
based mainly on the following criteria: 
• Papers containing the SAR term but with other meanings (e.g. specific adsorption rate, also 
SAR, is associated with magnetic and hyperthermia effect) 
• Papers describing the synthesis of NMs 
• Very specific papers describing the behaviour of NMs for catalysis applications 
• Scientific publications that state in the abstract “results provide the basis for a QSAR 
development”, etc. 
Most of the removed papers were experimental works dealing with nanomaterials, rather 
than publications developing or evaluating any model. In addition to the citation databases, 
new methodological approaches discussed in recent reviews (C Oksel, Ma, Liu, Wilkins, & 
Wang, 2015; R Tantra et al., 2015), and new scientific papers published during the execution 
of this work have also been taken into consideration to avoid missing any relevant QSPR-
QSAR model.  
Evaluation of the final set of 122 publications was performed following the OECD validation 
principles. This review was done in a chronological order starting from the oldest papers to 
be able to recognise the citations of already revised publications as well as identify possible 
new models, not captured using the strategy presented above.  
A considerable number of papers, in which the developed models were the same or closely 
related to previous ones, were not reported in the inventory as (new) entries, but were 
included as associated references of the previous models. As an example, the paper entitled 
“Machine Learning for Nanomaterial Toxicity Risk Assessment”(Gernand & Casman, 2014b) 
is actually a brief summary of one of the models generated in a previous work of the same 
group (Gernand & Casman, 2014a).  In this case, the first article (Gernand & Casman, 2014a) 
was used as main entry to describe the model while the paper (Gernand & Casman, 2014b) 
was included just as a reference of the previous model developed.  
After an accurate review of the search results, a total of 59 publications for QSAR (out of 
around 800 found in the initial search) and 29 publications for QSPR models (out of around 
                                                      
14 using “*”, all terms containing QSAR are captured (e.g. QSAR, QSARs, QSAR-model) 
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350 found in the initial search) were included in the final inventory. Quantification of the 
papers that have been either included or excluded in the final inventory is shown in Figure 
3.1.  
In addition, Figure 3.2 shows the number of publications included in the inventory with 
respect to the year of publication. From the figure it is clear that the number of QSAR 
publications follows an increasing tendency over time since 2010 since a variety of datasets 
and methods have been made available, while the rate of QSPR publications remains almost 
constant. However, it must be stressed that due to the need of limiting the number of 
papers, QSPR models aiming at predicting endpoints that could have an influence on toxicity 
and on the bioavailability of the nanomaterials in the environment have been prioritized to 
others. For instance, a few papers developing models to predict the mechanical 
reinforcement of polymer nanocomposites by the addition of metal oxide particles have not 
been taken into consideration.   
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Figure 3.1. Percentage of QSAR (n=78) and QSPR (n=44) papers included and excluded from the 
inventory 
 
 
 
Figure 3.2. Number of publications included in the inventory as a function of publication year 
 
Even though 59 QSAR and 29 QSPR publications were considered as relevant for the review, 
more than 88 rows were added to the inventory. This is because in some publications 
different cases are investigated, either because the same data is modelled by means of 
different statistical methods or because the same statistical method is applied to different 
NMs/endpoints. In such cases, all entries corresponding to the same paper are labelled with 
the same number followed by different letters in alphabetical order. The final number of 
entries was 152 and 52 for QSAR and QSPR models, respectively. 
Figure 3.3 shows the structure of the inventory, covering all different sections (8) and 
corresponding parameters (35) used to categorize the relevant models. These sections are 1) 
source information, 2) predicted endpoint, 3) NMs, 4) data sets, 5) descriptors, 6) statistical 
methods, 7) model performance and 8) miscellaneous.  
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Figure 3.3. Structure of the QSPR/QSAR inventory 
 
The content of each section is summarised below. It should be indicated that the structure 
of the inventory was inspired by the QSAR model reporting format templates (QMRF) which 
were developed for QSARs. The entries of the inventory can be easily transferred to the 
QMRF providing the latter is adapted to NMs by allowing the definition of physicochemical 
properties that define NMs. 
1. Source Information: reference details of the publication, contact author and also the model 
name. To assign a model name, its aim and the method use to generate it have been used as 
main criteria. 
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2. Predicted Endpoint: information about the type of cells or organisms used in the study, the 
toxicity endpoint, and whether it is an in vitro or in vivo experiment (for QSAR), or 
information about the physicochemical properties evaluated (for QSPR). 
3. NMs: in this section, first a more generic description of the type of NMs is provided, 
including metals, metal oxides, carbon-based or polymeric nanomaterials, and then the 
specific NMs are defined (i.e. Ag). Moreover, associated physicochemical properties are also 
indicated here, such as coating, size, shape, and any other relevant characterization 
performed. 
4. Descriptors: this section specifies the number and which are the descriptors used (e.g. 
fingerprints, topological, geometric, physicochemical) in the models. It also includes the ratio 
between chemical compounds and final descriptors, which is a value used to assess the 
possible correlation by chance and overfitting due to a greater number of descriptors than 
the size of the training data set (Topliss & Edwards, 1979). 
5. Data sets: size of the training, test and external validation data set are given. Details of data 
splitting are also specified when applicable.  
6. Statistical methods: here, an explanation of the descriptor selection process (screening from 
an initial set to obtain a reduced final set of descriptors) as well the details of the statistical 
method applied to generate the model are provided. The software tools are also specified if 
they are provided in the publication. 
7. Model performance: this section contains four inputs corresponding to the principles 3 and 4 
of the OECD guideline, i.e. applicability domain, goodness-of-fit, robustness and predictivity. 
8. Miscellaneous: definition of the abbreviations used is provided as well as the reference of 
data bases employed in the studies and relevant remarks, e.g. whether a mechanistic 
interpretation is presented which improves the reliability of a model (principle 5 of the OECD 
guideline). 
 
3.2.2 Analysis of the available QSPRs and QSARs 
To illustrate the current state of the art concerning the QSPR and QSAR model development 
applied to nanomaterials, we have selected four of the most representative inputs used to 
categorize such models in the inventory (Figure 3.4): 1) NMs, 2) descriptors 3) statistical 
methods and 4) endpoints predicted by the model. The figure also includes the 
quantification of the specific weight of each element within the same category assigned to 
either QSAR or QSPR models.  These four inputs will be discussed separately below.  
 
 126 
 
 
Figure 3.4. Summary of the most relevant inputs obtained in the inventory analysis for 
QSAR and QSPR models.  Numbers assigned to QSAR/QSPR models allow quantifying the 
specific weight of each element within the same type model of model. As an example, the 
number of models looking at carbon-based NMs corresponds to 14 and 43 for QSAR and 
QSPR models, respectively.  Total number of models corresponds to the total number of 
entries in the inventory (152 and 52 for QSAR and QSPR, respectively). *(1): Most 
representative descriptors were included. *(2): Size descriptor includes size, radius, 
diameter, length, volume and aggregation/agglomeration *(3): Endpoint defined by the 
author. *(4): Endpoint defined in this work to group highly associated endpoints. 
 
Nanomaterials 
Models found in the literature search cover a total of 44 different NMs, including metals, 
metal oxides and carbon, polymeric and lipid-based particles. As shown in Figure 3.4, metal 
oxides account for about 72 out of 152 QSAR published models, and 32 models included 
both metals and metal oxides nanoparticles (NPs). Carbon-based and polymeric NMs are 
applied in only 14 QSAR models. In Table 3.1, all specific NMs are listed and grouped 
following the same division than in Figure 3.4. 
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Table 3.1. List of NMs reported in the inventory. The number in brackets indicates the how 
many times each NM appears among the different models, including both QSAR and QSPR 
studies. 
GENERIC TYPE OF 
NANOMATERIAL 
SPECIFIC TYPE OF NANOMATERIAL 
Metal Au(27), Ag(25),Cu(23), Al(18), Ni(16), Co(11), Ti(10), Fe(9), Sn(8), Zn(2), Si(1), 
Ge(1) 
Metal Oxide ZnO(73), Fe2O3(70), TiO2(67), Fe3O4(53), Al2O3(50), SiO2(45), CuO(43), 
La2O3(41), NiO(39), SnO2(39),CoO(38), Y2O3(37), Sb2O3(35), Cr2O3(30), 
In2O3(30), CeO2(24), WO3(17), (Fe2O3)n(Fe3O4)m(16), Ni2O3(14), Mn2O3(12), 
Gd2O3(9), Yb2O3(9), Co3O4(7), HfO2(7), R-TiO2(5), ZrO2(1) 
Carbon-based Fullerene(33),  Nanotube(25) 
Polymeric p(NIPAm-co-AAc)  (5), Streptokinase (SK) and Chitosan (3) 
Lipid-based Phytantriol (2), Monoolein (2) 
 
As can be seen in Table 3.1, Au (27) and Ag (25) are frequently chosen as metal NPs (Papa, 
Doucet, Sangion, & Doucet-Panaye, 2016; Walkey et al., 2014), while ZnO (73), Fe2O3 (70) 
and TiO2 (67) are the most repeated metal oxide NPs (T. C. Le et al., 2016; Papa, Doucet, & 
Doucet-Panaye, 2015; Toropova & Toropov, 2013). This is in line with the reported values for 
global production of nanomaterials, as detailed elsewhere, since TiO2 and ZnO are two of the 
most produced nanomaterials over the world and with more range of applications (Arturo A 
Keller, Mcferran, Lazareva, & Suh, 2013). Furthermore, attention has been paid to evaluate 
the influence of TiO2 particle size, and TiO2 crystalline phase (i.e. anatase or rutile) which 
finally determines the reactivity of this material. For instance, E. Papa et al. investigated the 
membrane disruption (cytotoxicity) of TiO2 and ZnO NPs onto immortalized rat L2 lung 
epithelial cells and rat lung alveolar macrophages (in vitro experiments) by different 
statistical methods such as Multiple Linear Regression (MLR) or Radial Basis Function Neural 
Networks (RBFNN). A significant number of models (21) were reported for both TiO2 and 
ZnO NPs with different sizes in different media, as independent sets or including both NMs 
as part of the same data set (Papa et al., 2015).  
The applicability domain of a model depends on the number and variety of NPs included in 
its development. The number of NMs15 evaluated in each model differs considerably, 
ranging from 1 (TiO2 with different sizes in Papa, Doucet, & Doucet-Panaye, 2015b) up to 32 
(different metals and metal oxides having different sizes and coatings in Kleandrova, Luan, 
González-Díaz, Ruso, Speck-Planche, et al., 2014). For example, a model included CuO, Al2O3, 
Fe2O3, SnO2, TiO2, V2O3, Y2O3, Bi2O3, In2O, Sb2O3, SiO2, ZrO2, CoO, NiO, Cr2O3 and La2O3 (T 
Puzyn et al. 2011). 
Instead of using different sizes or different types of NMs, other authors have evaluated the 
effect of surface functionalization. Fourches et al. modelled the prediction of NMs cellular 
                                                      
15 Nanomaterials having the same composition but different sizes are considered different 
NMs in the inventory 
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uptake by pancreatic human cancer cells (PaCa2) using a dataset of iron oxide particles 
coated with 109 different chemical groups. A k-Nearest Neighbour method was applied to 
two-dimensional descriptors (D Fourches et al., 2010).  
Concerning the QSPR studies, carbon-based NMs (i.e. fullerenes and carbon nanotubes) 
account for an extremely high percentage of models (43 out of 52 QSPR models). This can be 
explained by the large number of papers (30 out of 52 QSPR models) reporting the solubility 
of C60 in different types of organic solvents (Huanxiang Liu et al., 2005; Petrova, Rasulev, 
Toropov, Leszczynska, & Leszczynski, 2011; Yousefinejad, Honarasa, Abbasitabar, & 
Arianezhad, 2013). Since C60 was discovered in 1985, there has been considerable interest 
in identifying possible applications for this highly symmetrical molecule.  
CNTs have been evaluated in 12 (out of 52) of the QSPR models reported in the inventory. 
For instance, descriptors for prediction of mechanical properties were identified through 
QSPR models and evaluate the qualitative and quantitative results against computational 
and experimental data (Young's modulus and Poisson's ratio). CNTs of 10 nm long and 0.2-
2.1 nm diameter were created with J Crystal Soft Nanotube Modeler version 1.6.1 and 
individually processed with Python scripts to create four types of surface defects: single 
vacancy, double vacancy, mixed single and double vacancy. The model was built with partial 
linear squares method and constitutional, topological, and physicochemical descriptors were 
used in this study. The final model contained the following critical descriptors: theoretical 
radius, chiral angle and ratio of non-sp2 hybridized carbons to total number of carbons 
(Borders, Fonseca, Zhang, Cho, & Rusinko, 2013).   
Significantly different to carbon-based nanomaterials, metal and metal oxide NPs only 
account for the 5 out of 52 QSPR models. From the studies reported in the inventory, only 
one attempt has been already applied to inorganic NMs to describe physicochemical 
properties. Zeta potential was predicted from a set of 18 metal oxides NPs applying 11 
microscopic- image-based and 17 theory-based (calculated) descriptors (Mikolajczyk et al., 
2015). In another study, the adsorption of methylene blue onto copper oxide NPs loaded on 
activated carbon (CuO-NP-AC) was modelled. Applied descriptors were pH, dye 
concentration, amount of NPs, time and amount of carbon active. After principal component 
analysis treatment, resulting principal components were used as independent variables into 
a MLR statistical method (Ghaedi et al., 2014a). 
Regarding the used data sets, as few as 47 out of 204 reported models in the inventory 
generated their own experimental data (A Gajewicz et al., n.d.; T Puzyn et al., 2011; Christie 
Sayes & Ivanov, 2010), and therefore most of the studies were limited to small datasets, 
obtained by the same research group at matching conditions. Several datasets have been 
used extensively in a large number of publications, such as those generated in Fourches et 
al. 2010, T Puzyn et al. 2011, Sayes and Ivanov 2010, Shaw et al. 2008 and Weissleder et al. 
2005. Such publications typically evaluate the same NMs as well as the same endpoints, but 
new models are implemented with different descriptors or different applied statistical 
methods. As a representative example, A. Toropov et al. 2012 retrieved cytotoxicity data on 
bacteria (E.Coli) from T Puzyn et al. 2011 for several metal oxide NPs, and developed a new 
model base based on SMILES (Simplified Molecular Input Line Entry Specification) notation 
and Monte Carlo optimization, compared to the MLR employed in the original reference. 
With the same data set (same NMs and endpoint) but different number and type of 
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descriptors (ΔHMe+16  in T Puzyn et al. 2011 and '['17 , '=' 18 and 'O'19  in A. Toropov et al. 2012) 
the statistical fit for internal validation was slightly higher for the MLR (R2=0.85) than for the 
SMILES-based model (R2 ranging from 0.74-0.84). On the contrary, considerably better 
results were obtained with the SMILES-based model as regard as external validation (R2 
ranging from 0.84 to 0.96) compared to the MLR model (R2=0.83). It is expected that in the 
following years, more data sets will become available resulting from the large effort done in 
the framework programmes FP7 and H2020, funded by the EU. An example is the dataset 
extracted from the data generated in the MODENA COST initiative (Cassano et al., 2016).  
Another point that must be underlined is that only 137, 72 and 77 out of 204 models 
reported size, coating/functionalization and shape, respectively, revealing that 
physicochemical characterization of NMs is not reported as a routine basis. This could by 
reasoned by the fact that experimental descriptors might had been generated by 
computational resources, such as Molecular Dynamics simulations (Borders et al., 2013) or 
by means of different software tools, such as DRAGON (Gharagheizi & Alamdari, 2008). 
Therefore, in those publications the physicochemical characterization could have been 
considered not to be relevant and consequently not reported by the authors.  
Size has been reported in 137 out of 204 works, while coating/surface functionalization, zeta 
potential and shapes are barely provided in literature. Another point to take into 
consideration is that ion dissociation, which is one the main processes driven toxicity of 
some NMs (e.g. Ag or CuO) is not generally included in the discussion of the models. 
Furthermore, some well-known technical challenges encountered when testing the effects 
of NMs on organisms (Love, Maurer-Jones, Thompson, Lin, & Haynes, 2012). For instance, 
the formation of protein coronas might lead to the modification of NMs properties 
compared to pristine NMs or the process of dispersing the particles might heavily influence 
the toxicity results.   
Between the different applied characterization techniques, Dynamic Light Scattering (DLS) 
was applied in the 43 out of 204 models to characterize the size and the zeta potential of the 
NMs, while Transmission Electron Microscopy (TEM) was used in the 41 cases for size 
determination as well as to extract information about the shape, aspect ratio, corner count, 
curvature and aggregation state of the nanomaterials. Other techniques identified are 
nuclear magnetic resonance spectroscopy (12 models), photon correlation spectroscopy (8 
models), or X-ray diffraction (8 models). 
Endpoints 
Most of the QSAR models published to date have attempted to predict the toxicological 
effects of NMs by means of cytotoxicity in vitro studies in different cell types. Such studies 
accounted for 152 out of 204 models, in fair agreement with the vast body of literature that 
exists examining the potential effect of NMs in in vitro experiments. Cytotoxicity endpoint is 
commonly (76 out of 152) evaluated in literature by the percentage of cellular viability (N 
                                                      
16 ΔHMe+  represents the enthalpy of formation of a gaseous cation having the same 
oxidation state as that in the metal oxide structure. 
17  '[' : each non-hydrogen atom is specified independently by its atomic symbol enclosed in 
brackets [ ] 
18 '=' : double bond 
19 'O' : oxygen   
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Sizochenko et al., 2014), i.e. LC50, EC50,20  membrane damage measured by LDH release or by 
propidium iodide uptake (R Liu et al., 2011) among others.  Due to the large variety of in 
vitro studies, some authors  (6 out of 152) have generated a generic “endpoint” named 
biological activity (D Fourches et al., 2010; Winkler et al., 2014), which is obtained 
aggregating related response measures of different assays such as amount of ATP content, 
reducing equivalents, caspase-mediated apoptosis, or mitochondrial membrane potential 
for different cell types.  This is an example of the trade-off between data availability and 
data quality – related endpoints are aggregated to obtain a generic prediction of biological 
activity. 
In addition, cell association represented 16 out of 152 QSAR endpoints reported in the 
inventory, which is highly relevant for biodistribution and inflammatory response. For 
instance, several models arising from an original data set generated and modelled by Walkey 
et al. 2014, evaluated the cell association of A549 human lung epithelial carcinoma cells 
(ATCC) with Au NPs surrounded by a protein corona. Cell association was predicted using the 
protein corona fingerprint and/or the physicochemical properties of NMs as descriptors (e.g. 
single NM Volume [nm3], molecular weight, percentage of polar/acidic amino acids and 
hydrodynamic diameter measured after exposure to serum) applying a wide variety of 
statistical methods, such as MLR, SVR, PLSR or k-NN (Kamath, Fernández, Giralt, & Rallo, 
2015; R Liu, Jiang, Walkey, Chan, & Cohen, 2015; Papa et al., 2016). 
As one of the cell association endpoints, cellular uptake21 accounted for 15 out of 152 QSAR 
models). However, all relevant models reported in the inventory used the same original data 
set (Weissleder et al., 2005)22 which describes the cellular uptake of cross-linked iron oxide 
NPs (coated (Fe2O3)n(Fe3O4)m) by pancreatic human cancer cells (PaCa2) (Chau & Yap, 2012; 
D Fourches et al., 2010; M Ghorbanzadeh, Fatemi, & Karimpour, 2012; R Liu, Rallo, Bilal, & 
Cohen, 2015; Melagraki & Afantitis, 2014; C Oksel, Winkler, Ma, Wilkins, & Wang, 2016; A A 
Toropov et al., 2013; Wen DAI, Xue-Ying SHAN, 2015). Finally, few researchers have 
addressed rodent lung inflammation23 (8 models, e.g. immune response measured by 
macrophages (MAC) in Gernand and Casman 2014a), cell differentiation (5 models, e.g.  
Bygd, Forsmark, and Bratlie 2015), ROS (3 models, e.g. Le et al. 2016), mutagenicity (3 
models, e.g. A. A. Toropov and Toropova 2015) and exocytosis (2 models, e.g. C Oksel et al. 
2016) as predicted endpoints.   
In analogy with the biological activity endpoint mentioned above, toxic effect (13 QSAR 
models) is an endpoint determined by aggregating related response measures, including 
mortality assays (e.g. cytotoxic concentration CC50, EC50, IC50) for both cell lines (e.g. HEK293, 
HepG2) and organisms (e.g. Danio rerio - juvenile; Daphnia pulex - adults). The aggregation 
of different endpoints, resulted in a binary classification into toxic ("1") or non-toxic ("-1") 
classes (V V Kleandrova, Luan, González-Díaz, Ruso, Speck-Planche, et al., 2014).  
                                                      
20  LC50 and EC50 are the effective concentration that kills or inhibits 50% of the living 
systems, respectively. 
21 Cell association is a wider term that also includes cellular uptake, membrane adsorption, 
etc.  
22 Some works  reference D Fourches et al. 2010 instead of Weissleder et al. 2005. 
23 Rodent lung inflammation includes different endpoints such as cell death, cell membrane 
damage and immune response. 
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Regarding ecotoxicity studies, “Ecotoxicological endpoint” (11 models, Figure 3.4) was 
defined as an aggregation of different ecotoxicity-related endpoints such as LC50 (G. Chen, 
Peijnenburg, Kovalishyn, & Vijver, 2016) , or percentage of mortality (Z. Zhou, Son, Harper, 
Zhou, & Harper, 2015a). 
To summarize, the corresponding weight percentages of in vitro and in vivo endpoints 
assessed in the QSAR models, differentiating between human and ecotoxicity are shown in 
Figure 3.5. It is evident that the number of in-vivo experiments is significantly low, which 
clearly indicates that the ability of current models to predict in vivo toxicity is insufficient. 
This might be partially due to ethical and economical considerations, since large research 
efforts are dedicated to the development of toxicity test alternatives in vitro. 
 
 
Figure 3.5. Number of QSAR models according to the different types of endpoints predicted. 
Differentiation between human and ecotoxicology is made as well as between in vivo and in vitro. 
Studies involving bacteria have been classified as in vivo ecotoxicological studies.  
 
Concerning QSPR models, almost half of the studies were published between 2000 and 
2010, and solubility of C60 in a large variety of organic solvents was the endpoint mostly 
evaluated (35 out of 52 models reported). This tendency has followed the same trend, as can 
be deduced from Figure 3.2. The reader is referred to a review which addressed this period 
(Saliner, Burello, & Worth, 2008). The solubility of a nanomaterial considers the interactions 
between both the nanomaterial and the solvent, which allows a modelling with information 
from both substances. It is to be noted that solubility studies including nanotubes and 
fullerenes C60/C70, accounted for the 43 out of 52 QSPR models. Solubility of carbon-based 
nanomaterials was modelled in different solvents. For instance, in Toropov et al., 2007, a 
model based on the parameters of chiral vectors (n,m) for CNT was generated by MLR to 
predict its water solubility. One representative example for fullerenes (C60-C70) was recently 
published by Sizochenko et al. (2016). The authors reported a prediction model for solubility 
in chlorobenzene, using atomic weight, partial charges, lipophilicity and polarization as 
physicochemical descriptors by means of a partial least squares method (PLS). From an 
environmental perspective, the solubility and different affinity for organic molecules is of 
extremely importance to determine the fate and transport of NMs in the different 
environmental compartments (A Praetorius, Arvidsson, Molander, & Scheringer, 2013). 
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Despite the large number of studies reported for carbon-based NMs, prediction of solubility 
for metal (e.g. Ag) or metal oxides NPs (e.g. Zn) remains unstudied by means of QSPR 
approaches.  
Other endpoints have been evaluated in literature, but their contribution into the total 
number of studies is fairly small compared to solubility. Those endpoints are adsorption and 
binding interactions (5 models, e.g. Ghaedi et al. 2014), liquid crystal structure (4 models, 
e.g. Le et al. 2013),Young’s modulus and Poisson’s ratio (5 models, e.g. Borders et al. 2013), 
octanol water partition coefficient (1 model, A. A. Toropov, Leszczynska, and Leszczynski 
2007), and  zeta potential (ζ) (1, Mikolajczyk et al. 2015). As underlined before, this is one of 
the few attempts applied to inorganic nanomaterials to describe physicochemical 
properties. Interestingly, in this work, zeta potential predicted for aset of metal oxide NPs 
was described by the weighted energy of the highest occupied molecular orbital (quantum 
mechanical descriptor) and the spherical size of the NPs, which is a descriptor generated 
from electronic microscopy images. It is also worth recalling that zeta potential has been 
frequently used as a descriptor in different QSAR studies (Figure 3.4), and is represented in 
19 out of 152 models (Epa et al. 2012; C Oksel et al. 2016; Silva et al. 2014). 
 
Descriptors 
Descriptors are the base of QSAR model frameworks. It has been already discussed in 
previous reviews that new specific descriptors for NMs are needed (C Oksel et al., 2015; T 
Puzyn, Leszczynska, & Leszczynski, 2009; Natalia Sizochenko & Leszczynski, 2016; Winkler et 
al., 2013; Ying, Zhang, & Tang, 2015). In this section an overview of the most applied 
descriptors as well as emergent useful "nano-descriptors" for different type of NMs are 
described. The most representative descriptors found in the inventory are shown in Figure 
3.4.  
Generally speaking, there are several descriptors which are most frequently applied in the 
models reported in the inventory. While for QSAR models, size (74), concentration/dose 
(48), charge24 (33), mass (26), solubility (25) are the most representative, polarizability (19), 
size (16) and SMILES-based (7) are the most regularly applied descriptors in QSPR models. In 
this chapter, descriptors have been categorized into 1) experimental and 2) molecular. Some 
of these descriptors are novel, having been developed to capture the size-related properties 
of particles not captured by traditional descriptors. 
 
Experimental descriptors 
Experimental descriptors can be divided into, namely geometrical (e.g. size, radius, volume, 
shape, level of aggregation) and physicochemical (e.g. surface charge, pH, zeta potential, 
solubility). It should be pointed out that only 16 reported models included just experimental 
descriptors for model building. 
NM size, either determined from electron microscopy images (i.e. real diameter) or 
determined in different relevant liquid exposure media as water, PBS or Dulbecco modified 
eagle medium  (i.e. hydrodynamic diameter typically obtained by light diffraction scattering) 
                                                      
24 Charge includes descriptors like atom charge, ion indexes and surface charge. 
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appears as the most common geometric descriptor (90 out of 204) used in the reviewed 
models (Chen et al. 2016; Papa et al. 2016), including primary or aggregated size (e.g. Pan et 
al. 2016) or volume  (e.g. Le et al. 2016). Besides size, shape is represented in 10 models. 
This fact is not surprising since the high surface reactivity is mainly due to the nano-size of 
the particles. In a representative example, nanoparticle size of a set of 24 different metal 
oxide NPs (e.g. Al2O3, CuO, SiO2)25, with a particle size ranging from 10 to 100 nm (it should 
be noted that both Cr2O3 and Ni2O3 were outside of this range), was used as a descriptor to 
predict cytotoxicity on rat alveolar macrophage cells (RAW 264.7), by means of a random 
forest statistical method  (N Sizochenko et al. (2015). In this work, particle size in Dulbecco 
modified eagle medium was quantified using a novel high-throughput DLS. 
Concerning relevant physicochemical descriptors, solubility and/or the ability of NMs to 
disperse in a media were also repeatedly used (25 out of 152 models). Unlike in QSPR 
models (5 out of 52) including carbon-based NMs, where solubility was actually the 
predicted endpoint, in a large number of QSAR models (35 out of 52), dispersion/solubility is 
employed as descriptor to predict the activity of NMs. For instance, Chen et al. (2016) 
applied the water solubility of metal and metal oxide NPs as one of the descriptors to classify 
materials in active or inactive, based on a hazard ranking. 
Furthermore, zeta potential has been frequently used in QSAR models (19 out of 152 
models). For instance, zeta potential data obtained from measurements of Au NPs before 
and after Au NPs opsonisation by serum proteins in the culture media was used as a 
descriptor to predict the exocytosis of the particles on human macrophage-like U937 cells 
(Bigdeli, Hormozi-Nezhad, & Parastar, 2015). As far as the relationship between zeta 
potential and toxicity is concerned, Cassano et al. recently revealed that less negative zeta 
potential  values (used as a descriptor) were associated with higher cytotoxicity of SiO2 NPs 
(Cassano et al., 2016). All zeta potential values reported in this work were negative. These 
findings are in contrast with results from literature which suggested that cytotoxicity 
increased as a result of positive zeta potential. It was argued that this discrepancy could be 
due to the fact that zeta potential was measured in water, rather than in the exposure 
medium used for cytotoxicity testing, which could substantially modify the measured values. 
To conclude with the experimental-based descriptors, attention should be paid to the 
concentration or exposure dose, which appeared in 48 QSAR models (Figure 3.4). This 
parameter is not a directly description of the structure or physicochemical property of a 
target NM, but rather is a variable in the experiment with direct influence on toxicity, since it 
is well known that toxicity is dose-dependent. Even though this descriptor is useful for 
predicting toxicity of NMs in QSAR models, it does not provide any information about the 
role that physicochemical properties or (molecular) structure play. For instance, Papa et al. 
(2015) published 16 models where TiO2 and ZnO NPs membrane disruption was modelled by 
different statistical methods and all of them selected concentration as one of the final 
descriptors. To exemplify it with statistics, the specific case of classification tree model 
selected size in water and concentration from five initial descriptors, and significantly high 
external predictivity was reported (100% sensitivity, 86% specificity and 93%accuracy)26. In 
                                                      
25 Original data set came from Zhang et al. 2012. 
26 According to the OECD guidance, sensitivity is defined as the fraction of active chemical 
correctly assigned, specificity as the fraction of non-active chemicals correctly assigned and 
accuracy as the fraction of chemicals correctly assigned. 
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line with this, other experimental conditions have been included as descriptors such as 
exposure time (e. g. Horev-Azaria et al. 2011) or temperature (e. g. Rispoli et al. 2010).  
 
Molecular descriptors 
Molecular descriptors are characterized by their theoretical and mathematical origin, and do 
not suffer from the inherent variability of experimental data. As explained in Chapter 1 
(Table 1.6), molecular descriptors are normally classified according to their dimensionality 
(i.e. 0D, 1D, 2D, 3D and 4D).   
The 0D and 1D molecular descriptors are directly extracted from the chemical formula of the 
NM, such as number of atoms or hydrogen bonds, functional groups, rings, etc. In a recent 
published study, the number of terminal primary C (sp3), number of atoms, number of 
bounds, number of non-H bonds and number of donor atoms for H-bonds were used to 
describe cross-linked iron oxide NPs, in order to predict NPs uptake by PaCa2 cells, using a 
genetic-program-based decision tree induction (GPTree) (C Oksel et al., 2016).  
2D molecular descriptors are based on the topological information of a substance, which is 
related with the shape representation of the molecules through molecular graph theory. An 
example of these descriptors is the Simplex Representation of Molecular Structure (SiRMS). 
SiRMS considers that every molecule can be represented as a group of simplexes, where 
simplexes are fragments with fixed composition and structure. Then, descriptors become the 
number of identical simplexes that are present in a molecule (N Sizochenko et al., 2014, 
2015). There were only few cases of 2D molecular descriptors classified in the inventory, 
which is consistent with the conclusions drawn in a recent published review (Natalia 
Sizochenko & Leszczynski, 2016).  
With respect to 3D molecular descriptors, these are properties that depend on a three-
dimensional representation of chemical structures, as introduced in Chapter 1 (Table 1.6). 
Size, shape and others, which are equal to some of the experimental descriptors listed 
above, are derived from theoretical sources, most of the times from molecular simulations 
(Pan et al., 2016). 3D molecular descriptors also include electronic descriptors, also known 
as quantum chemical descriptors. For instance, polarizability is frequently used in both QSAR 
and QSPR models. Because polarizability allows knowing how the molecular charge 
distribution responds to external electromagnetic fields, it is consistent to use this descriptor 
to predict a possible activity and/or property (Kleandrova, Luan, González-Díaz, Ruso, Melo, 
et al. 2014; Mu et al. 2016; Puzyn et al. 2011; Sivaraman et al. 2001; N Sizochenko et al. 
2016; ...). Finally, 4D descriptors, which are closely related to 3D descriptors, include 
energies for hydrophobic or electronic interactions (e.g. Durdagi et al. 2008).  
Most of the molecular descriptors reported in the inventory were generated by specific 
software programs. Such programs are listed in Table 3.2. It is worth recalling that currently, 
more than 1000 initial descriptors can be generated. 
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Table 3.2 List of identified molecular descriptor sources. 
Software name Description Reference in the Inventory 
Cerius Graphical molecular modeling program which 
can be used to generate topographical and 
physicochemical molecular descriptors 
(Harper et al., 2015) 
Chemistry 
development kit 
(CDK) 
Library programmed in Java for 
chemoinformatics and bioinformatics. 
Topological, electronic, geometrical and 
constitutional descriptors can be generated 
(V C Epa et al., 2012) 
CoMSIA/CoMFA Comparative Molecular Field Analysis (CoMFA), 
and Comparative Molecular Similarity Indices 
Analysis (CoMSIA) 
(Serdar Durdagi, 
Mavromoustakos, & 
Papadopoulos, 2008) 
CORAL CORrelation And Logic software that generates 
models under optimal descriptor based on 
SMILES strings 
(A A Toropov et al., 2012) 
DRAGON Software employed to generate widely types of 
molecular descriptors and also allows analyzing 
them by pair-wise correlation, PCA, etc. The 
last version (DRAGON 7) can calculate up to 
5270 molecular descriptors 
(C Oksel et al., 2016) 
HiTQSAR Software used to generate Simplex-
informational descriptors 
(N Sizochenko et al., 2016) 
MODESLAB Software used to generate physicochemical 
descriptors 
(A Poater, Saliner, Sol, 
Cavallo, & Worth, 2010) 
MOE Molecular Operating Environment has 
different fields of application, where “MOE 
Cheminformatics and QSAR” can generate up 
to 400 2D and 3D molecular descriptors 
(R Liu, Rallo, et al., 2015) 
MOLD2 From 2D chemical structure inputs, the 
program gives an output of diverse molecular 
descriptors 
(Melagraki & Afantitis, 
2014) 
MOPAC Molecular Orbital PACkage, is a semi-empirical 
quantum chemistry software, used for the 
optimization of substance geometry 
simulations and or  to obtain quantum 
mechanical descriptors 
(A Gajewicz et al., n.d.) 
PaDEL-Descriptor Software used to compute molecular 
descriptors and fingerprints. Up to 1875 
descriptors, where 1444 are 1D and 2D 
descriptors and 431 are 3D descriptors. PaDEL 
uses the library CDK to generate part of its 
descriptors 
(Chau & Yap, 2012) 
Pentacle From a set of structures, energy interaction in 
3D maps encoded into GRID based Molecular 
Interaction Fields, or MIFs are generated 
(Rofouei, Salahinejad, & 
Ghasemi, 2014a) 
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Software name Description Reference in the Inventory 
Chemspider Database holding 58 million chemical 
structures, properties, and associated 
information. It also integrates ChemAxon 
(allowing access to chemicalize, online 
platform for chemical calculations, search and 
text processing). It is owned by the Royal 
Society of Chemistry. 
(Z. Zhou et al., 2015a) 
Online Chemical 
Database (OCHEM)  
The website (www.ochem.eu) allows the users 
either to upload their own data or to use 
updated data by other users. With the 
different data sets, molecular descriptors can 
be computed from different descriptor 
packages. It includes almost all libraries and 
descriptors listed in this table and other 
packages which were not identified in the 
reviewed models. In addition, the program 
provides the possibility to build new models by 
means of a large set of possible statistical 
methods (e.g. neural networks, kNN, PLS). 
(G. Chen et al., 2016) 
 
Novel descriptors 
Following a novel approach, Gajewicz et al. (2015) derived a set of initial descriptors from 
images obtained with a Hitachi H-7600 TEM, having a 0.35 nm point-to-point resolution. 
Each image was converted to numerical format, by converting pixels to certain values. In the 
8-bit monochrome image (called gray scale image), each pixel had an assigned value ranging 
from 0 to 255, depending on the image gray levels. This method and also the data generated 
by Gajewicz et al. were used in further works to generate initial descriptors just as area, 
volume, surface diameter, aspect ratio, porosity, sphericity and circularity (Kar, Gajewicz, 
Roy, Leszczynski, & Puzyn, 2016; Mikolajczyk et al., 2015; C Oksel et al., 2016). In the same 
pioneer work, quantum mechanical descriptors were generated by (i) optimization of the 
cluster geometry with respect to the decreasing energy gradient and (ii) calculation of the 
descriptors on the basis of the optimized geometry.  
Kleandrova et al. (2014) investigated new descriptors based on a perturbation approach. The 
aim of this technique was to overcome the problem about the different experimental 
conditions used by different researchers when performing toxicity studies. Generating 
random pairs of NPs, one par is defined as the reference NM and the other one is defined as 
the new NMs in the new experimental condition. This increases considerably the number of 
data points, since 85 initial NMs lead to 4133 data points, which were generated by NM-NM 
random pairs. Linear Discriminant Analysis (LDA) was implemented using the reference NP 
toxicity (EC50, IC50, TC50 or LC50) and the differences between NMs (size, shape, 
experimental condition and biological targets) as descriptors. To predict the toxicity of new 
NMs, these are paired with the training NMs which are set as reference NMs. Further details 
about the model equations are given in the original publication Kleandrova et al. (2014). 
Similarly, considerable efforts have been devoted by other authors to expand the number of 
descriptors. Optimal descriptor method (applied in 22 out of 204), developed by Toropov 
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and co-workers, is based on SMILES notation. SMILES notation represents the molecular 
structure of a chemical compound in different fragments and the combination of the 
correlation weights (correlation with the endpoint) of each fragment generates a new 
descriptor which will be used in a linear regression to predict the endpoint. Monte Carlo 
optimization is used to select the most correlated fragments among the different 
possibilities (A. a Toropov, Leszczynska, and Leszczynski 2007; A A Toropov et al. 2008, 2009, 
2012; A A Toropov and Toropova 2015a; Toropova et al. 2016; Toropova and Toropov 
2013;). One of the first works was applied to the data set generated by Puzyn et al. (2011), 
to predict the cytotoxicity of metal oxide NPs in bacteria (E. Coli). The advantage of this 
method is that descriptors can easily be generated. However, the main disadvantage is the 
lack of mechanistic interpretation in the final model. Studies by A.A. Toropov and co-workers 
account for a 21 of the total reported models in the inventory.  
There is a variant of SMILES-based descriptors named pseudo- or quasi- SMILES-based 
descriptors, which were included the same optimal-based descriptors category (Figure 3.4). 
This variant of SMILES notation also uses a string of characters to represent a substance that 
can be fragmented as input for optimal descriptors method. These strings hold categorical 
variables and continuous variables (transformed into categorical variables) which are not 
molecular structure descriptions. An example of quasi-SMILES based descriptors within 
optimal descriptor method is the work reported by Toropov and Toropova  to predict the 
mutagenicity of multi-walled carbon-nanotubes and fullerene (A A Toropov & Toropova, 
2015b). In this study, the quasi-SMILES were categorical variables were fullerene (X) or 
MWCNT (Z), dark condition (0) or irradiation condition (1), with (Y) or without preincubation 
(N) and presence (+) or absence of S927  (-). In addition to categorical variables, continuous 
variables were dose (g/plate) of C60 (50, 100, 200, 400 and 1000, defined by letters) and 
dose (μg/plate) of MWCNT which was defined in a similar way than dose of C60. As an 
example of the combination of such variables, the string “X0+A” would mean C60 in dark 
conditions in the presence of S9 at dose 50 g/plate.  
There is also a recent study were pseudo-SMILES were tested as descriptors for random 
forest method and it was compared with the linear regression based on optimal descriptor 
method (Cassano et al., 2016). Interestingly, results showed that pseudo-SMLIES can be 
translated into descriptors for different statistical methods. 
Another interesting approach for descriptor generation is the Liquid Drop Model (LDM) in 
combination with SiRMS (N Sizochenko et al., 2014). In the LDM, NPs are densely grouped in 
clusters with a minimum radius of interaction defined by the Wigner-Seitz radius, which 
represents the idea of the use a drop of spherical shape. The molecules inside the drop do 
not behave as the external ones because of the particles located inside the drop are 
surrounded by other particles and the interactions are not equal to the surface particles 
where the number of interactions is lower. Thus the forces are not equally compensated as 
for the internal particles. The associated models in the Inventory are the predictive 
classification of metal oxide NPs cytotoxicity on Bacteria Escherichia Coli (E. Coli) and 
another for human keratinocyte cell line (HaCaT). Both models used random forest as 
statistical method.  
                                                      
27 product of an organ tissue homogenate which contains important enzymes used for 
metabolic activation in order to get a mutagenesis in Ames test (Mortelmans & Zeiger, 2000) 
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Finally, the parameters n and m, which define the chiral vector of carbon nanotubes, were 
used in a model as only descriptors to predict the water partition coefficient using MLR as 
statistical method (Andrey A Toropov et al., 2007). The chiral vector (Ch ) of carbon 
nanotubes is defined as following: 
 
Since a nanotube can be regarded as a "rolled up" graphene sheet, the direction of roll 
defined by linear combination of units vectors (a1,a2) of hexagonal lattice and the 
coefficients n and m are the integers which multiply such vectors. Different combinations 
results in so-called "armchair" (n=m), "zigzag" (m=0) or "chiral" nanotubes. Since the 
electronic band structure will be set with metallic and semiconductor behaviour depending 
on the coefficients n and m properties as it is explained in Charlier et al. (2007). Nanotubes 
defined by the n and m indices will be metallic if n−m=3l and I is an integer and 
semiconductor if I is a non-integer (n−m=3l±1). Since different electronic structures can 
result in different catalytic activity and behaviour, it chiral vector coefficient parameters 
have been used as descriptors. 
 
Statistical Methods 
As pointed out in the introduction, the most common supervised learning methods used to 
derive predictive models and a short description for each of them can be found in Table 1.5 
(Chapter 1). Regarding the specific contribution of every statistical method (Figure 3.4), 
decision and regression trees (38 and 0 models for QSAR and QSPR, respectively) and MLR 
(26 and 27 models for QSAR and QSPR, respectively) were the most frequently used 
methods.  
Even though MLR is also frequently applied in QSAR models, classification methods, 
including Support Vector Machines (SVM)28  (e.g. Rong Liu et al. 2013), Random Forest (RF) 
(e.g. N Sizochenko et al. 2015) or LDA (e.g. Kleandrova, Luan, González-Díaz, Ruso, Speck-
Planche, et al. 2014) have been also regularly employed to categorize the data points into 
several groups or classes. For instance, in Melagraki et al. (2015) and Oksel et al. (2016), 
biological response was categorized into active and inactive by means of a decision tree (DT) 
model.  
The highest proportion of regression methods in QSPR models can be attributed to the type 
of endpoints and properties usually included in the studies. These are continuous variables, 
such as adsorption (X. R. Xia et al., 2011) or solubility (Huanxiang Liu et al., 2005), rather 
than categorical variables. On the other hand, most of QSAR models aim at providing 
categorization for dependent variables, such as level of damage, toxic or not toxic, or active 
or not active.  
Neural networks have also been used in a large number of both QSAR (18 out of 152) and 
QSPR (9 out of 52) models. NN can be applied in both (non-)linear regression and 
classification models, and have shown better statistical results when compared with other 
methods. As an example, Le et al. (2016) predicted membrane damage by ZnO NPs using 
MLR with Expectation Maximization (MLREM) and Bayesian Regularization Artificial Neural 
                                                      
28 Support Vector Regression (SVR) is also considered as SVM for the count, since SVR uses 
the same principles as SVMs with only slight differences to generate a regression analysis.  
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Network applying a sparse Laplacian Prior (BRANNLP). The external validation increased 
from R2=0.57 in MLREM to R2=0.86 in BRANNLP. 
Model performance is defined by: 
(i) Applicability domain. 
(ii) Goodness-of-fit and predictive performance (training set). 
(iii) Robustness (cross-validation, Y-scrambling, bootstrap ...)  
(iv) Predictivity (external validation).  
As shown in Figure 3.6, over half of QSAR/QSPR models (122 out of 204) did not specify the 
applicability domain of the built model. The basic methodology used to report the 
applicability domain was to indicate the type of NMs and the range of values for the final 
descriptors. The most frequently mathematical approach applied (26 out of 204) was the 
leverage and Williams plot (included in the OECD (2007)). 
 
Figure 3.6. Number of models in which applicability domain was specified. Models were 
differentiated into QSAR and QSPR 
 
Regardless of the relevance of model validation, one of the common weaknesses in the 
reviewed models is the lack of external validation. 28 out of 88 reviewed publications did not 
applied an external validation in their models, which is one the important key aspects 
covered by the fourth OECD principle, and determines the level of model reliability. The 
reasons behind this fact are associated to the small size of data sets (not allowing data 
splitting) and also to what the authors consider as predictivity assessment. 
In this regard, cross-validation techniques are used to evaluate the robustness and avoid 
problems as overfitting in the models. Commonly, the authors apply cross-validation 
techniques, which split the data into training and test set several times, to evaluate the 
“predictivity” of a model. The result of repeating the splitting process several times, derives 
in the use of the training dataset to also evaluate the model “predictivity”. According to the 
OECD guideline, only external data which was not involved in the model building can be 
considered as valid external validation. Thus, there are models that only apply internal 
validation when they actually aim at reporting an external validation. For instance, this was 
observed in D Fourches et al (2010) and Papa et al. (2015).  
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Comparison between studies with and without external validation is shown in Figure 3.7. It 
can be concluded that there is no clear trend towards the reduction of the percentage of 
papers without external validation over time.   
Good examples of models in which a validation process has been applied covering the OECD 
principles are Puzyn et al. (2011)29 , Melagraki et al. (2014), Wen DAI et al. (2015), 
Yousefinejad et al. (2013), Rofouei et al. (2014) and Papa et al. (2016). 
 
 Figure 3.7. Number of publications with and without external validation over time 
 
3.2.3 Applicability of available QSPR and QSAR models  
 
In this section, the models most closely predict a REACH-related endpoint are discussed in 
more detail.  
As already reported, the most investigated endpoints in QSAR models is cytotoxicity to 
different cell lines. Some models are predicting cell uptake, exocytosis, immune response, 
cell differentiation, and oxidative stress. These models are not directly relevant for filling 
data gaps but could be useful for screening or supporting grouping and read-across. In the 
following paragraphs models have been associated where possible to REACH requirements 
listed in Appendix III of this report.  
The applicability domain of the collected models is not always explicitly defined; where it 
was not identified, the range of NMs to which the model was applied is reported instead. 
 
Physicochemical properties 
There are only 6 QSPRs that predict properties of NMs that are required for REACH, i.e. 1 for 
water solubility (Andrey A Toropov et al., 2007), 1 for octanol-water partition coefficient 
(Andrey A Toropov et al., 2007), 4 dispersion in organic solvents (Salahinejad and Zolfonoun 
2013, Rofouei et al. 2014, Yilmaz et al. 2015), and 1 adsorption/sorption (Ghaedi et al., 
2014b).  These models are reported in Table 3.3. Mapping of REACH required 
                                                      
29 Methodology followed in this work can be found in the supporting information file (S1) 
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physicochemical properties to REACH requirements. OECD TG are identified as for studies on 
NMs existing TGs are not always considered applicable. 
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Table 3.3. Mapping of REACH required physicochemical properties to REACH requirements. OECD TG are identified as for studies on NMs existing 
TGs are not always considered applicable 
REACH 
requirement 
OECD test guideline REACH relevance QSAR endpoint Applicability domain Reference 
Annex VII 
Water 
solubility 
105, water solubility. But only 
soluble NMs or NMs with high 
dissolution rates. 
Measurement of rate and 
extent of dissolution is 
recommended (OECD 
guidance 62). 
Yes logS=-5.1041 -3.5075n 
-3.5941m where n and 
m form the chiral 
vector of a given CNT.  
Carbon nanotubes 
(5<=n<18 and 
0<=m<=10 not 
specified in the 
publication)  
(Andrey A Toropov 
et al., 2007) 
Annex VII 
n-octanol-
water 
partition 
coefficient 
107, 117, 123 n-octanol-water 
partition coefficient but only 
for water soluble or with high 
dissolution rate NMs. 
The property is 
considered in REACH 
but the 
corresponding TGs 
are in general not 
applicable to NMs. 
logS=-3.9193 +3.7703n 
-3.6001m where n and 
m form the chiral 
vector of a given CNT 
Not specified.  
Carbon nanotubes 
(5<=n<18 and 
0<=m<=10 not 
specified in the 
publication)  
(Andrey A Toropov 
et al., 2007) 
Annex IX 
stability in 
organic 
solvents 
- The study does not 
need to be 
conducted if the 
substance is 
inorganic. Grouping, 
read-across and 
QSARs are not 
applicable at present 
Dispersibility1 = 
f((a_IC, diameter), 
hydrogen bonding 
ability and 
polarizability 
(BCUT_SMR), 
molecular flexibility 
(b_rotR) and 
electrostatic 
(Q_VSA_FPOS, 
AM1_Eele) 
Not specified.  
SWCNTs in organic 
solvents  
(Salahinejad and 
Zolfonoun 20131, 
Rofouei et al. 
20142, Yilmaz et al. 
20153) 
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REACH 
requirement 
OECD test guideline REACH relevance QSAR endpoint Applicability domain Reference 
interactions) 
Dispersibility3 = 
f(SRW09, ATS6m, 
Dipole Z, and X0Av) 
steric 
Dispersibility2 = f(TIP, 
DRY and N1 probes) 
Annex VIII & 
IX 
312, Leaching in Soil Columns 
303A Aerobic Sewage 
Treatment Simulation Test 
may be used as indirect 
measurement to predict 
sorption of NMs into sludge 
It is considered in 
REACH. 
Adsorption of 
methylene blue onto 
CuO-NP-AC= f(pH, 
contact time, amount 
of adsorbent, and 
temperature) 
Not specified.  
Methylene blue onto 
CuO nanoparticles on 
activated carbon ( 
CuO-NP-AC) 
(Ghaedi et al., 
2014b) 
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Ecotoxicity endpoints 
The inventory reported 5 models aimed at calculating ecotoxicological endpoints for 
nanomaterials. Of these, only 1 paper reports algorithms predicting REACH-relevant 
endpoints. The others are suggesting new biological metrics that integrate multiple 
toxicological endpoints. For instance, Liu et al. (2013) proposes an embryonic zebrafish (EZ) 
metric that combines endpoint information on mortality, delayed development, 
morphological malformations. 
Zhou et al. (2015b) focuses on whole animal evaluations using the embryonic zebrafish 
(Danio rerio) embryos. A total of 21 endpoints were observed during development at 24 and 
120 hours post-fertilization (hpf) that included mortality as well as morphological, 
behavioural and developmental endpoints in sub-lethal exposures. This model is not 
predictive of a REACH endpoint. 
Kleandrova et al. (2014; 2014) develop a model to classify NMs as toxic and non toxic taking 
into consideration different measures (EC50, IC50, TC50, LC50). Harper et al. (Harper et al., 
2015) develop a model that integrates different endpoints of toxicity to zebra fish embryo 
(e.g. mortality, malformation, developmental progression) though a weighted hazard score. 
Although these applications allow NMs to be grouped according to a broad set of ecotoxicity 
endpoints, they are not directly applicable for predicting REACH endpoints. 
Chen et al. (2016) report a series of global and species-specific models that could indeed be 
applied to predict REACH endpoints. QSAR models are built on EC50 and LC50 values for 
Danio rerio, Pseudokirchneriella subcapitata, Daphnia magna and Staphylococcus aureus; 
the species relevant to REACH and the respective models are reported in Table 3.4.  
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Table 3.4 QSAR models for ecotoxicological endpoints required by REACH, from (G. Chen et 
al., 2016) 
REACH requirement OECD test 
guideline 
QSAR endpoint Applicability domain 
Annex VII  
Growth inhibition study 
(aquatic plants, algae 
preferred) 
201, inhibition of 
algal growth (based 
on EC50) 
NMs are categorised 
as active or inactive ; 
the decision tree 
models are built on 
EC50 values 
Metal and metal oxide 
nanomaterials 
Annex VII  
Short term toxicity 
(invertebrates, 
preferred species 
Daphnia) 
OECD 202 Daphnia 
magna Acute 
immobilization 
(including EC50 
acute 
immobilisation 
test) 
NMs are categorised 
as active or inactive; 
the decision tree 
models are built on 
LC50 values 
Metal nanoparticles 
Annex VIII 
Short term toxicity fish  
OECD TG 203: Fish, 
Acute Toxicity Test 
 
NMs are categorised 
as active or inactive; 
the decision tree 
models are built on 
LC50 values for Danio 
Rerio 
Metal, metal oxide 
nanoparticles 
Annex IX 
Long term ecotoxicity 
(invertebrates, e.g. 
Daphnia) 
OECD TG 211. 
Daphnia magna 
Reproduction Test 
EC50 Metal nanoparticles 
 
Toxicological endpoints 
There are no models covering the toxicological endpoints on acute toxicity, repeated dose 
toxicity, (skin and respiratory) sensitisation, carcinogenicity, and reproductive toxicity. The 
only endpoint that is covered from available QSARs being also an endpoint of REACH 
relevance is "In vitro – Mutagenicity Bacterial Reverse Mutation Test (Salmonella 
typhimurium)", required under REACH Annex VII.  
The three different models build on two available datasets on Salmonella typhimurium 
(Shinohara, Matsumoto, Endoh, Maru, & Nakanishi, 2009; Wirnitzer, Herbold, Voetz, & 
Ragot, 2009), that was exposed in different test conditions to fullerene or multi-walled 
carbon nanotubes (MWCNTs). These tests were considered for model development; 
descriptors were related to test conditions (dark condition or irradiation, cells preincubation, 
presence or absence of metabolic activation, dose). The three models differ only in relation 
to the database used and, as a consequence, the descriptors used for the prediction. The 
reference OECD TG is the n. 471 (Ames test), providing indication on how to perform the test 
and to evaluate for mutagenicity depending on the count of revertant colonies. However, as 
reported in the ECHA guidance on REACH information requirements (ECHA, 2012b), the 
Ames test is not applicable to NMs, and Kumar and Dhawan (2013) explain that the tester 
strains would need to be modified with deep rough mutation so to improve cell permeability 
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to NMs. It is not mentioned in the source reference if this adaptation was applied, hence the 
data available and the resulting model simulations may not be relevant. 
 
3.2.4 Documentation of QSPR and QSAR models 
The suitability of QMRFs to report QSPRs and QSARs was evaluated by applying the reporting 
format to a QSAR for NMs (Burello & Worth, 2011a). In general it is concluded that the 
QMRF is adequate to report QSPRs and QSARs although the characteristics of NMs might not 
be covered in sufficient detail. The current QMRF only considers the presence of chemical 
name, CAS numbers, SMILES, INCHI, MOL, and formula as information on the training and 
test set compounds. Clearly, these data types are not all relevant or sufficient to 
unequivocally distinguish NMs, therefore it was found necessary to expand the properties 
section, at least until a standard nomenclature for NMs is created and generally adopted.  
In particular, the following parameters should be added to the QMRF to make it applicable 
to NMs:  
- NP composition: Yes 
- NP size: Yes 
- NP agglomeration/aggregation: No 
- NP crystalline phase: No 
- NP crystalline and grain size: No 
- NP aspect ratio/shape: No 
- NP specific surface area: No 
- NP Zeta potential: No 
- NP surface chemistry: No 
- NP dustiness: No 
- NP porosity: No 
- NP pour density: No 
- NP photocatalytic activity: No 
- NP radical formation potential: No 
- NP catalytic activity: No 
 
The full QMRF is provided in Appendix VI. 
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3.3 PBK, PBD and dosimetry model inventory 
3.3.1 Introduction 
A compilation of relevant papers describing toxicokinetic (CTK and PBK), toxicodynamic 
(PBD) models and dosimetry models (in vitro & respiratory tract models) has been 
performed based on a comprehensive state of the art analysis of existing literature on 
computational models for nanomaterials (NMs). The aim of this compilation is to document 
such models in searchable inventory templates and to provide an overall analysis of the 
“model landscape”.  
This will give insight into the availability and applicability of computational approaches that 
are potentially useful in the assessment of the hazardous properties of the manufactured 
NMs under REACH. Each relevant papers collected has been reported in an Excel file, and 
have been characterized with respect to several parameters, such as endpoint of the model, 
NMs evaluated, the parameters involved in the modelling process among other inputs that 
will be explained below. To capture information in a structured way, a template was first 
developed (Appendix VII). The Excel file (Supplementary Material S3) in which this template 
was implemented will hereafter be referred as the model inventory. 
Unlike QSAR models (compilation reported in a separate document), there is not an 
established OECD guidance on how to assess the quality of the above mention models. 
Within the drug development regulatory field, there are some recommendations on best-
practice methods but neither the FDA (Food and Drug Administration) nor EMA (European 
Medicine Agency) have adopted any formal guidance yet. In July 2016, the EMA released a 
draft guidance (“Guideline on the qualification and reporting of physiologically based 
pharmacokinetic (PBPK) modelling and simulation”; EMA/CHMP/458101/2016, CMPH 2016). 
This guidance has been not taken into consideration given that at the time of writing this 
report the guidance was still under revision and highly focused on processes related to 
traditional chemicals  (such as  metabolism). The applicability or the potential adaption of 
this guidance to evaluate NMs has not been addressed in this report.  
In the following sections, the search strategy used to compile the models will be first 
described, followed by a detailed description of the parameters used to characterize the 
models and the methodology applied for the literature review. Finally, an overall analysis, 
i.e. model landscape, of the current state of the above mentioned models will be given 
based on the outcomes of such inventory. 
 
3.3.2 Search and selection strategy  
A methodology approach has been defined in order to perform the characterization of 
available computational models including PBK, PBD and dosimetry models either in in vivo or 
in vitro systems. The work has been performed in three different steps:  
1 Selection of relevant papers, from robust and leading databases,  
2 Review of collected papers  
3 Reporting of the main characteristics in structured and searchable inventory   
4 Overall analysis of the model landscape.  
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In order to select the initial set of publications, the Scopus and WoS (Web of Science) 
database websites were employed as search engine tools and the relevant terms included 
for the initial screening were chosen. Specifically, the main terms were:  
• The model itself (i.e. PBK, PBD, PBPK, PBPD, “physiologically based”, “kinetic, 
“compartmental model”, “numerical”, “computational” and “modelling”)30 
• The NM term (nanomaterial*,  nanoparticle*, fullerene ) 
• The desired endpoint to which the mathematical model is aiming to give answer (e.g. 
”accumulation”) 
• Finally, the terms that generally describe the test systems used in the experimental 
procedures for toxicity assessments (“in vitro”, “in vivo”). 
Different combinations of the terms included above led to the compilation of almost 690 
publications which were included in the reference manager Mendeley. After removal of 
duplicates, the set of publications was reduced down to a number close to 474 papers. Then, 
a detailed revision of titles and abstracts was performed. To discard those publications 
related to cancer or drug research and therefore out of the scope of the project, papers 
including “tumour”, “cancer”, “drug”, "delivery system” or “thermal” in the title, abstract or 
keywords, where selected. This selection resulted in a large number of articles (247) that 
were checked and generally discarded once the general topic was identified. Literature 
references about imaging systems based on NMs (including the terms “imaging” or 
“magnetic” in the title, abstract of keywords) were also removed. The final set resulted in a 
total of 176 publications.  
The screening performed to remove non-relevant papers in the next step was based on the 
identification on those papers describing experimental data with NMs but not actually 
developing or evaluating any computational model were also excluded. As a result, 48 
publications were considered as relevant. 
In a next step, an additional search in Scopus including the term “CNT” in combination with 
other relevant search terms previously described was performed. A specific search on ATLA 
(Alternatives to Laboratory Animals) in Pubmed was also conducted given that this journal is 
not considered within the Scopus database. This search retrieved 8 papers but none of them 
was considered relevant. In addition, some papers previously identified by JRC and not 
included at this point were manually added to the final set of publications to be included in 
the inventory.  
As a result of this process, 62 papers were compiled. Eighteen publications were discarded 
after an accurate reading of the abstracts. The main reasons to discard them were:  
1) Articles using or evaluating a relevant model but not developing a new one,  
2) Articles considering QSAR methodologies  
3) Articles performing experimental toxicology evaluations.  
The final set of articles to be reported was reduced to 48 publications.     
                                                      
30 “*”: It is applied in the search engine to include all terms which include the “word” 
previous the “*” 
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3.3.3 Review and reporting 
A review of the final set of 48 publications was performed in a chronologic order starting 
from the oldest papers to be able to recognise the citations of already reviewed publications 
as well as identify possible new models, not captured using the strategy presented above. 
It must be also underlined that there were some papers which the developed models were 
in fact the same or closely related to previous models reported in the inventory. Even 
though these papers have not been included in the inventory as new entries, they are 
referred in the table as it will be explained below, in the following sections. After an accurate 
identification of this kind of publications and the inclusion of two new relevant ones, 35 
papers were included in the final inventory.  
The detailed reporting of the whole set of papers provided and overview of the different 
types of models considered. As a result, the following classification was adopted: 
1 Toxicokinetic (PBK) models: Numerical models commonly derived from physiologically 
relevant compartments and processes (physiologically based kinetics models (PBK)) 
and constructed from mass-balance equations (i.e. accounting for material entering 
and leaving a system). Classical toxicokinetic (CTK) models are also included within this 
classification. 
2 Toxicodynamic (PBD) models:  Models that simulate the intensity and time-course of 
NM effects on a biological system (e.g. prediction of the inflammatory response of 
macrophages under exposure to NMs). 
3 Dosimetry models: Computational models that predict the fate and the local 
concentration/dose of NMs in a defined in vitro or in vivo system. The models in this 
section have been divides in two different categories: 
3.1 Respiratory tract dosimetry: biologically-based mechanistic approaches to predict 
the fate of inhaled particles, by describing the physical and physiological factors 
that influence the deposition, clearance, and retention of inhaled particles.  
3.2 In vitro dosimetry: models that calculate the dose-rates and target cell doses 
based on particle kinetics and transport prediction of NMs to cells in liquid-based 
in vitro systems.  
 
It should be pointed that the Search Strategy was stressed more on physiologically based 
models due to their broader use and potential relevance for risk assessment purposes (they 
allow interspecies extrapolation, route-to-route extrapolation, dose extrapolation, etc).  
Although the search strategy did not explicitly include “dosimetry” as a search term, both in 
vitro and in vivo computational dosimetry models have been included in the inventory and 
thoroughly reviewed from the literature. On the other hand, toxicodynamic models were not 
covered in such wide manner and just a few examples (n=4) were incorporated and reported 
in the inventory. 
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Figure 3.8. Percentage of included and excluded papers for each model 
 
Figure 3.8 shows a graphical representation of the percentage of reviewed papers that have 
been either included or excluded in the final inventory and Figure 3.9 shows from the 
included papers the number of papers for each model in detail.  
In addition, Figure 3.10 depicts the number of publications included in the inventory with 
respect to the year of publication. Based on this figure, the number of PBK publications 
considered as relevant remains almost constant over the time. A peak of PBK publications 
(n=5) was observed in 2015. A constant number of publications is also observed for the 
Respiratory tract dosimetry models. For the rest of models there is some variability 
depending on the year of publication. It should be noted that this figure reflects the criteria 
adopted to include the publications as “relevant models” (principally new developed models) 
but it does not reflect the actual number of publications using these models in the 
nanotoxicology field.  
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Figure 3.9. Number of publications of each model included in the Inventory 
 
Figure 3.10. Number of publications included in the Inventory as a function of publication year 
 
The diagram depicted in Figure 3.11 represents the inventory structure, covering the 
different sections (n=5) and corresponding parameters (n=39) used to characterize the 
relevant models. These sections are 1) Model meta data, 2) Model description, 3) Inputs and 
outputs, 4) NP description and 5) Model domain. The contents of each one is summarized 
below: 
• Model metadata: includes model details (name, version, homepage) information 
about the model owner (ownership, contact point, email address, license), the 
reference (associated literature references and DOI). To assign a model name, its aim 
and a generic term to define the type of model have been used as main criteria. 
 
• Model description: this section gather the main characteristics of the model (i.e. a 
generic description of the model output(s), the level of organisation considered (i.e. 
compartments, tissues, cells), the model type), information about the processes 
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considered within the model (including units, level of description/definition). This 
section also allows the possibility to include free text to add any comment 
considered of importance. 
 
• Inputs and Outputs:  Information on the (nano)particle-specific or chemical-specific 
parameters that the model use as input or output is reported in this section 
(parameter, symbol, units, protocol for measured values). Assumptions or key 
information on the protocol related to the inputs are also covered by this section. 
 
• NPs description: in this section the type of NMs used to build the model or to 
evaluate it are described (i.e TiO2, Ag, CeO2, metal oxide, carbon-based, polystyrene, 
etc). Then other associated physic-chemical properties, such as coating, size, shape, 
and any other relevant characterization performed. This also contains the description 
of the NMs used in other literature references evaluating or using the same model. 
The information about these references is placed in the subsection “Used in 
reference”. 
 
• Model domain: in this section the applicability domain stated by the author or 
inferred from the description and the outcome(s) of the model is provided. It also 
state if one or more physicochemical properties of the NMs (i.e size, density, 
agglomeration state, etc) are used as input model parameters. General adopted 
assumptions by the model are also detailed at this level. 
 
 
3.3.4 Results of the analysis of the available PBK models 
The parameters considered most relevant in the characterization of a toxicokinetic model 
are summarised in Figure 3.12. These include: the type of generic NMs used in the model 
(either to develop or evaluate the model); the species and the exposure routes used to build 
the model and those physiologically relevant compartments (organs or tissues) considered. 
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Figure 3.11. Inputs included in the inventory for characterizing the different models 
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Figure 3.12.  Summary of the type of NMs, species, exposure routes and compartments used in the 
toxicokinetic (PBK) models for NMs. The numbers represent the times that each specific parameter 
has been identified. 
 
Most of the models included in the inventory are PBK models (PBK) except six of them (Zhu 
et al., 2009, Tien et al., 2010., Li et al 2011, Denim et al., 2015; van Kesteren et al., 2015 & 
Sahneh et al., 2015). These models are not stated as physiologically based models since they 
do not use any physiological parameter (i.e. organ weight, tissue volume, blood volume, 
blood flow) as direct input parameters. They generally follow classical toxicokinetic (CTK) 
modelling approaches and use empirically calculated physiological factors (i.e absorption, 
transportation, elimination rate constants). Despite their limited capability to extrapolate 
between species or exposure routes they are considered of relevance to predict the 
transport and concentration of NMs in several tissues. 
Nanomaterials 
Models found in the literature search cover a total of 15 different NMs including metals, 
metal oxides, polymeric and carbon-based nanomaterials. Metal NMs are the most common 
materials (covered by 10 out of 19 models).  As seen in Table 3.5, Ag (4) and Au (3) are the 
most frequently evaluated metals. Metal oxides, polymeric and carbon-based nanomaterials 
are represented at a similar extent.  It has to be pointed out that three of the models (Fallon 
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et al., 2004; Tien et al., 2010 & Sahneh et al., 2015) are not focused on the evaluation of a 
specific type of nanomaterial. They can be applied to nanoparticles in broad generic sense, 
independently of their chemical composition. Table 3.5 shows a list with the specific type of 
NM for each group: 
 
Table 3.5. List of NMs reported in the Inventory for kinetic models. The number in brackets 
indicates the how many times each NM appears among the different models, including both 
PBK and CTK studies. 
Generic type of NMs Specific type of NMs 
Metal  Silver (4), Gold (3), CdSeTe (1), Iridium (1), 
CdTe(1), CdS(1) 
Metal oxide Fe2O3 (1), TiO2(1), ZnO (1), SiO2(1) 
Polymeric Polystyrene (1), Poly(amidoamine(1), PLGA(1) , 
polyacrylamide (1) 
Carbon-based Carbon (3) 
Generic NM (3)
 
Exposure routes & Compartments 
As can be observed in Figure 3.12, the intravenous route is the most common route of 
administration taken into consideration (13 out of 19 models). Other administration routes 
such as those relevant for the oral route, the inhalation route (e.g. intratracheal 
administration), the dermal or the subcutaneous route are represented at a lesser extent. 
The PBK models compiled within this report vary on complexity from full PBK models where 
all of the distribution organs and tissues included are represented as separate perfused 
compartments (i.e. Péry et al. 2009 includes more than 20 compartments) to more 
simplified, minimal PBK models in which tissues with similar kinetics are lumped (i.e. van 
Kesteren et al. 2015 includes 3 compartments). Blood, liver, spleen and kidneys are the most 
represented compartments among the different models (see Figure 3.12). Liver and spleen 
are one of the major targets of nanoparticle accumulation, especially after intravenous 
administration and together with blood, the main compartments containing 
Reticuloendothelial system (RES; also called mononuclear phagocyte system or MPS) cells. 
Nanoparticles are rapidly captured and retained by these cells (monocytes circulating in the 
blood, reticular cells in the spleen and Kupffer cells in the liver). The RES has been 
considered as a separate compartment in six models (Bachler et al., 2013; Li et al., 2014, 
Bachler et al., 2015; Sahneh et al., 2015; Lin et al., 2016, Liang et al., 2016). 
Model inputs & outputs 
The input parameters considered by the models compiled in this section are physiological 
parameters generally used by PBK models not focused on NMs (i.e. body weight, organ 
weight, blood flow, organ and tissue volumes, blood flow to organs, etc). It should be noted 
that only one of the models (Bachler et al. 2013) uses a NP physicochemical property 
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(diameter) as a direct input parameter (to calculate the MPS uptake rate of NMs from the 
blood circulation).  Other physicochemical properties such as surface area, specific surface 
area, density or agglomeration state are not specifically considered as input parameters. 
As other computational kinetic models, the estimation of the concentration in tissues, 
organs or other specific compartments along the time is the main predicted model outcome 
of the compiled kinetic models for NMs.  
Applicability domain 
Some authors attempt to define the applicability domain of their models to those particles 
used to build or evaluate the model (i.e. Bachler et al. 2003 : “The model could successfully 
predict the biodistribution of ionic silver and 15–150 nm silver nanoparticles, which were not 
coated with substances designed to prolong the circulatory time (e.g., polyethylene glycol”). 
Some others expand the applicability domain to NMs with similar generic physicochemical 
properties (Li et al., 2011 develops and evaluates a model using a variety of different NPs 
(silver, gold, quantum dots, polystyrene, and carbon NPs) and states that the model can be 
applied to “Non-degradable/non-metabolizable nanoparticles”. However, most of the 
authors do not explicitly define the applicability domain of their model. In these particular 
cases, it has been assumed that the applicability domain should be limited to nanoparticles 
within the range of those used to develop or evaluate the model. 
Assumptions 
Some relevant model assumptions have been identified during the reviewing process. They 
can be considered as critical factors responsible for part of the uncertainty of the compiled 
models: 
Related to the NMs: 
• nanoparticles are insoluble 
• physicochemical properties of nanoparticles do not affect the bio-kinetics 
• no agglomeration of nanoparticles 
• no nanoparticle-overload effects in the lung.  
 
Related to the model structure and processes: 
• all compartments are well mixed (homogeneous),  i.e., no spatial gradients 
• The concept of partitioning between tissues and blood is clear for conventional 
substances and is based on the chemical potential of molecules in different phases 
such as water, fat and protein phase. It is less clear what determines the partition of 
nanoparticles but we can assume that hydrophilicity and lipophilicity are important 
factors. The hydrophobicity of particle coatings is well addressed for cosmetics and 
pharmaceuticals, for example, but not in REACH. Anyway, an equilibrium of 
concentrations of exchangeable moieties of nanoparticles in tissue and blood can be 
described by a steady concentration ratio referred to as partition (Lankveld, et al., 
2010). 
• The rates of mechanical transport are independent of the chemical composition and 
crystal form of the nanoparticles (Tien et al., 2010). 
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• All organs have the same blood over tissue partition coefficient value to facilitate 
parameters estimation (Péry et al., 2009) 
REACH relevance  
In general toxicokinetic data can be used for: "…  further acceptability and applicability of 
quantitative structure-activity relationships, read-across or grouping approaches in the 
safety evaluation of substances. Kinetic data may also be used to evaluate the toxicological 
relevance of other studies (e.g. in vivo/in vitro)." (OECD TG 417). 
REACH allows the use of any scientifically justified information as weight of evidence (Annex 
XI) supporting read-across approach.  
As stated in REACH (Chapter R.8: Characterisation of dose [concentration]-response for 
human health) for conventional chemicals), PBK can support the derivation of DNEL (Derived 
non-effect level) from animal data to account for human health risk. PBK models may 
potentially be used to determine some specific assessment factors (AFs): 1) route-to-route; 
2) interspecies and 3) high-dose-low-dose extrapolation. In addition PBK modelling data can 
aid in the quantification of intraspecies variability, which may be caused by variation in 
anatomical, physiological and biochemical parameters with, age, gender, genetic 
predisposition and health status.  PBK models can be used to quantify these, which would 
result in possible modification of additional AFs.  However, risk assessors, who are using 
these models, should be able to interpret them and their outputs. 
 
3.3.5 Results of the analysis of the available PBD models 
Four toxicodynamic models have been included in the inventory. Given the limited number 
of compiled publications, a comprehensive overview of this kind of models was not feasible. 
Alternatively, a general description has been provided for each of them:  
1)  Shelley et al., 2008 developed a model to simulate the cell population dynamics 
(including toxic effects and functional viability along time) of rat alveolar macrophages under 
exposure to 80 nm aluminium NP. A system of mechanistically ordinary differential 
equations was derived based on the following primary state variables: macrophage 
population, nanoparticle concentration and macrophage phagocytosis function level.  
The model demonstrates how in vitro data can be used within a simulation setting of in vivo 
cell dynamics. 
2) Maher et al., 2014 used a phenomenological rate equation model that numerically 
simulates uptake and cellular responses to polyamidoamine dendrimer (PAMAM) 
nanoparticles of different generations (number of initial branching points). Nanoparticle 
uptake and the subsequent cellular response measured by change in cellular markers of 
oxidative stress, mitochondrial damage, inflammatory response and apoptosis where the 
processes simulated.  
The model is intended to be used as a tool to interpolate and visualise the range of dose and 
temporal dependences and elucidate the mechanisms underlying the in vitro cytotoxic 
response to nanoparticle exposure.  
3) Mukherjee et al., 2013 developed a multiscale toxicodynamic model to quantify and 
predict pulmonary effects due to uptake of NMs in mice. The kinetics of surfactant and 
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pulmonary function due to interactions of NMs at the alveolar microenvirontment are 
simulated.  Collection of toxicodynamic modules to describe the dynamics of tissue focused 
on cells and the alveolar surfactant chemicals that regulate the process of breathing, as well 
as the response of the pulmonary system to xenobiotics. It is worth mentioning that the 
model uses some nanoparticles properties (i.e. zeta potential, diameter and surface area) as 
input parameters. 
The model predictions were compared with in vivo lung function response measurements in 
mice and the analysis of mice lung lavage fluid following exposures to citrate-stabilized                 
10-20nm Ag NPs and carbon black nanoparticles.  
4) Mukherjee et al., 2014 (b) developed a mathematical model that predicts the in vitro 
inflammatory response (i.e. expression levels of cytokines) of immune cells exposed to 
citrate-coated and PVP-coated Ag in a culture system. Additionally, the model was executed 
with and without the inclusion of the NP agglomeration-diffusion-sedimentation-reaction 
model (ADSRM; Mukherjee et al., 2014a), to determine the extent of effects due to in vitro 
cellular dosimetry of NPs. 
REACH relevance 
Interspecies differences result from variation in the sensitivity of species due to differences 
intoxicokinetics but also in toxicodynamics. Toxicodynamic models can potentially be 
coupled with toxicokinetic models and be used to calculate interspecies assessment factors 
during the human risk assessment process.  
 
3.3.6 Results of the analysis of the available respriratory tract dosimetry models 
The respiratory tract dosimetry models compiled in this section are based on modelling fluid 
and particle dynamics in subject-specific respiratory geometry tracts. Among these 
modelling techniques, computational fluid dynamics (CFD) models allow for simulations of 
airflow patterns and particle deposition efficiencies in complex geometries such as those 
found in the upper respiratory tract of laboratory animals and humans and provide a 
valuable supplement to experimental work in evaluating dose-response. 
The parameters considered most relevant in the characterization of the respiratory tract 
dosimetry models are summarised in Figure 3.13. These include: the type nanomaterial (NM) 
used in the model (either to develop or evaluate the model); the species considered to build 
the model and the input parameters (nanoparticle-independent or nanoparticle-dependent 
parameters) needed to run the model. 
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Figure 3.13.  Summary of the type of NMs, species/system, and input parameters (NP-dependent 
or NP-independent) used in the Respiratory tract dosimetry models for NMs. The numbers 
represent the times that each specific parameter has been identified. 
 
Nanomaterials and applicability domain 
Computational fluid and particle dynamic simulation models have been developed to study 
airflow, gas uptake and deposition fractions of particles that cover the nano-size range but 
also the micro-size range. Hence, this type of models can simulate the behaviour of a 
“generic” particle including but not limited to particles in the nano-size range. For instance, 
Schroeter et al.,  2013, uses a CFD model based on the architecture of the nasal passage of 
an adult and an infant rhesus monkey to simulate inhaled airflow and particle deposition for 
inhaled nanoparticles (0.5 – 1000 nm) and microparticles (1 to 20µm). Other authors 
(Anjilvel et al., 1995, Garcia et al., 2009, Zhang et al., 2011 and Henry et al., 2016) also use 
similar approaches that can be used to evaluate “generic” particles from 10 nm to 10µm. 
Other authors have evaluated their model with particles in the nano-sized range. For 
instance, Kolanjiyil et al., 2013, compared the predicted nasal depositions with experimental 
results using polymeric (polystyrene latex) and metal (silver wool) nanoparticles ranging 
from 3.6 to 100 nm, for validation purposes. 
A complementary approach to these models was followed by Kirch et al., 2012. This author 
investigated the fate of inhaled particles after deposition onto the pulmonary mucosa.  This 
study applied ex vivo and computational approaches to investigate the dependency of 
mucociliary clearance on size, shape, charge and surface chemistry of nano and 
microparticles. Polymeric particles (polystyrene particles ranging from 200 nm to 6µm) and 
metal oxide particles (maghemite (Fe2O3) particles ranging from 146 to 555 nm) were under 
investigation. 
The compiled Multiple-Path Particle Dosimetry (MPPD) Mode developed by Anjilvel et al 
1995 is freely available from https://www.ara.com/products/multiple-path-particle-
dosimetry-model-mppd-v-304 
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Species   
Assessment on human health risk from exposure to inhaled materials often relies on 
extrapolation of dose-response data from laboratory animals. Inhalation toxicological 
studies are mainly conducted in rodents such as mice or rats. Due to the differences in their 
respiratory tract architecture and other physiological parameters, determining lung 
deposition fraction becomes critical for being able to use the animal toxicity data to evaluate 
the potential human health effects associated with exposure to the inhaled materials.  
Three out of six models found in the literature (Anjilvel et al., 1995, Garcia et al., 2009, 
Schroeter et al., 2013) developed a respiratory tract dosimetry model for rats.  Zhang et al., 
2011 and Kolanjiyil et al., 2013 build their deposition models based on the human airway 
geometry. Finally, as mentioned above Schroeter et al., 2013 uses a model based on the 
nasal architecture of the rhesus monkey. 
Model inputs & outputs 
Unlike the majority of PBK models, the input parameters used in the respiratory tract 
dosimetry models include some of the physicochemical properties of the NMs. As can be 
seen in Figure 3.13, two main NM-dependent properties have been identified: Size related 
parameters (e.g. diameter, radius & diffusion coefficient) and particle density. Four groups of 
NP-independent parameters were also identified. These are related to the air properties 
(e.g. air density, viscosity, flow rate, etc), the airway architecture (e.g. airway length, 
diameter, volume, and area), respiratory function parameters (e.g. tidal volume and 
breathing frequency) and mucus properties (e.g. thickness and viscosity).  
Particle deposition (deposited mass or deposited fraction (as percentage)) in different 
respiratory sections of the upper respiratory tract (URT; olfactory region i.e. Garcia et al., 
2009 Schroeter et al., 2013 and Henry et al., 2016), the lower respiratory tract (LRT: lungs, 
bronchi, bronchioles, and alveoli; i.e. Anjilvel et al., 1995) or the whole respiratory tract (i.e. 
Zhang et al., 2011 & Kolanjiyil et al., 2013) are the main outcomes of the compiled models. 
Assumptions 
Some relevant model assumptions have been identified during the reviewing process. They 
can be considered as critical factors responsible for part of the uncertainty of the compiled 
models: 
Related to the architecture of the airway: 
• Homogeneity in the airway geometry (e.g.  alveolar volume was assumed to be 
equally distributed among all alveolar ducts; Anjilvel et al., 1995) 
• Disturbances in the air flow caused by the presence of the nanoparticles are 
neglected ( Garcia et al., 2009) 
• Constant and homogeneous parameters (e.g., constant velocity of ciliary beating; 
Zhang et al., 2011) 
• Related to the particles:  
• Uniform concentrations of monodisperse particles (Schroeter et al., 2013) 
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REACH Relevance  
Respiratory tract dosimetry models can be used to determine the internal dose following 
inhalation. However, care must be taken since the most sensitive endpoint may vary for 
different durations or routes of exposure resulting in different internal doses from the same 
external inhaled concentration. These models can also be to extrapolate from animal 
toxicological data to humans, e.g. calculation of a human equivalent dose (HED).  
 
3.3.7 Results of the analysis of the available in vitro dosimetry models  
Commonly, in vitro dosimetry models are based on mathematical approaches that describe 
the dynamics of particles in liquids. The parameters considered most relevant in the 
characterization of the respiratory tract dosimetry models are summarized in Figure 3.14.  
 
Figure 3.14.  Summary of the type of NMs, processes and input parameters (NP-dependent or NP-
independent) identified in the in vitro dosimetry models. The numbers represent the times that 
each specific parameter has been identified. 
Processes 
Kinetic processes such as diffusion (e.g. based Stokes-Einstein equation), sedimentation (e.g. 
based on Stokes law) and advection (transfer by motion of the fluid) are some of the 
processes that are considered in these models (e.g. in vitro Sedimentation, Diffusion and 
Dosimetry model – ISDD – by Hinderliter et al., 2010). Mukherjee et al., 2014 (a) also 
includes in their agglomeration-diffusion-sedimentation-reaction model (ADSRM), dynamic 
transformation processes important for nanoparticles, specifically dissolution. Neither the 
ISDD nor ADSRM models consider the interaction of nanoparticles with molecules present in 
 162 
 
the test system media. To overcome this limitation in the ASDRM model, Mukherjee et al., 
2015 extended of the ADSRM model to enabling the assessment of ENM interaction with 
various fractions of lipids and surfactant proteins.  Another enhancement worth mentioning 
is the semi-analytical solution for the ISDD model developed by Mahnama et al., 2014. Based 
on a generalized integral transform technique (GITT) the predictions concerning the 
advection-diffusion processes are improved and consequently the accuracy of the ISDD 
modelling. The above mentioned models are mainly designed for in vitro supporting systems 
such as tubes or cell culture well plates. 
A different approach included in this section was developed for NP injected in tissues by Su 
D et al., 2010. This model aims to predict the spatial distribution of nanoparticles in tissues 
after nanofluid injection into the extracellular space of tissues.  In this particular case, 
interactions of the NPs with the surrounding media are also considered. To this aim van der 
Waals interactions, electrostatic forces and attachment of nanoparticles to solid structures 
among others are incorporated into the model.  
Model inputs & outputs 
Physicochemical properties of the nanoparticles are relevant input parameters in the in vitro 
dosimetry models.  Size, density and zeta potential of the primary nanoparticles as well as 
properties related to the agglomeration state (e.g. agglomeration density, size and porosity) 
are the main representative “nanoparticle-dependent inputs” and have been depicted in 
Figure 3.14.  
It is important to note that, the effect of the nanomaterial coating was also addressed by 
Mukherjee et al., 2014 (a) that included an estimation of the fraction of citrate adhered to 
the NP and the fraction of NP surface area that is available for reaction. 
The properties of the assay media are also required model input parameters. Media 
characteristics identified in the models and classified in the inventory as “nanoparticle-
independent inputs” have been also summarized in Figure 3.14. 
The estimation of the fraction of administered particles that would deposit on cells as a 
function of time (Hinderliter et al., 2010, Mahnama et al., 2014, Mukherjee et al. 2014 (a)  
and Mukherjee et al., 2015) or the spatial distribution of the NPs in the extracellular space 
(Su et al. 2010)  are the main output parameters identified in the inventory. 
Nanomaterials & applicability domain 
As mentioned above, the computational models compiled in this section generally predict 
the dynamics of particles in liquids or predict the transport of colloids through a porous 
medium (i.e. Su et al. 2010).  Similarly to the Respiratory tract dosimetry, the models include 
but are not limited to particles in the range of 0-100 nm. For instance, Hinderliter et al. 2010 
states that the ISDD model can be used for non-interacting spherical particles and their 
agglomerates. The model was tested with multiple sizes of polystyrene spheres (20-1100 
nm), 35 nm amorphous silica and large agglomerates of 30 nm iron oxide particles. Other 
authors (Cohen et al., 2013, Cohen et al., 2014, Deloid et al 2014 & Teeguarden et al 2014, 
using the ISDD have evaluated a variety of different nanomaterials (<100nm) including metal 
(Au, Ag) metal oxides (Al2O3, CeO2, CoO, Cr2O3, Fe2O3, Fe3O4, Gd2O3, Mn2O3, SiO2, TiO2, ZrO2) 
and carbon nanoparticles.  
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Similarly to the ISDD model, Su et al., 2010 assumes that the model can evaluate spherical, 
chemically inert and solid particles, but in this case restricted to particles within the nano-
size range.  The model used 10nm Fe3O4  particles for simulation purposes. 
Mukherjee et al., 2014 (a) evaluated the ADSRM model with different AgNP sizes (from 1 to 
110 nm) and surfaces chemistries (i.e. citrate, PEG and PVP). It has to be noted that the 
author assumes that despite of using different surface chemistries, the model cannot 
adequately capture solution interactions (e.g. those involving polymer chains) due to the 
lack of information regarding the coating chemistry. However, the model deals at some 
extend with the dissolution of AgNP. A further publication from the same author (Mukherjee 
et al., 2015) enabled the assessment of NM interaction with various fractions of lipids and 
surfactant proteins of the alveolar lining fluid. In addition to the same AgNP the author also 
used 600nm SiO2 particles. 
Assumptions 
Some examples of assumptions taken by the in vitro dosimetry models have been identified 
and listed. They can be considered as critical factors responsible for part of the uncertainty 
of the compiled models:  
• Single average particle hydrodynamic diameter (Hinderliter et al., 2010) 
• Size, number and effective density of agglomerates remain constant over time 
(Hinderliter et al., 2010) 
• Non buoyant particles (particles immediately and permanently adhere to cells and 
are thereby removed from further influencing transport) (Hinderliter et al., 2010; 
Mukherjee et al., 2014). 
• Deposition of nanoparticles is assumed to be irreversible (Su et al., 2010). 
• Oxidation of AgNPs coatings has been assumed to be zero for PEG and PVP coatings 
(Mukherjee et al., 2014). 
 
REACH relevance  
REACH allows the use of any scientifically justified information as weight of evidence (Annex 
XI) supporting read-across approach.  
In vitro dosimetry models may also be helpful in the in vitro-in vivo extrapolation (IVIVE), and 
they are mentioned in ECHA guidance for estimating biotransformation rates in 
bioaccumulation assessments.  
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3.4 Fate model inventory 
3.4.1 Search and selection strategy 
The steps followed from the selection of relevant papers to their inclusion in the inventory 
are summarized below and are the same than those followed during the QSAR/QSPR and 
PBK model revision, with some modifications. 
1. Selection of papers by means of database websites 
2. First selection of relevant publications 
3. Removal of duplicates 
4. Prioritization of relevant papers based on the abstract 
5. Addition of relevant papers from other sources (EU projects, reviews) 
6. Reading of the articles  
7. Inclusion or exclusion of the model from the inventory 
In order to select the initial set of publications, Scopus and WoS (Web of Science) database 
websites were used as search engine tools and the relevant terms included for the initial 
screening were chosen (point 1 above). This case is substantially different than the QSAR 
example since the fate and transport of colloids in environmental media has been evaluated 
since long ago, and the number of terms related to the topic is rather broad. On the other 
hand, environmental exposure assessment to NMs is a more recent field and the number of 
papers and groups working on them is quite limited. Specifically, the main search 
components (SC) were: 
• SC1: model, modelling, simulation tool, fate, multimedia 
• SC2: nanomaterial* (therefore also including engineered nanomaterials), nanoparticle* 
• SC3: exposure, environmental concentration, environmental distribution, environmental 
exposure, human exposure, exposure assessment, flow, exposure to nanomaterial* and 
nanomaterial* exposure (also with nanoparticles*), transport, dissolution, aggregation, 
deposition, transformation and dissolution. 
• SC4: porous media, aquatic or water or aquatic. 
Different combinations of the terms included above led to the compilation of almost 1100 
publications, which were included in the reference manager Mendeley program (point 2 
above). After removal of duplicates (point 3 above), the set of publications was reduced 
down to a number close to 900. Then, a detailed evaluation of titles and abstracts further 
reduced the number of the final set (point 4 above). The main criteria used to remove non-
relevant papers and classify relevant papers were: 
• A large amount of papers describing measurements and transport modelling of particles 
generated from diesel engines were found, which are traditionally called ultrafine particles in 
literature. Modelling of ultrafine NMs in outdoor air and also modelling of NMs in indoor air 
have been not included in the environmental fate inventory. 
• Numerous papers evaluating inflammation in in vitro or in vivo experiments have been 
removed (specially related to the human exposure term). 
• Experimental environmental fate studies have been also removed, e.g. dissolution, stability 
or transport in porous media studies. 
As the typology of studies found is rather broad, it was decided to divide the papers by three 
different generic categories: 
1) Material flow (MF) models: these models typically track the materials from production and 
manufacturing to use and further to end-of-life stages and identify at each stage how much 
 165 
 
materials are released into which technical or environmental compartment. Depending on the 
model different assumptions are made, different environmental compartments are included and 
different transfer factors are used that describe the amounts of mass flowing from one 
compartment into another. 
 
2) Environmental process-based fate models: these models determine the fate (partitioning 
between compartments) and transport (advection and deposition fluxes) of the materials in a 
system by modelling physicochemical processes, such as agglomeration, or sedimentation. 
 
3) Bioaccumulation models: these models address the uptake or accumulation of NMs in 
aquatic organisms. 
As can be expected, some studies combining MF and process-based fate modelling 
approaches were found since available fate models rely strongly on input data to the 
environmental compartments that are provided by MFA models. Therefore, this division is 
justified by the fact that main focus of the different models was put in either MF or in 
process-based fate models.  From the literature search also some bioaccumulation models 
were available, and are distinguished as a separate type of approach. 
In addition to the citation database, new methodological approaches discussed in recent 
reviews (Baalousha et al., 2016; Dale, Lowry, & Casman, 2015), reports being drafted 
between NANoREG (FP7) and ProSafe (H2020) projects as well as new scientific papers 
published during the execution of this work have also been taken into consideration to 
expand the search (point 5 above). As a result of the search process, a total of 141 relevant 
publications were compiled, from which 38 corresponded to MFA models and 100 
corresponded to process-based environmental fate models, plus 3 bioaccumulation models.  
Review of papers was done in a chronologic order starting from the oldest papers to be able 
to recognise the citations of already revised publications as well as identify possible new 
models, not captured using the strategy presented above (point 6 above).  
A considerable number of papers, in which the developed models were the same or closely 
related to previous ones, were not reported in the inventory as (new) entries, but were 
included as associated references of the original models (point 7 above). 
After an accurate review of the search results, a total of 27 publications for MFA models (out 
of 38) and 54 publications for process-based environmental fate models (out of 100) were 
included in the final inventory. Figure 3.15 shows the number of publications included in the 
inventory with respect to the year of publication.  
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Figure 3.15. Number of publications included in the inventory as a function of publication year 
 
In the next section MF models, environmental fate process-based models (in either water or 
porous media) and bioaccumulation models will be discussed separately. The field has been 
extensively covered by several reviews recently published (Baalousha et al., 2016; Caballero-
Guzman & Nowack, 2016a; Cornelis, Hund-Rinke, Kuhlbusch, van den Brink, & Nickel, 2014; 
W. Peijnenburg, Praetorius, Scott-Fordsmand, & Cornelis, 2016). 
 
3.4.2 Analysis of the available fate models - material flow models  
MF models track NMs from one compartment to the other and identify at each stage the 
NM quantity (mass) that is released to the environmental (e.g. freshwater, soil, air) and 
technological compartments (e.g. waste water treatment plant).  This is realised through the 
identification of NMs applications and the definition of transfer coefficients.  The final aim of 
these models (the same as in process-based environmental fate models), is to estimate 
predicted environmental concentrations (PECs) (F Gottschalk, Lassen, Kjoelholt, Christensen, 
& Nowack, 2015), or to provide qualitative analysis by means of scores or rankings (Niall 
O’Brien & Cummins, 2010), therefore to assess environmental exposure. In some cases, 
however, PEC has been used to estimate consumer exposure via the air compartment 
(Royce et al., 2014).  
Depending on the scope of the published studies, there is a large variety in terms of the 
number of compartments evaluated, the number of product life cycle stages considered, the 
environmental/technological compartments identified as well as the extent to which some 
fate processess are evaluated. It has been already discussed in literature that MF models are 
meant to provide a first step in NMs environmental exposure estimation, but such estimates 
are in general not based on fundamental multimedia fate and transport analysis (Fadri 
Gottschalk, Scholz, & Nowack, 2010). Figure 3.16 shows an overview of the available models 
to predict the concentration of NMs in the environment (in some cases also exposure to 
consumers thorough the environment) with respect to some parameters used to report the 
models in the inventory:  1) NMs, 2) Environmental/technological compartments, 3) Life 
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cycle stages, 4) Regional (e.g. city) / national scale and static /dynamic modelling31, 5) 
Deterministic or stochastic approach. 
 
          
Figure 3.16. Summary of several relevant inputs obtained in the inventory analysis for mass-flow 
models.  Number of models allows quantifying the specific weight of each element within the 
same type of model. Total number of models corresponds to the total number of entries in the 
inventory (27). 1Include organo-silica, hydroxyapatite, latex, CuCO3, quantum dots, carbon black, Ca 
peroxide, keratin fibers and Al. These NMs only appear once in the inventory. 2 Includes surface 
water, rivers, natural freshwater and drinking water. 3Also including agricultural soil. 4Include 
incinerated ash landfill, groundwater, drinking water plant, environment, human body, lungs, 
swimming pools and bioactive landfill (slag). 7The dynamic modeling of release intends to describe 
the evolution over time of the amounts of NMs released to the environment. Includes models with 
dynamic consideration on NMs production, release from stocks or release coefficients.  
 
Nanomaterials and nano-enabled products 
Nanomaterials (NMs) covered by current MFA are limited to silver, metal oxides and carbon-
based NMs. As seen in Figure 3.16, Ag was included in 21 out of the 27 publications 
reported. TiO2 (19), ZnO (12) and CeO2 (10) were the most frequent evaluated metal oxides 
and the most studied carbon-based NM was MWCNT, which was represented in 10 studies. 
The total number of NMs covered in the inventory is 21. However, 10 of these NMs were 
only evaluated once, either in Boxall et al. (2007), Keller et al. (2013) or Tiede et al. (2016).  
                                                      
31 Dynamic modeling of release intends to describe the evolution over time of the amounts 
of NMs released to the environment 
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Although the number of papers on this subject is relatively large, very little information 
about the incorporation of NMs in commercial products is available from the manufactures, 
thus it is difficult to determine the real degree to which NMs have penetrated the market. It 
is worth pointing out that the EU has recently approved synthetic amorphous silicon dioxide 
as an existing substance for use in biocidal products for product-type 18 (insecticides). This is 
the first product registered as a nanomaterial form, tough the approval covers stable 
aggregated particles with sizes above 1 μm, with primary particles at the nano-scale.  
Different approaches have been followed in literature to determine how these NMs can 
reach the different environmental / technological compartments, being some models only 
applied for certain material in selected applications (Arvidsson, Molander, & Sandén, 2014) 
while others have the aim to be comprehensive (Arturo A Keller et al., 2013; Mueller & 
Nowack, 2008). On one hand, some studies have evaluated market size of specific products, 
market penetration and concentration of NMs in products to determine the total amount of 
NMs mass in different product families, like in the first quantitative approach for assessing 
NMs release and concentrations for environmental media (Boxall et al., 2007). In this 
particular case, the focus of the studies was put either on specific products such as CeO2-
based diesel additives  (B. Park et al., 2008) and cosmetics (Lorenz, Von Goetz, Scheringer, 
Wormuth, & Hungerbühler, 2011) or by contrast, in a wide range of products (UK specific 
case in Tiede et al., 2016).  
On the other hand,  another approach, firstly proposed by Nowack and co-workers, have 
been widely used by different authors with slightly different methodologies: 1) worldwide 
(an at a country level when available) production volume is allocated to different 
countries/regions by means of the population of industrialized world (Mueller & Nowack, 
2008), in proportion to Gross Domestic Product (Sun, Gottschalk, Hungerbühler, & Nowack, 
2014) or by the Inequality-adjusted Human Development Index (IHDI, which gives an idea of 
human development achievement)(A A Keller & Lazareva, 2014); 2) then production volume 
is allocated to different product categories (e.g. paints, coatings, electronics, textile) based 
on internet sources and also from knowledge about NMs concentrations in the different 
nano-enabled products. Some of the internet sources correspond to developed nano-
inventories trying to map different products containing NMs that are currently in the 
market32. In Keller et al. (2013), product allocation was performed following the indications 
of a market study, based on manufacturer information gathered through surveys and 
interviews. In another work reporting the flow of TiO2, ZnO, Ag and MWCNT trough recycling 
processes, 33 different product categories containing NMs were defined, which significantly 
expanded the range of nano-enabled products (Caballero-Guzman, Sun, & Nowack, 2015).  
Since it is well recognized that information about production volumes and product allocation 
is not available33, allocation of different NMs to products has been assumed to follow the 
same pattern for some NMs (Arturo A Keller et al., 2013; Mueller & Nowack, 2008). It is 
important to take into account that all these assumptions bring uncertainty to the final 
                                                      
32  Examples include the Woodrow Wilson Centre for Scholars’ Project on Emerging 
Nanotechnologies (WWI, 2012), the ANEC/BEUC Inventory (ANEC/BEUC, 2010) and the 
BUND inventory (BUND, 2011) 
33 Information on production volumes may be available in REACH registration dossiers 
through ECHA but this information is not available to the public 
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assessment as it will be discussed below. Most of the current models assume that in a given 
region, population is using products containing NMs distributed in certain applications, 
based on inventories or market reports, but with a lack of real evidence (Luoma, 2008). 
Two of the few existing studies assessing exposure to NMs applied in real products were 
aiming to estimate emissions to air (B. Park et al., 2008) and to soil and water compartments 
(A. C. Johnson & Park, 2012) of a CeO2-based fuel additive (Envirox). These studies relied on 
industry-provided figures, and in Park et al. the impact of Envirox on existing ambient 
particulate matter levels was assessed in real terms by atmospheric monitoring and also by 
the use of modelling with two emission models (COPERT and TRENDS). Results obtained 
showed that it was highly unlikely that exposure to CeO2 at the environmental levels will 
elicit pulmonary inflammation. Moreover, this product showed positive environmental 
effects associated with the increased fuel efficiency and low hydrocarbon emissions. This 
work also constitutes the only example which provides physicochemical characterization of 
the particles included in the product. 
On the whole, the MF models reported in the inventory worked with mass of NMs, and as a 
rule physicochemical properties were not taken into account (e.g. size, zeta potential, 
surface reactivity). However, one model reported a simple particle flow analysis approach 
(PFA) (Arvidsson, Molander, & Sandén, 2011) using three different case studies: TiO2 in 
sunscreen and Ag in textiles and circuit electronics. To determine particle number, 
representative sizes obtained from literature / company websites were assigned to both TiO2 
and Ag and release to the environment (compartments were not specified) was assessed 
qualitatively based on different factors such as technology diffusion, consumption per capita 
of nano-products or product lifetime. The study only concluded that most nano-TiO2 was 
released from sunscreen use.  
Release scenarios 
In MF models, each release scenario defines the type of process causing NMs release (or 
waste) in each of the life cycle stages of a nano-enabled product (Caballero-Guzman & 
Nowack, 2016b). For instance, considering a antimicrobial textile containing Ag NMs as a 
reference, the following release scenarios could be defined:  1) wearing, 2) washing 3) 
drying, 4) ironing  5) recycling, 6) incineration and 7) landfill (Wigger et al., 2015).34 
 In MF models, release of NMs during the different steps of the value-chain of a product is 
defined by means of release factors, which determines amount of NMs entering into the 
different environmental / technological compartments. This is a critical step in exposure 
assessment since depending on the flows that NMs follow, potential risks will be taken place 
in water or in soil for instance. This concept is currently applied in chemical environmental 
exposure assessment by the ECHA (ECHA, 2010a). Release factors or default parameters to 
estimate release rates are linked to different environmental release categories (industrial 
production, formulation and wide dispersive uses and associated release factors are based 
on the highest release factors available for representative use patterns). Importantly release 
factors are common to all products, regardless of its composition. In absence of 
experimental data some authors have adopted some of these factors to define worst-case 
scenarios, typically to estimate release of NMs during the synthesis /manufacturing stages 
                                                      
34 Release scenarios from 1-4 correspond to the use phase of the product and from 5-7 to 
disposal phase. 
 170 
 
(Fadri Gottschalk, Sonderer, Scholz, & Nowack, 2010). Release of NMs at industrial settings 
has to be assumed since this information is not provided by industry because of 
confidentially issues as a routine basis. In Shinohara et al. (2009), release of fullerenes to air 
outside the factory was estimated in 0.03 %, based on the  efficiency of HEPA filters for 
gases35.  
In contrast, release factors defining release amounts of NMs from products during their use 
have been established by numerous authors. It is well known that release from products 
depends on factors such as NMs distribution into the product (i.e. surface or embedded), 
NMs stock in the article or whether the intended use is either indoors or outdoors (Mitrano, 
Motellier, Clavaguera, & Nowack, 2015). Typically, release factors are defined by means of 
personal judgment or when available, from release experiments described in literature 
(Boldrin, Hansen, Baun, Hartmann, & Astrup, 2014; Fadri Gottschalk, Scholz, et al., 2010). 
These studies typically mimic conditions that resemble real use of products, as textile 
washing (Mitrano et al., 2014) or polymer weathering (Nguyen et al., 2012). These 
experiments give insight into both the quantification of the released material per time unit 
in each product life cycle stage, and also on the characteristics of the NMs released. In some 
models complete release into the environment is assumed, like release from textiles in 
Boxall et al. (2007) or Arvidsson et al. (2014). In other cases, complete release into air or 
water is more evident, when products are deliberately releases into the environment such as 
cleaning spray agents (Royce et al., 2014) or cosmetics products (Musee, 2011). 
It is also common to explore different scenarios, including realistic and worst case scenarios 
(Blaser, Scheringer, Macleod, & Hungerbühler, 2008). In O'Brien and Cummins (2010) it was 
assumed that Ag release from textiles into WWTP was 50% in NM form while 50% as ionic 
form. In other works it is also assumed that 100% of the NMs produced will be eventually 
released, but differentiating between environmental compartments (e.g. water) or 
technological compartments in which NMs will end up at certain point (e.g. landfill) (Arturo 
A Keller et al., 2013; Sun et al., 2014). As an example, TiO2 release from cement in Europe 
was assumed to be distributed between WWTP (1%),  landfill (29%), and recycling 
compartments (70%) (Sun et al., 2014). Therefore, in these studies long-term accumulation 
as stock is not considered since current models assume that NMs are produced and released 
to waste streams and environmental compartments during the same period of time, 
commonly one year. Consequently, resulting NMs concentrations are proportional to the 
NMs concentrations values used as input in the model. This issue will be introduced below 
because recently some studies have introduced time-dependent processes in material flow 
exposure assessment.  
Besides release factors, one point that has not being currently addressed is the exposure 
forms that NMs might exhibit when they are released into the environment. Only few 
studies have included transformations taken place during the use phase of the products, 
specifically for dissociation of Ag into Ag+ in water contact scenarios (Blaser et al., 2008; 
Mueller & Nowack, 2008), and also for sulfidation of Ag and ZnO once these NMs are 
released into the environment (F Gottschalk et al., 2015).  This is of extremely importance 
for two reasons: 1) exposure forms (e.g. free or aggregated particles, particles embedded 
                                                      
35 CEN standards on the efficiency of NMs filtering are under development in the frame of 
the EC mandate M461 
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matrices) determine further fate and transport (and toxicity) of particles in the environment, 
and 2) if NMs transform into non-nanoforms, predicted NMs concentrations in the 
environment might be actually overestimating real concentrations.  
Environmental / Technological compartments 
As can be seen in Figure 3.16, aquatic compartment has been the most evaluated 
environmental compartment in the reported papers, and examples of PECs in surface water 
(N. J. O’Brien & Cummins, 2011), river water (F Gottschalk, Ort, Scholz, & Nowack, 2011) and 
drinking water (N O’Brien & Cummins, 2010; Tiede et al., 2016) can be found.  Water, air, 
soil, WWTP, landfill and WIP compartments are habitually incorporated in the MFA with a 
product life-cycle perspective (Sun et al., 2015; Y Wang, Kalinina, Sun, & Nowack, 2016), with 
only few cases considering the sediment compartment. Among these, landfills, soil and 
water (or sediment) are defined as sink compartments, and from such compartments no 
downstream flows are modelled. Transformation products account as a removal (e.g. Ag2S 
generated from Ag in WWTP is considered as a degradation product and hence as a mass 
loss from the system Sun et al. 2016). It is worth recalling that models generally consider 
well mixed compartments, thus not being space oriented.  
Some authors have predicted concentrations in more specific compartments such as 
swimming pools (TiO2 NMs from different sources in David Holbrook et al., 2013). Other 
studies have modeled NMs flows during waste handing (different kind of landfills and WIP 
Mueller et al. 2013) and recycling process in Switzerland for large variety of nano-enabled 
products and possible treatments (Caballero-Guzman et al., 2015). Products considered for 
recycling were cars, cooling devices, electronic waste (e-waste), metals and batteries, 
mineral material coming from the construction and demolition waste, textiles and wood and 
the NMs evaluated were TiO2, ZnO, Ag and MWCNT. Results obtained revealed that the 
largest sink compartments for NMs were incineration plants and landfills. Moreover, flows 
were small compared to the overall flows in the whole system  described in (Sun et al., 
2014). 
Although MFA attempt to estimate NMs concentrations, such estimates are in general not 
based on fundamental fate and transport analysis. For instance, sedimentation, 
resuspension, surface erosion or water-sediment partitioning of NPs are based on very crude 
assumptions, since currently there is no data available concerning NP transfer to and from 
these compartments (Fadri Gottschalk, Scholz, et al., 2010). A worst case scenario of no 
sedimentation, i.e. all particles remained in the water phase, was considered by Arvidsson et 
al. (2011), and Gottschalk et al. (2011) reported a (i) a conservative scenario without any 
NMs transformation/deposition in rivers and (ii) an optimistic scenario with rapid NMs 
removal. These different scenarios try to address the current uncertainty associated to the 
behaviour of NMs in the aquatic environment. Similarly, in Sun et al., (2014) it was assumed 
that nanoparticles eventually deposited in water (40 days) and soil (10 days). Therefore 
10/365 and 40/365 of the total input flows into these compartments were considered as the 
fraction of NMs remaining in the two compartments.  
Besides fate processes in the different environmental compartment, (dimensionless) 
transfer coefficients have been applied to determine NMs amount that remained in waste 
water treatment plants as sludge and the fraction remaining in the effluent, and therefore 
reaching natural waters.  As for release factors, such coefficients have been taken from 
literature sources when available or from personal judgment. In a representative example, 
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the lowest reported specific removal efficiencies in waste water treatment plants were 
incorporated into the calculations for CeO2 (95% removal), and when no information was 
available on removal, two scenarios were considered: (1) a conservative scenario where the 
removal efficiency was assumed to be 0% and (2) a more realistic scenario, where a removal 
efficiency of 97% for particles in packed-bed filters was applied (Tiede et al., 2016). 
Regarding the PECs, MF models considering the whole life cycle of nano-enabled products in 
a more comprehensive way report that in general the highest concentrations of NM are 
found in sediments, followed by waste-water sludge treated soils and then surface water. 
Regarding technological compartments, NMs were more accumulated in waste water 
sludge, followed by landfills, waste incineration plants bottom and fly ashes compartments 
(Sun et al., 2016, 2014). These results are in reasonable good agreement with the values 
reported in Keller et al. (2013), but it should be pointed out that different results are 
motivated due to differences in scope (global vs. regional or single country) or types of NMs. 
It must be also underlined that waste practices might be region-specific, and therefore this 
could affect whether sludge produced in waste water treatment plants is deposited in 
landfills or burned in waste incineration plants, for instance.  In any case, from both 
representations it is evident that higher PECs of nano-TiO2 are expected than the other 
studied NMs in the different environmental compartments. This has been attributed to the 
large production and application of TiO2. To finalize, another important assumption adopted 
by current models is that NMs background concentration is in most cases neglected.  
Uncertainty, temporal and spatial scales 
It can be stated that current reference MF models are: 1) probabilistic mass flow models 
(PMFA), developed by Nowack and co-workers (Fadri Gottschalk, Scholz, et al., 2010) and 
deterministic models developed by UC CEIN (Fadri Gottschalk, Scholz, et al., 2010; Arturo A 
Keller et al., 2013). Both models are static and therefore determine steady-state 
concentrations. The main difference therefore relies in the fact PMFA applies a stochastic 
approach to computing probability distributions of mass flows and PEC, by means of Monte 
Carlo simulations and Markov Chain Monte Carlo (MCMC) modelling. This allows the model 
to cope with the uncertainties and inherent variability of its parameters (e.g. NMs 
production volumes, transfer coefficients etc.), since for such parameters all available 
information is collected and probability distributions are produced. Type of applied 
probability distribution depends on the amount of information available. For instance, 
uniform distributions are applied when data is lacking (Sun et al., 2014). In the case of 
deterministic models, values (such as production volumes) are only considered from single 
sources. Consequently uncertainty is not assessed for highly uncertain parameters such as 
production amounts, product allocation, and market penetration, amount of NMs in the 
products, release factors or removal efficiencies in waste water treatment plants or water 
incineration plants.  Unfortunately, the absence of analytical methods able to quantify trace 
concentrations of NMs has made impossible to validate the outcomes of such MFA models.  
Recently, PMFA modelling has been updated by the addition of a dynamic component 
(Bornhöft, Sun, Hilty, & Nowack, 2016; Sun et al., 2016). This improvement allows predicting 
the former, current and future mass-flows of NMs to the different compartments over time, 
by incorporating into the model the lifetime of a product, how many years the NMs release 
events take place for one product and how much of the fraction is released every year. In 
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contrast to previous reported models, these studies consider long-term NMs accumulation 
as stock. 
Finally, regarding the spatial scale of the models, as deduced from Figure 3.16, most models 
(n=18) have assessed NMs exposure at country (e.g. Germany, Wigger et al. 2015) or 
continent level (e.g. USA Mahapatra et al. 2015), while a lower number of studies (n=7) have 
focused on small regions such as Gothenburg city (Arvidsson et al., 2014). 
3.4.3 Process-based environmental fate models 
Process-based environmental fate models describing the behaviour of nanomaterials (NMs) 
take into consideration transformation and degradation (e.g. dissolution), interaction with 
suspended particulate matter (i.e heteroaggregation) and transport processess (e.g. 
sedimentation). These models have been splitted between two groups:  
1 Models describing the fate and transport of NMs in aquatic media (including 
multimedia box models) 
2 Models describing the fate and transport of NMs in soil media 
For details regarding colloidal theories underlying environmental and biological fate (e.g. 
DLVO and Smoluchowsky-Friedlander), the reader is refered to section 1.5.1 in Chapter 1. 
Moreover, some reviews have been recently published covering nanomaterials fate in the 
environment (Baalousha et al., 2016; Cornelis et al., 2014; W. J. G. M. Peijnenburg et al., 
2015; W. Peijnenburg et al., 2016).  
Fate in aquatic environments 
NMs covered by current environmental fate process-based models in aquatic media are 
limited to a restrict number of metal oxides (12, 9 and 5 out of 24 studies for CeO2, TiO2, and 
ZnO, respectively) and Ag which was included in 11 out of the 24 publications reported. This 
is in fairly good agreement with the numbers corresponding to the NMs evaluated in the MF 
models described above. The PEC of other NMs (CNT, Cu, Cu oxides, Fe, Al2O3, nanoclays and 
SiO2) in different environmental compartment was also evaluated in only single study (H H 
Liu & Cohen, 2014).  
Table 3.6 shows some representative examples of different types of models that have been 
included in the inventory. Two different categories have been established, in a similar way 
than reported previously by (Baalousha et al., 2016): 
1) Spatiotemporally averaged fate multimedia box models 
2) Spatiotemporally explicit fate models36 
Regarding the first type of studies, two large environmental fate models have been reported 
so far: i) the SimpleBoxNano (SB4N) (J. A. J. Meesters, Quik, Koelmans, Hendriks, & van de 
Meent, 2016; J. Meesters et al., 2014)  and the ii)  MendNano model from the US (H H Liu, 
Bilal, Lazareva, Keller, & Cohen, 2015; Haoyang Haven Liu & Cohen, 2014a). Both models 
consider the environment as a collection of well-mixed compartments, each representing a 
specific medium or biological entity, with intermediate mass transport between adjacent 
                                                      
36 Spatially and temporally resolved models, especially needed for site-specific higher tier NM exposure assessments on the 
scale of small rivers or hydrological units. Spatial (e.g. m or km) and temporal (e.g. months, weeks) resolutions depends on 
each model.  
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compartments. Models include aggregation/agglomeration 37 , hetero-aggregation, 
sedimentation, dissolution and transformation reactions in addition to transport affecting 
NMs bound to particulate matter. While SB4N has been solved at steady state, MendNano 
determines the dynamic environmental multimedia mass distribution and concentrations of 
NMs. However, both models are spatially unresolved, averaging concentrations over large 
regions (e.g. country scale). One of the main differences is that SB4N considers first order 
rate constants to model mechanistically transport and transformations processes, while 
MendNano assumes time independent partitioning ratios for processes of aggregation and 
attachment, which control the environmental fate of colloidal systems.  
These two models carried out simulations including emission release rates of different NMs 
obtained as the outputs in mass flow models (MFA), based on life cycle inventory 
assessment (Arturo A Keller et al., 2013; Mueller & Nowack, 2008). As mentioned in the 
previous section, fate and transport NMs processes in MFA models are generally based on 
assumptions, rather than defined mechanistically by physicochemical equations. Differences 
in the PEC estimated by MFA and multimedia box environmental fate models were different 
depending on the environmental compartments considered. For instance, SB4N showed that 
atmospheric deposition is a relatively effective removal process since PEC for TiO2 was 170 
times smaller than PEC calculated in (Mueller & Nowack, 2008). It was also shown that 
steady-state was reached within one year of study. On other hand, PECs estimated in the 
water compartment were in the same order of magnitude, revealing that removal by 
sedimentation of NMs did not lead to significant differences between both models.  
It is worth recalling that SB4N (J. Meesters et al., 2014) is an adaption of the SimpleBox 
model, and provides as an output PECs at the steady state. SimpleBox has been used as a 
regional distribution module in the EU system for Evaluation of Substances (EUSES) model, 
which is supported for application in environmental exposure assessment in REACH (ECHA, 
2016c). However, since thermodynamic equilibrium does not apply to NMs, (Markus, 
Parsons, Roex, de Voogt, & Laane, 2015), SB4N proposes different forms (species) for NMs in 
the different compartments: i) (1) freely dispersed, (2) hetero-agglomerated with natural 
colloidal particles (<450 nm), or (3) attached to larger natural particles (>450 nm), which are 
subjected to gravitational forces (sedimentation). Apart from this concept, other two 
elements are actually included in SB4N compared to the model addressing conventional 
chemicals: 1) transformations processes are considered as altered species of the same NMs 
(i.e. not consider a removal process) and 2) dissolution (release of ions from the NM surface) 
is applied as a removal process. In air, behaviour of NMs is interpreted via the aerosol 
coagulation, where first-order rate constant for “aggregation” and “attachment” in air are 
applied. 
SB4N model also stresses the need of more experimental data, since experimental values are 
required for some of the parameters not fully covered by existing colloidal theory (e.g. 
hetero-attachment efficiency) (Baalousha et al., 2016). Recently, Monte Carlo simulations 
were performed on the environmental fate, concentrations and speciation of three different 
                                                      
37 Agglomeration is defined as collection of weakly or medium strongly bound particles whereas aggregation refers to a 
particle comprising strongly bonded or fused particles held together by strong forces such as covalent bonds. In fact, 
modelling language does not distinguish between the two because often it is assumed that once an agglomerate is formed, 
it does not de-agglomerate (Avilov, Lamon, Hristozov, & Marcomini, 2017). As a result, the two terms are used 
interchangeably. 
 175 
 
NMs by a probabilistic modelling approach in order to reflect realistic distributions of 
variability and uncertainty of the original deterministic S4BN model (J. A. J. Meesters et al., 
2016).  
Other fate models in aquatic media with different degrees of complexity have been 
developed. Some of them explored the possibility to apply colloidal chemistry kinetic 
equations  to describe particle aggregation and sedimentation, such in Arvidsson et al. 
(2011), one of the first studies on the topic. In this work, a kinetic model was presented, 
based on kinetic laws that describe changes in particle concentration in a homogeneous 
fluid, and collision efficiency was identified as the most important parameter in 
understanding NM environmental fate. These laws were described by Smoluchowski (1917) 
and Friedlander (1977). The importance of fractal dimension and the assumption of 
irreversible agglomeration were also discussed. Hetero-aggregation was defined but not 
taken into consideration for the modelling exercise. 
 In another example, experimental data produced by other authors was used to explore the 
possibilities and limitations on the implementation of first-order rate constants for the 
sedimentation and dissolution processes (J T K Quik, Vonk, Hansen, Baun, & Van De Meent, 
2011). The outcome of this study was NMs concentration in water resulting from in lab-
based water column experiments. Reasonable correlations were found in this study. In order 
to further explore these findings, the same authors verified such model with experimental 
data of CeO2 NMs in natural river water containing natural colloids. By monitoring CeO2 
concentration in the water column at different initial NMs concentration, and with filtered 
/unfiltered river water, it was found that when hetero-aggregation was dominant (low initial 
NMs concentration) a first-order kinetic apply (ksed), since NMs deposit onto natural colloids, 
and then these underwent sedimentation. It is currently assumed that environmental 
relevant NMs concentrations are very low. Therefore the presence of NMs will lead to 
hetero-aggregation, instead of homo-aggregation (Antonia Praetorius, Scheringer, & 
Hungerbühler, 2012). Actually, in a recent reported model, NMs were assumed to hetero-
aggregate completely in all media, therefore sedimentation only accounted for solid 
particulate material (Amy L. Dale, Lowry, & Casman, 2015). On the other hand, when homo-
aggregation is dominant (high initial NMs concentrations), this process is faster than what 
first order kinetics describes (Petosa, Jaisi, Quevedo, Elimelech, & Tufenkji, 2010). 
Hetero-aggregation is the main process to include in the modelling of fate for nanomaterials, 
with the hetero-attachment efficiency as main parameter (αhet, see Table 1.1 in Chapter 1). 
In Praetorius et al. (2012), attachment efficiency is treated as the probability that two 
colliding particles stick to each other and is always between 0 and 1, and as mentioned 
above the way on how to define this value differs between models. It is already known that 
such parameters depend on both NMs surface properties as well as the properties of the 
surrounding medium, so for one NM it might be different if the NOM concentration in the 
media is different, for instance. In last few years, different approaches have been published 
on how to measure this parameter experimentally (L E Barton, Therezien, Auffan, Bottero, & 
Wiesner, 2014; A Praetorius et al., 2014).  
Other important processes extensively evaluated in literature are dissolution (e.g. ZnO) and 
transformation (e.g. from Ag to Ag2S). Several examples have been included in the inventory 
evaluating Ag dissociation with respect to pH and natural organic matter (NOM) 
concentration  (J. Liu & Hurt, 2010) or nanoparticles size (W Zhang, Yao, Sullivan, & Chen, 
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2011). There is a current discussion in the scientific community on how to incorporate both 
hetero-aggregation and dissolution processes in the existing environmental fate models.  
Praetorius et al. (2012) reported a river multimedia model that calculated the predicted 
environmental steady-state concentrations of TiO2 NMs in water and sediment in Rhine 
River. The model takes into account relevant processes for NM fate such as hetero-
aggregation (expressed with a pseudo-first-order rate constant), sedimentation, sediment 
resuspension and burial. Attachment efficiency is the parameter governing aggregation rates 
and fractal dimension is considered for the prediction of sedimentation rates. Due to the 
relative abundance of particulate matter compared to NMs in the system, homo-aggregation 
was considered negligible. The initial size distribution of the aggregated TiO2 NPs was set to 
be log- normal with a mode at 300 nm. Attachment efficiency for hetero-aggregation was 
varied from 0.001 to 1 (different values) to evaluate the effect on hetero-aggregation rate 
constant. Uniform conditions throughout the model were assumed (varying parameters in 
different runs) and it was found that concentration in the sediment was several order of 
magnitude higher than in the moving water in all scenarios evaluated (in both free and 
hetero-aggregated) (Antonia Praetorius, Scheringer, & Hungerbühler, 2012). 
In another study, a Monte Carlo method was applied to a simple model for TiO2, Ag, ZnO and 
CeO2, considering both aerobic and anaerobic conditions in waste water treatment (L E 
Barton et al., 2015). WWTP was compartmentalized, compared to a previous work published 
by the same group (Hendren, Badireddy, Casman, & Wiesner, 2013), into sewer system, 
primary clarifier, secondary treatment (aeration and secondary clarifier) and sludge 
processing (anaerobic digestion). Particularly, sedimentation was assessed indirectly by 
determining experimentally NMs attachment to suspended matter. As a result, distribution 
coefficients (ratio of NMs concentration in the supernatant and the settled material) allowed 
assigning NMs fraction ending up in the sludge and NMs fraction remaining in the WWTP 
effluent. Moreover, redox transformations of Ag and ZnO were assumed to be first order in 
the absence of more complete rate information.  
More recently, some spatiotemporal explicit models have been published (Amy L. Dale et al., 
2015; De Klein, Quik, Bäuerlein, & Koelmans, 2016a; Dumont, Johnson, Keller, & Williams, 
2015; Sani-Kast et al., 2015), allowing in some cases to predict hotspots of exposure (in 
certain regions or sections of a river for instance) and also consider the feedbacks between 
hydrology and nanoparticle behaviour.  
In a first attempt, in the framework of NANOFATE FP7 EU-funded project, Dumont et al. 
used a GWVA model to simulate expected concentrations of ZnO and Ag, which are likely to 
be emitted to surface waters across the whole Europe. GWAVA's main component simulates 
river discharge and a number of other hydrological variables, such as volumes of lake water 
and human water abstractions, in a spatially and temporally explicit manner. NMs loss in 
river water was assumed to follow first order-kinetics (Quik et al 2012). Different 
assumptions were made by the authors: 1) households were the only source of NMs loading 
from sewage effluent, 2) NMs input was assumed to be constant in time and represents the 
current situation, 3) dissolution losses of nano-Ag were not modelled because experimental 
results from literature showed these are negligible compared to the modelled sedimentation 
losses. As general conclusion it was found that concentrations tended to be higher further 
downstream in river systems because in this section of the rivers, STP discharges were more 
common (Dumont et al., 2015). As recognized by the authors, risk was overestimated since 
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transformation processes like sulfidation were not taken into account, which hence could 
reduce risk in surface waters.  
In a follow-up approach (Joris T K Quik, de Klein, & Koelmans, 2015), a model coupled NMs 
(CeO2 and Ag) fate processes to the hydrology of subsections of the modelled system for the 
first time (Dommel catchment river, The Netherlands). The basic input parameters of this 
model were the characteristics of the natural particles and the NMs (different size classes), 
which were used for the calculation of aggregation and sedimentation rates (input 
concentrations at flow time zero were 1,10 and 100 ng/L Ag or CeO2 NMs, with 10 ng/L). 
Main outputs were concentrations of free, homo- and hetero- aggregated NMs in the water 
column and in the sediment. Importantly, the shear rate (G) in the term for orthokinetic 
aggregation (see Section 1.5.1 for definition) was calculated from the flow rate as calculated 
by the DUFLOW hydrological model, thus providing a direct link between river 
morphometry, hydrology and aggregation behaviour. Attachment efficiencies were defined 
by taking into account variability and uncertainty of the hetero-aggregation rate constants 
by Monte Carlo probabilistic modelling. Moreover, different scenarios were proposed: 
default spatially explicit (different river sections) and spatially homogeneous scenario (one 
cross section is defined, with uniform flow velocity).  
Results from modelling over 40.3 km and simulated 9 days of flow, showed different total 
retentions of NMs in the whole river section (ranging from 10 to 50%), depending on the 
abundance or large NMs-suspended solids aggregates. For both Ag and CeO2, concentration 
of pristine NMs and homoaggregates decreased almost zero after only 5 km (Joris T K Quik et 
al., 2015), because they transformed into hetteroaggregates quickly. Actually, only 
aggregates with radius below 1.5 microns were stable in the water column and dominate at 
the end of the river. By contrast, removal of NMs was due to sedimentation of (hetero-
)aggregates, mainly of sizes larger than 5 microns. In other areas, resuspension was found to 
be the dominant process in the model, leading to negligible NMs concentrations in the 
sediment. It was concluded that the inclusion of details, e.g. heterogeneity of sizes of both 
pristine NMs and suspended solids, is highly recommended to avoid simplifications.  
Recently, NanoDUFLOW model has been evaluated against data, by comparting measured 
and modelled concentrations of <450 nm Ce, Al, Ti and Zr-based particles for river Dommel 
(De Klein et al., 2016a). Ce validation showed very good results, demonstrating as in the 
original paper than hetero-aggregates formed rapidly. Therefore, final concentration of NMs 
was rather unaffected for different values of attachment efficiency parameter (αhet). 
However, the authors stressed the fact that for a full model validation, longer field 
campaigns covering different season and years would be required.  
Finally, another model considering spatiotemporal variability was recently published in 
which the effect of stream dynamics and chemical transformations on the environmental 
fate of ZnO and Ag NMs in a watershed-scale model was evaluated (Amy L. Dale et al., 2015). 
ZnO and Ag NPs and their transformation by-products entered the model via wastewater 
treatment facility effluent and biosolids applications to row crops, hay, and pasture land. The 
river simulation calculated sediment transport rates as a function of spatiotemporal 
variability in streamflow, and tracked temperature-dependent chemical reactions including 
ZnO NP dissolution, oxygen-dependent dissolution of Ag NPs, sulfide-dependent sulfidation 
of metal ions, and metal ion complexation with particulate phases. NPs were assumed to 
heteroaggregate completely in all media, therefore initial particle size was not taken into 
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consideration. Zn in WWTP effluent was modelled as 7.5% ZnO NPs and 92.5% Zn2+. All Zn in 
soils was assumed to be complexed (particle-associated) Zn2+.  Ag NPs were assumed to be 
over 50% sulfidized in biosolids and effluent, as observed experimentally. Interestingly, very 
low retention compared to the model reported by Quick and co-workers (Joris T K Quik et 
al., 2015) was found and it was shown that mobility was due to flow-dependent sediment 
transport. Again, different concentrations between water and sediment compartments were 
explained by difference in regional stream velocities. Zn accumulated less than Ag because 
Zn2+ was moving with the water phase along the river. In this work, higher Ag concentrations 
could also be linked to areas in which agricultural runoff was a significant fraction of stream 
loads.   
It should be pointed out that in all models reported above (with the exception of the 
NanoDUFLOW model validation in De Klein et al., 2016), it was not the intention of the 
authors to estimate real PEC in a region over a specific period of time, since the input (mass 
loading entering into the system) was uncertain in all cases (e.g. taken from other MF 
studies, scale down from country estimations to local scale.).  These models intended, 
however, to evaluate the influence of natural variability in the environmental fate and 
transport of NMs in aquatic environment. 
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Table 3.6 Summary of representative spatiotemporally averaged and explicit environmental fate models reported in the inventory. The most 
complete models in terms of citations, comprehensive studies.  
Spatiotemporally average fate multimedia box models 
Reference Compartments Processes1 NMs Approach /Assumptions
(Haoyang Haven Liu 
& Cohen, 2014a) 
Air
Water 
Sediment 
Soil 
Biota 
Dry and  wet deposition, 
aerosolization, wind 
resuspension, 
sedimentation, 
resuspension, burial, 
dissolution 
TiO2, Ag CNT, Cu, 
Cu oxides, ZnO 
Fe, Fe oxide, 
Al2O3, CeO2 
Nanoclay, SiO2 
The approach considers the environment as a collection of well-mixed 
compartments each representing a specific medium or biological entity, 
with intermediate mass transport between adjacent compartments. 
Processes are defined as rates. Particle size distribution is discretized into a 
number of size fractions. It does not consider agglomeration kinetics (an 
attachment factor of 1 was chosen , i.e. 100% of NPs are bound to the 
suspended particulate matter), therefore the model assumes fixed (time 
independent) partitioning ratios for processes of aggregation and 
attachment, which control the environmental fate of colloidal systems 
(J. Meesters et al., 
2014) 
Air
Soil 
Water 
Sediment 
Aggregation and 
attachment2 of NMs in 
air, water, soils and 
sediments. Atmospheric 
deposition, 
sedimentation, 
dissolution, resuspension 
sediment burial 
soil run-off 
 
TiO2
3 Environmental fate model that uses first order kinetics (transport and 
transformation processes for colloids) to estimate environmental 
background concentrations for nanocolloids in an environmental system. 
The model solves simultaneous mass balance equations using simple 
matrix algebra. SimpleBox4nano (SB4N) is a modified version of the Simple 
Box model, which has served as a regional distribution module in the 
European Union System for Evaluation of Substances (EUSES) model. 
Homo-aggregation is not considered in the model. Within each 
compartment, NMs can occur in different physicochemical form (species): 
(1) freely dispersed, (2) hetero-aggregated with natural colloidal particles 
(<450 nm), or (3) attached to larger natural particles (>450 nm) that are 
prone to gravitational forces in aqueous media 
(J. A. J. Meesters et 
al., 2016) 
Same than above Same than above CeO2, TiO2, ZnO Same than above, applies a probabilistic approach. Monte Carlo 
simulations were performed on the environmental fate, concentrations 
and speciation of 3 different nanomaterials. For all inputs and model 
parameters data was collected, reflecting realistic distributions of 
variability and uncertainty 
(Antonia Praetorius, 
Scheringer, & 
Water Hetero-aggregation TiO2 Multimedia box model. Processes affecting NM behaviour and transport 
are parameterized and combined in a system of coupled mass-balance 
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Spatiotemporally average fate multimedia box models 
Reference Compartments Processes1 NMs Approach /Assumptions
Hungerbu, 2012) Sediment Sedimentation
Resuspension 
Exchange of water from 
moving to stagnant 
compartment 
Burial 
Bed Load transport 
Water flow in the moving 
water 
equations. The aim is to estimate the distribution of NPs along the Rhine 
River. SPM in the model are represented as a log- normal particle size 
distribution with a mode of 5 μm (particle diameter) and spanning from 
1.5 to 80 μm. It is assumed that particles do not reach the river in their 
original form. The initial size distribution of the aggregated TiO2 NPs was 
set to be log- normal with a mode at 300 nm. The nanoparticles in the 
distribution were assigned to five size classes (the model is run separately 
for each size class). Homoaggregation and dissolution are not taken into 
account. Attachment efficiency for heteroaggregation was varied from 
0.001 to 1 (different values) to evaluate the effect on heteroaggregation 
rate constant  
(Amy L Dale, Lowry, 
& Casman, 2013) 
Freshwater 
sediment 
Ag oxidation
Ag sulfidation 
Particle mixing due to 
bioturbation 
Diffusive mixing of 
dissolved species 
Ag Mass balance sediment model for metals, describes the speciation of 
cadmium in sediments. Total sediment Ag (concentration profiles of Ag+ 
ions, Ag and Ag2S nanoparticles, free Ag2S and Ag linked to organic matter 
as a function of sediment depth) concentration as a function of sediment 
depth. The model was calibrated to experimental data collected from 
nano-Ag dosed artificial freshwater wetland mesocosms. Constant for Ag 
oxidation decreases exponentially in response to Ag NP sulfidation. In 
general, reaction rates were assumed to exhibit a linear dependence on 
the concentrations of all reactants. Aggregation is not taken into account 
in this study, neither particle size variation. By omitting aggregation, the 
model assumes that Ag NPs mix in the sediment at approximately the 
same rate as the sediment particles themselves. Complexation between 
Ag+ and  Cl- is neglected 
(J T K Quik et al., 
2011) 
Water Homo-aggregation
Hetero-aggregation 
Sedimentation 
Dissolution 
MWCNT
CeO2 
Fe0 
ZnO 
TiO2 
Model aims to estimate concentration of NMs in water, based on the 
current approach to environmental risk characterization for chemicals in 
the EU. Possibilities and limitations on the implementation of first order 
rate constants for the processes sedimentation and dissolution of NMs are 
discussed. It is accepted, that sedimentation and dissolution of NMs can be 
explained by first order reactions / removal models (approximations are 
made based on experimental data, see Figure 2 and Figure 3 in the paper) 
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Spatiotemporally average fate multimedia box models 
Reference Compartments Processes1 NMs Approach /Assumptions
Ag
Al2O3 
(Money, Reckhow, & 
Wiesner, 2012) 
Water
Sediment 
Aggregation
Dissolution 
Deposition 
Ag Bayesian networks is used as a Tool for nanomaterials risk forecasting and 
develop a baseline probabilistic model that incorporates nanoparticle 
specific characteristics and environmental parameters, along with 
elements of exposure potential, hazard, and risk related to nanomaterials. 
The tool utilizes a combination of expert and empirical knowledge bases 
related to the aquatic behaviour and exposure of nano-Ag as a function of 
environmental conditions and particle characteristics. Continuous variables 
were discretized into states based on environmental-relevant thresholds. 
Connections presented in the model represent conditional relationships 
and do not explicitly use mechanistic or physical models to describe how 
one variable affects another. These conditional relationships are 
represented as probability distributions for the different parameters in the 
whole range of values considered (e.g. different size intervals; qualitative 
collision rates defined as low, intermediate, high). 
(Lauren E. Barton et 
al., 2015)4 
WWTP effluent 
WWTP sludge 
Sedimentation in WWTP
Transformation in WWTP 
Ag
CeO2 
TiO2 
ZnO 
 
Monte Carlo methods were applied to a simple model for aerobic 
wastewater treatment (Hendren et al., 2013). Previous model is expanded 
by incorporating experimental data, obtained in environmentally relevant 
media, into a waste watee treatment plant model that considers both 
aerobic and anaerobic processes (waste water treatment plant is here 
compartmentalized) and redox transformations of NMs that may occur 
during treatment. Sedimentation is measured indirectly by monitoring NP 
attachment to suspended matter, which is assumed to be further removed 
by sedimentation. Distribution coefficients, (ratio of NPs concentration in 
the supernatant and the settled material, see inputs section) was 
determined experimentally. Redox transformations of Ag and ZnO were 
assumed to be first order in the absence of more complete rate 
information.  
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Spatiotemporally explicit fate models 
Reference Compartments Processes NMs Approach /Assumptions
(Dumont et al., 2015) Freshwater Sedimentation
(Hetero-aggregation) 
Ag
ZnO 
This work describes the use of the GWVA model to simulate expected 
concentrations of ZnO and Ag, which are likely to be emitted to surface water. 
GWAVA's main component simulates river discharge and a number of other 
hydrological variables, such as water volumes and human water abstractions, in a 
spatially and temporally explicit manner. The model is deterministic. NMs are 
routed down the river network, during which concentrations are calculated by 
accounting for any NMs losses and dilution by river discharge. NMs loss in river 
water follows first order-kinetics (Quik et al 2012). Transformations (after 
production) do not make the particle size increase beyond 100 nm nor to individual 
molecules are not considered as NMs losses. It is assumed that households are the 
only source of NMs loading from sewage effluent. NMs input is assumed to be 
constant in time and represents the current situation. Dissolution losses of nano-Ag 
were not modelled because experimental results from literature showed these are 
negligible compared to the modelled sedimentation losses 
(Joris T K Quik et al., 
2015) 
Water (river) 
Sediment 
Homo-aggregation
Hetero-aggregation 
Sedimentation 
Dissolution 
Degradation 
Burial to deeper sediment 
layers 
Resuspension 
CeO2
Ag 
This model allows for the first time coupling of NMs fate processes to the hydrology 
of subsections of the modelled system (Dommel catchment river). Coupling is done 
with DUFLOW Modelling Studio (v3.8.7) that is a software package for simulating 
one-dimensional unsteady flow in open-channel systems. This enables the 
modelling of feedbacks between flow conditions and water quality processes, 
which has been recognized as a key feature in realistic system models. The basic 
input parameters of this model are the characteristics of the natural particles and 
the NMs (different size classes), which are used for the calculation of aggregation 
and sedimentation rates (input concentrations at flow time zero were 1,10 and 100 
ng/L of nano-Ag or nano-CeO2). Main outputs are concentrations of free, homo- 
and hetero- aggregated NMs in the water column and in the sediment. The shear 
rate (G) in the term for orthokinetic aggregation is calculated from the flow rate as 
calculated by the DUFLOW hydrological model, thus providing a direct link between 
river morphometry, hydrology and aggregation behaviour. Authors used a 
measured value for the attachment efficiency. Different scenarios have been 
proposed: default spatially explicit (different river sections) and spatially 
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Spatiotemporally explicit fate models 
Reference Compartments Processes NMs Approach /Assumptions
homogeneous scenario (one cross section is defined, with uniform flow velocity)
(Amy L. Dale et al., 
2015) 
Water (river) 
Sediment 
Surface run-off during 
rain 
Sediment run-off 
Deposition/sedimentation
Resuspension 
Burial 
Dissolution 
Transformation 
(complexation) 
Transformation 
(sulfidation) 
ZnO
Ag 
Model to evaluate the effect of stream dynamics and chemical transformations on 
the environmental fate of NMs in a watershed-scale model. James River Basin 
portion is coupled to the EPA publically available water quality modelling suite 
WASP7 and configured both to model NMs fate. ZnO and Ag NPs and their 
transformation by-products entered the model via wastewater treatment facility 
effluent and biosolids applications to row crops, hay, and pasture land. The river 
simulation calculated sediment transport rates as a function of spatiotemporal 
variability in streamflow; distinguished between oxic and anoxic sediment bed 
layers; and tracked temperature-dependent chemical reactions including ZnO NP 
dissolution, oxygen-dependent dissolution of Ag NPs, sulfide-dependent sulfidation 
of metal ions, and metal ion complexation with particulate phases. NPs were 
assumed to hetero-aggregate completely in all media (therefore initial particle size 
was not taken into consideration). Zn in WWTP effluent was modelled as 7.5% ZnO 
NPs and 92.5% Zn2+. All Zn in soils was assumed to be complexed (particulate- 
associated) Zn2+.  Ag NPs were assumed to be over 50% sulfidized in biosolids and 
effluent, as observed experimentally.  
1 Only the main processes affecting NMs are included 
2Heteroaggregation of NMs s with colloidal particles is referred to as “aggregation”, whereas association of NMs with larger particles is referred to as “attachment” 
3 The model is tested with values for TiO2 nanomaterials derived from Mueller, N. C., & Nowack, B. (2008). Exposure modeling of engineered nanoparticles in the environment. Environmental 
Science & Technology, 42(12), 4447–4453 
4 This work proposes a second conceptual model of a land application unit, where NMs are impacted by runoff, uptake, leaching and transformation processes. Parameters were obtained 
from literature. Where error estimates were unavailable, an error of 10% was applied. 
 
 184 
 
Fate in the soil compartment 
The categorization of models of colloid transport in porous media is complex as: i) analytical 
solution of transport equations is not possible and, so, apart from different transport 
equations we encounter different approaches for the numerical solution; ii) most models are 
for 1D transport in saturated packed-bed columns, which use to fail when predicting colloid 
fate in real environments. 
All the models analysed, but two, are based in the Colloid Filtration Theory (CFT). Since its 
beginnings in the 1970s, several processes affecting colloid filtration have been defined and 
used for colloid transport and retention in porous media. These processes are summarised in 
Table 3.7. 
Yao, Habibian and O’Melia published in 1971 the most cited model of colloid filtration in 
porous media (Yao, Habibian, & O’Melia, 1971), which derived from Friedlander model of air 
filtration (Friedlander, 1958) and collected the different mechanisms affecting colloid 
transport and colloid-collector attachment developed until the moment: settling, 
interception and diffusion. This model is usually referred in literature as YHO model. This 
model defines the colloid transport as a sum of three processes that define the traditional 
advection-diffusion equation with a sink term that is the irreversible colloid-collector 
attachment. This last depends on an attachment rate (katt), which was analytically 
determined. Attachment rate depends on collision efficiency factor (α) and the single-
collector efficiency (η), among others. YHO model derives single-collector efficiency from the 
sum of the contributions of the mechanisms of interception (ηI), diffusion (ηD) and gravity 
(ηG). However, no derivation of collision efficiency factor was done and it was assumed 
complete effectiveness (α=1). 
The analytical determination of the single-collector efficiency has been improved since then. 
In 1976, Rajagopalan and Tien included surface interactions (London forces and double layer 
interaction forces) in which is known as RT model (Rajagopalan & Tien, 1976). In 1996, Bai 
and Tien included different electrokinetic parameters to determine single-collector 
efficiency under unfavourable attachment conditions (R. B. Bai & Tien, 1996). In 2004, 
Tufenkji and Elimelech improved RT model for the determination of single-collector 
efficiency for Brownian dominated colloids, thus for nanomaterials (Tufenkji & Elimelech, 
2004), in which is known as TE model. TE model has been the most accepted and used 
model for the analytical determination of single-collector efficiency of nanomaterials since 
2004. Wei et al reported a modification of the model for submicroparticles with Lagrangian 
path instead of traditional Happel sphere-in-cell trajectories (Wei & Wu, 2010). Lately, in 
2015, Bradford and Torkzaban has published a new work including in the single-collector 
efficiency determination non-DLVO mechanisms, such as nano- and micro-roughness or 
nanoscale chemical surface heterogeneity (Bradford & Torkzaban, 2015). 
While, as seen, important research has been done for analytical determination of single-
collector efficiency (η), collision efficiency (α) has received little attention and or it is 
supposed to be 1 (full contact efficiency) or it is fitted using experimental results. Taghavy et 
al derived dependence of collision efficiency on ionic strength (Taghavy, Mittelman, Wang, 
Pennell, & Abriola, 2013). 
Anyway, although several works with nanomaterials use the TE model for deriving 
attachment rate (Bradford, Torkzaban, Kim, & Simunek, 2012; Y Li, Wang, Pennell, & Briola, 
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2008; Taghavy, Pennell, & Abriola, 2015; Yonggang Wang et al., 2008), most of models 
directly determine attachment rate by fitting of the transport equation with breakthrough 
curves (Babakhani, Fagerlund, Shamsai, Lowry, & Phenrat, 2015; Bradford, Simunek, 
Bettahar, van Genuchten, & Yates, 2003; Neukum, Braun, & Azzam, 2014; Raychoudhury, 
Tufenkji, & Ghoshal, 2012; Tosco & Sethi, 2009). 
Another important consideration on colloid-collector attachment is that traditional CFT 
consider attachment as the sink part of the function, so, irreversible attachment 
(Rajagopalan & Tien, 1976; Tufenkji & Elimelech, 2004; Yao et al., 1971). It was 
demonstrated that ionic strength (IS) strongly influences colloid-collector attachment, so, 
variations in IS may convert collector surfaces from favourable to unfavourable deposition 
sites (Bradford et al., 2012). This fact shows the reversibility of the process and, so, it 
justifies considering attachment as a reversible process (Bradford et al., 2003; Xueying Liu, 
O’Carroll, Petersen, Huang, & Anderson, 2009; Raychoudhury et al., 2012; Taghavy et al., 
2015). A last possibility is the combination of irreversible and reversible attachment as two 
separated processes as it is has been proved that even a change to unfavourable deposition 
does not force complete release of deposited colloids (Babakhani et al., 2015). Detachment 
rates are always fitted based on experimental breakthrough curves. 
Traditional CFT has been used in the colloid transport and retention, but breakthrough 
curves show profiles that need extra phenomena to be considered. The first and most 
important one is blocking, so, once a deposition site is occupied by a particle it is unutilized 
for attachment (deeper explanation in Table 3.7). This blocking directly affects attachment 
and is always considered as a function that “multiplies” the attachment part of transport 
function. Johnson and Elimelech compared in 1995 RSA and Langmuirian approaches for 
blocking (P. R. Johnson & Elimelech, 1995) and, despite RSA showing better fitting to 
experimental results, Langmuirian approach is the most used in the literature. An important 
point in colloidal filtration models evolution occurred in 2008 when Wang et al combined TE 
model for attachment determination with Langmuirian blocking reported by Johnson and 
Elimelech (Y Li et al., 2008; Yonggang Wang et al., 2008). The opposite of blocking would be 
ripening, so, colloid deposition catalyzes other colloid deposition, but it has never been 
included in the CFT functions. 
Another phenomenon that affects colloid retention is straining, that is the retention of a 
colloid in a pore or due to collector surface roughness. Straining is somewhere between 
attachment and physical filtration, and, at the moment, it has been always considered an 
irreversible process. The first important CFT model considering straining was the one 
presented by Bradford et al in 2003, which also considered attachment, detachment and 
exclusion (Bradford et al., 2003). This has been the only model at the moment considering 
exclusion (deeper explanation in Table 3.7). 
Finally, there are two important phenomena that are usually considered in fate in water, but 
their incorporation in CFT has only occurred lately: colloid aggregation or agglomeration and 
colloid dissolution. Homo-aggregation is an important phenomenon in water systems, but 
not as important in water as hetero-aggregation is more probable. Anyway, in highly 
concentrated systems and in especial cases showing high colloid-colloid contact efficiency it 
is important to consider homo-aggregation as colloid size is determinant in transport 
(Raychoudhury et al., 2012; Taghavy et al., 2015). Colloid dissolution is important in reactive 
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particles, as metal can be released and transported as cations, that in some cases we should 
consider (Taghavy et al., 2013). 
Table 3.7 gives summary of the most relevant CFT models. 
The main problem with CFT model is that they predict quite well colloid filtration in 
laboratory column experiments under controlled and homogeneous conditions though it 
becomes difficult to know in advance the correct model for each nanomaterial (Goldberg, 
Scheringer, Bucheli, & Hungerbühler, 2014), but it is rather difficult to predict their 
behaviour in real environment with non-saturated porous media and conditions that change 
with heavy rain periods, so, their use in long time fate prediction is still questioned. 
Two other approaches have been proposed. First, Bai and Li presented in 2014 a work based 
on an autoregressive integrated moving average (ARIMA) model (C. Bai & Li, 2014). Such a 
model was proven very useful to predict immediate transport and retention of 
nanomaterials as it would happen during an accidental spill. And, second, Goldberg et al. 
presented in 2015 a work based on machine learning, much more similar to a QSAR model, 
which predicts transport and retention based on multiple previous studies (Goldberg, 
Scheringer, Bucheli, & Hungerbühler, 2015). 
 
3.4.4 Accumulation / depuration models 
Three models have been included in the inventory and a summary is provided for each of 
them:  
1) Tervonen et al., 2010  fitted accumulation and depuration data of 235 nm fullerene_C60 
nanoparticles in Daphnia Magna to first order one-compartment kinetic model and a first-
order decay model respectively (Tervonen, Waissi, Petersen, Akkanen, & Kukkonen, 2010). 
The same approach was employed by Fan et al., 2016 to predict the bioconcentration factors 
of different TiO2 nanoparticles (i.e. anatase and rutile crystalline forms, ranging from 30 to 
200 nm and with different hydrophobic and hydrophilic coatings) 
2) Zhao and Wang (2010) developed a model for the uptake in Daphnia Magna of 20nm 
carbonate-coated AgNPs from the environment (water and food). The study provides the 
first quantitative estimate of the fraction of AgNP uptake from the water. 
3) Piccapietra et al., (2012) described the kinetics of intracellular silver nitrate and 
carbonate-coated  AgNPs (average diameter 29nm) over the time in Chlamydomonas 
reinhardtii. Based on the estimated uptake and release constants, non-linear and linear 
equations were built to model the intracellular accumulation of silver over the time.  
 187 
 
Table 3.7 Summary of phenomena affecting colloidal transport in porous media. 
Process considered Explanation Variables First reference in the table Important models that consider  the process 
Advection It is the transport of the colloid by bulk motion 
It depends on the local 
velocity of water (ν), which 
is usually assumed as 
constant 
Yao K-M, Habibian MT, O’Melia CR 
(1971) Water and waste water 
filtration. Concepts and 
applications. Environ Sci Technol 
5:1105–1112. 
All 
Hydrodynamic dispersion 
Dispersivity quantifies the 
colloids that stray away 
from the carrying water 
Depends on the position-
dependent diffusion 
coefficient (D), which is 
usually determined using 
the Einstein's equation 
All 
Irreversible colloid attachment or 
deposition 
It is the process that 
accounts for colloid-
collector aggregation, 
known as 
heteroaggregation in water 
media processes. In 
traditional CFT is 
considered irreversible, 
later was considered 
reversible and, finally, both 
reversible and irreversible 
attachments are 
considered simultaneously 
Attachment rates depend, 
among others, on colloid 
collision efficiency factor 
(α) and single-collector 
efficiency (η). The last 
depends on  diffusion, 
interception, 
sedimentation, DLVO and 
non-DLVO phenomena. 
Models may be single-site 
or dual-site, the last 
considering favourable and 
unfavourable deposition 
sites 
YHO model, RT model, TE model, 
Wang 2008-LiY 2008 model, 
Babakhani 2015 mode 
(reversible and irreversible) 
Reversible colloid attachment or 
deposition 
Bradford SA, Simunek J, Bettahar 
M, et al. (2003) Modeling Colloid 
Attachment, Straining, and 
Exclusion in Saturated Porous 
Media. Environ Sci Technol 
37:2242–2250 
Bradford 2003 model, MNM1D 
(Tosco 2010), Liu 2009 model 
(for non-spherical), 
Raychoudhury 20012 model, 
Torkzaban 2013 model, Vitorge 
2014 model, Neukum 2014 
model (for fractured stones), 
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Process considered Explanation Variables First reference in the table Important models that consider  the process 
Colloid detachment or release or 
remobilization 
It accounts for the number 
of colloids that return to 
the fluid flux after being 
deposited onto a collector 
It can be considered 
together with attachment 
as an 
attachment/detachment 
reversible process, or 
isolated as if irreversible 
attachment under 
favourable conditions and 
detachment under 
unfavourable conditions 
Taghavy 2015 model, Babakhani 
2015 model (reversible and 
irreversible) 
Blocking or exclude area effect 
It is the phenomena that 
considers monolayer 
coverage of collectors and, 
so, that the porous media 
has a maximum capacity of 
attached colloids 
Blocking is considered [B(θ) 
or ψb] in the attachment 
component of the 
transport equation. As it is 
only relevant once the 
attachment approaches 
the solid maximum 
capacity, it is very often 
not considered. Random 
sequential adsorption 
(RSA) and Langmuirian 
blocking are the most 
common approaches 
Johnson PR, Elimelech M (1995) 
Dynamics of Colloid Deposition in 
Porous Media: Blocking Based on 
Random Sequential Adsorption. 
Langmuir 11:801–812 
Johnson 1995, Johnson 1996 
(heterogeneous collectors), 
Wang 2008-LiY 2008 model, Liu 
2009 model, Torkzaban 2013 
model, Vitorge 2014 model 
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Process considered Explanation Variables First reference in the table Important models that consider  the process 
Straining or depth-dependent 
retention 
Similar to mechanical 
retention, it is the 
retention of the colloid in a 
pore, being in contact with, 
at least, two points (two 
collectors or due to surface 
roughness). But opposite 
to mechanical retention, a 
strained colloid does not 
block the fluid flux through 
the pore and is governed 
by the same mechanisms 
that govern colloid 
attachment. 
It depends on pore length, 
distance and shape of 
colloid spatial distribution. 
Differently to blocking, 
straining is usually 
considered as a different 
process, independent of 
attachment 
Bradford SA, Simunek J, Bettahar 
M, et al. (2003) Modeling Colloid 
Attachment, Straining, and 
Exclusion in Saturated Porous 
Media. Environ Sci Technol 
37:2242–2250 
Bradford 2003 model, Vitorge 
2014 model  
Filter ripening 
It occurs when colloid-
colloid attachment is more 
favorable than colloid-
collector attachment and, 
so, colloid deposition is 
enhanced over time, 
oppositely to blocking. 
- None None 
Exclusion 
It considers that only a 
portion of the pores are 
accessible to the colloids 
due to size limitations or to 
charge repulsions. 
To account for all type of 
exclusions, Darcy water 
velocity and volumetric 
water content are 
corrected. 
Bradford SA, Simunek J, Bettahar 
M, et al. (2003) Modeling Colloid 
Attachment, Straining, and 
Exclusion in Saturated Porous 
Media. Environ Sci Technol 
37:2242–2250 
Bradford 2003. 
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Process considered Explanation Variables First reference in the table Important models that consider  the process 
Colloid dissolution 
It is the reactive or 
dissolvable particles 
dissolution into ions 
It is usually considered as a 
one-way process and 
dissolved ions transport 
modelled simultaneously 
 Taghavy A, Mittelman A, Wang Y, 
et al. (2013) Mathematical 
modeling of the transport and 
dissolution of citrate-stabilized 
silver nanoparticles in porous 
media. Environ Sci Technol 
47:8499–8507 
Taghavy 2013 model 
Colloid aggregation or 
agglomeration 
Homoaggregation of 
particles in the water 
medium, which directly 
affects their transport due 
to changes in particle size 
It is usually considered as a 
one-way process 
Raychoudhury T, Tufenkji N, 
Ghoshal S (2012) Aggregation and 
deposition kinetics of 
carboxymethyl cellulose-modified 
zero-valent iron nanoparticles in 
porous media. Water Res 
46:1735–1744 
Raychoudhury 2012 model, 
Taghavy 2015 model, Babakhani 
2015 model 
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3.4.5 Assumptions made in fate models 
Some relevant model assumptions have been identified during the reviewing process and 
have been discussed in the main body text. They can be considered as critical factors 
responsible for part of the uncertainty of the compiled models and are summarized below: 
• Very little information about the NMs production volumes and the incorporation of NMs in 
commercial products is publicly available and this leads to high uncertainties in emissions 
estimates. This uncertainty has been addressed by some authors by using probabilistic mass-
flow modelling using more than one source to define a value (this applies to production 
amounts, product allocation, and market penetration, amount of NMs in the products, 
release factors and transfer coefficients)(Sun et al., 2014). 
• Commonly, allocation of different NMs to different products has been assumed to follow the 
same pattern for several NMs. 
• MF models reported in the inventory worked with the mass of NMs, and as a rule 
physicochemical properties are not taken into account (e.g. size, zeta potential, surface 
reactivity). Moreover, it is assumed that particles keep their properties during their whole 
life cycle (i.e. they do not exhibit transformations).  
• In absence of experimental data some authors have adopted worst case release factors to 
define worst-case scenarios, typically to estimate release of NMs during the synthesis 
/manufacturing stages into the different environmental compartments (e.g. ERC from ECHA 
Guidelines). On the other hand, release factors defining release amounts of NMs from 
products during their use have been established by numerous authors since there is more 
available data in literature. 
• In general, environmental fate models consider well mixed compartments, thus not being 
space oriented. Few examples have been already published which are spatially resolved (A L 
Dale, Lowry, & Casman, 2015b).  
• Transfer coefficients in MF models determining for instance NMs amount that remained in 
waste water treatment plants as sludge and the fraction remaining in the waste water 
treatment plants effluent, are most of the times defined from personal judgment and also 
from literature when available (similar to release factors).  
• MF models determine typically steady state-concentrations. Recently, probabilistic MF 
modelling has been updated by the addition of a dynamic component (Bornhöft et al., 2016; 
Sun et al., 2016). This improvement allows predicting the former, current and future mass-
flows of NMs to the different compartments over time, by incorporating into the model the 
lifetime of a product. 
• Generally speaking, process-based environmental fate models consider different NM forms 
(species) in the different environmental compartments, which is in contrast with traditional 
chemicals that reach thermodynamic equilibrium: (1) freely dispersed, (2) hetero-aggregated 
with natural colloidal particles (e.g. <450 nm), or (3) attached to larger natural particles (e.g. 
>450 nm) (J. A. J. Meesters, Koelmans, Quik, Hendriks, & Van De Meent, 2014). 
• It is currently assumed that environmental relevant NMs concentrations are very low, thus 
the presence of NMs will lead to hetero-aggregation, instead of homo-aggregation. 
Aggregation is regarded as irreversible process and consequently the break-up of such 
aggregates is not considered. It is also well accepted that particles reach the aquatic 
environment already hetero-aggregated, and therefore sedimentation kinetics is determined 
by the dynamics of suspended matter sedimentation.  
• In process-based environmental fate models the input (mass loading entering into the 
system) is highly uncertain because it is taken from other MF studies and sometimes they 
scale down the PEC value from bigger regions to local scale. The primary aim of these models 
is, however, to evaluate the influence of natural variability in the environmental fate and 
transport of NMs in aquatic environment. 
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• Application of colloidal models is also associated to high uncertainty because the values for 
the relevant constants are not generally defined or calculated for NMs and generally the 
information is not available (e.g. for the Hamaker constants, and for attachment 
coefficients). 
 
3.4.6 Conclusions on fate models 
After state of the art analysis, some general conclusions regarding how environmental fate 
models can give answer to regulatory needs can be drawn: 
• Multimedia mass-balance modelling has already been adopted as the basis for the risk 
assessment and chemical exposure model EUSES, and is based on a life-cycle perspective (Den 
Hollander, van Eijkeren, & van de Meent, 2004). This provides a firm scientific basis for 
regulators to consider the  applicability of mass flow analysis to nanomaterials.  
• In addition, some of the assumptions made to define release factors, which determine the 
amount of NMs entering into the different environmental/technological compartments, is 
currently being applied in chemical environmental exposure assessment by the ECHA (ECHA, 
2016b). Such release factors could substitute for the current environmental release categories 
(ERCs) used to determine chemical concentrations in the environment.  
• In order to assess uncertainty in production/release estimates, probabilistic assessment is highly 
recommended (EFSA, 2012; US EPA, 2014).  
• Some of the nano-considerations currently included in the models to predict the fate and 
transport of nanomaterials in the environment are widely accepted by the scientific community 
(e.g. definition of hetero-aggregation, transformation and dissolutions processes, etc.). These 
processes and also other physicochemical properties specific to NMs are summarized in a 
document published by ECHA, developed in order to provide advice to registrants for use when 
preparing registration dossiers that cover nanoforms (ECHA, 2017). In the latter document, 
details of some of the existing environmental fate models are given in its Appendix 1 (J. 
Meesters et al., 2014; Antonia Praetorius, Scheringer, & Hungerbu, 2012; Joris T K Quik et al., 
2015). For example SB4N as an adaption of the SimpleBox model has been used as a regional 
distribution module in the EU system for EUSES model, used for environmental exposure 
assessment in REACH (J. Meesters et al., 2014). An important drawback is that the lack of 
analytical techniques able to both measure trace concentration of NMs and differentiate 
between background and NMs hinders the validation of such models.  Research on detection of 
engineered nanomaterials from backgprund material is ongoing (Antonia Praetorius et al., 
2017). 
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4 Case studies on grouping and read-across between nanoforms 
In this chapter we report two case studies on the application of read-across between 
nanoforms of the same substance.  The aims of this exercise were to: 
• evaluate the applicability of the workflow for grouping and read-across proposed in 
the draft REACH guidance update 
• illustrate how computational methods can be used in the formulation of a grouping 
hypothesis 
• illustrate how a grouping and read-across argument should be documented 
• identify the different sources of uncertainty associated with filling data gaps by 
grouping and read-across 
• evaluate the extent to which ECHA's Read-across Assessment Framework (RAAF) 
captures the different sources of uncertainty for nanoforms 
• identify data gaps related to the selected case studies on grouping and read-across 
 
This work was carried out to explore the practical process of grouping and read-across 
between nanoforms, with a view to sharing the lessons learned about the overall process. 
Thus, the conclusions obtained for specific substances should not be regarded as 
recommendations for regulatory action. 
 
4.1 Selection of case studies 
Two case studies of different composition (nano-TiO2 and carbon nanotubes (CNTs)) were 
identified for the application of the workflow for grouping and read-across proposed by the 
ECHA’s draft REACH guidance document (ECHA, 2017b). The two manufactured 
nanomaterials (NMs) were selected mainly due to 1) the availability of a significant amount 
of data on toxicity and physicochemical characterisation (Creutzenberg, 2013; MWCNT 
REACH Dossier, 2016; NIOSH, 2013; OECD, 2015; OECD WPMN, 2016; SCCS, 2013a; Sellers et 
al., 2015; US-EPA & EPA, 2013)38, 2) their industrial relevance as they are produced in high 
volumes (more than 10000 t for TiO2 and more than 1000 t for CNTs per year) (EC, 2012a) 
and 3) in-house experience on the behaviour of these specific nanomaterials from EU-
funded projects (ENPRA, NanoMILE, NanoTEST and DEROCA).  
It is noted that both NMs are the subject of on-going policy discussions. An IARC 
monograph39 on the carcinogenicity of CNTs is in preparation and the proposal of classifying 
TiO2 as carcinogen 1B by the French Agency for Food, Environmental and Occupational 
Health & Safety (ANSES, 2016) is subject to debate as the industry has firmly opposed to 
                                                      
38 REACH registration dossiers for TiO2 were screened online but information on the 
analogues of interest in our study were not identified. 
39 IARC Monograph Volume 111, Fluoro-edenite, silicon carbide fibres and whiskers, and 
single-walled and multi-walled carbon nanotubes. Under preparation. 
The IARC Monograph Volume 93, Carbon Black, Titanium Dioxide, and Talc contains mostly 
old studies form TiO2 and the nanoform is not assessed separately from the bulk form. 
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such classification by making more than 500 comments to the proposal (European Industry, 
2016). As mentioned above, the case studies in this chapter are intended to evaluate, 
illustrate and inform the overall process of grouping and read-across between nanoforms.  
  
4.1.1 The structure of the dataset  
In order to survey the landscape of the available information on the identified NMs, a 
dataset was built containing two sets of information. Two clearly differentiated blocks of 
information were considered:  
a) the physicochemical characterisation, fundamental behaviour and reactivity of the 
identified NMs 
b) toxicological data of relevant REACH endpoints (e.g. genotoxicity, acute toxicity, skin 
sensitisation, carcinogenicity, etc.). 
The choice of properties to capture in the database was informed by the templates 
proposed by Schultz et al. (T. W. Schultz et al., 2015), which were developed to assist in 
assessing and reporting similarity assumptions in the context of chemistry, toxicokinetics 
and toxicodynamics, and thereby supporting read-across. Since the case studies presented 
here correspond to NMs, the templates were adapted by taking into account 
physicochemical parameters specific to NMs. These are identified in the REACH guidance 
update for NMs (ECHA, 2017b) as key physicochemical parameters following a proposal by 
ITS-Nano (U. K. V. Stone, Balharry, Fernandes, Johnston, Munro, Hartl, et al., 2013). Other 
physicochemical parameters were taken into account, as reported thoroughly in Table 1.1 of 
Chapter 1. These parameters are either held under the OECD harmonised templates or 
considered relevant in the scientific literature.  
The following physicochemical characteristics were collected in our dataset: 
1. What they are: Name, JRC Nanomaterials Repository number, Chemical composition, 
Impurities, Crystal type, Crystal size, Surface coating, Porosity, Basic morphology, 
Primary particle diameter, Average particle diameter, Average length (TEM), Aspect 
ratio, Particle size distribution, Pour density (weighing), Specific surface area, Volume 
specific surface area  
2. Where they go: Agglomeration, Hamaker constant, Dustiness, logKOW, 
Hydrophobicity, Solubility(ies), Dispersability, Stability of the dispersion, 
(Bio)persistence, Redox potential, Zeta potential, Isoelectric point, Abiotic 
transformation, Toxicokinetics, Metabolic products, Steric hindrance 
3. What they do: Conduction band, Radical formation potential, Catalytic activity, 
Photocatalytic activity, Hydrolysis, Protein binding, Electrophilicity/Nucleophilicity 
(electrophilicity index), Physical hazards (flammability, autoflammability and 
explosiveness), Dissociation constant 
Regarding toxicological endpoints, the following information was collected: 
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1. Acute toxicity 
2. Irritation, corrosion, sensitisation: Skin irritation, Eye irritation, Skin sensitisation 
3. Genotoxicity: Mutagenicity, Genotoxicity in vitro and in vivo 
4. Repeated dose toxicity: 28 days, 90 days, other duration, oral, instillation, inhalation 
5. Other endpoints (e.g. dermal/percutaneous absorption, immunotoxicity, 
epidemiological studies). 
Biological activity such as the induction of reactive oxygen species (ROS) is a relevant 
initiating event in nanotoxicology and was initially considered for its inclusion in the dataset. 
However, since the objective of the WPMN OECD dossiers was to test the applicability of 
existing OECD test guidelines to NMs, and there is no guidance on biological activity, test 
conditions are not harmonised and available results in the literature were so variable 
(Barillet et al., 2010; Jugan et al., 2012) that it was finally decided to neglect this information. 
The development of a test guideline to measure ROS generation would support the 
classification of nanomaterials as biologically active or inactive, which would be of great 
importance in read-across. 
All the listed properties were searched for during data collection, but some were not used in 
developing the case studies because of lack of information or low data reliability. 
4.1.2 Selection of the endpoint to read-across 
To compile the Excel spreadsheets (the dataset) for the selected case studies, information 
was scrutinised from the following sources: 
• Data available from public OECD dossiers (OECD, 2015; OECD WPMN, 2016) 
• REACH registration dossiers as of March 2016  
• IARC dossier on MWCNTs  
• report on nano-TiO2 proposal for classification from ANSES (ANSES, 2016),  
• in-house data (cytotoxicity data from the Nanomile project),  
• data from the Scientific Committee on Consumer Safety (for nano-TiO2) (SCCS, 
 2013a) 
• JRC Repository (K Rasmussen, Mast, & Temmerman, 2014; Kirsten Rasmussen et al., 
 2014) 
• Nanogenotox FP7 project (Nanogenotox, 2012) 
 
Figure 4.1 below shows the number of tests collected for each toxicological endpoint for the 
different forms of nano-TiO2 and MWCNT. "Other toxicological tests" include 
dermal/percutaneous absorption, immunotoxicity, cytotoxicity and epidemiological studies, 
if available. Considering the number of test results recorded, the endpoint with most 
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information was genotoxicity as it included ~30% of the available toxicological tests for 
nano-TiO2 and ~60% for MWCNTs (repeated dose toxicity tests include different routes of 
exposure and different test durations). Accordingly, genotoxicity was selected as the 
endpoint to read-across in both case studies as it was not only the toxicological endpoint 
with most tests available, but these tests were also covering the largest set of nanoforms 
(e.g. the maximum number of nano-TiO2 tested in a repeated dose toxicity study was three, 
whereas 6 nanoforms were tested in genotoxicity studies).  
The data available on genotoxicity consisted mainly of tests carried out within the 
Nanogenotox Joint Action (NanoGenoTox Joint Action, 2013) and covered in vitro and in vivo 
comet and micronucleus assays. Results from bacterial mutagenicity test (Bacterial reverse 
mutation assay; Ames test) were not included in the count, as this test is not considered 
applicable to NMs in its current form (Clift et al., 2012; OECD, 2014d). 
A) nano-TiO2 B) MWCNTs 
Figure 4.1 Number of toxicological tests identified for A) the nano-TiO2 case study and B) for the 
MWCNT case study 
 
Mutagenicity testing is required by the REACH regulation for all substances manufactured or 
imported in the EU above 1 tonne (per year per manufacturer/importer). At the lowest 
tonnage level (REACH Annex VII) an in vitro gene mutation study in bacteria is required. At 
higher tonnage levels both in vitro (in mammalian cells) and in vivo genotoxicity and 
mutagenicity tests may be required.  
Table 4.1 shows the mutagenicity tests that are accepted or required by the REACH 
regulation with increasing tonnage levels. The applicability of those tests to NMs is also 
addressed as some of the in vitro tests are applicable, but none of the in vitro tests would be 
because toxikokinetic investigations are needed to determine if a NM reaches the target 
tissue (Kirsten Rasmussen et al., 2016). The adaptation for the in vitro micronucleus test 
would involve the addition of cytochalasin B as a post treatment to allow the cell to be 
exposed solely to the tested NMs. 
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Table 4.1 List of in vitro and in vivo mutagenicity and genotoxicity tests with their corresponding 
guidance documents and applicability to NMs 
REACH recommended 
mutagenicity tests* 
EU or OECD test 
guideline (TG) 
Applicability of OECD TGs to 
NMs 
In vitro tests 
Bacterial reverse mutation assay EU: B.13/14 OECD TG 471 Not applicable 
In vitro mammalian cell gene 
mutation test – hprt test 
EU: B.17 
OECD TG 476 Applicable 
In vitro mammalian cell gene 
mutation test – Mouse 
lymphoma assay 
EU: B.17 
OECD TG 476 Applicable 
In vitro mammalian 
chromosome aberration test 
EU: B.10 
OECD TG 473 Applicable after modification
In vitro micronucleus test EU: B.49 OECD TG 487 
Applicable after modification 
(modification for NMs is not 
included in the TG) 
In vivo tests 
In vivo mammalian bone 
marrow chromosome aberration 
test 
EU: B.11 
OECD TG 475 Not applicable
1 
In vivo mammalian erythrocyte 
micronucleus test 
EU: B.12 
OECD TG 474 Not applicable
1 
Unscheduled DNA synthesis 
(UDS) test with mammalian liver 
cells in vivo 
EU: B.39 
OECDTG 486 Not applicable
1 
Transgenic rodent (TGR) somatic 
and germ cell gene mutation 
assays 
EU: B.58 
OECD TG 488 Not applicable
1 
In vivo alkaline single-cell gel 
electrophoresis assay for DNA 
strand breaks (comet assay) 
EU: none 
OECD TG 489 Not applicable
1 
 
* according to ECHA guideline (ECHA, 2015a)  
1 If there is evidence that the test substance(s), or its metabolite(s) will not reach the target tissue, it 
may not be appropriate to use this test. 
 
In general it is observed that the availability of applicable tests guidelines for NMs is 
relatively limited. Furthermore, as reported in more detail under the case studies below, the 
data available were scarce and not always of good quality. Nano-TiO2 repeated dose toxicity 
studies include sub-acute to chronic toxicity studies and account for 34% of the results but 
the collected results do not cover the whole set of nanoforms that are considered in this 
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study but only 3 nanoforms. The genotoxicity studies are the most populated endpoint for 
both nano-TiO2 and MWCNTs. 
The main purpose of these case studies is to determine the genotoxic hazard potential of the 
target substance via read-across and document the process. The case studies will identify 
groups of substances (category) that can be used to determine the in vitro comet assay 
results of the target substances. One key step will be the determination of the 
physicochemical properties that can be used to define the groups and similarities between 
analogues that will form the categories. Ideally, a relationship between physicochemical 
properties and genotoxic potential will be established. Such information could facilitate data 
gap filling for those target analogues that are sufficiently similar and could also be used for 
prioritisation of testing (to fill data gaps for other analogues not investigated in this case 
study). However, the latter is not within the scope of this work.  
Objective of this case study is also to consider the possibility of to read-across non-
nanoforms: in the particular case of TiO2, an analogue is considered a non-nanoform in the 
OECD Dossiers (NM-100).  
The case studies will follow the workflow structure proposed by ECHA for grouping and 
read-across of nanomaterials (ECHA, 2017b) and will show how some chemoinformatic 
techniques (hierarchical clustering, principal component analysis, random forest variable 
selection) can be used to substantiate the grouping hypothesis. 
Since the two case studies are based on the genotoxic potential of NMs, the description of 
the modes of action that can lead to genotoxicity of NMs are explained next.  
 
4.1.3 Possible modes of action of genotoxicity 
Two principle modes of genotoxic action have been reported for particles, known as primary 
and secondary genotoxicity and these are also reported specifically for MWCNT (Van Berlo, 
Clift, Albrecht, & Schins, 2012) and nano-TiO2 (Golbamaki et al., 2015). Primary genotoxicity 
is defined as genetic damage elicited by particles in the absence of inflammation (Schins & 
Knaapen, 2007). Hence, it may be principally indicated from in vitro 
genotoxicity/mutagenicity studies or in vivo studies performed with particle concentrations 
that do not elicit significant (pulmonary) inflammation.  
Direct primary genotoxicity can result from direct physical interaction between 
nanoparticles and the genomic DNA (Golbamaki et al., 2015; K. Li, Zhao, K. Hammer, Du, & 
Chen, 2013; Magdolenova et al., 2014; L. M. Sargent et al., 2012; Siegrist et al., 2014), 
whereas indirect primary genotoxicity may be the consequence of increased ROS formation 
upon interaction with other cellular components (e.g. mitochondria, cell membrane) or from 
depletion of intracellular antioxidants (Di Giorgio et al., 2011; Ken Donaldson, Poland, & 
Schins, 2010; Schins & Knaapen, 2007) (Table 4.2). The presence as impurities or in the 
composition of the NMs of reactive transition metals may also contribute to oxidative DNA 
damage induction.  
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Table 4.2 Pathways of particle-mediated ROS generation and their involvement in processes 
of primary and secondary genotoxicity (from Schins and Knaapen 2007) 
Genotoxicity Process/mechanism 
Primary 
(direct or 
indirect) 
Intrinsic ROS generation from particles. 
• Surface associated free radicals or oxidative groups (e.g., SiO· and SiO·2 
on crystalline silica) 
• ROS generation by particles in aqueous suspension (e.g., Haber–Weiss 
reactions by available metals, semiquinone radical redox cycling of 
biotransformed PAH. 
Primary 
(indirect) 
ROS generation upon interaction of particle with cellular components. 
• Damage to mitochondria/interaction with the electron transport chain 
• Activation of NAD(P)H-like enzyme systems. 
• Disturbance of endogenous antioxidant defences 
Secondary Generation of ROS and reactive nitrogen species (RNS) during particle-
elicited inflammation 
• Phagocytes: NADPH oxidase, nitric oxide synthase, myeloperoxidase 
 
Oxidative stress in cells may be formed directly via physicochemical reactivity (e.g. via active 
residual metal catalysts including Fenton chemistry) or indirectly via the activation of 
enzymatic pathways leading to release of oxidative species.  
Oxidative DNA damage based on the formation of intracellular ROS production is the best 
described and discussed mechanism following exposure to nanoparticles (Golbamaki et al., 
2015; Schins, 2002; Tournebize, Sapin-Minet, Bartosz, Leroy, & Boudier, 2013).  
High levels of ROS can be deleterious not only to DNA but to all classes of cell components: 
lipids, proteins, nucleic acids and other macromolecules (Tournebize et al., 2013). Reactive 
species are also formed under physiological conditions, reacting with cellular components, 
leading to the activation of intracellular signalling pathways, nuclear transcription factors, 
inducing gene expression and cell responses such as repair, adaptation or transformation. 
This process is described as redox signalling. Apart from ROS mediated genotoxicity, other 
genotoxic mechanisms have been reported, e.g. the disturbance of membrane stability 
(Cveticanin et al., 2010) by the negative charge of some materials (e.g. transition metals) or 
the inhibition of various DNA repair machineries (Van Berlo et al., 2012).  
Secondary genotoxicity implies a pathway of genetic damage resulting from an oxidative 
DNA attack by ROS and reactive nitrogen species (RNS) and possible other mediators. The 
aspect of secondary genotoxicity originates from observations in which various poorly 
soluble particles (e.g. MWCNT, carbon black, TiO2) were found tumorigenic in rat lungs after 
chronic high exposures. The process is associated with overload and persistent inflammation 
and seems not to be related to their chemical composition (Borm, Schins, & Albrecht, 2004; 
Greim et al., 2001). Genotoxicity in lung epithelial cells has been found to have a high 
correlation with cell proliferation and tumour frequencies, indicating that it may be a 
secondary effect following cell proliferation (Rittinghausen et al., 2013). These toxic reactive 
species can be formed through phagocytic oxidative burst as a consequence of frustrated 
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phagocytosis of inhaled fibres. Frustrated phagocytosis was observed for rigid MWCNT 
longer than 20 μm (Ken Donaldson, Poland, & Wargo, 2009). Particle-elicited inflammation 
from recruited and activated phagocytes (macrophages, neutrophils) is considered to involve 
a threshold, meaning that it is dependent on an exposure concentration triggering 
inflammation and overwhelming antioxidant and DNA damage repair capacities in the lung. 
Although secondary genotoxicity seems to be the most common mechanism for NMs like 
MWCNTs or asbestos, several in vitro studies in which nanoparticles including MWCNTs 
induced genotoxicity in the absence of inflammatory cells (NanoGenoTox Joint Action, 2013) 
indicate that primary genotoxicity cannot be ruled out per se. However, the predictive value 
of in vitro studies carried out with dispersed NMs in cultured cells to identify genotoxic NMs 
in vivo that could eventually be carcinogenic is presently unclear (NanoGenoTox Joint Action, 
2013). 
A distinction between primary and secondary genotoxicity seems relevant as currently 
available literature data merely indicate that the tumourigenesis of poorly soluble particles 
involves a mechanism of secondary genotoxicity (Ken Donaldson, Poland, et al., 2010; Schins 
& Knaapen, 2007). However, the (1) causality between pulmonary inflammation and 
genotoxicity has not yet been established, and (2) effects of inflammation on fundamental 
DNA damage responses that orchestrate mutagenesis and carcinogenic outcome, that is, cell 
cycle arrest, DNA repair, proliferation, and apoptosis, are currently poorly understood 
(Schins & Knaapen, 2007).  
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4.2 Workflow for grouping and read-across 
A review on available read-across frameworks and case studies was presented in chapter 2. 
In this project, the workflow recently presented in the draft appendix to the REACH guidance 
(ECHA, 2017b) is considered as a reference for reporting the read-across information. The 
framework is shown in Figure 4.2. In the case studies sections in this chapter each step of 
the framework is developed in a paragraph reporting the same title.  
 
Figure 4.2 Read-across workflow followed in the Nanocomput case studies (ECHA, 2017b) 
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Generally, read-across is an iterative process that starts defining a target substance with a 
property that needs to be determined. In the current case this will be genotoxicity of nano-
TiO2 and MWCNTs. The information for these case studies is obtained from data that is 
already available for a set of identified analogues.  
In the case of NMs the definition of analogues is not straightforward as for e.g. organic 
chemicals, because the influence of the different properties of NMs (e.g. size, coating, 
composition, or solubility) is not yet well understood. Step 1 of the framework is to define 
the nanoforms of the substance, i.e. “what they are”. In order to infer the property of 
interest, there is a need of a hypothesis that will substantiate the interpolation of data. In 
the case of NMs there is not a well established and unique mechanism of mutagenicity. It 
could be hypothesised, for instance, that NMs reactive to DNA would be genotoxic. This 
hypothesis would include primary and secondary mechanisms and would imply that particles 
reach the target organ. The hypothesis definition takes place in step 2 of the framework and 
is followed by the definition of 2 groups (categories), reactive vs non-reactive. Step 3 
consists of the gathering of data for each member of the group that will be used to assess 
the similarity within the groups and the grouping hypothesis. The disposition of these data in 
matrix form (step 4), will facilitate this grouping assessment, which will take place at step 5. 
In case the group rationale is not supported by the underlying data, a new grouping 
hypothesis will need to be formulated. On the contrary, if the group is robust but data is 
missing, new data will need to be generated and a testing strategy will be defined in step 6. 
If the group is robust and the data adequate, the prediction (read-across) can be accepted.  
 
4.3 Methods used to investigate similarity between nanoforms  
Given that there is not an agreement in the literature about the mechanism that can lead to 
genotoxicity of nano-TiO2 and MWCNTs, e.g. chemical reactivity, ROS generation, 
agglomeration and sedimentation, a set of chemoinformatic tools have been used to 
determine the (physicochemical) properties that differentiate the analogues, their similarity 
and that may drive genotoxicity. Thus, for each case study, the grouping hypothesis was 
based on the similarity between the physicochemical properties reported in the dataset. The 
formulation of similarity rules was supported by the application of the following data mining 
methods: 
1. Hierarchical clustering was applied to identify possible clusters or groups of analogues in 
the dataset (similar NMs) 
2. Principal component analysis was applied to have an indication of what are the 
physicochemical properties that differentiate the NMs and that can help in justifying the 
clustering, which is important in defining the grouping hypothesis 
3. Random forest variable selection was applied to verify which are the most relevant 
properties in predicting the assay results. For this methodology the toxicological 
information needs to be taken into consideration as the aim was to classify the relevance 
of each variable (physicochemical property) in predicting the result (toxicological assay). 
In this chapter the toxicological endpoint was genotoxicity but the same technique could 
be used for any other endpoint. The technique can be applied to any endpoint, but the 
result will be exclusive to each endpoint. 
The three data mining methods are introduced next. 
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4.3.1 Hierarchical clustering 
Hierarchical clustering is an unsupervised technique that supports the definition of 
categories of data, in the present case studies groups of TiO2 and CNTs nanoforms. In the 
divisive type of clustering the algorithm recursively divides the initial population, i.e. the 
source analogues, into two groups depending on their relative distances (similarity) until no 
more divisions are possible. The distances correspond to the Euclidean distances between 
two points in a space and are calculated using all the properties of each analogue. There are 
different ways of calculating the distances, which can determine the shape of the clusters. 
The most usual ones are the “complete”, “single”, and “average”. The complete distance is 
determined from the members of the two groups that have the largest Euclidean distance. 
The single distance corresponds to the distance of the members of the two groups that are 
closest, and the average distance corresponds to the average of distances of all members of 
each group with all members of the other group. For this exercise it was considered that the 
average distance was the most adequate measure as the different members of the two 
groups would be equally represented.  
Before clustering the NMs, the dataset had to be modified in order to remove those 
properties that were not useful to differentiate NMs. The usual procedure in these cases is 
the removal of properties with low variability/invariant values and the removal of properties 
with redundant information, i.e. with values similar to other properties across the NMs 
(highly correlated properties). Since the present two case studies corresponded to different 
forms of TiO2 and CNTs, respectively; chemical composition was not one of the properties 
considered as it was constant in each case study. In an hypothetical case in which different 
substances were used as analogues (e.g. read-across between different metal oxides), 
properties accounting for the differences in chemical composition as could be charge of the 
metallic atom, molecular weight, number of electrons, bond order, etc. could be included in 
the list of physicochemical properties that are used to determine the distance between 
analogues and that ultimately define the clusters.  
 
4.3.2 Principal component analysis 
Principal component analysis is another unsupervised common technique that can be used 
to determine similar substances (clusters) from their variables (properties) and to find the 
properties that differentiate them the most, i.e. show which properties are important and 
which properties are redundant. The PCA uses vectors of data, i.e. properties for each NM, 
and transforms them via a linear combination into other vectors (principal components, PCs) 
that are orthogonal to each other. PCs are formed from a linear combination of the initial set 
of properties and are usually named in decreasing order of variance. In general the first two 
or three PC account for more than 80% of the total variance across NMs and can be used to 
describe the whole dataset with just two or three vectors.  
 
4.3.3 Random forest for variable selection 
The two methods mentioned above are called “unsupervised” because they only make use 
of the properties of substances to determine their “similarity” and identify the properties 
that differentiate them. Random forest is a classification algorithm that uses the properties 
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of substances to classify them into categories. The algorithm uses predefined categories of 
the substances, e.g. genotoxic vs non-genotoxic, to determine the usefulness of the 
(physicochemical) properties to predict the categories. This type of algorithms is usually 
used to select a subset of variables from a large pool of variables and are called variable 
selection algorithms. 
One of the most commonly used methods for variable selection is implemented in the 
package “randomForest” of the R software(Liaw & Wiener, 2002), which is open source and 
freely accessible software (https://cran.r-project.org/). The algorithm determines the 
importance of the variables by building a random forest model and computing the mean 
decrease in accuracy that each variable causes when left out of the pool of variables when 
constructing the random forest. A random forest classifier operates by constructing a 
multitude of decision trees and outputting the class (category) that is the mode of the 
classes. Random forests correct the tendency for individual trees to overfit their training set. 
The variables that cause the highest accuracy decrease are considered the most important 
ones. In general the mean decrease of the Gini index (Gini, 1912) is used instead of the mean 
decrease of accuracy to determine variable importance. The Gini index is a measure of how 
each variable contributes to the homogeneity of the nodes and leaves in the resulting 
random forest and ranges from 0 (homogeneous) to 1 (heterogeneous). Each time a 
particular variable is used to split a node, the Gini indexes of the child nodes are calculated 
and compared to that of the original node. The variables that yield nodes with higher purity 
(homogeneity) have a higher decrease in Gini index, and therefore are considered more 
important. 
  
4.4 The nano-TiO2 case study: predicting the in vitro comet assay result 
In this chapter a set of 6 TiO2 nanoforms will be used as source substances (analogues) to 
predict via read-across the genotoxic potential of two target TiO2 nanoforms. The genotoxic 
potential is defined by corresponding in vitro comet assay results and is predicted using the 
category approach. The case study follows the workflow proposed by ECHA for grouping and 
read-across of NMs (ECHA, 2017b). 
 
4.4.1 Identification and characterisation of the nanoforms of the substance  
In this case study, the result of the comet Assay for TiO2 Rutile (R) nano (Sigma 637262) and 
TiO2 Anatase (A) nano (Sigma 637254) will be the data gaps to be filled by read-across. The 
first step in the read-across workflow (see Figure 4.5Figure 4.) is the identification and 
appropriate characterisation of the nanoforms of the substance (ECHA, 2017b).  
 
Identification of target NMs 
According to ECHA draft recommendations for the definition of nanoforms, the 
requirements to register a nanomaterial are: 
• Particle size (in one or more dimensions) 
• Particle shape, e.g.  spheroidal-like, high aspect ratio (≥5:1, nanotubes, nanorods), two-
dimensional (flakes or platelets), other (mixtures of particles with different shapes) 
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• Surface chemistry (chemical identity)  
The information for the target NMs used in the present case study was extracted from 
Guichard et al. (2012) and presented in Table 4.3. 
 
Table 4.3 Physicochemical properties of the NMs used as target substances in the case study. 
Data obtained from (Guichard et al., 2012).  
 
 
According to the physicochemical properties, the target materials consist of a nanopowder 
with particles of rutile and anatase TiO2 respectively, specific surface area of 149 and 177 
m2/g, different levels of non-TiO2 content (one is uncoated and has 99.5% w/w purity, the 
coated one has 87% w/w purity). The producer indicates that TiO2 R nano may contain up to 
5% w/w of SiO2 as surface coating. This NM has been tested for cytotoxicity and genotoxicity 
in Syrian hamster embryo cells by Guichard et al. (2012), and the reporting of results 
includes some physicochemical analysis that will be used to determine analogues, and the 
test results will be used to va\lidate the read-across prediction. 
The analysis of the physicochemical properties of the target substances shows that the 
measured ones are slightly different from those reported by the manufacturer. For instance, 
(Guichard et al., 2012) found for TiO2 R nano 11% w/w of impurities corresponding mainly to 
SiO2 (manufacturer declared up to 0.5%), the measured particle size corresponded to a rod 
of 62±10 x 24±2 nm (manufacturer declared 40x10nm40), and the surface area to 177m2/g 
(manufacturer declared 50m2/g). For the purpose of this study it is assumed that  the 
substance used by (Guichard et al., 2012) in their experiments really corresponds to coated 
TiO2 manufactured by Sigma. It is not clear though where is the limit to consider that two 
substances are the same.   
 
                                                      
40  According to details provided in the NM Aldrich catalogue 
http://www.sigmaaldrich.com/catalog/product/aldrich/637262?lang=it&region=IT 
Properties TiO2 R nano TiO2 A nano 
Crystal type  Rutile Anatase 
Total non-TiO2 content 
(including coating and 
impurities) (% w/w) 
13 0.50 
Surface chemistry (as declared 
by manufacturer) 
SiO2 (<5%) 
Na2SO4 uncoated 
Surface coating (% w/w) 11 0 
Primary particle diameter (nm) 10 nm diameter62 nm length 14 
Shape Rod Sphere 
Specific surface area (m2/g) 149 177 
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Identification of source analogues 
To identify analogues of the target NM, the initial sources for collecting information on 
physicochemical properties and on toxicological endpoints were the SCCS report and the 
OECD WPMN dossier on TiO2 nanoforms nano-(OECD, 2015; SCCS, 2013a). The information 
obtained from these sources was used to construct a table with 53 TiO2 nanoforms. 
Unfortunately, most of these analogues could not be identified because the reported data 
(mainly in the SCCS report) had been anonymised, and the information reported did not 
include systematic physicochemical characterisation that could be used to identify them.  
We therefore decided to consider only the nanoforms that were identified properly by 
means of fundamental parameters like solubility, hydrophobicity, zeta potential, and 
dispersability, which are among the ones that need to be taken into account in read-across 
of NMs nano-(ECHA, 2017b). This led to a dataset with 6 TiO2 nanoforms whose data were 
mainly obtained from the OECD dossier (from the version published online in March 2016). 
The 6 nanoforms differ in their size (from 7 to 117 nm), coating (two of them are declared 
coated by the manufacturer and the others are declared without a coating), crystal type 
(anatase or rutile) and hydrophobicity (hydrophobic or hydrophilic). For an overview of 
physicochemical characterisation of these TiO2 nanoforms, see Rasmussen et al. (2014b). As 
shown in Table 4.5, all collected nanoforms had several toxicological data available including 
comet assay results. The 6 analogues and the physicochemical properties relevant for their 
identification ("what they are") are shown in Table 4.4.  
One of the difficulties in identifying NMs is the presence of coating and impurities. 
Impurities are defined as "An unintended constituent present in a substance as 
manufactured" (ECHA, 2012a), while surface coating consists in the surface chemistry 
purposely added to the NM. The measurement of the elements present on the surface of 
the NM does not distinguish between the two, and hence "Total non-TiO2 content including 
coating and impurities (% w/w)" is reported as the measure for the total elements detected 
other than the core material. Thus, this measure includes also the coating, which is 
separately declared by the supplier and is also reported separately in our dataset and in  
Table 4.4. as "Surface chemistry (as declared by manufacturer)" and "Surface coating (%)" 
indicating the quantity of coating with respect to total weight of the NM. In the present 
case, NM-103 and NM-104 are declared coated and in fact the amount of total non-TiO2 
content is >10% w/w. NM-101 has quite a high content of impurities if compared to the 
uncoated NM-100, NM-102 and NM-105.  
Table 4.4.shows one of the problems of NMs which is data variability. For instance, some of 
the properties like crystallite size were obtained averaging different values provided by 
different laboratories (see Appendix VII and IX for further information). In the particular case 
of NM-100, 117nm is the average of 141, 61, 168, and 100nm. The way in which the data is 
summarized depends on the distribution of the values. If the distribution is normal, the 
values can be averaged but if the distribution is not normal and there are extremes, then the 
median is a better option. However, in these cases we do not have enough data to 
determine which is the right value. In this case, we have values obtained by different 
laboratories and some of these values correspond to triplicate measures with very low SD. 
Luckily, the mean and median were very similar and the statistical method used did not 
compromise the value. Similarly, the particle size diameter was obtained from two different 
measures with triplicates, one of 70 ± 20nm and another one of 116.9 ± 36.9nm. The final 
results indicate that the crystallite size is very similar to the particle size diameter (117 vs 93 
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nm), which would imply that the NMs are formed by a single crystal and this may not be 
100% true in some cases. NM-100 is a dry-milled NM and the variability in the measured 
values of its particle diameter and crystallite size just indicates that it does not correspond to 
a mono-dispersed substance but that it contains particle sizes ranging from 61-168nm. This 
will not represent a major problem in this case study as the endpoint of interest is in vitro 
genotoxicity, in which the primary size of the NMs may not dramatically affect the exposure. 
However, this could have big implications in in vivo endpoints in which the size of the 
particles may significantly affect the biodistribution of particles throughout the body and 
organs (e.g. lungs). The fact that the particle size diameter and crystallite size are very similar 
or that the latter is even larger is unexpected as it would indicate that the NMs are 
composed of just one crystal. Another factor that can help explaining this issue is the fact 
that the particle size diameter was measured with TEM and the crystallite size by XRD, which 
are two different methods whose comparison might be difficult. In this case, the latter 
would be less accurate as the authors of the Nanogenotox report acknowledged having 
some problems fitting the data to some of the equations that are used to derive the 
crystallite size from the diffraction values. 
 
Table 4.4 Physicochemical properties of the source analogues obtained from the OECD dossiers 
(downloaded March 2016) 
Property NM100 NM101 NM102 NM103 NM104 NM105 
Crystal type Anatase Anatase Anatase Rutile Rutile 83% anatase17% rutile 
Other info Dry-milled 
Semiconductor 
catalyst used in 
photocatalytic 
process 
photocatalytic hydrophobic hydrophilic - 
Total non-TiO2 
content including 
coating and 
impurities (% w/w) 
1.5 9 5 11  11 0.11 
Surface chemistry (as 
declared by 
manufacturer) 
uncoated uncoated uncoated Al2O3 and SiO2 Al2O3 and SiO2 uncoated 
Surface coating (% 
w/w) 
0 0 0 8 8 0 
Primary particle 
diameter (TEM) (nm) 
93 ± 23 5 ± 1 22 ± 10 24 ± 2 24 ± 2 20 ± 3 
Crystallite size (XRD) 
(nm)* 
117 ± 40 7 ± 2 24 ± 5 24 ± 4 25 ± 4 22 ± 5 
Particle Size 
Distribution (Z-
average) (nm)β 
210 ± 10 278 440 ± 37  135 ± 25 145 ± 35 177 ± 39 
Shape Spheroidal Spheroidal Spheroidal Spheroidal Spheroidal Spheroidal 
Aspect ratio 1.53 1.53 1.53 1.7 1.53 1.36
Specific surface area 
(m2/g)£ 
9 242 ± 73 77 ± 10 54 ± 4 54 ± 2 47 ± 0.5 
*
 values averaged from different instruments and principles (Peak fit, TOPAS, Fullprof, Scherrer eq., TOPAS, IB, 
  TOPAS FWHM) 
β values averaged from ICP-MS and DLS experiments. 
£ values averaged from SAXS/USAXS and BET 
 
These analogues are quite data rich because they have been investigated in several FP7 
projects and the WPMN testing program. The information available for each NM was 
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restructured starting from the OECD dossiers to build a complete dataset including both 
physicochemical information and toxicological information (genotoxicity) for NM-100, NM-
101, NM-102, NM-103, NM-104, NM-105. 
A summary of the genotoxicity studies that were collected from the cited sources is reported 
in Table 4.5. The table shows that there are in vitro comet assay results for all the identified 
source NMs and they exhibit both positive and negative results. This justifies the selection of 
in vitro comet assay as the endpoint to read-across. The results in the table report the 
positive tests over the total tests available. All the genotoxicity tests performed in the 
Nanogenotox WP6 were taken into consideration for the purpose of this case study. The 
testing protocol included a post-treatment of cythochalasin B that was added 6 h after the 
start of the treatment for all cell lines except CaCO2 where cytochalasin B was added after 
24 h, so it can be assumed that this protocol applied the adaptation of the OECD TG 473 as 
recommended in Rasmussen et al. (2016). However, only the in vitro comet assay was 
performed for the 6 source analogues, hence this endpoint was selected for the read-across 
case study, although no OECD TG is available. 
 
Table 4.5 Availability of genotoxicity tests for the source NMs in our dataset (number of positives 
over the total number of tests performed). Data obtained from the Nanogenotox Joint Action 
(Nanogenotox WP6, 2013; Norppa et al., 2013). 
Assay NM-
100 
NM-
101 
NM-
102 
NM-
103 
NM-
104 
NM-
105 
in vivo comet assays - 1/5 2/12 1/12 2/12 3/12 
in vitro comet assays 2/2 0/2 4/6 0/6 0/6 3/6 
in vivo micronucleus - 0/3 0/5 0/5 0/5 0/5 
in vitro micronucleus - - 1/7 2/7 2/7 1/7 
 
4.4.2 Initial grouping of nanoforms 
The second step of the ECHA guidance for grouping of nanoforms corresponds to the 
proposal of an initial grouping of the identified materials (ECHA, 2017b). 
Table 4.5 reports the genotoxicity tests available in the Nanogenotox project for the source 
analogues. Our hypothesis will be based on the fact that the data in Table 4.5 show that NM-
100, NM-102 and NM-105 have a higher tendency to giving positive results in the in vitro 
comet assay, whereas NM-101, NM-103 and NM-104 tend to give negative results.  
As mentioned in paragraph 4.1.2, and as reported in the literature (Golbamaki et al., 2015; 
Magdolenova et al., 2014), there are more experimental data on the in vitro comet assay for 
testing the DNA damage caused by NMs, compared to other tests. The in vitro comet assay 
detects DNA strand breaks at the level of single cells. In our case study, we aim at identifying 
NMs physicochemical properties that may affect DNA damage, to be able to read-across test 
results to our target NMs. 
Regarding the mechanism(s) of genotoxic action of NMs, Magdolenova et al. (2014) and 
Golbamaki et al. (2015) reviewed the mechanisms of genotoxicity of NMs and of the subset 
of metal oxides (including nano-TiO2), respectively. They report that DNA damage caused by 
nano-TiO2 may be classified as direct primary genotoxicity, indirect primary damage, and 
secondary genotoxicity. Direct genotoxicity assumes that DNA and NM are in contact. An 
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example of direct genotoxicity by TiO2 was found to involve the reaction of terminal DNA 
phosphate groups that influence the binding of DNA to nano-TiO2 (Rice et al., 2009). Indirect 
primary genotoxicity may be elicited by interaction of NMs with nuclear proteins (involved in 
replication, transcription, and repair), disturbance of cell cycle checkpoint functions, ROS 
arising from the NM surface, release of toxic metal ions from the NM surface, ROS produced 
by cell components, and inhibition of antioxidant defence (Jugan et al., 2012). Finally, 
secondary genotoxicity may be elicited by ROS production in inflammatory cells via an 
inflammation signalling pathway (Romoser, 2012), i.e. macrophages or neutrophils 
(activated phagocytes) generate ROS while trying to digest the NMs. This can cause  an 
inflammatory reaction that may subsequently cause oxidative DNA damage (Trouiller et al., 
2009).  
Although most experimental studies provide evidence for a mechanism of action for indirect 
primary genotoxicity via ROS (Golbamaki et al., 2015), several studies report that a clear 
correlation between the level of ROS production and DNA damage was not supported by 
their findings (Barillet et al. 2010, Golbamaki et al. 2015, Li et al 2013). For example, Li et al. 
(2013) investigated the ability of a set of NMs (including nano-TiO2, plus metal and metal 
oxide NMs and quantum dots) to inhibit DNA replication by binding to DNA: they concluded 
that ROS generation as an important cause of genotoxicity was not supported by their 
experiments as the amount of generated ROS did not explain the effect of NMs on DNA 
binding reported in their study. They suggested instead that direct binding activity of NMs to 
DNA was the likely genotoxicity mechanism. 
 
Development of grouping hypothesis 
Our dataset includes 6 NMs with different properties: different primary and crystallite sizes, 
different crystalline types and surface characteristics (some are coated and some uncoated), 
as reported in Table 4.4. From combining the in vitro comet assay results reported in Table 
4.5 and the physicochemical characteristics identifying the nanoforms shown in Table 4.4 we 
can formulate our grouping hypothesis: 
Nano-TiO2 in its uncoated form has the potential to damage DNA, but this can be masked by the 
presence of coating or by the large amounts of impurities on the surface of the NM. 
This hypothesis is supported by the random forest analysis reported in paragraph 4.4.5. The 
variable importance plot in Figure 4.8 shows that the Total non-TiO2 content, which includes 
coating and impurities, and organic matter, which accounts mostly for coating, are the most 
valuable properties to predict in vitro comet assay results.  
In fact, it can be readily seen in the dataset of analogues that the coated NMs turn out 
negative in the comet assay while the ones without coating and organic impurities turn out 
positive. This can be explained if a direct interaction mechanism of genotoxicity or an 
indirect primary genotoxicity are considered (Magdolenova et al., 2014). The conduction 
band of TiO2 falls in the range of biological redox potentials (Burello & Worth, 2011a), 
meaning that TiO2 with or without the presence of UV light can generate reactive species 
that react with cell constituents such as DNA. In both direct and indirect primary 
genotoxicity, physical interaction of the NM with DNA (direct) or another cellular component 
(e.g. enzyme mediated a redox reaction) that generates ROS (indirect) is necessary for the 
DNA damage to occur. The NM coating acts as a physical barrier that can prevent this 
contact between the Ti and O atoms of TiO2 and DNA or other cellular components. 
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Therefore, coated nano-TiO2 will not turn out positive in the comet assay as there will be no 
physical interaction between the Ti / O atoms and DNA / cellular components.  
The way in which the coating can prevent DNA damage is not entirely clear, in fact several 
works show contradictory results and explanations for the in vitro genotoxicity of TiO2 with 
coating playing a main role. For instance, it was shown (Falck et al., 2009; Mano, Kanehira, 
Sonezaki, & Taniguchi, 2012) that the addition of PEG coating to nano-TiO2 increased the 
dispersion of NMs which resulted in lower cytotoxicity and genotoxicity. Magdolenova et al. 
(2012) showed that the degree of dispersion of TiO2 NMs had an influence on the DNA 
damage in three cell lines. Agglomerates of less than 200 nm had no effect on genotoxicity 
while larger ones showed positive results. These results could be due to larger agglomerates 
precipitate and deposit on the cells increasing the actual exposure to the NM or even 
covering them completely and suffocating them. Another consideration is the effect that the 
use of media with proteins (e.g. BSA, FBS) can have on the results. If the NMs are 
surrounded by proteins, they are more dispersed and also less toxic as the “reactive” part is 
encapsulated (“hidden”) behind the protein corona. Another aspect that cannot be ignored 
when analysing the in vitro results of TiO2 is its photocatalytic activity, which can be even 
triggered by a simple fluorescent tube (Karlsson, Di Bucchianico, Collins, & Dusinska, 2015). 
Thus, it is obvious that the mechanism of genotoxicity of TiO2 is not well defined and that 
there might be more than one that could even take place simultaneously. Probably the truth 
is a combination of all factors that have as common source the presence of coating either by 
preventing aggregation of NMs, deposition, and therefore reducing exposure, or by 
preventing physical contact with DNA and/or other cell components after uptake. However, 
what is relevant in this case is that the majority of studies agree with the hypothesis 
presented here which is the fact that coated nano-TiO2 show fewer positive results in the 
comet assay than the uncoated ones, therefore it can be fairly concluded that the presence 
of coating reduces the genotoxic effects of nano-TiO2. It is important to keep in mind that 
the present coatings are mainly not “charged” as could be coatings with reactive or non-
neutral groups such as terminal –COOH or –NH2, in which cases the grouping hypothesis 
might change. 
Identification of the nanoforms within each group  
From Table 4.6 it can be seen that a trend can be identified only for the in vitro comet 
results, where the test has positive results (the group of positives) for NM-100, NM-102 and 
NM-105. The group of materials that are not causing DNA damage (the group of negatives) is 
NM-101, NM-103 and NM-104. This grouping is schematically presented in Table 4.6. 
 
Table 4.6 Assignment of the analogues to the two groups identified upon DNA damage potential 
measured with the in vitro comet assay, depending on the characteristics of the NMs. 
 Naked particle Particle with high non-TiO2 
content (coating + 
impurities)  
Source NMs NM-100, NM-102, NM-
105 
NM-103, NM-101, NM-104 
DNA damage + - 
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4.4.3 For each group member, gather and evaluate data adequacy and reliability 
The third step of the framework is aimed at defining the purpose of the grouping 
(endpoint(s)), and at developing the hypothesis and the scientific basis for a robust 
justification of the read-across (ECHA, 2017b). 
The dataset of source analogues was adapted to other properties relevant for grouping as 
provided in Appendix 1 of the ECHA guidance (ECHA, 2017b) and following Table 1.1.  Table 
4.7 shows the complete dataset for the identified source analogues. The table was analysed 
to identify a set of properties that can be used to define (structurally) similar NMs as well as 
to identify those physicochemical properties that can help in predicting by read-across the 
results of an in vitro comet assay. The dataset reported here contains only data that were 
used in the analyses. The full dataset is reported and described in Appendix X. 
Available information was collected considering the list of physicochemical properties 
reported in Section 4.1.1. A detailed analysis on physicochemical properties is reported in 
Appendix VIII. 
Physicochemical parameters 
The total non-TiO2 content of the source analogues varies from 0.11% to 11%, where the 
highest values are justified by the presence of coating. NM-103 and NM-104 contain 6% of 
Al2O3 6 and 2% of organic functionalisation (silanes and dimethicone for NM-103 making it 
hydrophobic; tetramethyl silicate; glycerol; silanes; hexadecanoic acid, methyl ester, 
octadecaonic acid for NM-104 making it hydrophilic). NM-101 with 9% of non-TiO2 content 
of organic composition (silane, Hexadecanoic acid, methyl ester, octadecaonic acid) could be 
considered to have coating although this nanoform was not declared coated by the 
manufacturer (Birkedal et al., 2012). This difference is reflected in Table 4.7, where the 
presence of surface coating is represented by its %w/w and where the Total non-TiO2 
content accounts for the amount of matter that is not TiO2, thus including coating and 
impurities.   
Since there was abundant information on the particle size distribution in biological media 
submitted in the OECD dossiers, this was also considered in the reported dataset. 
The dependence of the NM properties on the environment (fate) is addressed in the dataset 
by including physicochemical properties measured in different media. For example, particle 
size distribution, zeta potential, polydisperisity index are measured in milli-Q water, in 
Dulbecco's modified eagle medium, and in foetal bovine serum, whereas solubility and redox 
potential are measured in Gamble's solution (representing a lung fluid) and Caco2 medium 
(representing the intestinal environment). 
The numerical values in the table are deducted from the data analysis presented in Appendix 
VIII; particle size distribution is determined in MilliQ water and biological media. Biological 
media applied in the studies reported in the table are Dulbecco's modified eagle medium 
with and without L-glutamine, fetal bovine serum and phosphate-buffered saline. 
Dispersions were either untreated or underwent 1 minute probe sonication or 20 minutes 
ultrasound bath sonication. Inputs on solubility and biodurability were deducted by 
elemental analysis of the particle-free tested media (K. A. Jensen et al., 2013). 
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Table 4.7. Physicochemical properties of the target analogues. MQ: milli-Q water; 1 min: 
sonication time, as direct probe; 20 min: sonication time, ultrasound batch mode; DMEM: 
Dulbecco's modified eagle medium; PBS: phosphate-buffered saline (PBS: 137 mM NaCl, 2.7 
mM KCl, 0.02 M PO4) FBS: fetal bovine serum; PdI: polydispersity index; BSA: bovine serum 
albumin. 
Name NM-100 NM-101 NM-102 NM-103 NM-104 NM-105 
In vitro comet assay 1 0 1 0 0 1 
Total non-TiO2 content including coating and 
impurities (% w/w) 1.5 9 5 11 11 0.11 
Impurity(% w/w Fe) 0.49 0 0.07 0.06 0 0.06 
Impurity(% w/w Si) 0.28 0.29 0.08 0.68 0.018 0.07 
Impurity(% w/w K) 0.25 0 0.001 0.001 0.001 0 
Impurity(% w/w P) 0.21 0.27 0.001 0 0 0 
Impurity – coating (% w/w Al) 0.09 0.09 0.05 3.4 3.2 0.04 
Impurity(% w/w  Cr) 0.03 0 0 0 0 0 
Impurity(% w/w Zr) 0.005 0.01 0.005 0.001 0.001 0 
Impurity(% w/w Ca) 0.001 0 0.005 0.005 0.01 0 
Impurity(% w/w Na) 0.001 0.1 0.001 0.01 0 0.001 
Impurity(% w/w S) 0 0.22 0.001 0.01 0.01 0.26 
Impurity(% w/w Mg) 0 0 0 0.001 0.001 0 
Crystal type (Anatase) 1 1 1 0 0 0.84 
Crystal type (Rutile) 0 0 0 1 1 0.16 
Crystal type (Cubic) 0 0 0 0 0 0 
Crystallite size (mean) 117.81 7.69 23.93 24.32 24.71 22.44 
Primary particle diameter (mean) 93.45 5.25 22.00 24.00 24.50 20.13 
Aspect ratio 1.53 1.53 1.53 1.70 1.53 1.36 
Specific surface area (m2/g) 9.23 316.07 77.86 53.98 54.33 47.00 
Shape (elongated=1, spherical=0) 0 0 0 1 0 1 
Surface coating (% w/w) 0 0 0 8 8 0 
Organic matter (% w/w)  0 8 0 2 2 0 
IsoelectricPoint(Mean) 7.02 5.5 6 8.3 8.5 6.8 
IsoelectricPoint(Min) 6.86 5.3 6 8.2 8.2 6.6 
IsoelectricPoint(Max) 7.18 5.7 6 8.5 8.8 6.9 
Density 3.84 3.99 3.84 4.015 4.09 4.052 
Mean of total pore volume (ml/g) 0.0324 0.319 0.2996 0.2616 0.1935 0.1937 
Micro surface area (m2/g) 0 13.625 1.108 0 0 0 
Micropore volume (ml/g) 0 0.00179 0.00034 0 0 0 
Specific surface area (mean) 9.23 242.785 77.864 53.984 54.331 47 
Dustiness-Respirable(mg/kg) 1500 5600 9200 19000 6400 11000 
Biodurability 24h 0.05% BSA (Ti content) 
(µg/l) 5.2 0 0 0 0 0 
Biodurability 24h Gambles solution (Ti 
content) (µg/l) 0 0 3388 0 0 0 
Biodurability 24h Caco2 (Ti content) (µg/l) 796 3414 1741 222 3386 2724 
Biodurability 24h 0.05% BSA (Al content) 
(µg/l) 0 175 0 198 137 0 
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Name NM-100 NM-101 NM-102 NM-103 NM-104 NM-105 
In vitro comet assay 1 0 1 0 0 1 
Biodurability 24h Gambles solution (Al 
content) (µg/l) 0 177 0 868 413 0 
Biodurability 24h Caco2 (Al content) (µg/l) 24 252 0 182 413 0 
Biodurability 24h 0.05% BSA (Si content) 
(mg/l) 0 0 0 0.9 0 0 
Redox Caco2 medium Ω 1 -1 -1 1 -1 -1 
Redox Gamble's solution Ω 1 0 -1 1 -1 -1 
Redox BSA Ω 0 0 0 0 0 0 
Particle Size Distribution (Z-average) (nm) 210 278 439.8 135.11 144.47 176.78 
Particle Size Distribution in PBS, untreated 
(nm) 2289 1229 1579 1397 1600 3342 
Particle Size Distribution in MQ Water, Mode 
1,1min sonication (nm) 259.3 719.5 703 2649 207.7 352.6 
Particle Size Distribution in DMEM + L-
glutamate, Mode 1, 20min sonication (nm) 1059 1974 2001 2916 3207 1956 
Zeta Potential in MQ Water,1min sonication 
(mV) -24.5 -27.2 -27.1 39.1 -23.4 -23.8 
Zeta Potential in DMEM + 10%FBS, Mode 1, 
1min sonication (mV) 78.4 0.13 -10.5 -12.4 -9.38 -9.92 
Zeta Potential in PBS, 20min sonication (mV) -20.2 -21.7 -18.5 -20.9 -20.3 -33.2 
Zeta Potential in DMEM + 5% FBS, 20min 
sonication (mV) -10.4 -11.3 -9.47 -13.7 -9.38 -11.9 
Polidispersability Index in DMEM + 1% FBS - 
1min sonication 0.207 0.232 0.243 0.243 0.194 0.177 
Polidispersability Index in MQ water - 1min 
sonication 0.205 0.274 0.248 0.393 0.236 0.211 
Polidispersability Index in DMEM + 
Lglutamine - 20min sonication 0.515 0.247 0.227 0.264 0.209 0.341 
Polidispersability Index (PdI) 0.303 0.323 0.427 0.292 0.227 0.245 
Ω values obtained from Nanogenotox 4.7 determined by measuring the content of O2. Oxidising properties (1), neutral (0), reducing (-1) 
 
Toxicological information 
ANSES (2016) performed a literature search on available genotoxicity case studies published 
in the period 2010-2015, reporting also registration dossiers collected by ECHA. Studies 
identified by ANSES that were missing in our dataset were then included and a further 
literature search was carried out to include other available studies (Appendix XI) on the six 
source analogues, and a reliability assessment of the studies was made according to the 
criteria identified by ANSES and reported here.  
In vitro studies were considered reliable if: 
1. The NMs are characterized (at least size, crystallinity and coating) and a description 
of the dispersed materials are provided (particle size distribution, zeta potential, 
polydispersity index) 
2. The NM uptake is observed and/or cytotoxicity is tested 
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3. Positive and negative controls are considered, and replicates are included. 
The in vivo studies are considered reliable if conditions 1 and 3 above are applied; negative 
results are taken into account only when it has been proven that the nanoparticles have 
reached the organ investigated (condition 2). In in vitro studies, this could be confirmed with 
data on uptake or if cytotoxicity was detected. 
In our data collection we reported micronucleus, comet and chromosomal aberration tests 
because the current OECD test guidelines fort these tests are considered applicable to NMs. 
Although some efforts are being done to evaluate the in vitro comet assay (Azqueta & 
Dusinska, 2015; Golbamaki et al., 2015), an OECD test guideline is not available. This 
endpoint was considered anyway in our data collection because of larger availability of 
studies. Previous reviews on genotoxicity tests applied to NMs claimed that the comet and 
micronucleus assays are the most commonly used tests in the field (Golbamaki et al., 2015), 
and our search results confirm this.  
Details on the literature search for genotoxicity studies is reported in Appendix XI. Table 4.8 
shows the results of the tests reported in the collected literature; the studies taken into 
consideration include the tests reported previously in Table 4.5. The results are shown as the 
number of positives out of the total studies. The numbers refer to reliable studies, identified 
according to the criteria identified by ANSES.  
 
Table 4.8 Total number of reliable genotoxicity studies for nano-TiO2 found in the literature and 
reported in Appendix XI. The comet in vitro assay is the most performed assay and it gives mostly 
positive results for NM-100, NM-102 and NM-105.  
N of positives 
/ total N 
studies 
in vitro in vivo 
Micronucleus 
assay comet
Chromosoma
l aberration 
Micronucleus 
assay comet 
Chromosoma
l aberration 
NM-100 - 2/2 - - - - 
NM-101 - 2/6 - 0/3 1/5 - 
NM-102 3/10 5/8 - 0/6 2/13 0/2 
NM-103 3/8 0/6 - 0/5 1/12 - 
NM-104 3/8 0/6 - 0/5 2/12 - 
NM-105 4/18 10/14 0/1 2/9 4/15 - 
 
4.4.4 Construct a matrix to identify available data 
The fourth step of the framework proposed in the ECHA draft guidance on grouping for 
read-across is dedicated to building a matrix for reported the data collected and evaluated in 
the previous step (ECHA, 2017b). 
The target NMs identified in Table 4.3 are allocated to the two identified groups according to 
the presence or absence of coating. Table 4.9 reports graphically our read-across, and 
includes the physicochemical properties of the source and target NMs ("what they are"). For 
the analogues also information on fundamental behaviour ("where they go") and reactivity 
("what they do") is reported. 
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As mentioned earlier, our target NMs have actually been tested, so we can validate our 
conclusion by means of the in vitro comet assay results (Guichard et al., 2012). A detailed 
analysis is reported in Section 4.3.5. 
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Table 4.9 Grouping hypothesis and read-across of comet assay results. TiO2 R and TiO2 A are the two target nanomaterials. According to the grouping 
hypothesis based on the presence or absence of the coating, the two targets NMs are assigned to the positive and negative group, respectively. 
 Name NM-100 NM-101 NM-102 NM-103 NM-104 NM-105 TiO2 R TiO2 A
 In vitro comet assay + - + - - + ? ? 
W
h
a
t
 
t
h
e
y
 
a
r
e
 
Total non-TiO2 content including coating and impurities 
(% w/w) 1.5 9 5 11 11 0.11 13 0.5 
Surface coating (%) 0 0 0 8 8 0 11 0 
Organic matter (%) 0 8 0 2 2 0 9 0 
Crystal type (Anatase) 1 1 1 0 0 0.84 0 1 
Crystal type (Rutile) 0 0 0 1 1 0.16 1 0 
Crystal type (Cubic) 0 0 0 0 0 0 0 0 
Crystallite size (mean) (nm) 117.81 7.69 23.93 24.32 24.71 22.44   
Shape (rod=1, spherical=0) 0 0 0 1 0 1 1 0 
Aspect ratio 1.53 1.53 1.53 1.7 1.53 1.36 6.2 1 
Primary particle diameter (mean) (nm) 93.45 5.25 22.00 24.00 24.50 20.13 62x10 14 
Specific surface area (m2/g) 9.23 316.07 77.87 53.98 54.33 47 149 177 
W
h
e
r
e
 
t
h
e
y
 
g
o
 
Isoelectric Point (Mean) (pH) NA 5.5 6 8.3 8.5 6.8   
Density (g/mL) 3.84 3.99 3.84 4.02 4.09 4.05   
Mean of total pore volume (mL/g) 0.032 0.319 0.300 0.262 0.194 0.194   
Micro surface area (m2/g) 0 13.625 1.108 0 0 0   
Micropore volume (mL/g) 0 0.00179 0.00034 0 0 0   
Dustiness-Respirable(mg/kg) 1500 5600 9200 19000 6400 11000   
Biodurability 24h 0.05% BSA (Ti content) (µg/l) 5.2 0 0 0 0 0   
Biodurability 24h Gambles solution (Ti content) (µg/l) 0 0 3388 0 0 0   
Biodurability 24h Caco2 (Ti content) (µg/l) 796 3414 1741 222 3386 2724   
W
h
a
t
 
t
h
e
y
 
d
o
 
Redox Caco2 medium Ω 1 -1 -1 1 -1 -1   
Redox Gamble's solution Ω 1 0 -1 1 -1 -1   
Redox BSA Ω 0 0 0 0 0 0   
Ω values obtained from Nanogenotox 4.7 determined by measuring the content of O2. Oxidising properties (1), neutral (0), reducing (-1) 
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4.4.5 Perform a preliminary assessment of the group and fill data gaps 
The fifth step of the ECHA draft appendix to the ECHA guidance on grouping for read-across 
(ECHA, 2017b) aims at combining all the gathered information into an overall assessment.  
The identification of the structural similarities41 in the analogues dataset is a way to assess 
the strength of the stated grouping hypothesis. This was done through the application of 
hierarchical clustering, principal component analysis and was supported by decision tree 
analysis, as introduced in paragraph 4.3.  
Assessment of the grouping hypothesis 
Hierarchical clustering 
The initial dataset included 6 analogues with approximately 147 properties for each of them 
(Table A8.1 in Appendix X). Four properties were discarded because of low variability 
(Crystal type cubic, Redox BSA, Biodurability after 24h in Caco2 ((Si content) and 
Biodurability after 24h in Gamble's solution (Si content)). If a correlation filter was applied to 
such a small dataset, the correlation would be derived from just 6 values and this could lead 
to the filtering of properties that are not really related. For instance, the correlation 
between “Organic matter” and “Micro surface area” is 0.93. Such a correlation is not 
meaningful because the former property only contains values for three NMs, and the latter 
for two. Thus, a correlation filter was not applied in order to avoid such problems. The 
dataset contained a number of DLS measures for the NMs in 6 different solvents (MQ water, 
PBS, DMEM + 1% FBS, DMEM + 5% FBS, DMEM + 10% FBS, and DMEM + L-glutamate) and 3 
different treatments (untreated, 1min tip sonication, 20min bath sonication). This made a 
highly biased dataset as it contained 62 properties related to DLS particle size distribution, 
21 to Zeta potential, and 20 to polydispersability index. In order to reduce the weight of 
such measures and obtain a more balance dataset, these properties were reduced to 4 DLS 
measures, 4 Zeta Potential and 4 PdI. A hierarchical clustering of the transposed dataset was 
used to determine clusters of similar properties (e.g. particle size distribution in DMEM + 5% 
FBS and 1min sonication with particle size distribution in DMEM + 10% FBS and 1min 
sonication). This allowed the determination of groups of similar properties which could be 
reduced to a single property and yield a more balanced dataset. Four groups were 
considered for each type of property, i.e. particle size distribution, Zeta Potential, and PdI, 
and one property was kept for each set of related properties and the others were discarded.  
The hierarchical clustering of the resulting dataset, which contained 50 variables, is 
presented in Figure 4.3 and shows that NM-103 and NM-104 form a very solid group 
(p<0.01). The other 4 NMs form another group as they are clustered together with high 
significance (AU value). It is worth mentioning that the clusters obtained here must be only 
considered from an exploratory point of view and in a weight of evidence context. This 
information alone cannot be used to define clusters of NMs but must be complemented 
with other techniques and rationales (e.g. PCA, variable selection, mechanistic information) 
to be used in read-across. 
                                                      
41 In this context with structural similarity we intend the similarity in the properties under 
the nanoforms identification, fundamental behaviour and reactivity 
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Figure 4.3. Hierarchical clustering of the TiO2 analogues. The numbers in red correspond to 
the “Approximately Unbiased” (AU) p-value that is computed by multiscale bootstrap 
resampling, and the ones in green to “Bootstrap Probability” p-value (BP), which is 
computed by normal bootstrap resampling. The height in the Y-axis indicates the distance 
between clusters computed as average linkage. AU p-value will be used for the 
interpretation as it is usually a better approximation to the real p-value. 
 
Principal component analysis (PCA) 
While the hierarchical clustering indicates similar NMs by taking into account all 
physicochemical properties and forming subsequent groups of 2 substances, the PCA is a 
dimensionality reduction technique that shows the properties that account for the 
maximum variance between individuals, NMs in this case. The PCA also uses all properties 
to determine each of the principal components (PC) but are weighted in such a way that a 
minimum number of properties can be used to explain the differences between the 
different NMs.  
The principal component analysis of the same dataset used for the hierarchical clustering of 
the analogues shows a similar picture (Figure 4.4) to the one obtained in the hierarchical 
clustering. The different NMs are placed in the plot by using the PC1 and PC2 scores and the 
loadings of each property with respect to PC1 and PC2 are indicated as arrows. NMs that 
appear close to each other indicate similarity in the space defined by PC1 and PC2. Long and 
light blue arrows indicate high contribution of that specific property to one of the PCs. The 
closer the arrow is to an axis, i.e. to a PC, the higher the contribution it has to that PC. It is 
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necessary to remember that the PCs are simplifications of the whole picture and that the 
fact that NMs appear close to each other only indicates that these NMs are similar to each 
other in that reduced representation of reality given by 2 variables, i.e. PC1 vs PC2. PC1 and 
PC2 typically account for a rather large variance (>50%) and indicate what are the variables 
that differentiate the NMs. The fact that these variables be related with the endpoint of 
interest cannot be assured and is not the purpose of PCA or other unsupervised techniques.   
In Figure 4.4, NM-103 and NM-104 appear close to each other at the positive side of PC2. 
The arrows show that these positions are mainly driven by the properties related to 
impurities of Al (Biodurability 24h in Gambles solution (Al content)), Mg, by the crystal type 
rutile, and % of surface coating. NM-100 appears at the top part of the plot mainly driven by 
Particle primary diameter and Crystallite size, which matches the fact that NM-100 is the 
biggest NM of the series (considered as bulk material). For the same reason, NM-101 
appears at the bottom of the plot as it is the smallest NM, and NM-102 and NM-105 appear 
next to each other on the negative side of PC1, mainly driven by Crystal type anatase and by 
not having surface coating. 
 
 
Figure 4.4. Principal component analysis of the dataset of 6 TiO2 analogues. The position of 
the analogues (individuals) on the space of PC1 vs PC2 are indicated as black dots. Arrows 
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correspond to the 10 variables with higher contribution to the PCs. The colours are defined 
by the squared loadings (cos2) and indicate their contributions to the PCs.    
 
The squared loadings of the two first principal components are given in Table 4.10 and show 
that the properties with the higher contributions to PC1 are the Biodurability 24h Gambles 
solution (Al content) and Impurity (Al), which are similar properties; crystal type (anatase 
and rutile), and % of surface coating and Mg impurity. For PC2 the main contributors are the 
specific surface area, total pore volume, primary particle diameter, crystallite size, and Fe 
impurities.  
 
Table 4.10. Squared loadings of PC1 and PC2 of the PCA of the source analogues. 
Property PC1 loadings2 Property 
PC2 
loadings2 
Biodurability 24h Gambles 
solution (Al content) 0.90 Specific surface area (mean) 0.77 
Impurity(Al) 0.89 Mean of total pore volume (ml/g) 0.74 
Crystal type (Rutile) 0.89 Primary particle diameter (mean) 0.73 
Crystal type (Anatase) 0.89 Crystallite size (mean) 0.67 
Surface coating 0.87 Micropore volume (ml/g) 0.63 
Impurity(Mg) 0.87 Impurity (Fe) 0.63 
 
 
It can be deduced from the PCA that the differences between NMs are mainly due to the 
presence of impurities and coating (Al content mainly provides from coating), crystal type 
(anatase vs rutile), particle size (including surface area), and pore volume. The fact that 
crystal type variables appear so high in the list is due to they correspond to the percentage 
of crystal of that type, and since most of the particles are either 100% anatase or 100% 
rutile, the differences between the NMs is extreme. Primary particle diameter is also one of 
the main differences between NMs as the biggest one is 115 nm and the smallest is 5 nm. 
Biodurability 24h Gambles solution (Al content) and Impurity(Al) are very similar properties 
as the former one corresponds to the quantity of Al dissolved in media after 24h, and the 
second one correspond to the quantity of Al found after calcination of the NMs. The former, 
is also part of coating as NM-103 and NM-104 have around 6% of Al2O3 coating and 
therefore a large amount of Al. Surface coating, which includes not only Al2O3 but also 
organic matter like sylanes or glycol is also one of the main contributors to PC1. The 
loadings also show that other properties like Zeta Potential, PdI, or particle size distribution 
have less influence. 
Random forest as variable selection to predict the comet assay 
Hierarchical clustering and PCA are unsupervised techniques as they only make use of the 
physicochemical properties of substance to determine clusters of similar substances and the 
properties that differentiate the most those substances. The random forest variable 
selection algorithm, instead, is a supervised technique as it uses the physicochemical 
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properties to predict a given outcome, in this case positive or negative results in comet 
assays, and provides a relative importance of the variables for the prediction.  
The variable importance plot of the source analogues (Figure 4.5) clearly shows that the 
most important variables to predict the comet assay results for the 6 analogues are the 
Total non-TiO2 content and the amount of organic matter. As mentioned above, Total non-
TiO2 content corresponds to the sum of the impurities and coating found on the analogues, 
and this distinction had to be made because it is impossible to determine from the data 
whether NM-101 was coated because, according to the manufacturer, NM-101 has no 
coating. However, the tests performed in the Nanogenotox Joint Action (see Deliverable 4.3 
Table 2-1, and page 57) showed that there was a significant mass loss at 200 °C that was 
identified by GC-MS analysis as hexa/octadecanoic acid and others. These impurities 
accounted for around 9% of the total weight and were considered as coating by 
Nanogenotox. They were not considered coating in this work because NM-101 is stated to 
be uncoated by the manufacturer, and according to REACH, it can only be considered 
coating those materials that were intentionally added. Therefore, the 9% of organic matter 
of NM-101 has been considered as “impurities” in this report. In addition, the level of 
stability or binding of these “impurities” to the particles is unknown. It could be that they 
were just adsorbed on the particles and would dissociate from the particle when put in 
contact with the media. The properties that follow in the list correspond to Al impurities 
(Biodurability 24h), which are also related to the presence of coating as they are measured 
as the content of Al in solution after 24h.   
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Figure 4.5. Relative importance of variables in terms of their predictivity of the comet assay. 
Variable importance expressed as mean decrease of the Gini index of the source nanoforms.  
 
Conclusion 
Hierarchical clustering and PCA source nanoforms show that two groups of NMs can be 
clearly defined from their physicochemical properties. NM-103 and NM-104 (negative in the 
comet assay) form a very strong group (p<0.01). Actually, they are very similar NMs of rutile 
type with a size of ~24nm, high content of impurities like Al and surface coating. The coating 
in fact contains Al2O3, which explains that Al impurities content was found as a relevant 
property. Another group is the one formed by the other NMs, more precisely NM-102 and 
NM-105 appear next to each other in the PCA (both are positive in the comet assay) as both 
correspond to uncoated anatase TiO2 (100% and 84%) with ~23nm and low amount of 
impurities. NM-100 does not cluster together with any of the other NMs in the PCA. The 
reason for this is because it corresponds to a relatively large "NM" (>117nm), which makes it 
significantly different from the rest. For instance in the PCA, PC2 has a strong component of 
particle size and, therefore these property sets NM-100 at the higher part of the plot. 
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However, if only the crystal type and coating are considered, NM-100 groups perfectly with 
NM-102 and NM-105 as it is uncoated, and 100% anatase. In addition, such a classification 
matches the toxicological profile of these NMs as they all turn out positive in the comet 
assay. 
NM-101 is more difficult to classify because it is the smallest of all NMs with a diameter of 
5nm (lower part of PCA), it is also declared as uncoated by the producer but the elemental 
analysis showed the presence of around 9% of organic matter or impurities. Moreover NM-
101 is of type anatase but negative in the comet assay.  
If NM-101 is not considered, it can be clearly stated that uncoated anatase NMs are the 
ones positive in the comet assay. This in fact is in line with the higher photoreactivity of 
anatase with respect to rutile (Luttrell et al., 2014). Although comet assays are carried in lab 
facilities were very little UV light should be present to differentially photoactivate anatase, it 
was recently shown that anatase samples exposed to fluorescent tube lab light caused 
statistically significant higher amounts of DNA breaks (Karlsson et al., 2015) to BEAS-2B cells. 
However, NM-101 is also of anatase type but turns out negative in the comet assay breaking 
the abovementioned relation between anatase and positive comet assays. NM-101 contains 
a large amount of organic impurities (9%), which is of similar composition to the coating of 
NM-103 and NM-104. Whether these organic impurities (organic matter in Table 4.) are 
considered coating or not – in order to be considered coating the substance must be 
intentionally added – it is clear that there is a correlation between the NMs that have 
coating and/or organic impurities and the result of the comet assay. Moreover, this 
correlation is supported by the results of the random forest variable selection which shows 
that the two variables with the highest discriminant power to predict comet assay are Total 
non-TiO2 and Organic matter. Following our hypothesis, uncoated rutile would also be 
predicted as possibly genotoxic. However, it would be desirable to dispose of data for this 
type of nanoform in order to be able to have a prediction with less uncertainty. 
Filling data gaps by read-across 
In the previous paragraph the grouping hypothesis for the nano-TiO2 analogues was 
supported by the results obtained from hierarchical clustering, PCA and random forest 
variable selection algorithms.  
The two target NMs were identified in Table 4.3, including the coating of the two 
nanoforms. According to the physicochemical properties of the identified target NMs, we 
can assume they are included in the same variable space as the source NMs: primary 
particle size, shape, total non-TiO2 content, organic matter, crystal type, and specific surface 
area are included in the range defined by the source NMs. Because of the lack of some 
physicochemical data for the target NMs, it was not possible to include them in the PCA 
analysis or in the clustering exercise. However, it is possible to assign the two target NMs to 
a class according to some of their characteristics. Since the presence of coating or high 
amount of non-TiO2 content on the surface of nano-TiO2 appears to prevent NM to cause 
DNA damage detected by the in vitro comet assay, it is possible to group TiO2 R nano with 
the analogues –NM-103 and NM-104 and possibly NM-101, giving negative results, and TiO2 
A nano with NM-100, -102 and -105, which cause DNA damage. 
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As shown in Table 4.9 and Table 4.11, the two target NMs have different characteristics with 
respect to coating or non-TiO2 content. TiO2 R has a coating, and thus it is predicted to have 
a negative outcome in the in vitro comet assay. TiO2 A, instead, has a relatively low level of 
impurities and no coating, and thus our prediction is that it gives positive result in the in 
vitro comet assay. The prediction is reported in Table 4.11. This outcome is confirmed by the 
in vitro comet assay carried out by Guichard et al. (2012) which shows that TiO2 A is 
genotoxic and TiO2 R is not. 
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Table 4.11 Read-across matrix showing the prediction for the identified target NMs. 
 Name NM-100 NM-101 NM-102 NM-103 NM-104 NM-105 TiO2 R TiO2 A 
 In vitro comet assay + - + - - + - + 
W
h
a
t
 
t
h
e
y
 
a
r
e
 
Total non-TiO2 content including coating and impurities 
(% w/w) 1.5 9 5 11 11 0.11 13 0.5 
Surface coating (%) 0 0 0 8 8 0 11 0 
Organic matter (%) 0 8 0 2 2 0 2 0 
Crystal type (Anatase) 1 1 1 0 0 0.84 0 1 
Crystal type (Rutile) 0 0 0 1 1 0.16 1 0 
Crystal type (Cubic) 0 0 0 0 0 0 0 0 
Crystallite size (mean) (nm) 117.81 7.69 23.93 24.32 24.71 22.44   
Shape (rod=1, spherical=0) 0 0 0 1 0 1 1 0 
Aspect ratio 1.53 1.53 1.53 1.7 1.53 1.36 6.2 1 
Primary particle diameter (mean) (nm) 93.45 5.25 22.00 24.00 24.50 20.13 62x10 14 
Specific surface area (m2/g) 9.23 316.07 77.86 53.98 54.33 47 149 177 
W
h
e
r
e
 
t
h
e
y
 
g
o
 
Isoelectric Point (Mean) (pH) NA 5.5 6 8.3 8.5 6.8   
Density (g/mL) 3.84 3.99 3.84 4.02 4.09 4.05   
Mean of total pore volume (mL/g) 0.032 0.319 0.300 0.262 0.194 0.194   
Micro surface area (m2/g) 0 13.625 1.108 0 0 0   
Micropore volume (mL/g) 0 0.00179 0.00034 0 0 0   
Dustiness-Respirable(mg/kg) 1500 5600 9200 19000 6400 11000   
Biodurability 24h 0.05% BSA (Ti content) (µg/l) 5.2 0 0 0 0 0   
Biodurability 24h Gambles solution (Ti content) (µg/l) 0 0 3388 0 0 0   
Biodurability 24h Caco2 (Ti content) (µg/l) 796 3414 1741 222 3386 2724   
W
h
a
t
 
t
h
e
y
 
d
o
 Redox Caco2 medium Ω 1 -1 -1 1 -1 -1   
Redox Gamble's solution Ω 1 0 -1 1 -1 -1   
Redox BSA Ω 0 0 0 0 0 0   
Ω values obtained from Nanogenotox 4.7 determined by measuring the content of O2. Oxidising properties (1), neutral (0), reducing (-1) 
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4.4.6 Perform and/or propose testing 
The sixth step of ECHA draft guidance (ECHA, 2017b) asks for identifying testing, where the 
data collected to support the grouping hypothesis is not considered reliable or sufficient. 
This case study was intended to show how to document read-across following the workflow 
proposed in the recommendation for grouping of NMs. For this purpose, genotoxicity by 
means of comet assay was selected as it allowed the definition of two groups of NMs, 
positive in the comet assay and negative in the comet assay. The adequacy of using in vitro 
comet assay for NMs has been debated in the literature (Azqueta & Dusinska, 2015; 
Magdolenova et al., 2014) and if compared with other methods it shows some tendency to 
provide more positive results (Armand et al., 2016; Guichard et al., 2012; Jugan et al., 2012; 
Kansara et al., 2015; L Browning, The, & Sr., 2014; Prasad et al., 2014; Prasad, Wallace, 
Daniel, Tennant, Zucker, Strickland, Dreher, Kligerman, Blackman, & DeMarini, 2013; 
Stoccoro et al., 2016; Tavares et al., 2014b; Vales, Rubio, & Marcos, 2014). Therefore, the 
available data for nano-TiO2 does not seem to confirm genotoxicity and the overall 
conclusion should be limited to the result of the in vitro comet assay and not on the 
genotoxic potential of TiO2 nanoforms. Extension of the dataset with reliable in vivo 
genotoxicity could be a possible next step. In in vivo studies, toxicokinetic data show that 
after intravenous administration, liver, spleen and lungs may be considered as target organs 
as there is evidence that nano-TiO2 reaches these organs and tend to accumulate there. This 
evidence is supported by the Heringa et al. (2016), who identify a potential human health 
risk for liver, spleen, ovaries and testes.  
Since biological reactivity is an important property in supporting similarity, it would be 
interesting to have a test guideline to fulfil to this requirement, as at the moment there are 
a few data available and there is no standardised experimental approach to investigate this 
property. 
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4.5 The carbon nanotube case study: predicting genotoxicity 
Genotoxicity was also selected as the toxicological endpoint to read-across, as most data for 
the analogues were available for this endpoint (Figure 4.). Under the Nanogenotox Joint 
Action in vitro and in vivo comet assays and chromosomal damage (micronucleus) tests 
were carried out for some of the analogues (NanoGenoTox Joint Action, 2013). 10 analogues 
were selected based on their data from in vitro and in vivo comet assays as performed by 
the Danish National Research Centre for the Working Environment (NRCWE) (Poulsen et al., 
2016). The in vitro comet assay detects DNA strand breaks as well as oxidative damage to 
DNA at the level of single cells. The chromosomal aberration assay or the micronucleus test 
assess chromosomal damage, i.e. when part(s) of a chromosome is/are deleted, added or 
rearranged (clastogenic effects), or aneuploidy (numerical modifications of chromosomes). 
In our case study, we aim at identifying MWCNTs PC properties that may affect DNA 
damage, to be able to read-across to target MWCNTs. 
 
4.5.1 Identification and characterisation of the nanoforms of the substance  
Carbon nanotubes are graphene sheets rolled into a cylinder (Figure 4.6). Depending on the 
number of cylinders arranged in concentric layers single walled (SWCNT) and multiple 
walled carbon nanotubes (MWCNT) can be distinguished. CNTs are considered a nanoform 
without a corresponding bulk form.  
 
Figure 4.6. A multi-walled armchair carbon nanotube, rendered in POVRay" by Eric Wieser, 
published on 27 December 2010 on Wikimedia Commons at 
https://commons.wikimedia.org/wiki/File:Multi-walled_Carbon_Nanotube.png under the Creative 
Commons Attribution-ShareAlike 3.0 Unported (CC BY-SA 3.0) licence. 
 
The physicochemical properties of MWCNT can vary, depending on the production process 
and consequent modifications. Catalytic metals are required in the manufacturing process 
and may remain as impurities in the CNTs. The most important differences in 
physicochemical properties that may have been reported to have an impact on toxicological 
outcomes are: Length, diameter, impurities/catalysts, surface reactivity, surface 
modification, flexibility/rigidity and agglomeration state (Allegri et al. 2016; Braakhuis et al. 
2014; Hamilton et al. 2013; Jackson et al. 2015).  
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Other relevant parameters such as chemical composition, biopersistence and (in)solubility 
apply to all (non-functionalised) analogues as MWCNT consist of elemental carbon which is 
not soluble in any (physiological) media tested and recalcitrant to biodegradation.  
19 analogues (Table 4.12) were selected for this case study based on the richness and 
quality of the physicochemical and toxicological data. Information on these MWCNT was 
retrieved from the i) OECD WPMN Testing Programme; ii) FP7 Nanogenotox Joint Action, iii) 
REACH dossier iv) IARC dossier v) peer reviewed literature, of which the publication by 
Jackson et al. 2015 (Jackson et al., 2015) and Poulsen et al 2016 (Poulsen et al., 2016) was 
given special attention (see below). The analogues are arranged by increasing number (NM-
400, NM-401, NM-402, NM-403 and NM-404) in the JRC repository, then the 2 Mitsui types, 
Nikkiso and Hanwha and finally the NRCWE analogues tested by Jackson et al. (Jackson et 
al., 2015). Analogues 1-8 are synthesised by chemical vapour deposition (CVD) and are not 
functionalised. Analogues 11-12, 14-15 and 17-19 are surface modified (Table 4.12). The 
order of the first 8 analogues was not informed by any physicochemical or other property; 
the other analogues are grouped by size and surface modification as suggested by (Jackson 
et al., 2015). Carbon black and Crocidolite (asbestos) were added as reference materials. 
The information available for each NM was restructured starting from the above mentioned 
sources to build a complete dataset including both physicochemical and toxicological 
information with focus on genotoxicity, as this was the endpoint with the most abundant 
information.  
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Table 4.12 Analogues selected for the case study 
Analogue 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Ref 1 
Ref
2 
Name NM-400 
NM-
401 
NM-
402 
NM-
403 
Mitsui 
NRCWE-
006 
Mitsui 
NRCWE-
007 
Nikkiso 
Hanwh
a CM-
100 
NRCWE-
26 
NRCWE-
040 
NRCWE-
041 
NRCWE-
042 
NRCW
E-043 
NRCW
E-044 
NRCW
E-045 
NRCW
E-046 
NRCW
E-047 
NRCW
E-048 
NRCW
E-049
Printe
x 90 
Croci
dolit
e 
Production 
process CVD CVD CVD CVD CVD CVD CVD CVD  
            
TEM image  
 
  
Main 
source of 
informatio
n 
JRC 
Rep; 
OECD, 
Nanog
enoto
x, 
REAC
H 
dossie
r 
JRC 
Rep; 
Jackso
n 
2015 
JRC 
Rep; 
OECD, 
Nanog
enoto
x; 
Jackso
n 
2015,  
JRC 
Rep; 
OECD
, 
Nano
geno
tox, 
REAC
H 
dossi
er; 
Jacks
on 
2015 
OECD , 
Nanogen
otox; 
Jackson 
2015 
Nanoge
notox 
OECD 
SP 
OECD 
SP 
Jackson et al 2015; Poulsen et al 2016 
 
 281 
 
Identification of target analogues 
Defining similarity between NM analogues is challenging as it is not only based on similarity 
of the chemical structure/composition, but is also influenced by physicochemical properties. 
19 MWCNT were selected as analogues for which data for relevant physicochemical and 
most toxicological endpoints was available (Table 4.13). Physicochemical data was not 
reported consistently for the analogues and it was found to be very heterogeneous. For 
example the description of crystalline phase is very dissimilar; diameter and length are 
reported as average values or ranges, impurities are reported as absolute values or 
percentages and information on rigidity or tangle can be identified only from TEM pictures. 
This makes it difficult to compare the analogues as with regard to their similarity of 
physicochemical properties. 
The data matrix was filled with available data to determine the source substances, i.e. those 
with data on genotoxicity, and the target analogues, i.e. those with data gaps. In this case 
study we follow a category approach, thus source and target analogues may change 
depending on the endpoint of interest and the availability of data for these endpoints 
(Section 4.5.4 and Table 4.17). 
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Table 4.13 Identification of the 19 analogues and 2 reference materials: Overview the physicochemical properties  
Analogue 1 2 3 4 5 6 7 8 Ref 1 Ref 2 
Name NM-400 NM-401 NM-402 NM-403 Mitsui NRCWE-006 
Mitsui 
NRCWE-
007 
Nikkiso Hanwha CM-100 
Printex 
90 Crocidolite 
Chemical composition 
(carbon purity) 
89.91% -  
99%  
99.19% ( >92 - 99.19% 90% - >95% > 99% >98% 95% >99%
Impurities (% 
elements) 
> 0.01%: 
Al, Fe, Na, 
S; 0.005-
0.01%: Co, 
0.0001-
0.005%: 
Ca, K  
 
> 0.01%: 
Al. Fe. S;  
<5% (OECD)
>0.0% 0.005-
0.01 %: not 
detected; 
0.001.0.005%: 
Ag 
<5% (OECD)
<3wt% Mn 
Mg, Al, Na, Ni, 
Fe; 
>0.01%: Al, 
Co, Mg, Mn, 
Ca 
Fe: 0.3 - 
1.06% Cr 14 
ppm, 
Bismuth: 
6ppm, Ni 4 
ppm  
Na: 
0.05%, Al: 
0.00086%, 
Cr: 
0.0149%, 
Fe: 
0.048%, 
Ni: 0.4843 
Li 0.00005%; 
Al 0.0080%; 
Ca 0.0176%; 
Fe 0.0053- 
0.36%; Cd 
0.0016%  
Ga 0.0176% 
Cr 0.0014%, Bi 
0.00006%, Ni 
0.00004% 
Fe: 5% FeO3
0.006%; 
NiO  
0.0003; 
Cl 0.03, 
CuO 
0.0005%, 
SO3 
0.66%, 
ZnO 
0.001%; 
FeO3 
7.23%; 
MgO 0.19; 
MnO 0.03,  
Surface coating pristine pristine pristine pristine - -
COOH (mmol/g)  0.02 0.14 0.09 0.04  
Primary particle 
diameter (nm) 
5-35 
(mean 9) 
11-90 6-69 
internal: 4.8; 
external: 11.7 
10-16 
D50: 11 nm 
40-90 15 48 -63 nm 10-15 90% 
<460 
9-14 
Average length (TEM) 
(nm) 
100-
10.000;  
mean 
1500 
1300 -
5000  
 
100-1300 400 ->10000 1000-19000 368, 
10000-
50000  
940 -1100 From < 
20000 to 
>20000 
µm  
90% 
<4500 
ND 
Aspect ratio  79±50 66±46 125±66 42±29 63.7 - 100  24.1
Mass median diameter 
(µm) 
85;  
D10: 31.6; 
D50: 85  
D90: 228 
  0.416 - 2.56 0.400 - 3 0.07--1.6 0.45 0.543.-
8.421 
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Analogue 1 2 3 4 5 6 7 8 Ref 1 Ref 2 
Name NM-400 NM-401 NM-402 NM-403 Mitsui NRCWE-006 
Mitsui 
NRCWE-
007 
Nikkiso Hanwha CM-100 
Printex 
90 Crocidolite 
Pour density 
(weighing) (g/cm3) 
0.06 - 0.08 0.11 0.02 - 0.09 0.16 3.8 
Specific surface area 
(m2/g) (BET) 
250-300 226.4 24-300 189-300 23-28 69 224.9 5.24 182 
Respirable Dustiness < 420 mg/kg  
< 4200 
mg/kg 
< 1700 mg/kg < 4900 mg/kg 2.4% 0.061 mg/m3
Solubility in water  
< 2 mg/L 
(20°C, pH 
7.5 - 9.2) 
(practically 
insoluble)  
  < 2 mg/L 
(20°C, pH 7.5 - 
9.2) 
(practically 
insoluble) 
oxidised 
MWCNT 
was 
completely 
dispersed 
in 
deionised 
water 
(Bio)persistence (time)
(Bio)degradation 
    not readily 
biodegradable 
not readily 
biodegradable 
not readily 
biodegradable 
not readily 
biodegradable 
Zeta potential (mV) 
not 
relevant 
for 
MWCNT 
not 
relevant 
for 
MWCNT 
not relevant 
for MWCNT 
not relevant 
for MWCNT 
ca -14.7 mV 
+/-0.9 (DME-
FBS 10% ) 
-45 < -10 
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Analogue 9 10 11 12 13 14 15 16 17 18 19 
Name NRCWE-26 
NRCWE-
040 NRCWE-041 NRCWE-042 NRCWE-043 
NRCWE-
044 NRCWE-045 
NRCWE-
046 
NRCWE-
047 
NRCWE-
048 
NRCWE-
049 
Chemical composition 
(% carbon purity) 84.4 98.6 99.2 99.2 98.5 98.6 96.3 98.7 98.7 98.8 98.8 
Impurities (% 
elements) 
Al2O3 
14.97; 
CaO 0.01; 
Cl 0.01, 
CoO 0.11, 
Cr2O3 
0.0007, 
FeO3 
0.29; 
NiO 
0.0008, 
ZnO 
0.002; 
CaO 0.05; 
Cl 0.05, 
CoO 
0.001, 
Cr2O3 
0.02, 
CuO 
0.0013, 
FeO3 0.2; 
La2O3 
0.32, 
MgO 
0.01, 
MnO 
0.002, 
NiO 0.56, 
P2O5 
0.15, SiO2 
0.02, SO3 
0.01, ZnO 
0.001; 
CaO 0.13; Cl 
0.02, CoO 
0.001, Cr2O3 
0.02, FeO3 
0.13; K2O 
0.003, La2O3 
0.03, MgO 
0.02, MnO 
0.001, 
NiO 0.31, 
P2O5 0.20, 
SiO2 0.01, 
SO3 0.01, 
ZnO 0.001; 
CaO 0.25; Cl 
0.02, Cr2O3 
0.02, CuO 
0.008, CuO2 
0.007, FeO3 
0.08; K2O 
0.005, La2O3 
0.02, MgO 
0.03, MnO 
0.001, 
NiO 0.21, 
P2O5 0.14, 
SiO2 0.1, SO3 
0.01, ZnO 
0.001; 
CaO 0.04; 
CoO 0.001, 
Cr2O3 0.02, 
FeO3 0.008; 
K2O 0.001, 
La2O3 0.02, 
MgO 0.01,  
NiO 1.2, P2O5 
0.15, SiO2 
0.006, SO3 
0.04, ZnO 
0.001; 
CaO 
0.08; Cl 
0.01, 
CoO 
0.002 
CuO 
0.0024, 
FeO3 
0.004; 
K2O 
0.003, 
La2O3 
0.01, 
MgO 
0.02,  
NiO 
1.04, 
P2O5 
0.14, 
SiO2 
0.01, 
SO3 
0.03, 
ZnO 
0.001; 
Al2O3 0.52; 
BaO 0.06, 
CaO 0.08; Cl 
0.02, CoO 
0.250, Cr2O3 
0.02, CuO 
0.0038, FeO3 
1.17; K2O 
0.003, La2O3 
0.01, MgO 
0.02, MnO 
0.002 
NiO 1.34, 
P2O5 0.16, 
SiO2 0.02, 
SO3 0.06, 
ZnO 0.001; 
Al2O3
0.29; CaO 
0.03; Cl 
0.01, CoO 
0.25, 
Cr2O3, 
0.02, CuO 
0.0015,  
FeO3 
0.008; 
MgO 
0.22, 
MnO 0.3, 
NiO 
0.0045, 
P2O5 
0.14, SiO2 
0.007, 
ZnO 
0.001; 
Al2O3
0.27; 
CaO 
0.03; Cl 
0.02, 
CoO 
0.25, 
Cr2O3, 
0.001, 
CuO 
0.0006,  
FeO3 
0.007; 
MgO 
0.22, 
MnO 0.3, 
NiO 
0.0043, 
P2O5 
0.15, 
SiO2 
0.02, SO3 
0.01, 
ZnO 
0.001; 
Al2O3
0.26; 
CaO 
0.02; 
CoO 
0.24 
Cr2O3, 
0.001,  
FeO3 
0.007; 
MgO 
0.19, 
MnO 
0.28,  
NiO 
0.0037, 
P2O5 
0.14, 
SiO2 
0.007, 
ZnO 
0.001; 
Al2O3 
0.26; 
CaO 
0.03; 
CoO 
0.25, 
Cr2O3, 
0.001, 
CuO 
0.0004,  
FeO3 
0.004; 
MgO 
0.19, 
MnO 
0.29,  
NiO 
0.0038, 
P2O5 
0.15, 
SiO2 
0.008, 
SO3 0.01, 
ZnO 
0.001; 
Surface coating pristine pristine OH COOH pristine OH COOH pristine OH COOH NH2 
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Analogue 9 10 11 12 13 14 15 16 17 18 19 
Name NRCWE-26 
NRCWE-
040 NRCWE-041 NRCWE-042 NRCWE-043 
NRCWE-
044 NRCWE-045 
NRCWE-
046 
NRCWE-
047 
NRCWE-
048 
NRCWE-
049 
COOH (mmol/g) 0.4 0.18 0.84 2.04 0.09 0.11 0.31 0.32 0.13 0.29 0.16 
Average length (TEM) 
(nm ± SD) 
1500 518.9 
(±598) 
1005 
(±2948) 
723.2 
(±971.9) 
771.3 
(±3471) 
1330 
(±2454) 
1553 
(±2954) 
717.2 
(±1214) 
532.5 
(±591.9) 
1604 
(±5609) 
731.1 
(±1473) 
Aspect ratio     
Pour density 
(weighing) (g/cm3) 
   
Specific surface area 
(m2/g) (BET) 245 150 152 141 82 74 119 223 216 185 199 
Respirable Dustiness    
Solubility in water    
(Bio)persistence (time)
(Bio)degradation 
   
Zeta potential (mV)    
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4.5.2 Initial grouping of nanoforms 
In the literature grouping approaches for different types of nano-objects have been 
proposed, based on the presumption that there are common modes of action for several 
types of nanomaterials (see also previous chapter on nano-TiO2). Some grouping approaches 
(Arts et al., 2015, 2016; Schröder et al., 2014) have proposed 4 different groups including 
Granular Biopersistent Particles (GBP) with no or little intrinsic chemical toxicity, 
(nano)particles with specific toxicity, soluble (nano)particles without significant toxicity and 
Nanotubes (Nanofibres). This case study focuses on nanotubes and the evaluation of 
MWCNTs as part of this group. All MWCNTs were initially gathered in one group. The 
possibility to form subgroups based on physicochemical properties (e.g. length, diameter, 
content of impurities) was also considered but no other groups than those defined by 
Jackson et al. could be identified. 
For the selection of analogues it was decided to focus only on MWCNT to keep i) the number 
of analogues and ii) influencing properties manageable. The most important 
physicochemical properties for the analogues are summarised in Table 4.13. Those 
properties for which no data for any of the analogues was found or which were considered 
not applicable/relevant for MWCNTs (e.g. Crystal size, Log Kow, Hamaker constant, 
hydrophobicity) were removed from the list. More MWCNT analogues from different 
producers have been found in literature but were not included in the case study due to lack 
of consistent data (e.g. uncertainties about identity, physicochemical characteristics). It is 
anticipated that the grouping could apply also to other MWCNTs that fit the category as 
defined within this case study and which are reasonably presumed to follow the same 
toxicokinetics and mode of action. Although the present case study is limited to the analysis 
of multiple walled carbon nanotubes, it is likely that the category can be expanded to 
include other CNTs (e.g. single walled carbon nanotubes) or even other carbon based 
nanomaterials such as fullerenes or carbon black, on a case by case base, depending on their 
similarities in physicochemical, translocation and toxicological properties. Carbon black as 
spherical carbon based material and crocidolite as high aspect ratio material have been 
included as reference material to assess the potential impact of the chemical and 
morphological similarity respectively.  
Develop a grouping hypothesis (rationale for similarity) 
Multiwalled carbon nanotubes consisting of >90% carbon within a size range of 5–90 nm 
diameter and 0.1 –20 µm length have the potential to induce ROS production and (chronic) 
lung inflammation following inhalation. This can potentially lead to genotoxicity (DNA strand 
breaks and/or increased mutation frequency) as secondary effect and increased risk of 
tumour formation (Schins and Knaapen,  2007). 
The mutagenic activity of CNTs can be influenced by its size, morphology, rigidity, stiffness 
(the property of a solid body to resist deformation), surface coating and nature of impurities.  
For none of the analogues a proposal for classification (according to CLP) for mutagenicity 
(and carcinogenicity) has been identified.  
One of the analogues, Mitsui NRCWE-006 or MWNT-7, was suggested by IARC (International 
Agency for Research on Cancer) to be classified as possibly carcinogenic to humans (Group 
2B) based on the evidence of observed mesothelioma following intraperitoneal (or 
intrascrotal) injection in rats. All other MWCNTs and SWCNTs were categorised in group 3 as 
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not classifiable to their carcinogenicity to humans (Grosse et al., 2014). Assuming 
carcinogenicity would be a consequence of genotoxicity, this could suggest two subgroups 
based on long (MWNT-7like) and short MWCNTs (see discussion below under 4.5.3.1).  
Hereunder we assess if subgrouping based on size or other physicochemical properties is 
feasible or recommended.  
 
Identification of the nanoforms within each group (attempts to create subgroups) 
Physicochemical Properties (what they are) 
Based on common starting material used during their synthesis, all category members are 
considered structurally/chemically similar: all MWCNT are synthetic graphite in tubular 
shape, with a purity (carbon content) ≥90%.  
One of the problems to determine similarity of CNT is the fact that there are no "classical" 
structural alerts (fragments) for MWCNTs and molecular properties are not applicable, as 
MWCNT do not have a uniquely defined molecular structure like regular chemicals. Though 
some physicochemical properties such as morphology, size (long fibre-like shape; high 
aspect ratio), content of oxidising impurities, and rigidity could be comparable to structural 
alerts as they have been suggested to be predictive for MWCNT toxicity in some studies 
(Allegri et al., 2016; Braakhuis, Oomen, & Cassee, 2015; Jackson et al., 2015; Poulsen et al., 
2016). Biopersistence, length and rigidity have been proposed to be determinants of 
MWCNT in vivo toxicity, in analogy with the toxicity of asbestos and other inorganic fibres 
(Ken Donaldson et al., 2006; Murphy, Poland, Duffin, & Donaldson, 2013). All these 
properties were investigated to be used to subgroup MWCNTs by using chemoinformatic 
techniques like hierarchical clustering and principal component analysis, which will be 
presented in section 4.5.5.  
Physicochemical properties that were found for most of the analogues were presented in 
Table 4.. The properties that are considered necessary by ECHA (ECHA, 2017b) to identify 
nanoforms were individually analysed to be used to subgroup MWCNTs. The analysis and 
rationalisation are presented below. Raman spectroscopy which would yield information 
about the purity, defects and tube alignment, and which assists in the distinction of 
MWCNTs with respect to other carbon allotropes was only available for the analogues 1-3 
(NM-400, NM-401 and NM-402) (K Rasmussen et al., 2014).  
Chemical composition, content of impurities (residual metals) 
All MWCNT analogues consist of > 90% pure carbon. MWCNTs possess intrinsic ROS-
scavenging properties but they are also capable of generating intracellular ROS upon 
interaction with cellular components, and can cause antioxidant depletion (Van Berlo et al., 
2012). Catalysts on CNT surface could be released and may have an impact on toxicity 
(Aldieri et al., 2013; Kagan et al., 2006; Y. Liu, Zhao, Sun, & Chen, 2013). Fenton-reactive 
metals content (Van Berlo et al., 2012) used as catalysts during synthesis of MWCNTs may 
contribute to oxidative stress and thereby promoting MWCNT-induced toxicity. Fe-rich 
(SW)CNTs (26% w/w) were found to be significantly cytotoxic and genotoxic in murine 
alveolar macrophages and induced a severe oxidative stress, compared to Fe-free (SW)CNTs 
(0.23% w/w) (Aldieri et al., 2013; Vietti, Lison, & van den Brule, 2016). Iron has also been 
identified as contributing to asbestos toxicity, which has been described to be consequence 
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of frustrated phagocytosis and multiple cellular processes (Boyles et al., 2015). The MWCNT 
analogues in this case study have very low levels of iron impurities; in general the amount of 
iron impurities of MWCNT are much lower than those of SWCNT which can reach up to 30% 
w/w. The contribution of other metals (aluminium, nickel, cobalt (see Table 4.)) to MWCNT 
toxicity have been suggested to be rather low (Boyles et al., 2015) although some of these 
metals are classified as carcinogens (Ni) or possible carcinogens (Co) (Mulware, 2012). The 
highest amount of impurities was reported for analogue 9, which contained 15% of Al2O3 
(Jackson et al., 2015). Analogue 8, contained 5% Fe and analogue 4 <3% (Mn, Mg, Na, Ni, Fe) 
(OECD WPMN, 2016). Not only the amount but also bioavailability is a key determinant of 
metal impurities. In addition, a potential contamination with endotoxin (lipopolysaccharide, 
LPS) is also suggested to have an impact and therefore needs to be carefully tested (Esch, 
Han, Foarde, & Ensor, 2010; Jackson et al., 2015). Analogues 1-4 and 9-18 were tested for 
endotoxins and showed very low amounts of endotoxins (Jackson et al., 2015). 
 
Besides catalytic metals, other types of impurities that might cause pulmonary toxicity (Ken 
Donaldson et al., 2006) can be present. For instance, support material such as aluminates, 
silicates, and magnesium oxide and residual organics like amorphous particles, or micro-
structured particles such as graphite sheets, which might arrange into carbon nanofibers or 
spheres. Nevertheless, there is little toxicity information available that correlates them to 
adverse pulmonary effects and the presence of such substances is hardly found to be 
reported. 
Morphology (size and rigidity)  
Long MWCNTs are usually considered to be more hazardous than short ones in in vivo 
tests(Ken Donaldson, Duffin, Murphy, & Poland, 2012; Grosse et al., 2014; Murphy et al., 
2013; Sweeney, Grandolfo, Ruenraroengsak, & Tetley, 2015). Long MWCNTs were shown to 
induce frustrated phagocytosis and affect alveolar macrophage function, including cell 
death, ROS generation and release of pro-inflammatory cytokines (reviewed e.g. by 
(Johnston et al., 2010; Vietti et al., 2016). Long and rigid fibres were shown to have problems 
to be incorporated into phagosomes, leading to the release of harmful oxygen radicals and 
hydrolytic enzymes which can cause chronic inflammation (Ken Donaldson, Murphy, Duffin, 
& Poland, 2010). The length and rigidity of MWCNT may also influence the translocation and 
clearance from respiratory airways making the smaller and more flexible tubes get more 
easily into deeper compartments of the lungs like alveoli.  
Such results may suggest a possible sub-categorisation into long and short MWCNTs that 
would be relevant in predicting in vivo effects. Different thresholds have been suggested, 
but there is no agreement on a cut-off value. For this case study we suggest a threshold of 5 
µm in accordance with the WHO fibre definition42. A similar threshold of 4 µm for 
pathogenicity of fibres to the pleura has also been suggested by (Schinwald et al., 2012). 4 
                                                      
42 The World Health Organization (WHO) characterised the properties of bio persistent 
fibers. This refers to inorganic fiber dusts (except asbestos fibers) with a length > 5 microns, 
a diameter < 3 microns and a length-to-diameter ratio of > 3:1. 
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µm is also the median aerodynamic diameter of particles that fall within the respirable size 
range43.  
The groups based on this threshold are presented in Table 4.. Due to the varying numbers 
for MWCNT length reported in different reports, not all MWCNT types could be clearly 
assigned. Analogues 2, 3 and 4 are usually considered as short tubes with a length of ≤ 1 µm, 
however the Nanogenotox reports also stated a length from up to or above 10 µm. 
Lengths greater than 15-20 µm can be important as they are associated with frustrated 
phagocytosis (Boyles et al., 2015; Ken Donaldson, Murphy, et al., 2010) due to the relatively 
small size of macrophages (10 µm) compared to the length of the fibre. Applying this 
threshold would separate analogue 8 with a length of ~ 20 µm from the other analogues. 
Numbers for length presented in (Poulsen et al., 2016) suggest that analogues 10-19 are 
short; based on data in (Jackson et al. 2015; from manufacturer) analogues 10-12 could be 
considered as very long (10-50 µm) and 13-15 as probably long (10-20 µm). Preference was 
given to the values determined by SEM image analysis.  
Diameter and rigidity of MWCNT have also been reported as critical factors in mesothelial 
injury and carcinogenesis (Allegri et al., 2016; Fenoglio et al., 2012; Nagai et al., 2011). The 
outer diameter of MWCNT is directly related to surface curvature which influences protein 
adsorption and the formation of a corona (Gu et al., 2015). Thin MWCNTs (∼10-50 nm) 
showed mesothelial cell membrane piercing and in general higher cytotoxicity, 
inflammogenicity and mesotheliomagenicity compared to thicker ones (diameter >40-150 
nm) or tangled MWCNTs (Allegri et al., 2016; Fenoglio et al., 2012; Nagai et al., 2011). Larger 
diameter however has been suggested in some studies to be a significant predictor of 
genotoxicity in BAL and lung tissue (Jackson et al., 2015; Poulsen et al., 2016) while no 
significant difference between short/thin and longer/thicker MWCNTs with regard to 
pulmonary inflammatory response was found by (Poulsen et al., 2015). 
A categorisation of MWCNT based on their diameters is difficult as no cut-off values have 
been suggested; moreover, the diameters reported for MWCNT show a big variability 
making it difficult to assign them to a thin or thick group. All analogues can probably be 
considered thin with a diameter <150nm (Table 4.15). 
Straight/rigid MWCNT have been described to have higher potential for inflammogenicity 
and mesotheliomagenicity than tangled ones. They were also described to induce DNA 
damage in vitro and DNA damage and micronuclei in mouse lungs while tangled MWCNTs 
showed only slight increase in DNA damage in vitro (Catalán et al., 2015).  
Information on rigidity is only described in few sources. If MWCNTs are tangled or straight 
can be estimated from scanning electron microscope (SEM) images if they are published. 
Analogue 1, 3, 4 and 6 have been described as tangled or highly bended, while analogues 2 
and 4 as straight-wall MWCNTs (Catalán et al., 2015; de Temmerman et al., 2012). The TEM 
image of analogue 8 suggests tangled MWCNTs, while analogue 7 tubes seem rather straight 
(see images in Table 4.12 and overview in Table 4.16).  
                                                      
43 European Committee for Standardisation 1993. Workplace atmospheres – Size fraction 
definitions for measurement of airborne particles. CEN Standard EN481, Brussels; 
http://www.inhaledparticles.org.uk/files/2013/08/G-Fern-Presentation-Session-.pdf 
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Results from raman spectroscopy show that analogue 2 had a spectroscopic profile with a 
high G-band (G for Graphite, sp2 hybridised bonds) intensity and low D-band (D for diamond 
or defect; sp3-hybridised carbon-carbon bond) (K Rasmussen et al., 2014) suggesting it has a 
more graphitic structure than analogues 1 and 3. It was also found to have the largest tube 
diameters and analogue 1 and 3 the smallest tube diameters among the similar MWCNT 
characterized by TEM. This is interesting as for MWCNT the intensity of the D-band increases 
compared to the G-band with increasing number walls. It was suggested to analyse further 
the influence of graphite particle impurities (K Rasmussen et al., 2014). No such information 
was found for the other analogues to allow a comparison. 
Table 4.14 Attempts to subgroup MWCNT analogues based on length 
 Short MWCNT 
(< 5 µm) 
Probably short 
(< 5 µm) 
Not 
assignable 
Long MWCNT 
(≥ 5 µm 
Very Long 
MWCNT (≥ 20 
µm 
Analogue  1, 2, 3, 4, 10-
19 
6 5 8 
 
Table 4.15 Attempts to subgroup MWCNT analogues based on diameter  
 Thin MWCNT (≤50 
nm) 
Probably thin
(≤150nm) 
Not assignable Thick MWCNT 
(≥150 nm) 
Analogue 1, 2, 4, 6, 8, 10-19 3, 5, 7   
 
Table 4.16 Attempts to subgroup MWCNT analogues based on rigidity 
 Tangled Not assignable/probably 
straight 
straight 
Analogue 1, 3, 4, 6, 8, 10-
19 
7 2, 5 
Aspect ratio 
MWCNT by definition have a high aspect ratio and are considered HARNs; aspect ratio was 
reported only for analogue 5 (63->100) and 6 (24). Aspect ratio as such has been described 
as not affecting genotoxicity of MWCNT (Kim et al., 2011). 
Surface area 
The surface area concept may apply to the fibrous structure of MWCNT; however also the 
length and diameter may be determinants of their biological/toxicological effects, based on 
the three-dimensional (3D) paradigm that is well known from asbestos and glass fiber 
toxicology; it is considered unlikely to be applicable for highly tangled/agglomerated CNT 
(Günter Oberdörster, Castranova, Asgharian, & Sayre, 2015) As most MWCNT agglomerates 
do not usually consist of straight, well-aligned parallel tubes, theoretical calculations or BET 
measurements may not provide direct information on the surface area which becomes 
available to the biological environment and may trigger a reaction. Such information may be 
more relevant to estimate the biologically effective dose (BED) (Ken Donaldson et al., 2013), 
however as it is system-dependent it will not be generally available. Functional groups 
attached to the sidewalls can also influence the surface area values (Allegri et al., 2016). 
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The fibrotic potency of SWCNT > MWCNT ≫ CNF was observed to correlate with their 
increasing specific surface areas (Mercer et al., 2011; Murray et al., 2012), though. 
Surface chemistry 
Functionalisation of MWCNT with hydroxyl or carboxyl groups can increase their 
dispersibility. It may alter surface charge, stability, functionality and reactivity and is often 
used to reduce MWCNT toxicity (Allegri et al., 2016). So far diverging results have been 
shown on its effects in vitro (Kakwere et al., 2015; Z. Liu et al., 2014) and in vivo (Jain et al., 
2011; Sager et al., 2014). Surface chemistry influences the absorption of macromolecules to 
CNT, depending on available specific surface area, solution, pH, pKa value, and ionic strength 
in the solution (Cho, Huang, & Schwab, 2011). Sub-categorisation based on surface 
modification has been assessed for analogues 11-19 based on their surface coating, but no 
specific trends were identified (Jackson et al., 2015; Poulsen et al., 2016). 
Surface charge was not reported for any of the analogues. For some it was stated that it was 
not measurable as they were agglomerated (W. Wohlleben et al., 2013). Zeta potential was 
only reported for two analogues and was found to be negative. Analogue 7 was -14.7mV and 
analogue 8 -45>-10. Zeta potential was considered not relevant for the other analogues 
(OECD WPMN, 2016). 
Agglomeration and Dispersion 
MWCNT are rarely present as isolated fibres but rather as self-assembled, intertwined, and 
coil-like structures (aggregates or agglomerates) depending on the various types of adhesion 
forces acting between tube surfaces (Pauluhn, 2009).  
Agglomeration has an impact on the deposition of MWCNTs within the airways of the 
respiratory tract and assemblages of MWCNT may trigger pulmonary overload-related 
cascades of events at lower mass-based exposure levels than the high density poorly soluble 
particles (Pauluhn, 2009). Functionalised MWCNT were shown to form larger agglomerates 
than pristine counterparts when suspended in cell culture medium which is probably 
influenced by the different interaction with proteins (Allegri et al., 2016; Hamilton, Wu, 
Mitra, Shaw, & Holian, 2013). CNTs taken up as agglomerates have been shown to be less 
easily degraded by macrophages and could thus represent a higher risk of long-term toxicity 
(X. Wang et al., 2011). 
Agglomeration behaviour was assessed from variation in the average particle size for the 
NRCWE analogues in different concentrations in exposure media (Poulsen et al., 2016).  
 
As no single physicochemical parameter seems suitable to be predictive of toxicity, it is 
generally recommended to consider a number of property combinations in order to assess 
the overall hazard of a single material type (Arts et al., 2016; A. G. Oomen et al., 2014). It 
should also be considered that primary physicochemical descriptors of nanomaterials may 
not be the most appropriate to predict their toxicological behaviour, in part as many of these 
are "context" dependent, i.e. are affected by the surrounding matrix (pH, ionic strength, 
biomolecules or macromolecules etc.) or the route of exposure. Many NM properties are 
interdependent such that changing one property may inadvertently result in changing 
several others, e.g. changing NM shape/length may cause surface defects or change the 
surface chemistry. NM can be transformed by ageing and throughout their lifecycle (Mitrano 
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et al., 2015) what will inevitably affect surface chemistry, and thus should be considered 
when grouping CNTs and NMs in general.  
Transformation 
MWCNT consist of elemental carbon which is recalcitrant to biodegradation, though some 
biodegradation of CNTs by naturally occurring enzymes or organelles has been observed 
(Petersen et al., 2011). Nevertheless, data of various category members consistently show 
across in vivo, in vitro, and in chemico methods that MWCNTs do not undergo metabolism 
and are persistent (OECD WPMN, 2016). It can reasonable be assumed/predicted that 
untested category members (analogues 1, 2, 6, 8 for biodegradation/biopersistence) behave 
in the same way. The bioavailability of CNTs is generally considered low and CNTs are not 
considered to be transformed in the human body (Binderup et al., 2013; Jacobsen et al., 
2013; MWCNT REACH Dossier, 2016). Catalysts on CNT surface could be released and may 
have an impact on toxicity (Aldieri et al., 2013; Y. Liu et al., 2013) due to their oxidising 
properties caused mainly by metals such as iron, aluminium, nickel, or cobalt (see Table 4.). 
However, the concentration of these metals on the surface of the MWCNTs is usually so low 
that its impact can generally be considered negligible; at least for the analogues considered 
in this case study. 
 
Translocation (Physiological and cellular) (where they go) 
The translocation determines the target organ/site where possible genotoxic actions could 
take place. 
The deposition efficiency following inhalation in the parts pharynx, bronchi and alveoli 
differs and depends on the size of MWCNT which is determined by their agglomeration state 
(Günter Oberdörster et al., 2015). Agglomeration state and size have also been described to 
affect the clearance rate and the translocation from deposition sites (lungs of mice) to 
pleural sites, to local lymph nodes, and to secondary organs (Braakhuis et al., 2014; Mercer 
et al., 2013).  
Uptake strategies in cells are dependent on the cell and the NM property. From the 
described pathways, phagocytosis (immunogenic > 0.5 μm) seems to be the most relevant 
for MWCNT (Kettiger, Schipanski, Wick, & Huwyler, 2013), whereas also Clathrin-mediated 
endocytosis, caveolae-mediated endocytosis and macropinocytosis have been described to 
play a role for uptake in bronchial epithelial and mesothelial cells (Maruyama et al., 2015). 
The adsorption of proteins and biomolecules to NM surfaces can influence physicochemical 
properties (e.g. size and surface charge) and thus shape the biological identity and influence 
the interactions at the nano-bio interface (Aggarwal et al., 2009). However, due to 
continuous protein association and dissociation the composition of the corona varies over 
time (Cedervall et al., 2007). The binding of proteins to MWCNT is dependent on the surface 
chemistry. Negatively charged MWCNTs enhanced binding for some proteins but not others. 
However, in the case of CNTs it was also suggested that besides electrostatic properties also 
the stereochemical nature of both nanotubes (3-dimensional arrangement of carbon atoms) 
and proteins will determine the nanotube/protein binding (Cai et al., 2013; Q. Mu et al., 
2008). Proteins were suggested to require a suitable surface curvature for binding as 
(functionalised) MWNTs with a larger diameter (∼40 nm) generally exhibited stronger 
protein binding compared to those with a smaller diameter (∼10 nm) (Q. Mu et al., 2008) 
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Toxicity (Genotoxicity) (what they do) 
As described above, different mechanisms for possible genotoxicity of nanoparticles and 
CNTs have been proposed. Assuming that MWCNT genotoxicity is a secondary effect 
following inflammation, all factors influencing inflammation may be also relevant for the 
onset of genotoxicity.  
Inhalation is considered the critical route of exposure route for MWCNT as no absorption via 
the oral or dermal route is expected (Binderup et al., 2013; OECD WPMN, 2016).  
Following pulmonary exposure of mice or rats MWCNTs were observed to induce 
inflammation, granulomas and interstitial fibrosis. The mechanisms involved with adverse 
pulmonary responses of MWCNT are not completely understood, as well as the contribution 
of biopersistence of catalytic metals, fiber dimensions, and surface functionalisation.  
Following inhalation, MWCNT due to their morphology could be too long to be engulfed and 
removed by macrophages and due to their biopersistence have very long retention times in 
the lungs (Ken Donaldson et al., 2006; Pauluhn, 2009). MWCNT are suspected to show 
similar toxicity to asbestos fibres and due to their needle-like structure may penetrate 
biological membranes, thereby inflicting mechanical damage (Kettiger et al., 2013). 
Specifically long MWCNTs have shown to be more cytotoxic and more potent in inducing 
pro-inflammatory and pro-fibrotic immune responses (Boyles et al., 2015; Ken Donaldson et 
al., 2012). The most evident response to long CNTs is frustrated phagocytosis, respiratory 
(oxidative) burst and pro-inflammatory and pro-fibrotic reactions (Johnston et al., 2010). 
Micronucleus formation has been observed in different cell types following exposure to 
MWCNTs (see Table 2 in Van Berlo et al. 2012; NanoGenoTox Joint Action 2013). 
Micronucleus formation can result froth either a high level of chromosome damage or 
mitotic spindle disruption. SWCNTs have been described to interact with the mitotic spindle 
apparatus, including mitotic tubulin and chromatin, which could explain aneugenic effects as 
observed in several studies (L. Sargent et al., 2009). The similarity of CNTs and microtubules 
may facilitate interaction with the centrosome and mitotic spindle (Cortez & Machado-
Santelli, 2008; L. Sargent et al., 2009). (SW)CNTs have been described to bind to DNA at G-C 
rich regions in the chromosomes including telomeric DNA (X. Li, Peng, & Qu, 2006; X. Li, 
Peng, Ren, & Qu, 2006). DNA intercalation and telomeric binding can induce chromosome 
breakage suggesting that interaction of the CNT with DNA may also be a source of 
chromosome damage.  
4.5.3 For each group member, gather and evaluate data adequacy and reliability 
The dataset of source analogues (Table 4.13) was analysed to identify a set of properties that 
can be used to define (structurally) similar NMs as well as to identify those PC properties 
that can help in predicting by read-across the results of genotoxicity. The dataset reported 
here contains only data that were used in the analyses. The full dataset is reported and 
described in Appendix X.  
Physicochemical parameters 
In order to properly study all CNTs it is necessary to have the same type of data. If not 
possible, a subset with the most consistent data can be used. This is the case for the NRCWE 
analogues (Jackson et al., 2015; Poulsen et al., 2016), which were used for the hierarchical 
clustering and PCA. The data found in (Jackson et al., 2015) was pre-treated in order to be 
able to use it for clustering and for PCA. For instance, the values that were given as ranges, 
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e.g. Diameter 67 nm (24-138nm), were transformed into 3 different properties 
corresponding to minimum diameter (24nm), maximum diameter (138nm), and average 
diameter (67nm). The contents of impurities that were not declared were considered to be 
0%. Subsequently, all properties were scaled. In the case of content of impurities, viability, 
and proliferation; the maximum and minimum were set to 100 and 0%, respectively. 
Otherwise, small differences in viability (94% vs 97%) would have been over-represented 
after scaling. Invariant properties and those highly correlated (>0.90) were removed from 
the dataset that was finally used for the clustering and PCA exercise.  
Toxicological information 
Genotoxicity data from studies carried out with the MWCNT analogues was collected. Based 
on the availability of data, the following tests were considered for the grouping hypothesis 
assessment: in vitro studies in mammalian cells for gene mutation such as chromosome 
aberration (micro nucleus) and DNA damage (Comet assay), and in vivo studies such as 
chromosome aberration (micro nucleus) and DNA damage (Comet assay) if they were of 
reliability 1 or 2 (Klimisch et al., 1997). 
Data were considered reliable if: 
1. The NMs were characterized (size, coating or trade name or repository number 
provided to allow identification of the analogue) and the description of the 
dispersed materials should ideally be provided (particle size distribution, zeta 
potential, polydispersity index) 
2. NM uptake was observed and/or cytotoxicity was tested 
3. Positive and negative controls were considered, and replicates were included. 
The in vivo studies were considered reliable if conditions 1 and 3 above were fulfilled; 
negative results should be taken into account only when it has been proven that the 
nanoparticles have reached the organ investigated. This could be confirmed with data on 
uptake or if cytotoxicity was detected. 
Results from the bacterial mutagenicity test (Bacterial reverse mutation assay; Ames test) 
were collected but not taken into consideration in the evaluation because this test was 
concluded to not be applicable to NMs (OECD, 2014a) as they may not penetrate the cell 
wall and therefore potentially lead to false negative results. (Clift et al., 2012).  
Most of the assessed genotoxicity studies of analogues 1-8 were carried out as part of the 
Nanogenotox Joint Action (Nanogenotox, 2010). WP5 of this project investigated the in vitro 
genotoxicity of MNs (Norppa et al., 2013). Various human cell lines of different origin were 
used for the comet and the micronucleus assays: pulmonary (bronchial epithelial BEAS 2B 
and 16 HBE; adenocarcinomic human alveolar basal epithelial A549), intestinal (epithelial 
colorectal adenocarcinoma Caco2, primarily undifferentiated cells used) and epidermal 
(NHEK). In addition, the comet assay was also performed in a 3-dimensional human 
reconstructed full thickness skin model. The micronucleus assay was also performed in 
human primary lymphocytes, a cell system widely used in genotoxicity testing of soluble 
chemicals. 
The alkaline comet assay, a simple and sensitive method for the detection of DNA strand 
breaks (single- and double-strand breaks), alkali-labile sites, and excision repair sites, was 
used in all the human cell systems applied in the 1st part of WP5. In some laboratories, a 
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modified comet assay based on the use of FpG (formamidopyrimidine-DNA-glycoslyase), 
which improves the detection of oxidative DNA damage, was voluntarily used as a 
supplementary assay. In addition, all NMs were also tested in the mouse lymphoma assay, 
performed in mouse lymphoma L5178Y TK+/- cells. This technique is able to detect a wide 
spectrum of mutations, including gene mutations. 
Additional genotoxicity test results were found in the OECD testing programme (OECD 
WPMN, 2016) and in peer reviewed literature, where we also found information on the 
analogues 7 and 8. We carefully checked for multiple reporting of the same studies in these 
sources.  
In the Nanogenotox Joint Action data from selected in vivo genotoxicity tests (work package 
6) was generated with the aim to assess the correlation between in vivo and in vitro results 
also taking into account the kinetic results (Nanogenotox WP6, 2013). 3 complementary 
tests were performed on rodents: comet assay, micronucleus assay (chromosome and 
genome mutations) and mutation Lac Z assay to measure gene mutations. The oral route 
was tested for analogues 1-3, whereas the endotracheal route for analogues 1-3 and 5.  
For analogues 9-19 systematic in vitro and in vivo comet assays were carried out. 
 
4.5.4 Construct a matrix to identify available data 
All collected information on the analogues on physicochemical and toxicological properties 
was inserted into an Excel data sheet (see supplementary information S4). From these data 
sheets the availability of genotoxicity studies was determined and data gaps identified (see  
Table 4.17 and discussion below). Positive results out of the total number of identified tests 
are presented in Table 4.17. 
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Table 4.17 Total number of reliable genotoxicity studies for MWCNT found in the literature and reported in Supplementary material S4. In vitro 
and in vivo genotoxicity studies are presented as number of positive results/total number of tests identified. Data gaps are highlighted in red. 
Analogue 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Ref 1 
Ref 
2 
Name NM-400 
NM-
401 
NM-
402 
NM-
403 
Mits
ui 
MW
NT-7 
Mitsu
i 
NRC
WE-
007 
Nikki
so 
Hanw
ha 
CM-
100 
NRC
WE-
26 
NRC
WE-
040 
NRC
WE-
041 
NRC
WE-
042 
NRC
WE-
043 
NRC
WE-
044 
NRC
WE-
045 
NRC
WE-
046 
NRC
WE-
047 
NRC
WE-
048 
NRC
WE-
049 
Print
ex 90 
Croci
dolit
e 
in vitro gene 
mutation in 
mammalian cells 
0/1 0/1 0/2 0/2 0/2 0/1                
in vitro chromosome 
aberration - micro 
nucleus 
3/7 1/5 3/6 3/8 4/8 3/5 0/1 0/1              
in vitro DNA damage 
(Comet assay) 0/4 0/4 0/4 0/5 0/4 0/4   0/1 0/1 0/1 0/1 0/1 0/1 0/1 0/1 0/1 0/1 0/1   
In vivo DNA damage 
- COMET assay 0/2 0/1 1/3  0/2  0/1 2/2 0/1 0/1 0/1 0/1 0/1 0/1 0/1 0/1 0/1 0/1 0/1 0/1 0/1 
In vivo micronucleus 
frequency and 
chromosomal 
aberrations 
1/6 0/4 0/5  0/5  0/1 0/1              
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The majority (59 out of 77) of the in vitro genotoxicity (Table 4.17) tests were found 
negative. The highest rate of positive in vitro tests (3 out of 10, for details refer to Annex X) 
was found in analogue 6, the lowest (2 out of 11) in analogue 2. All identified in vitro gene 
mutation studies in mouse lymphoma L5178Y TK+/- cells and V79, Chinese hamster lung 
fibroblast for analogues 1-6 were negative. Likewise, all in vitro comet assays in four 
different cell lines were negative. No gene mutation and chromosome aberration tests were 
found for analogues 7-8.  
From the in vitro chromosome aberration (micronucleus) tests, some analogues showed in 
almost half of the tests increased numbers of micronuclei at concentrations starting from 10 
– 30 μg/ml. Based on these results analogue 6 could be interpreted as positive, whereas 
analogues 1, 3, 4 and 5 may be considered borderlines. Positive results were mainly 
observed in BEAS-2B cells, human pulmonary epithelial cell A549 and undifferentiated 
human epithelial colorectal adenocarcinoma Caco2 cells. In 16 HBE cells all analogues tested 
were negative. 
The authors concluded that although dose-dependent effects could be seen in many 
experiments, the genotoxicity of the MNs studied was usually relatively low; in such a 
situation, experimental variation may determine if the result will turn out positive or 
negative. They also considered that it was presently unclear how much of this variation 
represented true differences among the cell systems and how much could be explained by 
experimental variation, e.g. in MN dispersion, agglomerate size in the cell culture, MN 
sedimentation on the cells, and thereby cellular uptake and intracellular dose (agglomerates 
of different size and shape may have differential effects on cells), and variation in scoring. 
In a second phase of the Nanogenotox Joint Action, a round robin study (an inter-laboratory 
test performed independently in 12 different laboratories) was carried out to assess the 
reproducibility of the genotoxicity tests. In this study (see Table 4.18), analogue 3 showed 
relatively reproducible results for the comet assay in Caco2 cells, and for the micronucleus 
assay in BEAS-2B cells. Both tests turned out mostly negative, 1/4 and 1/6, respectively. The 
comet assay in BEAS-2B cells showed low reproducibility (3/6) while micronucleus in Caco2 
cells showed high reproducibility with positive results (3/4).  
The authors concluded that in the case of the tested NMs the usual practice applied in 
validating short-term assays for genotoxic carcinogens cannot be followed. In particular it is 
unclear how important are genotoxic events in the carcinogenesis of the NMs that have 
been shown to be carcinogenic (Norppa et al., 2013). 
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Table 4.18 Results of in vitro round-robin test (Nanogenotox; Norppa et al. 2013) 
Partner MWCNT analogue 3 Comet CBMN 
Caco-2 cells 
ANSES - + 
NRCWE + + 
BfR - + 
IPL -  
RIVM   
INRS - (+) 
BEAS 2B cells 
IMB-BAS + + 
FIOH - - 
NIOM + - 
UAB - - 
IPH - - 
INSA + - 
+: positive, -: negative; (+): equivocal; grey box: no data; 
From the in vivo genotoxicity tests carried out (Table 4.17) the majority (30 out of 34) of the 
in vivo tests were negative. The in vivo micronucleus tests of the Nanogenotox Joint Action 
following oral and endotracheal route were all negative, whereas in the comet assay 
analogue 1 lead to an equivocal result based on positive findings in kidney following 
intratracheal instillation. Positive in vivo results were found in other studies published in 
peer reviewed papers whose reliability was doubtful (see comments in the annexed Excel 
sheet). 
We conclude from these results, that the tested MWCNT analogues are most probably not 
genotoxic in vivo.  
The NRCWE analogues 9-19 and 2-5 were tested in in vitro and in vivo comet assay (Jackson 
et al., 2015; Poulsen et al., 2016). These studies had the aim to find physicochemical 
properties that are predictive of pulmonary inflammation and genotoxicity. Levels of DNA 
strand breaks (% DNA in tail and tail length) for concentrations ≤ 200 μg/ml were tested in in 
vitro comet assays. All analogues of this case study except the carboxylated MWCNT 
NRCWE042 were found negative at all tested concentrations. NRCWE042 showed a 
statistically significant increase of % DNA in the tail with respect to control for the highest 
concentration. Other NRCWE analogues showed a decrease in tail length at the highest 
concentrations.  
In the in vivo follow up study three different doses (6, 18 and 54 μg) were administered via 
intratracheal instillation in mice. DNA strand breaks in lung tissue and neutrophils in BALF 
were measured to assess genotoxicity and lung inflammation, respectively. After day 1, a 
statistically significant increase in % of DNA strand breaks were detected for analogue 14 
(NRCWE-044) at the lowest concentration (6 μg/mouse). After 28 days the same MWCNT 
showed statistically significant increases of % of DNA strand breaks for the two highest 
concentrations (18 and 54µg/mouse), and NRCWE-045 for the highest concentration. After 
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90 days no significant increase in % of DNA strand breaks compared to the control were 
observed for any of the MWCNT.   
After 1 day the total number of neutrophils in BALF was statistically significantly increased 
at 18 and 54 μg/mouse for all MWCNTs and for three of them also at 6 μg/mouse. 28 days 
after exposure only the highest dose groups had increased numbers of neutrophils in BALF, 
whereas at the lower concentrations most analogues reached normal level. At 92 days only 
group 3 (NRCWE 46-49, analogues 16-19) MWCNT had statistically significant increased 
neutrophil counts, all other MWCNTs had “normal” neutrophil counts. These data suggest 
that lung inflammation is the predominant effect following exposure to high concentrations 
of MWCNTs and that MWCNT are not genotoxic.  
These results support our conclusion that the assessed MWCNTs including the analogues of 
this case study are (probably) not genotoxic and this conclusion may be extrapolated to 
other MWCNTs within the assessed ranges of size, content of impurities and surface area. 
Surface modification as tested in these studies did not have an impact on the results.  
 
4.5.5 Perform a preliminary assessment of the group and fill data gaps 
A preliminary assessment of the grouping hypothesis was carried out by identifying the 
structural similarities between the identified nanoforms. Two unsupervised 
chemoinformatic techniques were used, i.e. hierarchical clustering and principal component 
analysis. 
The MWCNTs for which in vitro and in vivo studies of sufficient reliability (1, 2) were 
available were used for this assessment. This in in line with the good read-across practice 
(GRAP) which among others recommends that the source data must be adequate to meet 
the REACH information (Ball et al., 2016). To allow comparison of the different analogues we 
did not consider the different information requirements according to REACH Annexes and 
took into account all possible in vitro and in vivo tests required at the highest tonnage level. 
So the data gaps in this case study are only data gaps for the exercise with the option to be 
filled by read-across and do not represent real data gaps in the context of a REACH 
registration as according to the tonnage level these (e.g. in vivo) test may not be required or 
only a chromosome aberration or DNA damage study may be necessary.  
Target substances were those analogues for which data gaps for one of the 5 study types as 
described above were identified (highlighted in red in Table 4.17).  
 
When deciding on the read-across approach according to the RAAF (ECHA, 2015b) the 
category approaches Scenario 4 and 6 were considered (see Section 4.6.1). This is justifiable 
as no biotransformation is taking place. Although there are variations in physicochemical 
parameters (length, rigidity/straightness, impurities) between the analogues (Scenario 4 
RAAF), they do not seem to play a relevant role for the endpoint genotoxicity and therefore 
similar strength of effect(s) for the target substances can be predicted (Scenario 6 RAAF).  
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Hierarchical clustering 
Due to the availability of data, this part only covers analogues 9-19. Analogues 1-8 will be 
included in case additional physicochemical data becomes available. 
The data used for the hierarchical clustering is that published by (Jackson et al., 2015) and 
includes several properties like purity, length, diameter, amount of impurities, cell viability, 
agglomeration state, etc. The list of properties used is detailed in Table 4.19. 
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Table 4.19. Physicochemical parameters and used for the assessment of the grouping 
hypothesis via hierarchical clustering and PCA 
Property Explanation 
Purity (%) Purity 
LengthMin(µm) Minimum length 
LengthMax(µm) Maximum length 
LengthAverage(µm) Average length 
DiameterMin(nm)  Minimum diameter 
DiameterMax(nm)  Maximum diameter 
DiameterAverage(nm)  Average diameter 
BET(m2/g) Surface area 
Impurities (Al2O3, BaO, Fe, CuO, Cl, etc.) Amount of impurities (%) 
Endotoxin (EU/ml) Amount of endotoxine 
CEA:C,H,N,O (wt%) Combustion elemental analysis of different elements 
-OH,-COOH, -NH2 (mmol/g) Amount of surface coating 
Zave at 12.5 and 200 µg/ml Aggregation/agglomeration  
PdI at 12.5 and 200 µg/ml Polidispersibility Index 
ROS Reactive oxygen species determined by Dichlorofluorescin (DCFH) oxidation assay 
Viability at different concentrations (0-
200 µg/ml) Cell viability 
Cell proliferation at different 
concentrations (0-200 µg/ml) Cell proliferation 
 
The result of the hierarchical clustering is shown in Figure 4.7. Three strong groups (p<0.05) 
can be identified and are shown in red squares. Cluster c (right hand side) includes the 
analogues 13-15 NRCWE 043-045 which are the MWCNTs classified as group II by Jackson et 
al. These MWCNT are the ones with the largest diameter (50-80nm). Cluster b includes NM-
401 and NRCWE-006, which are named (reference) Materials by Jackson et al. and which are 
MWCNTs of different sizes but very similar BET (18 and 26 m2/g, respectively) with similar 
viabilities and proliferation values. Cluster a is the biggest of the clusters and contains 
Jackson et al. Group III MWCNTs (analogues 16-19) and some reference materials (NM-402, 
NM-403) as well as the Standard MWCNT. Group III MWCNTs correspond to short CNTs (1-
10µm) with intermediate diameters (11-15.5nm). However, some of the MWCNTs of the 
reference materials group have similar sizes to Group III CNTs and this is probably the 
reason why they clustered together. 
On the left hand side of Figure 4.7 there are analogues 10-12 NRCWE 040-042. They do not 
show significant similarity between them as (p>0.15). These MWCNT correspond to Group I 
defined by Jackson et al., the long MWCNTs (10-50µm). The fact that they are different from 
all other MWCNT can make them a group of their own. Similarly, Carbon black was not 
clustered with any MWCNT as it is quite different from the MWCNTs and was also missing 
some of the data, which the algorithm assigned as 0. 
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Figure 4.7. Hierarchical clustering of the Jackson et al. dataset. Distances between CNTs 
correspond to Euclidean distance and the clusters were generated from the “average” distance of 
the members of each group. Main clusters are indicated in red boxes. 
 
Summing up, hierarchical clustering shows that the clusters are mainly driven by the size of 
the CNTs and by proliferation and viabilities although to a lower extent. At the same time it 
seems that the groups are not determined by the impurities and functionalization of the 
CNTs. Interestingly, the clusters formed correspond to some extent to those defined by 
Jackson et al., which were mainly defined by size. A way to determine the physicochemical 
parameters that account for the variability between CNTs, therefore that could explain 
eventual differences in toxicological behaviour, is through a PCA.  
Principal component analysis (PCA) 
PCA is dimensionality reduction technique that uses linear combinations of the original 
variables (see  Table 4.19) to define new variables (principal components) that are 
orthogonal to each other and that can describe a large amount of the total variance of the 
system (~60-70%) with just two variables, principal component 1 and principal component 
2. This technique provides information about the variables that distinguish the individuals 
(MWCNTs) the most. The PCA of the same dataset that was used for the hierarchical 
clustering is shown in Figure 4.8.  
It is interesting to observe in the PCA that Group I, Group II, and Group III CNTs as defined 
by Jackson et al. appear at different parts of the representation and that they cluster in 
different groups. Additionally, it can be observed that the MWCNTs that belong to the 
Materials group are spread between Group II and Group III. Actually, clusters b and c of 
Figure 4.7 appear in the same region of the PCA at the bottom left part. Regarding the 
variables that compose PC1 and PC2, the minimum length, maximum length and BET, are 
a b
c 
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the ones that contribute the most to the principal components, that is the ones that 
differentiate them the most.  
Regarding the analysis of the positions of the MWCNTs in the PCA plot (Group III falls at the 
positive side of PC1 while Group II falls at the negative side of PC1), the fact that BET and 
ROS are parallel to PC1 explains this disposition. Group III CNTs, which are the short CNTs, 
have statistically significant larger BET (average ~ 205m2/g) than Group II CNTs, which are 
the thick CNTs (average ~ 92m2/g), p<0.001. NM-402 and NRCWE-026, which appear in the 
same cluster with Group III CNTs, also have very high BETs, 226 and 245m2/g, respectively. 
Therefore, BET clearly drives PC1 and the position of the MWCNT with respect to the X-axis 
of the plot.  
 
 
Figure 4.8. Principal component analysis of the MWCNTs dataset. The MWCNTs are colour-coded 
according to the Groups defined by Jackson et al., and the variables are colour-coded by their 
contributions to PC1 and PC2. The variance explained by each PC is indicated in the axis title. 
 
Group I CNTs appear at the positive part of PCA2, which according to the loadings (see Table 
4.19) is mainly driven by maximum length and combustion elemental analysis of H and N, 
CEA.H..mmol.g..f and CEA.N..mmol.g..f., respectively. In fact, Group I corresponds to long 
CNTs, which are 50µm long while Group II CNTs are 20µm long. The combustion analysis 
also shows a statistically significant difference between CEA.H..mmol.g..f of Group I and II 
(p<0.004). The difference for CEA.N..mmol.g..f. is not statistically significant because the 
value for NRCWE-040 is very low, but the values of NRCWE-041 and NRCWE-042 are 
statistically significant from those of Group III (p<0.005). 
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Thus, the PCA shows that the CNTs of Group I, II, and III can be distinguished by the 
minimum and maximum length, BET, ROS, and combustion elemental analysis of H and N. 
The PCA also shows that NM-401 and NRCWE-006 cluster with Group II CNTs, and that NM-
403, NM-402, and NRCWE-026 cluster with Group III CNTs. The variables that contribute the 
most to PC1 and PC2 (loadings) are shown in Table 4.19 and confirm the analysis above. 
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Table 4.20. PC1 and PC2 loadings of the corresponding PCA carried out for the CNTs dataset. 
Variable PC1 loadings2 Variable 
PC2 
loadings2 
Minimum Length (µm) 16.14 Maximum Length (µm) 18.07 
BET (m2/g) 15.22 CEA-H (mmol/g) 15.67 
ROS 10.31 CEA-N (mmol/g) 15.5 
Endotoxin (EU/ml) 9.57 Zave at 12.5 (µg/ml) 10.13 
PdI 8.95 OH mmol/m2 9.64 
ROS peak (µg/ml) 7.68 Minimum diameter (nm) 9.14 
Minimum Diameter (nm) 7.06 PdI 7.1 
PdI at 12.5 µg/ml 5.51 Endotoxin (EU/ml) 4.42 
Maximum Length (µm) 5.01 Minimum Length (µm) 2.96 
 
In order to show whether the functionalization could explain the physicochemical 
differences between CNTs, the same PCA shown above was repeated and colour-coded by 
type of functionalization in Figure 4.9. However, it is clear in this figure that pristine, COOH, 
and OH functionalised CNTs do not form any group, and that therefore, the physicochemical 
differences of the CNTs cannot be explained by their functionalization. In fact, Jackson et al. 
already noted that the amount of functionalization of the CNTs was rather small, what 
confirms this observation. It may be necessary to define what amount of surface 
functionalization is needed in order to consider a CNT functionalised.  
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Figure 4.9. Principal component analysis of the CNTs dataset. The individuals CNT are colour-coded 
according to the type of functionalization reported by Jackson et al., and the variables are colour-
coded by their contributions to PC1 and PC2. The variance explained by each PC is indicated in the 
axis title. 
 
In order to analyse the similarity of the CNTs present in Jackson et al. with the targets, the 
amount of variables used for the initial PCA were reduced. Only the main contributors to 
PC1 and PC2 were selected to carry out another PCA, in this case using only LengthMin, 
LengthMax, BET, CEA H, and CEA N. Ideally, this PCA would also contain the targets but since 
this kind of data was not available they could not be added. Either way, the plot is presented 
here to show that the reduction of variables shows a very similar picture to the previous 
PCA and that it seems that the physicochemical differences between the Jackson et al. 
MWCNTs can be explained in terms of these 5 variables. The resulting PCA is shown in 
Figure 4.10 which is obviously different from the one in Figure 4.9 but the three main 
clusters groups seen in Figure 4.9 remain almost invariable.   
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Figure 4.10. PCA of the CNTs with a reduced set of variables. The variables used were LengthMax, 
LengthMin, BET, CEA H, CEA N. The MWCNTs are colour-coded according to the Groups defined by 
Jackson et al., and the variables are colour-coded by their contributions to PC1 and PC2. The 
variance explained by each PC is indicated in the axis title. 
 
Conclusions of hierarchical clustering and PCA 
The hierarchical clustering and PCAs shown above have served to determine the clusters or 
groups of similar CNTs as well as the physicochemical properties that determine their 
similarity and that drive the grouping. However, we are interested in reading across the in 
vitro comet assay. In order to determine the physicochemical properties that can be related 
to genotoxic properties of CNTs, in vitro comet assay results for the CNTs used in the PCAs 
above were collected from (Jackson et al., 2015). The comet assay results were to be used 
to assign the CNTs to different categories, in this case genotoxicant or non-genotoxicant. 
Subsequently, a random forest algorithm was to be used to determine the physicochemical 
properties that are more discriminating in predicting these categories.  
Unfortunately (in this case study), the results obtained by Jackson et al. showed that all 
CNTs at all concentrations were not different from the vehicle control. Only NRCWE-042 
showed a statistically significant increase in % of DNA strand breaks at 200µg/ml compared 
to the control. Taking into account all these results, it does not seem reasonable to consider 
any of the CNTs as genotoxic. Since none of the source CNTs can be considered positive, the 
random forest algorithm cannot be used as there is need of having at least two categories. 
Otherwise, all variables will be equally important to predict negative genotoxicity. 
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The results obtained by Jackson et al. for % of DNA strand breaks and tail length for the 
different CNTs at the tested concentrations (0-200 µg/ml) are shown in Figure 4.11A and  
Figure 4.11B, respectively. Figure 4.11A only shows statistically significant differences with 
respect to vehicle control for NRCWE-042 (200µg/ml) and H2O2 (60µg/ml), which is the 
positive control. Figure 4.11B shows a statistically significant decrease in tail length for the 
highest concentrations of NRCWE-042, NRCWE-046, NRCWE-047, and NRCWE-049. 
Although it could seem that these variations indicate genotoxicity, it was shown by the 
authors that these variations were mainly caused by the reduced cell proliferation that 
occurred for these CNTs at high concentrations.  
 
 
Figure 4.11. In vitro comet assay results for different CNTs and at different concentrations as 
reported in Jackson et al. 2015. A) corresponds to % of DNA strand breaks. B) corresponds to tail 
length. Carbon black (Printex 90) and H2O2 were used as negative and positive control, 
respectively.  
The authors observed that the content of Fe2O3 and NiO clustered with % of strand breaks in 
a PCA and suggested that the content of Fe and Ni could be related to genotoxic effects, but 
no statistical significance with respect to controls was observed. In fact, the CNTs with 
higher content of Fe2O3 and NiO are NM-402 and NRCWE-045 for Fe2O3, and NRCWE-042, 
NRCWE-043, and NRCWE-044 for NiO. Of these CNTs, only NRCWE-044 at the highest 
concentration shows a decrease in tail length significantly different from the control. The 
rest do not show differences with the control in % DNA strand breaks or tail length. 
Therefore, the present results do not clearly show a causal effect between Fe and Ni 
content and genotoxic effects.  
The analysis that we performed on the data provided by Jackson et al., however, shows that 
NRCWE-042, the CNT that shows significant % of DNA strand breaks at the highest 
concentration, has the highest content of OH or COOH, 4.09 and 2.04 mmol/g,  respectively. 
In spite of the high content, the corresponding surface concentration of OH and COOH is not 
different from the other CNTs. However, the total content of OH and COOH in the samples 
of NRCWE-042 is 10 times higher than the average of the rest of CNTs. This of course, should 
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not affect toxicity unless some of the OH or COOH detached or reacted with biological 
entities. Having a loose functionalization would explain the dose response shape of NRCWE-
042 and possibly the positive result for mutagenicity at the highest dose. 
Overall, judging by the data found in Jackson et al. and the other analogues (see Table 4.17), 
it seems that CNTs turn out negative in the in vitro comet assay and that they should not be 
considered genotoxic on such basis.  
 
Figure 4.12. DNA strand breaks in the lung tissue after exposure to MWCNT and reference 
materials at day 1(A), 28 (B), and 92(C).  
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This observation can be extrapolated to the in vivo situation as the same group published a 
follow-up article on the genotoxicity of CNTs in vivo (Poulsen et al., 2016). 
The authors analysed the genotoxic effects of the CNTs (comet assay) in rats after 
instillation (Figure 4.12). They measured the % of DNA strand breaks in lung tissue and BAL 
fluid at day 1, 28, and 92. Of all CNTs and doses tested, only NRCWE-044 showed positive 
results for 6µg/ml at day 1, and 18 and 54 µg/ml at day 28. All other CNTs and doses tested 
at day 1, 28, and 92 were not significantly different from the control. These results point out 
that CNTs are in general not genotoxic, and that in the rare cases in which they turn out 
positive (e.g. positive at day 1 for NRCWE-044 at 6µg/ml but not at 18 or 54 µg/ml), there is 
full recovery after 92 days.  
The results in the BAL fluid were similar, with the only difference that from NRCWE-040 to 
NRCWE-045 were found positive at day 1 for at least one test concentration. Nevertheless, 
all CNTs were found negative for all concentrations after 28 and 92 days, showing again a 
recovery process.  
Taking into account the results obtained by Jackson et al. 2015 and Poulsen et al. 2016, it is 
reasonable to conclude that CNTs are most probably negative in the comet assay, both in 
vitro and in vivo, up to 200µg/ml in vitro and 54µg/ml in vivo. 
Poulsen et al. showed, however, that inflammation behaviour is different as all CNTs 
showed statistically significant increase in neutrophils count in BAL fluid at day 1 and 28; 
and Group III CNTs at day 92 too. This result shows that CNTs can cause lung inflammation 
and that it can still be present 92 days after exposure. This seems to be a common 
mechanism for fibres, which may induce carcinogenicity via long-term inflammation.   
 
Fill data gaps by reading across 
Data gaps (as highlighted in red in Table 4.17) exist for analogues 4, 6, 7 and 8 for some 
endpoints and for the analogues 9-19 for all endpoints except the comet assay in vitro and 
in vivo. Considering read-across endpoint by endpoint, the in vitro gene mutation in 
mammalian cells and in vitro DNA damage may be predicted to be negative for analogue 7 
and 8 as all tests with the other analogues were negative. For analogue 4 and 6 no in vivo 
data was located. Both analogues had some positive results in the in vitro micronucleus 
tests, but the other tests were all negative. As the other analogues tested under more 
reliable conditions (see discussion above) were negative, it may be predicted that also these 
analogues would not be genotoxic in vivo. From their physicochemical properties, their 
differences to be considered are: analogue 7 seems to be straight/rigid, similar to analogue 
5 and analogue 8 has been described as very long MWCNT which also had the highest Fe 
content. Analogues 4 and 6 do not show properties that would make them suspicious to 
have a higher propensity for genotoxicity/lung inflammation.  
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4.5.6 Perform and/or propose testing 
In this case study we have made an appraisal to fill identified data gaps. In this case no 
further testing of the assessed analogues seems necessary. Based on the available data, we 
do not suggest to extrapolate this conclusion to other MWCNT, whose size is beyond the 
tested ones (i.e. longer or larger diameter), which are surface modified or which have a 
higher content of oxidising impurities.  
In general to increase the knowledge and, considering the low reproducibility of some in 
vitro tests, it is suggested to adapt the test protocols to increase the reliability of test 
results. 
Further, the predictability of in vitro genotoxicity of NMs for in vivo genotoxicity and 
carcinogenicity needs to be better understood.  
 
4.5.7 Summary and conclusion 
Previous research has shown that physicochemical properties can influence translocation 
and toxicity of MWCNT (Braakhuis et al., 2014; Ken Donaldson et al., 2012). Although length 
and rigidity/straightness are cited in the literature as important properties in influencing 
lung deposition and thereby the onset, location and/or severity of the pulmonary response 
(e.g. genotoxicity/carcinogenicity) (Braakhuis et al., 2014; Ken Donaldson et al., 2012), 
experimental measures of "rigidity" are usually not reported. In fact, it is complex to 
characterise and measure such mechanical property at the nanometer scale (Pantano, M. 
Parks, & Boyce, 2004), and in our attempt to group MWCNTs depending on this parameter, 
rigidity was defined based on TEM images. As reported in the literature, Young's modulus is 
a measure of rigidity (Pantano et al., 2004; Sakharova, Pereira, Antunes, & Fernandes, 2016) 
and this physical characteristic could be required and used to quantitatively classify 
MWCNTs in terms of rigidity. A QSPR for Predicting Young’s modulus for metal-based NMs is 
available in the Nanocomput model inventory (supporting  material S1, Toropov and 
Leszczynski 2006). Considering the relevance of this property, further research activities 
could aim at developing predictive models for (MW)CNTs rigidity. 
Concerning genotoxicity no major differences between the analogues assessed in this case 
study were observed that could be attributed to length or rigidity/straightness.  
In vitro gene mutation tests in mammalian cells and comet assays were negative for the 
analogues. Some analogues showed a higher rate of positive results in the in vitro 
micronucleus assay. There were fewer in vivo genotoxicity tests available but the majority 
did not point to a genotoxic effect for MWCNT. Genotoxicity and the generation of reactive 
oxygen species are frequently investigated in in vitro studies with respect to their general 
predictive power for in vivo situations. However as they neglect defence mechanisms their 
predictivity for in vivo situations may be limited (Ken Donaldson, Poland, et al., 2010). In 
addition, recent analyses have shown, that carcinogenicity is not predicted very well for 
particles (Roller, 2011). It is thus also difficult to establish a clear correlation between 
MWCNT properties with in vivo results (Roller, 2011; Ziemann et al., 2011). 
Size and rigidity may however determine fate and kinetics of MWCNT and thus 
bioavailability and target organs.  
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In vitro tests ROS generation has been shown to correlate well with inflammation in vivo 
(increase of neutrophils after intratracheal instillation) (Rushton et al., 2010), provided that 
particles are compared based on particle surface and the steepest slope of the dose 
response curve as dose metric. This could be relevant if genotoxicity arises as secondary 
effect.  
Our results suggest that the investigated MWCNT are not genotoxic. Genotoxicity thus does 
not seem to be (the sole) responsible for the initiation of carcinogenicity following MWCNT 
inhalation. It is therefore not possible to determine physicochemical properties that are 
responsible for the presence or absence of a genotoxic effect. MWCNT physicochemical 
properties have shown to have an impact on the translocation, clearance and persistence of 
MWCNTs in the body and thus on the onset and persistence of inflammation and release of 
reactive oxygen species. This cannot be tested in an in vitro test.  
 
4.6 Uncertainty analysis 
The approach of chemical grouping and read-across includes uncertainties. There are 
various areas that contribute to the overall uncertainty: uncertainty associated with the 
data, assumptions, and predictions used to justify similarity and analogue suitability 
between the group members; and toxicological uncertainty with the read-across prediction 
of hazard derived (evaluated based on the number and suitability of analogues contributing 
data, source study quality, likelihood of effect and potency concordance between target and 
source chemical).   
For the present case studies we have used the ECHA Read-Across Assessment Framework 
(RAAF) (ECHA, 2017a) as a systematic guidance to identify and summarise the different 
sources of uncertainty associated with filling data gaps by grouping and read-across, with a 
view also to evaluate the applicability of the RAAF for nanomaterials and to find possible 
issues that need to be taken into account particularly for nanomaterials. 
 
4.6.1 Uncertainty assessment using the Read-Across Assessment Framework  
The Read-Across Assessment Framework has been developed by ECHA to provide guidance 
for a structured analysis of read-across submissions and justifications (ECHA, 2017a). Six 
possible read-across scenarios are considered, depending on the number of substances 
(analogue or category approach), the effect caused by common or different substances for 
source(s) and target(s) or, for a category, whether the predicted property is following a 
regular pattern (trend) or not changing across source structures. Sets of Assessment 
Elements (AEs) per scenario describe ‘crucial scientific aspects to judge validity and 
reliability of read-across’ (ECHA, 2015b). For each AE multiple considerations are listed, 
which should be addressed in the justification of the read-across argumentation. There are 
general (common) AEs and scenario-specific AEs. Assessment Options (AOs) reflect the 
conclusions on adequacy and scientific robustness. They are defined as scores as from 1 to 5 
according to whether the information provided is not acceptable (1), not acceptable in its 
current form (2), acceptable with just sufficient (3), medium (4) or high (5) confidence. 
The ECHA RAAF was used to assess the uncertainties in the read-across for the two 
nanomaterial case studies. Moreover, the case study evaluation was used to identify 
 313 
 
nanomaterial particularities considered in the read-across exercise. Thus this exercise also 
evaluates the applicability of the RAAF for the assessment of read-across for nanomaterials 
and might point out possible respective adaptions or extensions of the RAAF AEs for this 
specific case of read-across. 
Generally the reliability, relevance, consistency and completeness of data and 
argumentation are evaluated.  
From the six RAAF scenarios, Scenario 6 does describe the nanomaterial case studies best. 
Both the TiO2 and MWCNT case studies use category approaches (reading-across from a 
group of substances to a target), different compounds (in this case nanoforms) are 
considered in the category which have the same type of effect, and there are no variations 
in effect (e.g. Comet assay result either positive or negative). Although there are variations 
in the strengths of observed different effects for CNT depending on e.g. length and 
impurities, they do not influence the considered binary genotoxicity endpoints (yes/no). 
In Table 4.21, the AEs for RAAF Scenario 6 are listed. They cover the general overarching 
topics: 
• similarity hypothesis, substance(s) considered, and available data 
• toxicant(s) the organism is exposed to 
• mechanism of toxicity. 
AEs C.1-C.6 are common AEs for all scenarios considering a category approach; AEs 6.1-6.5 
are scenario-specific. The terms used correspond to the terminology used in the RAAF, i.e. 
applicable to conventional organic substances. Nanospecific adaptions of the terms will also 
be discussed in the following. 
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Table 4.21. RAAF Assessment Elements for Scenario 6 (category approach, different 
compounds with same effect, no variation in effect), summarising the crucial points of a 
read-across argumentation that should be justified  (see ECHA 2017a). 
 RAAF Assessment Elements (Scenario 6)  
C.1 Substance characterisation 
including impurity profile 
 
 
 
 
Similarity 
hypothesis,  
 
Substance(s) 
considered,  
 
Available data 
C.2 Structural similarity and category hypothesis 
Allowed/non-allowed differences (category) 
C.3 Link of structural similarities and structural differences 
with the proposed regular pattern 
C.4 Consistency of effects in the data matrix 
C.5 Reliability and adequacy of the source study(ies) 
Data quality 
C.6 Bias that influences the prediction 
Other possibilities excluded?  
6.1 Compounds the test organism is exposed to 
Different compounds with same effect 
 
 
 
Toxicant the 
organism is 
exposed to  
 
 
6.4 Exposure to other compounds than to those linked to 
the prediction 
Other compounds present or formed, e.g. 
metabolites…? Impurities? Systemic availability of the 
compounds?  
6.5 Occurrence of other effects than covered by the 
hypothesis and justification 
6.2 Common underlying mechanism, qualitative aspects 
Mode of action hypothesis (link to structure); 
What is the biological target? Same for source/target 
compounds? 
 
Mechanism of 
toxicity  
6.3 Common underlying mechanism, quantitative aspects 
Similar exposure to source/target compounds? 
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4.6.2 The TiO2 case study 
 
The RAAF AE elements (Scenario 6) are used to highlight uncertainties in the grouping and 
read-across argumentations. The evaluation and nanospecific considerations are 
summarised in Table 4.22. 
Substance characterisation (C.1) 
In the first step of the read-across process the identification of the nanoforms is considered, 
i.e. “what they are”. The identification includes particle size, particle shape and surface 
chemistry. The characterisation should also include impurities present, which are defined as 
"unintended constituent present in a substance as manufactured" (ECHA 2012); on the 
contrary, NMs contain surface coating purposely added. 
The core chemical composition is TiO2, the crystal type and size are reported. Impurity 
information is given by the provider only as a generic percentage of purity. Additional 
measurements are available from different Nanogenotox deliverables; however, in some 
cases there were some inconsistencies between different tests. 
For the considered target substances, analysis of the physicochemical properties (as 
reported in (Guichard et al., 2012)) showed that the measured properties were slightly 
different from those reported by the manufacturer.  
Of the physicochemical properties considered during data collection, some were 
disregarded because of lack of information or low data reliability. Appendix VIII reports the 
analysis of the variability of the physiochemical property measurements, particle size 
distribution, Zeta potential being dependent for example from the dispersion medium used, 
different sonication methods. As a consequence of the huge data variability in particle size 
distribution (and consequently on Zeta potential), this measurement is not reliable and 
could in principle be excluded from the grouping exercise. 
Overall there is uncertainty associated with the nanoform identification and 
physicochemical characterisation, which is subject to high variability in measurements 
(different experimental conditions, result ranges; see Appendix VIII). 
Structural similarity and category hypothesis (C.2) 
The criterion of structural similarity considered in the RAAF for conventional organic 
substances needs to be extended for nanoforms to their properties regarding identification, 
fundamental behaviour and reactivity. 
In order to investigate criteria for similarity of the nanoforms considered and form a 
category hypothesis, cheminfomatics methods have been used to determine the 
(physicochemical) properties that differentiate the analogues, their similarity and that may 
drive genotoxicity. The properties differentiating the two groups were surface coating, Al 
coating and crystallite type. 
The nanoform NM-101 was not declared coated by the manufacturer (Birkedal et al., 2012). 
However it contains 9% organic impurities. Therefore it is considered coated for the purpose 
of this case study and part of the respective group of nanoforms. 
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Link between structural (physicochemical) similarity and predicted property (C.3) 
For NMs, the similarity cannot be based on molecular structure as for conventional 
chemicals. Moreover, in general very little is known about the mechanisms of toxic action of 
NMs. Therefore it can be challenging to develop the grouping hypothesis of the link 
between similar properties and the predicted property/toxicity, in this case the outcome of 
the in vitro comet assay.  
The link between physicochemical properties of the analogues and the predicted property, 
i.e. genotoxicity, has been investigated with cheminformatics methods. The hypothesis is 
that Nano-TiO2 in its uncoated form has the potential to damage DNA, but this can be 
masked by the presence of coating or by large amounts of impurities on the surface of the 
NM (total non-TiO2 content). 
Consistency of effects in the data matrix (C.4), Reliability and adequacy of the source 
studies (C.5) 
Data were collected following a reliability assessment based on the ANSES criteria (see 
ANSES 2016).  
The data for micronucleus, comet and chromosomal aberration assays were included in the 
data collection, because the current OECD test guidelines fort these tests are considered 
applicable to NMs and thus sufficiently reliable. For the in vitro comet assay however, an 
OECD test guideline is not available. This endpoint was considered nevertheless in the data 
collection because of larger availability of studies. Previous reviews on genotoxicity tests 
applied to NMs claimed that the comet and micronucleus assays are the most commonly 
used tests in the field (Golbamaki et al. 2015). 
Generally, the assessment of quality, reliability and relevance to human health endpoints of 
measured toxicity data as well as their interpretation is difficult, partly due to the 
uncertainty in applying existing testing protocols to nanomaterials. The applicability of 
current OECD test guidelines to NMs is still under discussion and artefacts affecting the 
results of toxicity assessment of NMs have been reported (see Marchese Robinson et al. 
2016). 
Bias in selection of category members (C.6) 
Because of the scarcity of the data available (as full datasets covering all properties 
considered) or insufficient quality, the set of analogues considered in this case study was 
limited. Only the nanoforms that were completely identified by means of fundamental 
parameters like solubility, hydrophobicity (currently not well defined for nanomaterials), 
zeta potential, dispersability were considered. This led to a dataset with 6 TiO2 nanoforms, 
differing in their primary particle size (from 7 to 117 nm), coating (two of them are declared 
coated by the manufacturer and the others are declared without a coating), crystal type 
(anatase and rutile) and hydrophobicity (materials functionalised to be hydrophobic or 
hydrophilic). Thus, our hypothesis is based on a small dataset and considers a single in vitro 
endpoint (Comet assay). Other in vitro tests available for TiO2 nanoforms do not confirm 
genotoxicity, so an overall conclusion on genotoxic potential cannot be made with certainty. 
Compound the test organism is exposed to (6.1) 
TiO2 nanoforms without coating are considered to cause the adverse effect. The presence of 
coating and/or a high amount of organic impurities is hypothesised to mask the potential 
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DNA damage. The definition of the toxicant is based on evaluation of the physicochemical 
properties. Some uncertainty remains about the property driving the genotoxicity. 
Exposure to other compounds (6.4) 
Exposure to impurities might influence the observed genotoxic effects. Another factor to 
take into consideration is the presence of proteins in the medium. If the NMs are 
surrounded by proteins, they are more dispersed and also less toxic since the “reactive” part 
is “hidden” behind the protein corona. 
Common underlying mechanism, qualitative and quantitative aspects (6.2, 6.3) 
The mechanisms of primary and secondary genotoxicity are not fully understood. 
Generally, there is some uncertainty related to the mechanism: The majority of studies 
supported the hypothesis that the genotoxic effect of TiO2 is masked by the presence of 
coating (i.e. total non-TiO2 content including impurities). However, the way in which the 
coating can prevent DNA damage is not entirely clear. The mechanism of genotoxicity of 
TiO2 is not well defined and still discussed in the literature, it is also possible that several 
effects take place at the same time. There is general uncertainty about the mechanism of 
action for indirect primary genotoxicity via ROS (Golbamaki et al., 2015), a clear correlation 
between the level of ROS production and DNA damage was not supported in several studies. 
Therefore measured information on ROS formation (bioactivity) would be useful for 
supporting the hypothesis in the case study. 
Exposure to other compounds (6.4) 
The presence of reactive transition metals as impurities or in the NM composition may also 
contribute to oxidative DNA damage induction. 
Occurrence of other effects (6.5) 
There might be more than one mechanism responsible for genotoxicity of TiO2; and possibly 
a combination of several factors are responsible for masking the DNA damage. They may 
have as common source the presence of coating / high amount of impurities either by 
preventing aggregation of NMs, or by preventing physical contact with DNA and/or other 
cell components. 
There is also an indication for the fact that the degree of agglomeration of TiO2 nanoforms, 
which depends on the presence of coating, may have an influence on the DNA damage.  
A direct interaction mechanism of genotoxicity or an indirect primary genotoxicity are 
considered (Magdolenova et al. 2014). Furthermore, the conduction band of TiO2 falls in the 
range of biological redox potentials (Burello and Worth 2011), meaning that TiO2 with or 
without the presence of UV light can generate reactive species that react with cell 
constituents such as DNA. However, the band gap is not the only predictor of reactivity, but 
also for example the geometry of the crystal, the nature of surface defects. 
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Table 4.22 Evaluation of the uncertainties of the TiO2 case study according to the ECHA RAAF Scenario 6. 
 RAAF Assessment Element 
(Scenario 6) 
Uncertainties in the TiO2 case study Nanospecific issues 
C.1 Substance characterisation 
• Measured physicochemical characteristics of the NMs 
vary: measurement uncertainty. Is there an influence on 
other properties of the nanomaterials? 
• Impurity information not always available or inconsistent 
• Physicochemical characterisation of 
NMs: high variability of measurements 
(influence of different experimental 
conditions) 
C.2 Structural similarity and category hypothesis 
• NM-101 is not declared as coated, but has % of impurities 
corresponding to a coating. Thus it was considered 
coated. 
 
• For NMs, the similarity cannot be based 
on chemical (e.g. molecular) structure 
as for conventional chemicals, but 
should consider physical form and key 
physicochemical properties 
C.3 
Link of structural similarities 
and structural differences with 
the proposed property 
• Little is known about the mechanisms of toxic action, 
making it challenging to link similarity to the property 
(genotoxicity) considered 
C.4 Consistency of effects in the data matrix 
• Uncertainty in applying existing testing protocols to 
nanomaterials and thus uncertainty in assessment of 
quality, reliability and relevance to human health 
endpoints of measured toxicity data 
 
• Artefacts affecting the results of toxicity 
assessment of NMs are discussed in the 
literature C.5 
Reliability and adequacy of the 
source study(ies) 
C.6 Bias that influences the prediction • Selection of analogues based only on data-availability 
 
6.1 Compounds the test organism is exposed to 
 
 
 
 
• For conventional chemicals, either the 
parent molecule of (bio)transformation 
products are the indirect/direct 
toxicants; for NMs the considerations 
extend to coating, released metals etc  
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 RAAF Assessment Element 
(Scenario 6) 
Uncertainties in the TiO2 case study Nanospecific issues 
6.2 Common underlying mechanism, qualitative aspects 
 
• The mechanism of genotoxicity of TiO2 is not well defined. 
It is also possible that several effects take place at the 
same time. 
 
 
6.3 
Common underlying 
mechanism, quantitative 
aspects 
 
6.5 
Occurrence of other effects 
than covered by the hypothesis 
and justification 
 
6.4 
Exposure to other compounds 
than to those linked to the 
prediction 
• For example the presence of reactive transition metals 
may also contribute to oxidative DNA damage induction 
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4.6.3 The CNT case study 
 
The RAAF AE elements (Scenario 6) are used to highlight uncertainties in the grouping and 
read-across argumentations. The evaluation and nanospecific considerations are 
summarised in Table 4.23. 
 
Substance characterisation (C.1) 
The MWCNT are considered structurally/chemically similar based on the same starting 
material for their synthesis. However, the purity of the MWCNT varies between 90 and 99%, 
and thus may influence similarity.  
The same material from the same producer and identified by the trade name may still be 
subject to variations, such as batch to batch variability, surface modification (though this is 
usually reported) or ageing. Impurity information is given by the provider as a generic 
percentage of purity. Furthermore, measurements are available from different 
Nanogenotox deliverables; however, in some cases there were inconsistencies between 
different tests. Measured physicochemical characteristics measured by the customer may 
vary from those delivered by the manufacturer, sometimes because they are dependent on 
the sample preparation and test conditions. 
Thus there is uncertainty associated with the nanoform identification and physicochemical 
characterisation, which is subject to high variability in measurements (different 
experimental conditions, result ranges). 
Structural similarity and category hypothesis (C.2), Link between structural 
(physicochemical) similarity and predicted property (C.3) 
For NM, the similarity cannot be based on molecular structure as for conventional 
chemicals. Therefore physicochemical and NM characterisation parameters were analysed 
to identify possible categories and link the parameters to genotoxicity. 
Subgrouping of the MWCNT can be done according to different parameters, e.g. length or 
diameter, which influence different toxic behaviour, resulting in different subcategories. 
However, there is uncertainty for example in the lengths reported for MWCNT, therefore 
not all MWCNT types could be clearly assigned to respective subcategories. 
Subcategorisation based on diameter is also difficult since there is no clear cut-off value and 
the values for the same analogue are reported sometimes for huge ranges. No major 
differences concerning genotoxicity between the analogues assessed in this case study were 
observed that could be attributed to length or diameter. Size for example may however 
determine fate and kinetics of MWCNT and thus bioavailability and target organs. Overall no 
single physicochemical parameter seems suitable to predict toxicity, and some may be 
interdependent.  
As a more in depth-analysis, the dataset of physicochemical parameters was analysed by 
hierarchical clustering and principal component analysis in order to identify the properties 
possibly linked to genotoxicity. Generally there is a large variation in several of the 
physicochemical properties reported, i.e. only available as ranges. Therefore the data had to 
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be pre-treated for the analysis, for example values given as ranges such as for the diameter 
were considered as minimum, average and maximum diameter. Moreover, all properties 
were scaled.  
Consistency of effects in the data matrix (C.4), Reliability and adequacy of the source 
studyies (C.5) 
The case study analogues have been selected according to the quality of the available 
physicochemical and toxicological data, according to defined reliability criteria (see 0). 
However the data for physicochemical characterisation possess a high variability. To 
increase the knowledge and considering the low reproducibility of some in vitro tests it 
could be suggested to adapt the test protocols to increase the reliability of test results. 
Generally, it has to be noted that not all test protocols are suitable for nanomaterials, 
including artefacts affecting the results of toxicity assessment of NMs (see (Marchese 
Robinson et al., 2016)). For this reason Ames test results were not considered in this case 
study: the test has a limited applicability to NMs as they may not penetrate the cell wall and 
therefore potentially lead to false negative results (Clift et al., 2012). The predictability of in 
vitro genotoxicity of NMs for in vivo genotoxicity and carcinogenicity needs to be better 
understood. 
Bias in selection of category members (C.6) 
The case study was focused on MWCNT to keep the number of analogues and influencing 
properties manageable. The MWCNT analogues were selected based on data availability for 
all relevant physicochemical and most toxicological endpoints, leading to a dataset of 19 
NMs. There are many more MWCNT types described in the literature but because lack of 
consistent data leading to uncertainty about the identity and physicochemical 
characteristics they were not included in this case study. Generally, it is assumed that other 
MWCNTs would also fit into the category considered as defined within this case study, if 
they can be reasonably presumed to follow the same toxicokinetics and mode of action, and 
the category could be extended to other CNT types, e.g. SWCNTs, or even fullerenes or 
carbon black, on a case by case base, depending on their similarities in physicochemical, 
translocation and toxicological properties (see 4.5.2). 
 
Compound the test organism is exposed to (6.1) 
The toxicants are the considered MWCNT, high aspect ratio nanomaterials consisting of >90 
carbon which are not biodegradable (see Table 4.12). 
Common underlying mechanism, qualitative and quantitative aspects (6.2, 6.3) 
There is currently no agreement in the literature on the mode of action, nor on the 
genotoxic potential of nanoparticles as the overall results seem to indicate that some tests 
are more prone to give positive results than others.  
Ring trials carried out as part of the Nanogenotox Joint Action showed that for some tests 
there was low reproducibility. Remarkably, the comet assay showed better reproducibility in 
Caco-2 cells, while micronucleus test was better in BEAS 2B cells (see Table 4.18). 
Genotoxicity and the generation of reactive oxygen species are frequently investigated in in 
vitro studies with respect to their general predictive power for in vivo situations. However as 
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they neglect defence mechanisms, their predictivity for in vivo situations may be limited 
(Ken Donaldson, Poland, et al., 2010). In addition, recent analyses have shown that 
carcinogenicity is not predicted very well for particles (Roller, 2011). It is thus also difficult to 
establish a clear correlation between MWCNT properties with in vivo results (Roller, 2011; 
Ziemann et al., 2011). 
There is also some uncertainty related to the adverse effects, due to different types of 
effects that can be caused by properties related to the particle, nanosize or inorganic nature 
of the NM or a combination thereof. Test conditions and selection of tested concentrations 
may contribute to a big variability.  
Exposure to other compounds (6.4) 
As discussed above, impurities might de facto constitute differences between MWCNT 
which then may influence the toxicity. For example, catalytic metals from the production 
process and remaining as impurities on the CNT surface may be released and increase 
toxicity, e.g. contribute to oxidative stress. This has been mainly described for SWCNTs 
which may have up to 30% of iron; MWCNT have much lower concentration of catalytic 
metals.  
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Table 4.23. Evaluation of the uncertainties of the CNT case study according to the ECHA RAAF Scenario 6. 
 RAAF Assessment Element
(Scenario 6) 
Uncertainties in the CNT case study Nanospecific issues 
C.1 Substance characterisation 
• Uncertainty related to the nanoform identification 
• Measured physicochemical characteristics of the NMs 
vary: measurement uncertainty. Is there an influence on 
other properties of the nanomaterials? 
• Physicochemical characterisation of 
NMs: high variability of measurements 
(influence of different experimental 
conditions) 
C.2 Structural similarity and category hypothesis 
• No single physicochemical parameter seems suitable to 
predict toxicity, and some may be interdependent 
 
• For NMs, the similarity cannot be based 
on chemical (e.g. molecular) structure 
as for conventional chemicals, but 
should consider physical form and key 
physicochemical properties 
C.3 
Link of structural similarities 
and structural differences with 
the proposed property 
C.4 Consistency of effects in the data matrix 
• Uncertainty in applying existing testing protocols to 
nanomaterials and thus uncertainty in assessment of 
quality, reliability and relevance to human health 
endpoints of measured toxicity data 
 
• Artefacts affecting the results of toxicity 
assessment of NMs are discussed in the 
literature C.5 
Reliability and adequacy of the 
source study(ies) 
C.6 Bias that influences the prediction 
• Selection of analogues based only on data-availability; 
many MWCNT types not considered 
 
6.1 Compounds the test organism is exposed to 
 
 
 
 
• For conventional chemicals, either the 
parent molecule of (bio)transformation 
products are the indirect/direct 
toxicants; for NMs the considerations 
extend to coating, released metals etc  
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 RAAF Assessment Element
(Scenario 6) 
Uncertainties in the CNT case study Nanospecific issues 
6.2 Common underlying mechanism, qualitative aspects 
 
• The mechanism of genotoxicity of CNT is not well defined  
• It is also possible that several effects take place at the 
same time 
 
 
6.3 
Common underlying 
mechanism, quantitative 
aspects 
 
6.5 
Occurrence of other effects 
than covered by the hypothesis 
and justification 
 
6.4 
Exposure to other compounds 
than to those linked to the 
prediction 
• Impurities might constitute differences between MWCNTs 
which then may influence the toxicity 
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4.6.4 Summary of uncertainties in the case studies 
 
The major uncertainties encountered in the nanomaterial case studies were related to: 
• Complexity of nanostructures: similarity, category boundaries and members  
• Identification of nanomaterials 
• Quality and inconsistency/reproducibility of study data; missing protocols or 
uncertainty in the applicability of protocols to nanomaterials, both for  
• Material characterisation 
• Toxicity assays  
• Physicochemical properties driving the toxicity 
• Limited datasets  
• Read-across of negative effects 
• Possible combination of physicochemical properties affecting toxicity 
• Relevant test systems (in vitro mechanistic studies). 
 
Nanospecificities to be considered in the RAAF 
 
The following nanospecific issues have been identified related to a read-across for 
nanomaterials: 
• Similarity based on chemical structure to be replaced with appropriate and relevant 
other parameter(s), i.e. consider consider physical form and key physicochemical 
properties  
• However, for soluble nanoparticles the similarity in chemical structure can be 
applied; the solubility bringing back the NM into a classical substance case. 
• Definition of the “identical or different compounds” in the RAAF should be adapted 
to nanoforms and take factors such as coating, size/length into consideration  
• Definition of the compound the organism is exposed to and leading to an adverse 
effect:  
In the case of nanomaterials it is not only a distinction between parent compounds 
and (bio)transformation products such as metabolites, but for example needs to 
consider either the nanomaterial as such, or impurities/coating, released metals. 
• Are there specific nano-toxicity mechanisms or kinetics of exposure which have to be 
taken into consideration? 
The question of similarity is a specific fundamental issue. The RAAF, as related to the REACH 
legislation, is anchored on similarity of chemical structures.   
 326 
 
For nanomaterials, the first step of defining a group of similar analogues, i.e. nanoforms, has 
to be approached differently and similarity has to be defined based on the essential and 
relevant properties of the NMs. There is not a generally accepted way of defining similarity 
between NMs. It has been reported that the importance of physicochemical data for NM are 
dependent on the type of NMs (Sellers et al., 2015).  
Composition can be crucial for some applications and it could allow grouping (e.g. CNTs), 
however in other occasions coatings or solubility can be more important as could be the 
case for NMs that leach ions (e.g. Ag, ZnO). In addition, there is lack of publicly available data 
for NMs what makes it difficult to determine if two NMs have similar properties. But most 
importantly there is lack of standardised methods that guarantee that the same kind of data 
(e.g. size distribution) are generated in the same conditions and are comparable, starting 
with differences in the methods for the sample preparation. Currently, some data for NMs 
can be found in publications but closer inspection shows that the same type of data was 
usually measured with different protocols (solvents, sonication times, sonication types, etc.) 
and by different research groups. These variations in protocol raise the question of whether 
data generated in different conditions are comparable. All this results in smaller datasets 
and data gaps, taking also into account that there are very few in silico tools that can be 
used to calculate properties for specific NMs based on similarity between nanoforms for the 
purpose of prediction of toxicity.  
 
Thus, for nanomaterials the RAAF Assessment Elements based on chemical structure would 
need to be adapted appropriately.  
Furthermore, the variability of the measurement data of the NM characterisation hampers 
linking the characteristics to the observed effects. In the literature, appropriate definition of 
the requirements for characterisation is repeatedly called for (e.g. Fadeel, Fornara, Toprak, 
& Bhattacharya, 2015; Marchese Robinson et al., 2016; A. E. Nel et al., 2015).  
In general, however, the case studies have shown that the RAAF framework is applicable to 
nanomaterials as well as to conventional chemicals. 
 
4.7 Conclusions  
In this chapter the ECHA draft framework for grouping and read-across of NMs has been 
applied for the first time to two NM case studies. These case studies have been documented 
by providing mechanistic interpretation of the available data, where possible, and according 
to the state of the art in the field. However, it has also to be acknowledged that our dataset 
for application of read-across to NMs was quite limited due to the data availability. Although 
TiO2 nanoforms and MWCNTs are well studied NMs, it was not possible to identify a more 
suitable/relevant endpoint for carrying out our read-across case studies, and also the set of 
analogues was limited.   
In this paragraph, the conclusions and lessons learnt while carrying out the read-across case 
studies are summarised.   
 
 
 327 
Applicability of the ECHA workflow  
• The workflow proposed in the draft ECHA guidance for grouping and read-across of 
NMs (ECHA, 2017b) was applied to our case studies, and as reported in this chapter, 
it allows to present all the information collected and used to build and test the 
grouping hypothesis. Figure 4.13 shows a graphic where some pragmatic suggestions 
on how to deal with each step of the workflow are summarised. Such specifications 
would guide the applicant through the workflow, and are formulated according to 
our experience in grouping of NMs for read-across.   
• The approach followed in presenting the case studies was based on the pattern 
identified in the toxicological and physicochemical tests that are presented in step 2; 
then, chemoinformatic tools are applied in step 5 to assess the grouping hypothesis. 
Figure 4.16 reports some suggestions on the computational methods that could be 
suitable for this purpose. It would be possible also to apply computational methods 
in step 2 of the ECHA original workflow to define the grouping hypothesis that would 
then be assessed in step 5 by looking for toxicological tests to confirm it (the 
literature review on genotoxicity studies). 
• The narrative supported by the framework proposed by ECHA is complex and tends 
to cause repetition in reporting the case, because it assumes the hypothesis (stated 
in step 2, Figure 4.13) is built a priori from the data gathered for the identified 
analogues (steps 3 and 4). From the examples examined in this chapter it is evident 
that the hypothesis is a result of data evaluation and treatment, but this step comes 
after in the workflow. The read-across framework proposed by RIVM et al. (2016) 
goes in this direction as the whole dataset is introduced earlier in the process (step 
2), together with the initial grouping. Our suggestion in this respect would be to 
anticipate the data gathering process in step 2, so that the grouping hypothesis 
would take into account all the available information. This is also presented on the 
right-hand side of Figure 4.13. 
• The ECHA workflow is not specific to read-across between nanoforms only, but can 
also be used, in principle, for read-across from the bulk form to the nanoform. This 
depends on how similar the analogues are to one another, which has to be judged on 
a case by case basis. Our suggestion would be to make this clearer in the 
nomenclature applied to the workflow, for instance by referring to "different physical 
forms of a substance" instead of using the term "nanoform". 
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Figure 4.13. ECHA framework for grouping and read-across of NM properties. The ECHA proposed 
framework is presented on the left side, while on the right side suggestions on possible specifications 
to help applicants based on the lessons learnt in Nanocomput are presented. According to the case 
studies that were carried out, the step "Gather the available data for each group member and 
evaluate the data for adequacy and reliability" should occur earlier in the process, before the "Initial 
grouping of nanoforms". Construction of a matrix could come as a result of the data gathering, 
instead of consisting of a separate step. 
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Considerations on the read-across approach applied to NMs 
• Analogue vs category approaches. The analogue approach (one-to-one read-across) 
is implicitly covered in the category approach (many-to-one read-across). 
Multivariate approaches like PCA and cluster analysis are best suited to the category 
approach, where multiple analogues are available, and where relative pairwise 
similarities are meaningful. 
• Possibility to read across more than one endpoint. In principle this is possible, 
provided that the underlying rationale for grouping is valid for the different 
endpoints. This could be the case when the mode of action is based on the same 
fundamental properties, e.g. skin sensitisation and mutagenicity being dependent on 
particle reactivity. In practice, though, the group will be endpoint-specific due to the 
multiplicity of underlying modes of action. 
• In the hypothesis formulation stage, the starting point for grouping analogues is 
flexible and subject to expert judgement, depending on scientific (mechanistic 
knowledge) and practical (data availability) considerations. The initial choice of 
descriptors follows from this. For example, if the initial category hypothesis is that 
the toxicity of all metal oxides depends on their reactivity, and that reactivity is 
dependent on the atoms present, then metal composition could be a useful 
descriptor. If however the broad category of metal oxides is subcategorised to a 
specific subgroup (e.g. iron oxides), composition itself is unlikely to provide a means 
of discriminating between members of the group. Instead, additional descriptors 
would be required, e.g valence and/or band gap energy. This is consistent with the 
approach for categorisation and subcategorisation of organic substances in the OECD 
QSAR Toolbox. 
 
Relevance of computational methods in grouping for read-across 
• It has been shown how unsupervised techniques like hierarchical clustering and PCA 
can support the grouping hypothesis by identifying the differences between 
nanoforms and by supporting the weight of evidence in the read-across hypothesis.  
• Supervised and unsupervised techniques were applied in the case studies presented 
in this chapter. Unsupervised techniques are more useful early in the process for 
hypothesis formulation, to identify which properties are more relevant for grouping 
and to define the similarity between analogues on the basis of these properties. 
Supervised techniques are more useful later in the process, for model building when 
there is already evidence of property-activity relationships. In our case study, a 
supervised variable selection algorithm was used to determine the most valuable 
properties in predicting genotoxicity, to support the grouping hypothesis. 
Irrespective of the techniques used, they should be considered as feeding 
information into an overall weight of evidence, rather than being conclusive 
themselves. 
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Uncertainty in grouping NMs for read-across  
• Uncertainty associated to the read-across exercises has been taken into account; 
uncertainty is related to the identification of the (non-)nanoforms, experimental 
variability associated with the physicochemical and toxicological information and to 
the lacking measurement protocols, and, finally, to the lack of knowledge on the 
mechanisms of genotoxic action of NMs. 
• We have developed a table of uncertainties that relate back to the ECHA RAAF. This 
indicates clearly additional considerations that need to be considered: e.g. 
o Applicability of in vitro test methods 
o Problem of particles precipitating onto cell surface and causing false positives 
due to membrane damage / "suffocation" 
• A RAAF scenario was applied to our case studies for uncertainty analysis; therefore, 
the RAAF is applicable to NMs. A key aspect that is missing and would need to be 
more articulated for its application to NMs, is the concept of similarity, as in the 
RAAF it is limited to chemical similarity, and for a more consistent application to 
NMs, other principles for similarity shall be included.  
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5 Recommendations for further research and development 
5.1 Nanotoxicity modelling project landscape 
5.1.1 European nanosafety research activities 
European research projects addressing the safety of materials and technologies using 
nanomaterials are organised under the overarching umbrella of the NanoSafety Cluster 
(NSC) (http://www.nanosafetycluster.eu), in order to foster exchange and synergies and 
avoid duplication of work. Topics of the projects include safety assessment, assessment of 
toxicity to human health and the environment, exposure, mechanism of interactions and 
also definitions, standardisation and regulatory aspects. 
Cross-NanoSafety Cluster working groups bring together researchers from the different 
projects to contribute to the discussion of specific topics and tackle issues common to the 
different projects. The original working groups were dedicated to: 
• Materials https://www.nanosafetycluster.eu/working-groups/materials-wg.html 
• Hazard https://www.nanosafetycluster.eu/working-groups/2-hazard-wg.html 
• Exposure https://www.nanosafetycluster.eu/working-groups/3-exposure-wg.html 
• Database https://www.nanosafetycluster.eu/working-groups/4-database-wg.html 
• Risk https://www.nanosafetycluster.eu/working-groups/5-risk-wg.html 
• Modelling https://www.nanosafetycluster.eu/working-groups/6-modelling-wg.html 
• Dissemination https://www.nanosafetycluster.eu/working-groups/7-dissemination-wg.html
• Systems Biology https://www.nanosafetycluster.eu/working-groups/8-systems-biology-wg.html
• Safe by Design  
and Industrial 
Innovation 
https://www.nanosafetycluster.eu/working-groups/8-systems-biology-wg.html
 
The status and activity are variable. In the recently presented NSC Action Plan 2017, it is 
foreseen to re-organise the working groups to match the planned transition of the NSC to an 
Innovation Governance platform (Cassee et al. 2017).  
The NSC issues a yearly compendium describing the status of current EU projects on 
nanomaterial toxicity, exposure assessment and risk management, as well as giving an 
update on the NSC working groups. The focus is increasingly shifting towards safety-by-
design considerations, predictive toxicology and high throughput / Tox21 type approaches 
(Lynch 2016). A biannual newsletter gives updates on the projects. Furthermore, the NSC has 
published a Strategic Research Agenda “Nanosafety in Europe 2015-2025” (Savolainen et al. 
2013), and an update on research priorities in 2017 (Stone et al. 2017). The latter builds on 
proposals made by the ITS Nano project in their final report, which stressed the major topics 
of physicochemical characterisation, exposure identification, hazard identification and 
modelling approaches for the risk assessment of NMs (Stone et al. 2014). 
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For the scope of the Nanocomput project, the NSC Modelling and Database working groups 
are specifically relevant, since they discuss building of and guidance for models for 
nanomaterial characterisation and toxicity prediction, and databases and ontologies related 
to nanomaterials, respectively. The latter is particularly active and has carried out initiatives 
to provide a list of nanosafety related databases in Europe and globally (Mustad et al. 2014), 
a definition of data quality and recommendation of a minimal reporting standard, in 
particular which experimental details need to be recorded. Members have also contributed 
to an international effort of assessing data completeness and quality (Marchese Robinson et 
al. 2016). While data completeness is not explicitly defined in the paper, it generally 
“assesses the extent to which experimental details are described and associated 
experimental results are reported” (Marchese Robinson et al. 2016). This can be achieved 
for example by checking against a list of minimum information requirements which would 
need to be defined in the context of specific applications.  
The NSC Database working group is in contact with the US-EU Communities of Research on 
Databases (http://us-eu.org/communities-of-research/search-communities-of-
research/databases-ontologies/) and the US Nano WG (https://nciphub.org/groups/nanowg) 
(see 5.1.2). 
 
 
 
Figure 5.1. Schematic representation of the nanosafety related projects and working groups at 
European level and their interaction with international initiatives. 
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Table 5.1 lists the individual EC 7th Framework Programme research projects (including a 
LIFE+ project) that have been identified as related to computational modelling and grouping 
approaches for NMs. 
Table 5.1. EU funded projects related to computational modelling and grouping approaches 
for nanomaterials 
• eNanomapper • NanoFATE 
• ENPRA • NanoMILE 
• FutureNanoNeeds • NanoPUZZLES 
• ITS-NANO (support action) • NANoREG 
• MARINA • NanoReTox 
• MembraneNanoPart  • NANOSOLUTIONS 
• MODENA (COST initiative) • NanoTEST 
• MOD-ENP-TOX • NanoTranskinetics  
• MODERN • PreNanoTox 
• ModNanoTox    • REACHnano (LIFE+). 
• NanoBRIDGES (Marie Curie Action)  
 
More details on the projects are given in Appendix IV. 
Out of these projects, five have been dedicated to computational modelling and started at 
the same time. With two other modelling projects, already running, they formed the NSC 
Modelling Cluster (Table 5.2), agreeing in a Memorandum of Understanding to collaborate, 
share expertise and use common synergies. They held regular harmonisation meetings. 
eNanomapper joined this cluster later. 
 
Table 5.2. Projects forming the NanoSafety Cluster (NSC) Modelling Cluster 
MembraneNanoPart: Modelling the mechanisms of nanoparticle-lipid interactions and 
nanoparticle effects on cell membrane structure and function 
MOD-ENP-TOX: Modeling platform to predict the toxicity of metal-based 
nanoparticles 
MODERN: Modelling the environmental and human health effects of 
nanomaterials 
NanoPuzzles: Modelling properties, interactions, toxicity and environmental 
behaviour of engineered nanoparticles 
PreNanoTox: Predictive toxicology of engineered nanoparticles 
ModNanoTox: Modelling nanoparticle toxicity: principles, methods, novel 
approaches 
NanoTranskinetics: Modelling the basis and kinetics of nanoparticle cellular interaction 
and transport 
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5.1.2 International activities  
The European research projects are in contact with US colleagues through the Communities 
of Research (CoRs). Each CoR is dedicated to a specific topic and serves as discussion forum 
for researchers, interested stakeholders from academia, government, industry, and NGOs 
from both sides of the Atlantic in this US-Europe dialogue (http://us-eu.org/), bridging Nano 
Environmental Health and Safety (Nano EHS) research efforts: 
• Databases & Computational 
Modeling for NanoEHS 
http://us-eu.org/communities-of-research/search-communities-of-
research/databases-ontologies/ 
• EcoToxicity http://us-eu.org/communities-of-research/search-communities-of-
research/ecotoxicity-testing-predictive-models/ 
• Risk Assessment http://us-eu.org/communities-of-research/search-communities-of-
research/risk-assessment/ 
• Exposure through Product 
Life 
http://us-eu.org/communities-of-research/search-communities-of-
research/exposure-through-the-life-cycle/ 
• Risk Management & Control http://us-eu.org/communities-of-research/search-communities-of-
research/risk-management-control/ 
• Human Toxicity http://us-eu.org/communities-of-research/search-communities-of-
research/predictive-modeling-for-human-health/ 
• Characterisation http://us-eu.org/communities-of-research/search-communities-of-
research/characterisation/ 
 
On the US side, the Nanotechnology Working Group (NanoWG) is a working group of the 
National Cancer Informatics Program (NCIP, https://cbiit.nci.nih.gov/ncip/ncip-home) and is 
very active in the community. It included the Nanomaterial Data Curation Initiative (Hendren 
et al. 2015), relevant for the data-related issues for modelling. The NanoWG has close bonds 
to the NSC Database working group. 
Furthermore, projects including aspects of modelling and grouping for NMs are funded by 
the National Center for Environmental Research (NCER) (see Appendix V). 
On an international level, the OECD Working Party on Manufactured Nanomaterials (WPMN) 
promotes international co-operation in human health and environmental safety aspects of 
manufactured NMs. 
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5.2 Challenges and needs for the development and use of computational methods 
 
There is consensus in the literature that computational models for prediction of nanotoxicity 
will be able to make an important contribution to nanosafety assessment, since it is not 
possible to test all existing nanoforms, which differ in particle size, shape, coating and other 
characteristics. It is also in line with general efforts in applying alternative methods in 
chemicals risk assessment. However several limitations and barriers to the development and 
use of computational prediction models for nanoparticles have been identified. 
 
From the analysis of available models as described in Chapter 3, limitations on the 
availability and utility of computational models for NMs for regulatory purposes can be seen 
as: 
• Limitation of existing models / applicability domains:  
Models available cover a limited number of endpoints and in some cases several 
have been derived from the same datasets. Most models were derived from small 
datasets. 
• Limitation of use in the regulatory context:  
There is an insufficient number of QSPR and QSAR models for directly filling data 
gaps for REACH endpoints (physicochemical properties, ecotoxicity endpoints and 
human health endpoints). However available models can be used for screening or 
support grouping and read-across. On the other hand, the applicability and 
availability of environmental fate models is more promising. 
In terms of challenges and knowledge gaps for the development of models, the overarching 
problems for the development of models can be summarised as follows, as described in the 
literature (Gajewicz et al. 2012)(Oksel et al. 2015) (Richarz et al. 2014)(Marchese Robinson 
et al. 2016). They are mostly linked to the underlying data and thus to experimental issues, 
apart from chemoinformatics problems and the general uncertainties of linking effects 
mechanistically to NMs: 
• Lack of data (quantity) – large datasets needed for development of robust models 
• Data completeness, data quality insufficient 
• Lack of comparability – limiting creation of larger datasets by pooling data from 
different sources 
(comparability between labs, between different types of nanomaterials –variability, 
different protocols for characterisation) 
• Validity for nanotoxicity (reliability, relevance) uncertain – link of NM properties with 
effect. 
 
The knowledge gaps are detailed in Table 5.3. 
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Table 5.3. Limitations hampering the development of computational models for NMs and 
the specific related knowledge gaps. 
Limitation Specific related knowledge gaps 
  
Data quantity: 
large datasets 
needed 
o Standardised reporting format to enable pooling and comparison of data 
o Reference materials to allow comparison between studies (Eugenia 
Valsami-Jones 2016) 
o Existing data easily and freely accessible 
o Central data repository 
Data quality o Harmonised protocols (SOPs) for NM characterisation and toxicity 
measurements, also allowing for comparability of data measured in 
different laboratories  
o Polydispersity and heterogeneity of NMs  
o Batch to batch variability of nominal identical NMs (Marchese Robinson 
et al. 2016)) 
Data 
completeness 
o Minimum requirements on parameters to measure and report 
Validity for 
nanotoxicity 
prediction models 
o Finding the appropriate (nanospecific) descriptors to link the complex, 
nonuniform NM properties to toxicity (Oksel et al. 2015) 
o Applicability of toxicity test guidelines to nanomaterials, i.e. validity of 
the results for nanosafety assessment; e.g. artefacts affecting reliability 
of NM biological assessment (Kroll et al. 2012), (Klaine et al. 2008) 
Technical issues 
of modelling 
o Transformation of NM structures into computer-usable representation 
(Oksel et al. 2015) 
 
The quality and robustness of a computational prediction model depends indeed on the 
quality of the data used for the model development. Therefore the consideration and 
evaluation of the data, and steps to improve data availability and quality are a crucial for 
modelling. Key concepts of data completeness, minimum information checklist and data 
quality for example are highlighted in (Marchese Robinson et al. 2016). An important point is 
the aim to allow comparability of data from different sources and provided by different 
laboratories in order to create a more robust data basis, ideally in an overarching and 
comprehensive data repository, for analysis of property-effect relationships, building of 
predictive models and using grouping and read-across approaches (Richarz et al. 2017). 
The uncertainties identified in the TiO2 and CNT case studies (Tables 4.21 and 4.22) point at 
the same issues, i.e. uncertainty related to the nanoform identification, high variability in the 
experimental measurements, uncertainty in applying exiting test protocols and relevance for 
human health endpoints, lack of knowledge of the mechanism of toxic action. 
As a way forward, recommendations have been given in the past, in the literature and e.g. 
OECD workshops (OECD 2016, 2017):  
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• Setting of minimum requirements on experimental parameters to record 
• Standardisation of the data format, templates for data exchange and harmonisation 
• Creation of a database framework for public availability and access of data 
• Creation of ontologies for a harmonised terminology 
• Implementation of standard operation procedures (SOPs) for experimental 
measurements, both for NM characterisation and toxicity measurements 
• Clarification which test guidelines are applicable to nanomaterials, establishment of a 
set of caveats → adapƟon of test guidelines to nanospecific characterisƟcs (Hansen 
et al. 2017) 
• Elucidation of mechanisms underlying nanotoxicity and link to NM properties. 
 
5.3 Recent progress against the challenges and needs 
 
The research initiatives described in Section 5.1 have and are continuing to work towards 
solving the issues hampering model development and use. For example: 
• The NSC Modelling Cluster aimed at harmonising data collection and recording between 
the projects by using a common standard (ISA-TAB-Nano)(Thomas et al. 2013, 
https://wiki.nci.nih.gov/display/ICR/ISA-TAB-Nano) in view of bringing all data together in 
one common database. However, while the envisaged cross-project data collection did 
not happen, some projects of the Modelling cluster did use the ISA-TAB-Nano format and 
made the collected and formatted data publicly available separately; e.g. NanoPuzzles 
(Marchese Robinson et al. 2015, all NanoPUZZLES ISA-TAB-Nano datasets available at 
Zenodo: https://doi.org/10.5281/zenodo.35493) and MOD-ENP-TOX (Vriens et al. 2017). 
• The cross-NSC Database working group worked on the definition of minimum information 
requirements, based on the MINChar Initiative parameters list 
(https://characterizationmatters.wordpress.com/parameters/) and discussed data quality 
and completeness, together with US groups, e.g the NCIP Nanomaterial Data Curation 
Initiative (Hendren et al. 2015)  
• The eNanomapper project set out to create a bespoke infrastructure to store data from 
EU research projects and also share predictive models for NMs. eNanomapper has indeed 
achieved to provide the technical framework to upload and store data from research 
projects in different formats). So far only few data have been uploaded:all data from 
NanoREG, plus data from MARINA (6 substances), Modena (59 substances), NanoWiki, 
Protein Corona Fingerprinting Predicts the Cellular Interaction of Gold and Silver 
Nanoparticles.csv (121 substances). This infrastructure can be used for further efforts to 
create a centralised data repository. Two current projects are using the infrastructure 
(NANoREG2, caLIBRAte) for internal data sharing at the moment. Regarding models: 
eNanomapper makes available cheminformatcs tools to create own models, including a 
nano-read-across application; but no models from EU projects are included. 
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• A dialogue between modellers and experimentalists was seen as essential, as stressed 
and for example in the NanoBRIDGES project. 
 
An analysis of the ongoing work in European research projects has been carried out, in order 
to assess the (future) availability of more models, tools or knowledge contributing to close 
the gaps. 
 
5.3.1 Review of deliverables from current EU-funded research projects 
In the systematic review of EU projects, 18 projects under the 7th Framework programme 
related to modelling approaches were considered, plus a support action, a COST initiative 
and a LIFE+ project (Table 5.1 and Appendix IV). Most projects have reached their end since 
beginning of the analysis within Nanocomput, the last will end – as generally all FP7 projects 
– by 31 December 2017.  
Tasks, work packages and deliverables in the projects relevant for the scope of NanoComput 
were identified by a keyword search of the project Descriptions of Work (DoWs). The 
keywords used were:  
- group; grouping; category; read-across 
- QSAR; QSPR; in silico 
- Fate model; multimedia; kinetic 
- Behaviour. 
Steps followed in the evaluation of results of current EU projects: 
1. Selection of projects relevant to NM computational modelling and grouping approaches 
2. Identification of relevant tasks and deliverables by keyword search of the DoWs 
3. Exclusion of deliverables not available within the time frame of Nanocomput (see 
section 5.3.2) 
4. Request of deliverables from the project coordinators 
5. Identification of relevant content: new models, tools, other knowledge possibly allowing 
progress towards the challenges and gaps  
6. In case of not receiving the deliverables from the projects: consideration of other 
information e.g. from public project reports or the project websites. 
Several projects only replied after several reminders or had concerns about intellectual 
property, which could be solved after discussions. For some projects, the coordinator did not 
reply, but material was available from JRC being a project partner. For two projects no reply 
or material at all was received. 
This was also a lesson in how difficult it can be to assess research results which should 
ideally be public and be used to advance public knowledge and science. 
Table 5.4 gives an overview of the results from current EU projects related to NM 
computational modelling and grouping approaches, as identified in the review exercise. 
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Table 5.4. Selected results and examples from current EU projects related to NM computational modelling and grouping approaches.  
Project Models (QSAR/fate/kinetic) or 
grouping approach 44 
Tools  Contribution to modelling e.g. related 
to data  
eNanomapper  Jaqpot Quattro (JQ) web application, including 
model validation and optimal experimental 
design functionalities; Nano-Lazar extended for 
NMs, build toxicity predictions from a local 
nano-QSAR, based on eNanomapper database, 
supports grouping/read-across. 
Publicly available database (Jeliazkova 
et al. 2015) able to importdata in 
different formats. 
Ontology. 
Annotated spreadsheet templates for 
capturing experimental data and 
software to convert the spreadsheets 
into different formats. 
ENPRA Development of structure-activity 
models for NP for binary oxides. 
 Led to publications by Enrico Burello 
(Burello and Worth 2011) 
FutureNanoNeeds   Experimental data, e.g. degradation 
kinetics, nanoparticle-cell interactions 
ITS-NANO     Framework of future research priorities 
(Stone et al. 2014) 
MARINA Grouping approach outlined (Oomen 
et al. 2015) 
Decision tree construction tool (GPTree): 
application to nanoSAR modelling in case 
studies (Oksel et al. 2016) 
Data for TiO2, SiO2, ZnO and MWCNT; 
reporting format based on OECD 
harmonised templates 
MembraneNanoPart  Modelled dispersions of NP from 5 
main groups of nanomaterials at 
physiological conditions. 
 Insights into interaction with lipid 
membranes. 
                                                      
44 Models published by the project in the scientific literature were included in the Nanocomput model landscape review. 
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Project Models (QSAR/fate/kinetic) or 
grouping approach 44 
Tools  Contribution to modelling e.g. related 
to data  
MOD-ENP-TOX Models developed predicting the 
effects of MeNPs on effects on 
mitochondria and their potential to 
damage DNA or otherwise interfere 
with genetic processes. 
PBK modeling of zinc oxide NPs and 
zinc nitrate in mice(Chen et al. 2015) 
Modelling Assays Platform "MAP" for hazard 
ranking of engineered nanoparticles. Predicting 
the toxicity or hazard level of metal-based 
nanoparticles (MeNPs) - silicon, titanium, silver, 
zinc and their oxides.  
Constructed a database with published 
experimental data on well-
characterised silica and zinc oxide NPs 
(Vries et al. 2017).  
MODERN QNARs developed: (Kamath et al. 
2015), (Liu et al. 2015), (Toropov et al. 
2015), (Liu et al. 2013). 
NP categorisation criteria for category 
identification and formation. Data-
driven grouping approaches: 
Multiscale bootstrap hierarchical 
clustering, Self-Organizing Maps, 
Complex Network analysis. 
Robust ranking hazard methodology 
for NMs using their toxicological and 
their physical-chemical data 
developed. 
ISA-TAB-Nano Validator tools to validate ISA-
TAB-Nano datasets based on compliance with 
the specifications. 
nanoDMS (Nanomaterial Data Manage-ment 
System) to facilitate data sharing via the ISA-
TAB-Nano format. 
Anapath (Pathway Analisys): to identify 
pathways which are differentially expressed, 
from high-throughput transcriptomics or 
proteomics assays. 
Integration of NP categories and hazard ranking 
into a quantitative risk assessment scheme: 
framework implemented into an tool that will 
be made freely available. 
Identification of NP bioactivity 
signatures from high-throughput omics 
data. 
Size-consistent nanodescriptors 
developed for QNPR modelling. 
 
 
 350 
Project Models (QSAR/fate/kinetic) or 
grouping approach 44 
Tools  Contribution to modelling e.g. related 
to data  
NanoBRIDGES  Software tools with guidance documents made 
available at http://nanobridges.eu/software/: 
Standardisation of data sets, modelability of 
the dataset, data pre-treatment, Dataset 
Division, Kennard Stone Algorithm (Euclidean 
and Mahalanobis distance based), variable 
selection methods, applicability domain, 
Clustering - Modified k-Medoid Tool, 
NanoProfiler - Endpoint-dependent analogues 
identification software. 
Coral software for descriptor calculations for 
NMs 
(http://www.insilico.eu/coral/SOFTWARECORA
L.html) 
 
NanoFATE   Insights into fate processes regarding 
behaviour of NPs  
NanoPUZZLES Conceptual framework for grouping 
NPs based on physicochemical and 
molecular properties 
 Standardised ISA-TAB-Nano templates 
to record data and submit them to 
databases (Marchese Robinson et al. 
2015).  
Collected data made publicly available.  
Reviewed systems describing the 
structural characterisation of NPs. 
Considerations about data quality 
assessment. 
Discussion of validation criteria for 
nanoQSARs. 
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Project Models (QSAR/fate/kinetic) or 
grouping approach 44 
Tools  Contribution to modelling e.g. related 
to data  
NANoREG Pooling approach to analyse published 
in vitro data for grouping of NPs, 
balancing out the lack of 
standardisation of tests (Simkó et al. 
2015) 
 Dispersion SOPs and minimum 
requirements for characterisation; data 
publicly available through 
eNanomapper; ISA-TAB Nano 
templates (Totaro et al. 2017). 
Harmonised terminology for NM 
environmental health and safety 
assessment. 
 
NanoReTox   Approaches providing practical ways to 
compare nanomaterials, identify those 
physicochemical parameters that are 
relevant for toxicity assessment, and 
form the basis for an implementable 
risk assessment framework. Datasets 
and methodologies developed made 
extensively available in the scientific 
literature. 
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Project Models (QSAR/fate/kinetic) or 
grouping approach 44 
Tools  Contribution to modelling e.g. related 
to data  
NANOSOLUTIONS  Completed the development of the 
computational infrastructure of the ENM 
classifier. ENM safety classifier is intended to 
be a data-driven computational model derived 
from machine-learning algorithms. Multiple 
data layers, spanning from the physicochemical 
properties of the materials investigated, to 
their effects (mode of action) on living systems 
at the molecular, cellular, organismal and 
ecological levels will serve as the input. An easy 
to use graphic user interface is planned. - 
Development of a novel evolutionary algorithm 
explores the space of all the possible 
combination of features (solutions) to be used 
for prediction purposes. Method outperforms 
other existing multi-view clustering algorithms 
such as Tw-Kmeans and SNF.  
Experimental translocation studies. To 
better understand the mechanisms of 
uptake of NMs via different routes into 
the body and into tissues/organs. 
NanoTranskinetics    High quality data from previous 
experimental research projects and 
additional dedicated experiments in 
collaboration of experimentalists and 
modellers 
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Project Models (QSAR/fate/kinetic) or 
grouping approach 44 
Tools  Contribution to modelling e.g. related 
to data  
PreNanoTox New category descriptors "collectors 
of eclectic information" instead of 
traditional descriptors;  
Monte Carlo technique used to build 
predictive models for the prediction of 
cell membrane damage of metal oxide 
nanoparticles; cellular viability (CV%) 
towards silica NPs. 
Suggestion of building predictions for 
NM related endpoints based on quasi-
SMILES. 
 Database of collected data to be made 
available.  
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Overall the systematic review of the current EU project research into nanosafety assessment 
showed that: 
  
• new models have been developed – the new models published in the scientific 
literature have been included in the Nanocomput model landscape review, including 
the evaluation of applicability in a regulatory context. Models still under 
development or not fully described or made public might add to the landscape in the 
future. 
• new tools have been developed contributing to individual tasks related to 
computational modelling or designed as comprehensive modelling tools (see Table 
5.4) – for example accessibility of cheminformatics tools on the eNanomapper 
website  
• nanospecific descriptors were studied  
• progress has been made towards data format standardisation, ontologies, data 
sharing, for example ISA-TAB-Nano based templates for data recording developed 
withing NANoREG and NanoPuzzles; the eNanomapper database technology to  
upload and store project data.  
• SOPs for the experimental measurements. For example, within the MARINA project 
eight OECD TGs were adapted based on the testing of at least one ion-releasing NM 
(Ag) and two inert NMs (TiO2) (Hund-Rinke et al, 2016). Protocols have also been 
developed by the NanoValid project (http://www.nanovalid.eu/) and by NANoREG 
(Gottardo et al, 2017). 
• new data have been generated and/or collected from the literature. Data from for 
example NANoREG, MARINA and NanoPUZZLES have been made publicly available. 
Altogether, this contributes towards reducing the knowledge gaps and overcoming current 
limitations. Some examples are listed in Table 5.5. 
 
Table 5.5 Mapping current project results against challenges 
Limitation New results filling specific related knowledge gaps
  
Data quantity: 
large datasets 
needed 
o Standardised reporting format based on ISA-TAB-Nano developed in 
NAnoPUZZLES and NANoREG 
o New data created 
o eNanomapper public database to serve as repository, compatible with 
different data formats 
Data quality o SOPs developed in NANoREG, all measurements within the project 
carried out according to these SOPs 
Data completeness o Contribution to discussion about data quality, completeness and 
minimum requirements (Marchese Robinson et al. 2016) 
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Validity for 
nanotoxicity 
prediction models 
o Descriptors studied and derived in several projects 
o New insights into mechanisms, NM behaviour and kinetics 
Technical issues of 
modelling 
o Representation of NM structures discussed 
 
5.3.2 New Horizon2020 projects 
In the framework of H2020, several new nanosafety projects have started. Since these 
projects started later than those described above (Section 5.3.1), deliverables were not 
available for review. These projects are listed in Table 5.6. 
 
Table 5.6. New Horizon2020 projects related to NM computational modelling and grouping 
approaches. 
Project Aims 
SmartNanoTox 
http://www.smartnanotox.eu 
Coordinator:  
University College Dublin 
• To identify main pulmonary adverse outcomes induced by 
NMs, associated MIE, KEs and toxicity pathways  
• To establish relationships between physicochemical 
properties of NMs and KEs, suggest descriptors for 
grouping of NMs according to their toxicological mode-of-
action 
• To create a database of bionano interactions that will 
enable development of read-across and QSAR tools 
• To develop a smart screening approach, with predictions of 
NM toxicity made on the basis of purely computational or 
limited in vitro screening test 
NANoREG II 
www.nanoreg2.eu  
Coordinator: INERIS 
• To develop supportive tools for Safe by Design, based on 
regulatory orientated grouping approaches, placed in a 
general ITS 
NanoFASE  
http://www.nanofase.eu 
Coordinator: NERC 
• Nanomaterial fate and speciation in the environment, the 
overarching objective is to deliver an integrated Exposure 
Assessment Framework. 
ProSafe  
http://www.h2020-
prosafe.eu 
Coordinator: Ministerie van 
Infrastructuur en Milieu 
• To support the aims of EU and international efforts (OECD, 
COR, EU-USA) by streamlining data acquisition, collection 
and management 
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5.4 Conclusions and recommendations 
 
The systematic review of the recent EU project research into nanosafety assessment showed 
that considerable progress has been made towards addressing the challenges of modelling 
nanomaterials. However there is still a fragmentation in the scientific results and a lack of 
coordination, and the lack of public access to the results and tools is preventing their uptake 
and use in regulatory decision making. To address these shortcomings, the Commission 
should consider implementing a number of recommendations. They are addressed and  
summarised in the Chapter 6. 
 
5.4.1 Conclusions on the needs addressed  
The following conclusions can be made after reviewing the scientific progress from current 
research progress: 
• There is still fragmentation of the work. Similar developments have been conducted in 
parallel in several projects, e.g. ISA-TAB-Nano-based templates in NANoREG (Totaro et al. 
2017) and NanoPUZZLES (Marchese Robinson et al. 2016).  
• Public availability of scientific results, models and tools is not a given. While some results 
have been made available through the project websites or public repositories, others are 
not easily accessible (as also experienced in trying to obtain the deliverables from the 
project coordinators). Specifically, some new models have been disseminated as 
publications, others are only described in project deliverables, and not always in a usable 
form. Ideally models should be documented and made available in a suitable format (e.g. 
QMRF) in a public repository. 
• Even though data templates and SOPs have been developed, they have not gained 
widespread use within projects, thereby creating a barrier to data sharing and 
dissemination.  
• There are significant issues in terms of data quality and reproducibility of experiments. 
While new and future projects can be expected to produce higher quality data by 
following more standardised SOPs and harmonised reporting standards, this does not 
solve the problem of how to use existing data in a regulatory context. A strategy must be 
devised on how to interpret and integrate these data, while recognising their limitations.  
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5.4.2 Recommendations  
Taking into account the experience from the reviews of the modelling landscape (Chapter 3), 
the read-across case studies (Chapter 4) and the review of recent EU project results (Chapter 
5), the following recommendations can be given with a view to increasing the availability 
and utility of computational methods: 
 
• Continued efforts should be made to address the already identified and still existing and 
knowledge gaps and technical challenges. The NSC organisation and structure could be 
exploited to support the scientific coordination across projects. 
• Within the context of Horizon 2020 and related EU research programmes, the 
Commission should consider implementing quality guidelines to improve the overall 
consistency of reporting of data, models and tools. For example, the use of standardised 
SOPs and reporting formats for data and models, could be made a requirement in 
upcoming projects.  
• In addition, the Commission should consider making the public dissemination of 
research and development outputs a contractual obligation. 
• There is also a need to raise awareness in the research community that model 
development should be carried out with concrete regulatory applications in mind. For 
example, in our read-across case studies, we identified a need to develop QSPRs for the 
mechanical properties (e.g. rigidity) of carbon nanotubes, and to explore the utility of 
these (predicted) properties in supporting grouping and read-across. 
• Models should be made available in a usable form. At the very least, they should be 
documented appropriately in a public repository so they can be reproduced, and ideally 
they should be implemented in the form of a software tool, to increase practical 
usability. Nanocomput has made a valuable contribution in creating/updating templates 
to record computational models, adapted for NMs. These templates should be made 
available for universal use. In addition, appropriately documented models could be 
disseminated via JRC information sources such as the QSAR Model Database (for 
QSPR/QSAR models), DB-ALM (for in vitro models and computational models other than 
QSPR/QSAR), as well as via project websites. 
 
The creation of a “one stop” hub with all necessary information, linking to the respective 
tools and information sources, would be valuable. It seems that the planned ECHA 
Observatory for nanomaterials (EU-ON) could play this role. The overarching hub would 
include existing infrastructure technologies and refer to available repositories, such as the 
eNanomapper database to further integrate data, and the JRC QSAR Model Database and 
the OECD QSAR Toolbox for documenting and sharing models. 
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6 Conclusions and Recommendations 
This chapter presents the overall conclusions from the Nanocomput project, including 
lessons learned in conducting literature reviews and research-based case studies on 
grouping and read-across. A number of recommendations are also offered with a view to 
overcoming current shortcomings in our knowledge of NM behaviour, and in the availability 
of tools (such as databases and predictive models) and practical guidance to use such tools 
in the regulatory assessment of NMs. 
Figure 6.1 summarises the major barriers to the development and regulatory use of 
predictive models in nanotoxicology. These play a role at different levels in the creation and 
application of knowledge: A) experimental methods for NM physicochemical and toxicity 
characterisation creating the knowledge needed for model development, and existing 
computational models; B) standardisation of the obtained information and tools for 
comparability; C) sharing and accessibility of both data and models; D) dissemination and 
awareness; E) actual use of data and models for application in regulatory decision-making. 
 
 
 
Figure 6.1. Summary of the issues hampering the successful development, uptake and use of 
prediction models to support regulatory decision-making on NMs. The problems identified (red) 
impact on computational nanotoxicology at different levels (blue): A) experimental methods for NM 
physicochemical and toxicity characterisation, existing models; B) standardisation of information and 
tools for comparability; C) sharing and accessibility; D) dissemination and awareness; E) use of data 
and models for application in regulatory decision-making. Possible measures to improve the situation 
are indicated (green). 
 
6.1 Inherent scientific uncertainties 
There are still significant knowledge gaps regarding the physicochemical characteristics of 
NMs and their influence on determining physicochemical, biokinetic and toxicodynamic 
properties of the materials. Even if non nano-specific mechanisms of toxicity have been 
identified (Gottardo et al, 2017), it is considered that the particle properties of NMs affect 
their kinetics / fate, as well as the nature of any Molecular Initiating Events in their 
toxicological pathways (Gerloff et al, 2017). 
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These knowledge gaps need to be filled. European research projects (Chapter 5) such as 
NANoREG, MARINA, NanoPUZZLES and MOD-ENP-TOX are generating new data and/or 
collecting literature data. However, these are data needed for the specific aims of the 
respective projects, and not a targeted approach to fill data gaps for regulatory assessments.  
Furthermore, our review of the progress made and results obtained in European research 
projects has revealed the difficulty of actually finding and accessing publicly disseminated 
data from the projects. 
In developing and applying computational models, it should also be borne in mind that NM 
behaviour depends on many parameters, and this dependence could be very sensitive to 
initial conditions. Therefore in some circumstances it could even be theoretically impossible 
to accurately predict the behaviour of NMs, especially over longer time periods. Therefore, 
modelling efforts should avoid false precision, such as for example the exact time-dependent 
composition of the protein corona. Despite this theoretical challenge, we believe that even 
relatively simple models can be useful aids for decision-making (e.g. Burello & Worth, 2013). 
 
6.1.1 Recommendation 
• Dedicated and focused research efforts are needed to elucidate the behaviour (toxicity 
and fate) of NMs of regulatory interest and to investigate which fundamental 
characteristics and properties are relevant for predictive modelling. 
 
6.2 Data quality and availability 
One of the major issues hampering the modelling of NMs is the lack of good quality data and 
the high variability of available data.  
Reliable and relevant data are essential for deriving the underlying principles of NM 
behaviour, and for correlating physicochemical properties and activities/toxicity as the basis 
for building prediction models, grouping similar substances / materials and performing read-
across. 
For the Nanocomput read-across case studies, a reasonable amount of data was generally 
available for the selected NMs. However, closer inspection of the data and exclusion of 
inconsistent and highly variable data left only a limited selection of analogues for both TiO2 
and MWCNT with available data for the main physicochemical parameters and toxicological 
endpoints. This led to restricted datasets, and limited the endpoints that could be read 
across (in vitro Comet assay in the case of nano-TiO2). 
Moreover, an extensive data treatment (e.g. Appendix IX) was necessary to deal with the 
inhomogeneity in experimental measurements and to make the data sufficiently 
homogeneous to compare the analogues in the read-across process. One factor contributing 
to the inhomogeneity of available data is the lack of standardised and validated methods for 
physicochemical characterisation and toxicity assessment. The other factor is the low 
reproducibility of some measurements, such as zeta potential, due for example to 
dispersability problems (Appendix VIII). The importance of ensuring dispersion stability has 
been demonstrated by Cupi et al 2016. 
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Extensive data analysis and treatment will continue to be a significant step before modelling, 
as long as reliable and comparable methods for physicochemical characterisation and 
toxicological testing are not available, and existing data are not recorded in standardised 
formats, with agreed minimum data inclusion criteria. A lack of comparability between data 
from different studies means that individual datasets cannot always be merged and will 
therefore tend to be small, limiting their usefulness. 
Data treatment such as averaging values from highly variable measurements - for example 
for crystallite size values obtained averaging different measures provided by different 
laboratories - has to be used with some caveats. The use of average values from highly 
variable measurements could result in different choices in the read-across process and 
potentially different conclusions. Therefore clear guidelines on how to select and pre-treat 
data should be developed for a transparent and consistent approach. 
6.2.1 Recommendations 
• To supplement ECHA’s guidance on grouping and read-across (ECHA, 2017), which is 
written at a generic level, there is a need for more detailed and practical guidance on how 
to apply the grouping and read-across workflow. For example, this should include 
guidance on which experimental and modelling data to use, which should ideally be 
based on standardised procedures, on the avoidance of potential bias in analogue and 
data selection, on data treatment protocols, as well as the transparent recording of the 
results and conclusions. 
• The collection of data should be a directed and systematic community effort to allow for 
targeted filling of data and knowledge gaps regarding physicochemical, biokinetic and 
toxicological properties of NMs. This process should take into account the reliability and 
relevance of available experimental methods, and apply suitable methods to NMs of 
regulatory interest. 
 
6.3 Model landscape 
As shown in the review of the model landscape (chapter 3), a number of QSPR, QSAR, PBK 
and environmental fate models have been developed for selected groups of NMs. However, 
these models cover a limited number of endpoints and have usually been derived from a 
limited number of small datasets. There are very few QSPR and QSAR models 
(physicochemical properties, ecotoxicity endpoints and human health endpoints) with 
regulatory relevance, e.g. which could directly be used to fill data gaps for REACH. For 
example many models (76 out of 152) have been developed for cytotoxicity which is not a 
regulatory endpoint. Furthermore, there are no models covering acute toxicity, repeated 
dose toxicity, skin and respiratory sensitisation, carcinogenicity and reproductive toxicity. 
The only endpoint of REACH relevance is the QSAR for "In vitro – Mutagenicity Bacterial 
Reverse Mutation Test (Salmonella typhimurium)", required under REACH Annex VII. 
However, the Ames test is not applicable to NMs (OECD, 2014). Development of many QSPR 
and QSAR models has been started in recent EU research projects, however not all have 
finalised or made them publicly available (yet). The applicability for REACH seems to be most 
promising for environmental fate models at the moment.  
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However, available models can be used for screening purpose and to support grouping and 
read-across (for example, properties such as solubility and cytotoxicity could be used to 
group NMs). In this context, some gaps in the model landscape were identified. For example, 
in the Nanocomput read-across case studies, a need to develop QSPRs for the mechanical 
properties (e.g. rigidity) of carbon nanotubes was identified, as a means of supporting 
category formation and read-across argumentation.  
Apart from the current limited availability and relevance for regulatory applications, another 
barrier to the uptake of the models in decision-making is their limited public visibility and 
accessibility. Many models are “hidden” and have only been described in project reports so 
far. Even when models are eventually published in the scientific literature, their use is 
limited without a user-friendly software implementation for their application, such as the 
planned Nanosolutions project software tool for predicting health or environmental hazards 
of NMs. The step from model and tool development within individual research projects to 
their public availability and sustained maintenance after the end of the projects is not often 
made. 
At the very least, an appropriate and complete documentation of the models should be 
made available in a public repository so they could be reproduced. Nanocomput has made a 
valuable contribution in reviewing the current state of existing nanomaterial models (QSPR / 
QSAR; modified QMRF; PBK, PBD, dosimetry models; environmental fate models) and 
creating/updating templates to record the computational models, adapted for NMs. These 
templates will be made available for universal use by the JRC. Similarly, information on all 
the models of the Nanocomput model inventory could be disseminated via JRC information 
sources such as the QSAR Model Database (for QSPR/QSAR models), DB-ALM (for in vitro 
models and computational models other than QSPR/QSAR). Ideally, the models should be 
implemented in the form of a software tool, to increase practical usability. Possible 
platforms include eNanoMapper (https://www.enanomapper.net/), the Estonian QSAR DB 
(https://qsardb.org/), and the OECD QSAR Toolbox (https://www.qsartoolbox.org/). 
 
6.3.1 Recommendations 
• To raise awareness in the research community that model development should be 
targeted: either to fill specific knowledge gaps or with concrete regulatory applications in 
mind. Calls for new EU projects should take these needs into account. 
• Public dissemination of research and development outputs such as QSPR/QSAR models 
should be a contractual obligation for EC research projects and facilitated via publicly 
accessible platforms (e.g. JRC QSAR DB, Estonian QSAR DB, OECD QSAR Toolbox).  
• Models should be documented in the bespoke model description templates from the 
Nanocomput project and made available in a public repository (see below).  
• Models should ideally be implemented in a user-friendly form, e.g. as online tools or 
KNIME workflows, to facilitate their uptake and application. 
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6.4 Practicality of applying the ECHA guidance 
As discussed above, there is a lack of data and models for regulatory endpoints, and 
knowledge gaps linking the NM properties to their potential toxicity. There is also a 
disconnection between legal information requirements and the minimal data set 
recommended to support grouping and read-across. Thus at the moment no incentives exist 
for filling the data gaps or for data sharing in view of regulatory applications. 
The ECHA Guidance for applying read-across for NMs (ECHA, 2017) is generally useful to 
guide the user. However, it is more a general framework and may be difficult to apply in the 
light of the above. A concrete and detailed operational guidance is needed to facilitate the 
uptake of the read-across approach for nanomaterials in the regulatory context. 
Application of the ECHA guidance framework within the Nanocomput case studies has 
shown some practical issues in following the proposed workflow. Suggestions are provided 
(Fig. 4.16) on how to deal practically with each step of the workflow. As a slight modification 
of the workflow, the data gathering step is considered first and the subsequent building of 
the hypothesis based on the analysis of all available data. 
The Nanocomput case study could serve as a blue print for more concrete guidance on how 
to deal with available and often imperfect data and how to develop the read-across 
argumentation. 
An important part has been the applicability of cheminformatics tools to support the 
grouping hypothesis: There was no agreement in the literature about the genotoxicity 
mechanism of nano-TiO2 and MWCNTs, e.g. chemical reactivity, ROS generation, 
agglomeration and sedimentation. Furthermore, the variability of the measurement data of 
the NM characterisation hampered linking the characteristics to the observed effects. 
Therefore chemoinformatic tools have been used to analyse the NMs’ physicochemical 
properties and find correlations for similar analogues and indications on how they may drive 
genotoxicity. The read-across hypothesis is based on or verified by this type of analysis. 
Cheminformatics tools for modelling of NMs have been made publicly available for example 
from eNanomapper (e.g. Nano-Lazar extended for NMs) and NanoBRIDGES (e.g. tools for 
data pre-treatment, variable selection methods, applicability domain, endpoint-dependent 
analogue identification software) on the respective project websites. These tools are useful 
to complement read-across approaches, but should be used carefully and adapted to the 
specific case investigated.  
 
6.4.1 Recommendations 
• To provide a detailed practical guidance supplementing the ECHA guidance for NM read-
across. The Nanocomput case study and adaptations of the ECHA workflow could serve as 
blue print for more concrete guidance on how to deal with available and often imperfect 
data and how to develop the read-across argumentation. 
• To collect cheminformatics tools (software, web-applications), make them publicly 
available and raise awareness (e.g. through a one-stop-hub for NM modelling) and 
provide guidance for their application in supporting regulatory applications. 
• A requirement or recommendation on the use of relevant and reliable in vitro and 
computational models to fill data gaps in regulatory assessments (e.g. in a WoE 
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approach), would be an incentive to generate adequate data. A focused data generation 
effort could be established to generate such data. 
 
6.5  Utility of the ECHA Read-Across Assessment Framework (RAAF) 
As for read-across of the properties of conventional chemicals, transparent consideration 
and documentation of all uncertainties is essential. 
The ECHA RAAF was applied to the Nanocomput case studies for uncertainty analysis. It was 
shown that the RAAF structure and Assessment Elements are applicable also for 
nanomaterials, with some adaptations and explanations to accommodate nanospecific 
issues. 
A key aspect is the concept of similarity, which in the RAAF is limited to chemical structure 
similarity, and for a more consistent application to NMs, other principles for similarity need 
to be included, i.e. the similarity of the group of analogues has to be based on the essential 
and relevant properties of the NMs, considering the physical form and key physicochemical 
properties. Moreover, the definition of the “identical or different compounds” in the RAAF 
should be adapted to nanoforms and take factors such as coating, size and length into 
consideration. In the case of nanomaterials it is not only a distinction between parent 
compounds and (bio)transformation products such as metabolites, but for example needs to 
consider either the nanomaterial as such, impurities/coating, released metals, and 
transformations through the life cycle. The underlying biokinetic and toxicodynamic 
mechanisms should also be taken into consideration. 
 
6.5.1 Recommendations 
• Overall the RAAF is applicable to nanomaterials and should be used to investigate and 
document uncertainties and confidence in the read-across argumentation. 
• A note should be published in connection with the RAAF pointing out the nanospecific 
issues to be taken into consideration. 
• As for the “normal” RAAF, more detailed practical guidance on how to apply the 
framework, including for example templates for data collection, should be provided. 
 
6.6 Need for infrastructures 
A centralised infrastructure is needed for information, data and models, to make them 
publicly available and accessible, and allow knowledge exchange. Even when information, 
data and models, are publicly available, it might be difficult to find them or know that they 
exist in the first place. Therefore a pointer is needed to the respective repositories and 
individual websites to build and assemble the community knowledge and reduce 
fragmentation of knowledge. This will also avoid duplication of work, which still exists to a 
certain extent in recent nanosafety projects (e.g. development of ISA-Tab-Nano templates). 
Thus to ensure visibility and overcome the fragmentation of nanotoxicity related 
information (SOPs, data, models, tools), the creation of a “one stop” hub is essential. This 
does not necessarily need to store all information directly, but needs to assemble the 
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information in a structured manner, and link to the individual websites containing the 
information and/or tools. It should be maintained to accommodate all upcoming 
information and knowledge in the future, and could be filled also retrospectively with 
existing information, e.g. by systematic review of the literature and past EU project reports. 
This needs to be resourced and centrally coordinated. In view of the limited quality of data 
obtained with non-standardised experimental methods so far, a strategy should also be 
devised for the selection and use of sub-optimal data. 
It seems that the planned ECHA Observatory for nanomaterials (EU-ON) could play this role, 
making use of and referring to existing technologies and compilations. A promising example 
is the eNanomapper project, which has provided a technical framework to upload and store 
data from research projects, with some flexibility of the data formats. eNanomapper is also a 
resource for chemoinformatic tools that could be used to support read-across. In addition, 
well established model repositories, such as the JRC QSAR database, Estonian QSAR DB and 
OECD QSAR toolbox should be used additionally to advance the uptake of computational 
methods in nanosafety assessment. It is important though, to link them all to a central hub 
to avoid fragmentation of knowledge. The NSC organisation and structure could be further 
exploited to support the scientific coordination across research projects. 
 
6.6.1 Recommendations 
• To evaluate the utility of data produced in EU projects and upload useful datasets into a 
centralised repository such as eNanomapper. 
• To create an EU level “one-stop” hub with links to information sources, databases, 
modelling tools, and their websites. 
• To establish an organisational mechanism for the targeted development of methods and 
their application to fill data gaps of regulatory relevance. 
• To develop a knowledge sharing strategy to raise awareness in the research and 
regulatory communities of relevant initiatives, and facilitate access to available methods, 
tools, databases and guidance documents. 
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Appendix I. Glossary of specialised terms 
 
Many terms commonly used in nanotoxicology are defined in Gottardo et al (2016): 
http://publications.jrc.ec.europa.eu/repository/handle/JRC100906 
 
Term  Definition  
Agglomerate Collection of weakly bound particles or aggregates or mixtures of 
the two where the resulting external surface area is similar to the 
sum of the surface areas of the individual components. The forces 
holding an agglomerate together are weak forces, for example van 
der Waals forces, or simple physical entanglement. (ISO/TS 
27687:2008) 
Aggregate Particle comprising strongly bonded or fused particles where the 
resulting external surface area may be significantly smaller than the 
sum of calculated surface areas of the individual components. The 
forces holding an aggregate together are strong forces, for example 
covalent bonds, or those resulting from sintering or complex 
physical entanglement. (ISO/TS 27687:2008) 
Adverse Outcome Pathway Conceptual construction that portrays existing knowledge 
concerning the link between a molecular initiating event (MIE) and 
an adverse outcome (AO), by capturing the sequential chain of 
causally-linked events at different levels of biological organisation. 
(Ankley et al., 2010) 
Alternative method A method that replaces, reduces or refines the use of animals in 
toxicity testing or biomedical research. Replacement alternatives 
include in silico and in vitro methods, as well as the use of read-
across. 
Chemical category  (group) A chemical category is a group of chemicals whose physicochemical 
and human health and/or environmental toxicological properties 
and/or environmental fate properties are likely to be similar or 
follow a regular pattern as a result of structural similarity. 
The terms category approach and analogue approach are used to 
describe techniques for grouping chemicals. The term analogue 
approach is used when the grouping is based on a very limited 
number of chemicals, where trends in properties are not apparent 
(ECHA, 2008; OECD, 2014a). In a category approach, more members 
are generally present, enabling the detection of trends across 
endpoints. 
(ECHA 2008, OECD 2014) 
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Chemical descriptor A molecular descriptor is a mathematical representation of 
chemical structure (Todeschini & Consonni Viviana, 2009). 
More generally a chemical descriptor can be considered as 
any numerical representation of a structural or 
physicochemical property of a substance. Descriptors are 
used as independent variables in QSAR models, and to 
support the grouping of chemicals. 
A list of descriptor types is given in Table 1.3. 
DLVO theory  
 
The classical DLVO (Derjaguin, Landau, Verwey and Overbeek) 
theory of colloidal stability has been proposed to address the 
kinetics of agglomeration processes. DVLO theory combines the 
opposing effects of the van der Waals attractive force and the 
electrostatic repulsive force due to the so called 'double layer' of 
counterions, i.e. zeta potential for NMs. 
Engineered nanomaterial Designed for specific purpose or function (ISO 2014). 
Extensive property A property that is independent on the amount or mass (e.g. 
volume). 
Extrinsic property Characteristics resulting from interactions occurring at the interface 
(i.e. boundary) and the surrounding medium (which may be an 
environmental or biological matrix or medium in an experimental 
test system). 
Flocculation Process of contact and adhesion where dispersed particles are held 
together by weak physical interactions leading to phase separation 
by the formation of precipitates larger than colloidal size. (IUPAC 
1997) 
In silico (method, tool, 
approach) 
Computational (method, tool, approach) 
In vitro (method, tool, 
approach) 
Conducted using components of an organism that have been 
isolated from their usual biological surroundings, such as 
microorganisms, cells, or biological molecules. Wikipedia: 
https://en.wikipedia.org/wiki/In_vitro 
Integrated Approach to 
Testing and Assessment (IATA) 
An approach based on multiple information sources used for the 
hazard identification, hazard characterisation and/or safety 
assessment of chemicals. An IATA integrates and weights all 
relevant existing evidence and guides the targeted generation of 
new data, where required, to inform regulatory decision-making 
regarding potential hazard and/or risk. Within an IATA, data from 
various information sources (i.e. physicochemical properties, in 
silico models, grouping and read-across approaches, in vitro 
methods, in vivo tests and human data) are evaluated and 
integrated to draw conclusions on the hazard and/or risk of 
chemicals. (OECD 2016) 
Intensive property A property that is independent on the amount or mass (e.g. 
temperature, pressure). 
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Intrinsic property Characteristics of the material itself and do not account for 
interactions with other components. (OECD, 2010a) 
Manufactured nanomaterial Intentionally produced for commercial purpose to have selected 
properties or specific composition. (ISO 2014) 
Physicochemical property Physical properties, solvation properties related to interactions 
with different media, and properties or molecular attributes that 
define intrinsic chemical reactivity (NAS, 2014)  
https://www.ncbi.nlm.nih.gov/books/NBK253965/pdf/Bookshelf_N
BK253965.pdf 
A list of physicochemical properties is defined in Table 1.5 
Quantitative Structure-Activity 
Relationship (QSAR) 
SARs and QSARs, collectively referred to as (Q)SARs, are theoretical 
models that can be used to predict in a qualitative or quantitative 
manner the physico-chemical, biological (e.g. toxicological) and 
environmental fate properties of compounds from knowledge of 
their chemical structure. (ECHA 2008) 
In this report, QSAR is a theoretical model that can be used to 
predict in a quantitative manner biological (e.g. toxicological) or 
fate properties of compounds from knowledge of their chemical 
structure or physicochemical properties. 
Quantitative Structure-Activity 
Relationship (QSPR) 
In this report, QSPR is distinguished from QSAR, as a theoretical 
model that can be used to predict in quantitative manner the 
physicochemical or environmental fate properties of compounds 
from knowledge of their chemical structure. (ECHA 2008) 
Read-across Read-across is an approach for filling data gaps, either by using a 
category or an analogue approach. For the purposes of the REACH 
Regulation (Article 13(1)), read-across is considered by ECHA to be 
an alternative method. 
(Gottardo et al 2016) 
Structure-Activity Relationship 
(SAR) 
See QSAR 
Smoluchowski- Friedlander 
theory  
 
Theory describing the kinetics of dispersed spherical particles in 
fluids. Sometimes considered to represent the kinetics involved in 
aggregation and coagulation processes. 
Supervised learning Supervised learning is a machine learning approach that 
approximates the mapping function (relationship) between input 
(X) and output variables and an output variable (Y). The goal is to 
approximate the mapping function so well that when you have new 
input data (x) that you can predict the output variables (Y) for that 
data. Supervised learning methods can be used for developing both 
regression and classification methods 
A list of supervised methods that are commonly used to derive 
predictive models is given in Table 1.2. 
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Unsupervised learning Unsupervised learning is a machine learning approach that 
discovers the underlying structure and patterns in the input data 
(X), but there are no output variables (Y), and thus no attempt to 
approximate a relationship between X and Y. 
In this report, principal components analysis (PCA) and cluster 
analysis were used as unsupervised methods to support the 
grouping and read-across case studies (Chapter 4).  
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Appendix II. Definitions of "Nanomaterial" in EU legislation 
 
Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 
November 2009 on cosmetic products (European Parliament & Council, 2009) 
"nanomaterial" means an insoluble or biopersistant and intentionally manufactured material 
with one or more external dimensions, or an internal structure, on the scale from 1 to 100 
nm; 
 
Regulation (EU) No 1169/2011 of the European Parliament and of the Council of 25 October 
2011 on the provision of food information to consumers  (European Parliament & Council, 
2011) 
"engineered nanomaterial" means any intentionally produced material that has one or more 
dimensions of the order of 100 nm or less or that is composed of discrete functional parts, 
either internally or at the surface, many of which have one or more dimensions of the order 
of 100 nm or less, including structures, agglomerates or aggregates, which may have a size 
above the order of 100 nm but retain properties that are characteristic of the nanoscale.  
 
Commission Recommendation of 18 October 2011 on the definition of nanomaterial 
(2011/696/EU) (EC, 2011a) 
"Nanomaterial" means a natural, incidental or manufactured material containing particles, in 
an unbound state or as an aggregate or as an agglomerate and where, for 50 % or more of 
the particles in the number size distribution, one or more external dimensions is in the size 
range 1 nm-100 nm.  In specific cases and where warranted by concerns for the 
environment, health, safety or competitiveness the number size distribution threshold of 50 
% may be replaced by a threshold between 1 and 50 %.  
By derogation […], fullerenes, graphene flakes and single wall carbon nanotubes with one or 
more external dimensions below 1 nm should be considered as nanomaterials.  
[…], "particle", "agglomerate" and "aggregate" are defined as follows:  
"particle" means a minute piece of matter with defined physical boundaries; 
"agglomerate" means a collection of weakly bound particles or aggregates where the 
resulting external surface area is similar to the sum of the surface areas of the individual 
components;  
"aggregate" means a particle comprising of strongly bound or fused particles.  
Where technically feasible and requested in specific legislation, compliance with the 
definition […]- may be determined on the basis of the specific surface area by volume. A 
material should be considered as falling under the definition […] where the specific surface 
area by volume of the material is greater than 60 m2 /cm3. However, a material which, based 
on its number size distribution, is a nanomaterial should be considered as complying with 
the definition […] even if the material has a specific surface area lower than 60 m2 /cm3. 
The EC Definition includes a revision clause which allows taking into account new scientific 
and technical insights by the time the definition is reviewed in 2014.  
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Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 
concerning the making available on the market and use of biocidal products (European 
Parliament and Council, 2012) 
"nanomaterial" means a natural or manufactured active substance or non-active substance 
containing particles, in an unbound state or as an aggregate or as an agglomerate and 
where, for 50 % or more of the particles in the number size distribution, one or more 
external dimensions is in the size range 1-100 nm.  
Fullerenes, graphene flakes and single-wall carbon nanotubes with one or more external 
dimensions below 1 nm shall be considered as nanomaterials.  
For the purposes of the definition of nanomaterial, "particle", "agglomerate" and 
"aggregate" are defined as follows:  
- "particle" means a minute piece of matter with defined physical boundaries,  
- "agglomerate" means a collection of weakly bound particles or aggregates where the 
resulting external surface area is similar to the sum of the surface areas of the individual 
components,  
- "aggregate" means a particle comprising strongly bound or fused particles;  
Fullerenes, graphene flakes and single-wall carbon nanotubes with one or more external 
dimensions below 1 nm shall be considered as nanomaterials. 
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Appendix III. Overview of REACH Standard Information Requirements (Annexes VI-
X) 
The text and tables below summarise the Standard Information Requirements of REACH 
Annex VI and Annexes VII-X. Proposed changes for a revision of the REACH Annexes to better 
address nanomaterials are highlighted in italics. 
 
REACH ANNEX VI 
1. GENERAL REGISTRANT INFORMATION  
2. IDENTIFICATION OF THE SUBSTANCE  
2.1. Name or other identifier of each substance 
2.1.1. Name(s) in the IUPAC nomenclature or other international chemical name(s) 
2.1.2. Other names (usual name, trade name, abbreviation) 
2.1.3. EINECS or ELINCs number (if available and appropriate) 
2.1.4. CAS name and CAS number (if available) 
2.1.5. Other identity code (if available) 
2.2. Information related to molecular and structural formula of each substance 
2.2.1. Molecular and structural formula (including SMILES notation, if available) 
2.2.2. Information on optical activity and typical ratio of (stereo) isomers (if applicable and 
appropriate) 
2.2.3. Molecular weight or molecular weight range 
2.3 Composition of each substance 
2.3.1. Degree of purity (%) 
2.3.2. Nature of impurities, including isomers and by-products 
2.3.3. Percentage of (significant) main impurities 
2.3.4. Nature and order of magnitude (… ppm, … %) of any additives (e.g. stabilising agents 
or inhibitors)  
2.3.5. Spectral data (ultra-violet, infra-red, nuclear magnetic resonance or mass spectrum) 
2.3.6. High-pressure liquid chromatogram, gas chromatogram 
2.3.7. Description of the analytical methods or the appropriate bibliographical references for 
the identification of the substance and, where appropriate, for the identification of 
impurities and additives. This information shall be sufficient to allow the methods to be 
reproduced. 
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3. INFORMATION ON MANUFACTURE AND USE(S) OF THE SUBSTANCE(S)  
4. CLASSIFICATION AND LABELLING 
5. GUIDANCE ON SAFE USE 
6. INFORMATION ON EXPOSURE FOR SUBSTANCES REGISTERED IN QUANTITIES BETWEEN 
1 AND 10 TONNES PER YEAR PER MANUFATCURER OR IMPORTER  
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REACH ANNEXES VII-X 
 
Table 1a: REACH tonnage dependent information requirements: Physicochemical properties 
 
Annex VII 
≥ 1 t 
Annex VIII 
≥ 10 t 
Annex IX 
≥ 100 t 
Annex X 
≥ 1000 t 
State of the substance at 20°C and 101,3 
kPa 
   
Melting/freezing point    
Boiling point    
Relative density    
Vapour pressure    
Surface tension    
Water solubility    
Partition coefficient  
n-octanol/water  
   
Flash point    
Flammability    
Explosive properties     
Self-ignition temperature    
Oxidising properties    
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Granulometry    
  Stability in organic solvents and identity of 
relevant degradation products - only for 
organic substances/when stability is critical 
 
  Dissociation constant  
  Viscosity  
 
 
Table 1b: REACH tonnage dependent information requirements: Toxicological Information 
 
Endpoint Annex VII 
≥ 1 t 
Annex VIII 
≥ 10 t 
Annex IX 
≥ 100 t 
Annex X 
≥ 1000 t 
Acute toxicity Oral Inhal/dermal   
Irritation/corrosivity Skin/eye (in vitro) Skin/eye (in vivo)   
Sensitisation  Skin (in vivo)    
Repeated dose toxicity - 28 d 
 
28 d 
90 d 
 
Mutagenicity Gene mutations bacteria 
(in vitro) 
 
Gene mutations in 
mammalian cells (in vitro) 
Cytogenicity or 
micronucleus  
If positive in vitro, then in 
vivo somatic cells 
If positive in vivo, then 
potential for germ cell 
If positive in vitro, then in 
vivo somatic cells (2nd test) 
If positive in vivo, then 
potential for germ cell 
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 mutagenicity mutagenicity 
Carcinogenicity - - - 2-yr 
Reproductive toxicity - Screening 
repro/developm. tox 
Pre-natal developm. tox 
2-gen-study (if the 28 d 
and 90 d is positive) 
Developm. tox  
 
2-gen-study  
Toxicokinetics - From relevant available 
information 
  
 
 
Table 1c: REACH tonnage dependent information requirements: Ecotoxicological Information 
 
Endpoint Annex VII 
≥ 1 t 
Annex VIII 
≥ 10 t 
Annex IX 
≥ 100 t 
Annex X 
≥ 1000 t 
Aquatic toxicity Short term tox 
(invertebrates) 
Growth inhibition 
study (aquatic 
plants) 
Short term tox 
 (Fish) – long term testing 
may be considered 
Activated sludge respiration 
inhibition testing 
Long term tox 
(invertebrates, e.g. 
Daphnia)) 
Long term tox (fish): fish 
early life stage test, test 
on embryo and sac-fry 
stages, juvenile growth 
test 
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Degradation Biotic: 
ready 
biodegradability - 
for organic 
substances 
Abiotic (hydrolysis as a 
function of pH) 
. 
Biotic: simulation testing 
in surface water, soil, 
sediment, and 
identification of 
degradation products.  
Biotic: (additional studies 
depending on results of 
CSA 
Fate and behaviour in the 
environment 
- Adsorption/desorption 
screening 
 
Bioaccumulation in 
aquatic species (fish) 
Further 
adsorption/desorption 
studies (depending on 
results of previous 
studies) 
Further studies 
depending on results of 
CSA 
Effects on terrestrial organisms - - Short term toxicity 
(invertebrates) 
Effects on soil micro-
organisms 
Short term toxicity 
(plants) 
Long term toxicity 
(invertebrates, plants, 
sediment organisms, 
birds  
- depending on results of 
CSA) 
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Appendix IV. List of EU projects including aspects of modelling (including grouping) 
 
 Project Title Project 
Acronym  
Frame-
work 
Contact 
(coordinator) 
Project website Topics directly related to NanoComput Duration 
1 A Database and 
Ontology 
Framework for 
Nanomaterials 
Design and Safety 
Assessment 
eNanomapper FP7 Barry Hardy  
Douglas 
Connect 
GmbH 
Switzerland 
http://www.enano
mapper.net/  
Creation of a platform that consists of an 
ontology addressing all standardisation and 
regulatory requirements supporting the 
exploration of SAR and of a data 
wharehouse for NMs 
1/02/2014 – 
31/01/2017 
2 Risk Assessment of 
Engineered 
Nanoparticles 
ENPRA FP7 Lang Tran  
Institute of 
Occupational 
Medicine UK 
http://www.enpra.
eu  
Identification of physicochemical 
properties that are useful as descriptors for 
building QSAR models for toxicologically 
relevant properties and effects 
01/05/2009 
– 
31/10/2012 
3 A framework to 
respond to the 
regulatory needs of 
future 
nanomaterials and 
markets 
FutureNano 
Needs 
FP7 Kenneth A. 
Dawson 
University 
College Dublin 
http://www.future
nanoneeds.eu/ 
Development of a novel framework to 
enable naming, classification, hazard and 
environmental impact assessment of the 
next generation nanomaterials 
01/01/2014 
– 
31/12/2017 
4 Intelligent testing 
strategies for 
engineered 
nanomaterials 
Project 
ITS-NANO   FP7 
(Support 
action) 
Vicki Stone  
Herriot Watts 
University UK 
http://nano.hw.ac.
uk/research-
projects/itsnano.ht
ml   
Definition of testing strategies based on 
protocols to support grouping and ranking 
of NMs 
01/03/2012 
– 
31/05/2013 
5 Managing Risks of 
Nanomaterials 
MARINA FP7 Lang Tran  
Institute of 
Occupational 
Medicine UK 
http://www.marina
-fp7.eu/  
Harmonised database on Reference NMs  
fate-determining parameters in the 
environment and biota 
01/11/2011 - 
31/10/2015 
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6 Modelling the 
mechanisms of 
nanoparticle-lipid 
interactions and 
nanoparticle 
effects on cell 
membrane 
structure and 
function 
MembraneNa
noPart  
FP7 Vladimir 
Lobaskin  
University 
College Dublin 
http://www.memb
ranenanopart.eu/ 
Development of physically justified models 
and computational tools to quantitatively 
describe and understand the molecular 
mechanisms of nanoparticle/cell 
membrane interactions, which are crucial 
in modelling of nanoparticle toxicity 
1/1/2013 – 
31/12/2015 
7 Modelling 
Nanomaterial 
Toxicity  
MODENA 
(COST 
initiative) 
FP7 Lang Tran  
Institute of 
Occupational 
Medicine UK 
http://www.moden
a-cost.eu/ 
MODENA COST Action has been 
established to promote and to co-ordinate 
these inter-disciplinary collaborations, with 
the ultimate aim of producing QNTR 
models for ENM. MODENA aims at The 
creation of transparent, validated and 
rigorous QNTR tools for regulatory 
purposes in the field of nanotoxicology 
according to OECD principles. 
1/01/2014 - 
31/12/2016 
8 Modeling Platform 
to Predict the 
Toxicity of Metal-
based 
Nanoparticles 
MOD-ENP-
TOX 
FP7 Jean Pierre 
Locquet  
KU Leuven  
http://fys.kuleuven
.be/apps/modenpt
ox/  
Focussed on metal nanoparticles. It 
combines novel Computational Modelling 
Package (CMP) based on structural, 
mechanistic, as well as kinetic modelling 
tools and an innovative high content 
screening (HCS) strategy that allows 
performing multiplexed streamlined assays 
for calibration, refinement and validation 
of the computed models 
01/01/2013 - 
31/12/2015 
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9 MODelling the 
EnviRonmental and 
human health 
effects of 
Nanomaterials 
MODERN FP7 Robert Rallo  
Universitat 
Rovira i Virgili 
http://modern-
fp7.biocenit.cat  
Establishment of new modelling 
approaches suitable for relating 
nanotoxicity with the intrinsic molecular 
and physicochemical properties of NMs. 
Definition of a categorization and hazard 
ranking protocol for NMs based on 
structural similarity principles and on the 
analysis of their toxicological profiles 
01/01/2013 - 
31/12/2015 
10 Modelling 
nanoparticle 
toxicity: principles, 
methods, novel 
approaches 
ModNanoTox   FP7 Eugenia 
Valsami-Jones 
University of 
Birmingham 
http://www.birmin
gham.ac.uk/generi
c/modnanotox/ind
ex.aspx  
Development of QSAR for NMs toxicity as 
far as current data availability allows. 
improving the accessibility and 
sustainability of the WP2 database by 
convert it into a format compatible with 
emerging standards (ISA-TAB NANO).  
01/11/2011 - 
31/10/2013 
11 Building bridges 
between specialists 
on computational 
and empirical risk 
assessment of 
engineered 
nanomaterials 
NanoBRIDGES FP7 
(Marie 
Curie 
Actions) 
Tomasz Puzyn 
Uniwersytet 
Gdanski 
http://nanobridges
.eu/  
Investigation on the relationship between 
cytotoxicity of 17 different types of nano-
sized metal oxide nanoparticles to bacteria 
Escherichia coli and their structure  
01/01/2012 - 
31/12/2014 
12 Nanoparticle Fate 
Assessment and 
Toxicity in the 
Environment 
NanoFATE FP7 Claus 
Svendsen  
NERC Centre 
for Ecology & 
Hydrology at 
Wallingford, 
UK 
http:// 
www.nanofate.eu 
Nanoparticles ecotoxicology and 
bioavailability; environmental fate data 
and models 
01/04/2010 - 
31/03/2014 
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13 Engineered 
nanomaterial 
mechanisms of 
interactions with 
living systems and 
the environment: a 
universal 
framework for safe 
nanotechnology 
NanoMILE FP7 Eugenia 
Valsami-Jones 
University of 
Birmingham 
http://www.nanom
ile.eu/  
Development of quantitative structure 
(property) –activity relationship - QS(P)ARs 
- enabling predictive work to evolve and 
feed into risk assessment 
01/03/2013 - 
28/02/2017 
14 Modelling 
properties, 
interactions, 
toxicity and 
environmental 
behaviour of 
engineered 
nanoparticles 
NanoPUZZLES FP7 Tomasz Puzyn 
Uniwersytet 
Gdanski 
http://www.nanop
uzzles.eu  
Grouping and read-across; 
To create new computational methods for 
comprehensive modelling the relationships 
between the structure, properties, 
molecular interactions and toxicity of 
engineered nanoparticles 
01/01/2013-
31/12/2015 
15 A common 
European 
approach to the 
regulatory testing 
of Manufactured 
Nanomaterials 
NANOREG FP7 Tom van 
Teunenbroek 
Ministry of 
Infrastructure 
and the 
Environment 
NL 
http://www.nanor
eg.eu/  
Work package 5 will develop a proposal for 
grouping of NMs in categories with similar 
biological, ecological and/or toxicological 
effects 
01/03/2013 - 
28/02/2017 
16 The Reactivity and 
Toxicity of 
Engineered 
Nanoparticles: 
Risks to the 
Environment and 
Human Health 
NanoReTox FP7 Eugenia 
Valsami-Jones 
Natural 
History 
Museum UK 
http://www.nanor
etox.eu/ 
Study of molecular and cellular reactivity of 
sleected metal NMs in aquatic species and 
in cells and cell lines originating from 
different human target organs 
01/12/2008 - 
30/11/2012 
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17 Biological 
Foundation for the 
Safety 
Classification of 
Engineered 
Nanomaterials 
(ENM): Systems 
Biology 
Approaches to 
Understand 
Interactions of 
ENM with Living 
Organisms and the 
Environment 
NANOSOLUTI
ONS 
FP7 Kai Savolainen 
Finnish 
Institute of 
Occupational 
Health, (FIOH)  
http://nanosolutio
nsfp7.com/  
Development of reliable testing protocols 
for qualitative and semi-quantative 
approaches for protein corona detection 
by mass spectrometry 
Generated data on nanomaterials and 
biological specimens has been defined 
along the ISA-TAB Nano specifications 
A basic data repository has been created 
and tested 
A computer algorithm capable of 
simulating synthetic data, and a novel 
computational method for feature 
selection and prioritization based on fuzzy 
logic and random forests have been 
developed 
01/04/2013 - 
31/03/2017 
18 Development of 
methodology for 
alternative testing 
strategies for the 
assessment of the 
toxicological 
profile of 
nanoparticles used 
in medical 
diagnostics 
NanoTEST FP7 Maria 
Dusinska 
Norwegian 
institute for 
Air Research 
http://www.nanot
est-fp7.eu/ 
Development of a theoretical model for 
predicting the reactivity of metal oxide NPs 
as well as their ability to cause oxidative 
stress through the generation of ROS 
01/04/2008 - 
31/03/2012 
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19 Modelling the basis 
and kinetics of 
nanoparticle 
cellular interaction 
and transport 
NanoTranskin
etics  
FP7 Kenneth 
Dawson  
University 
College Dublin 
http://www.nanotr
anskinetics.eu/  
Development of an user-friendly Bundle for 
Bio-nano Large-scale Efficient Simulations 
BUBBLES 
http://ovilanova.github.io/BUBBLES/ 
Data from FP6 NANOINTERACT project and 
the FP7 NEURONANO project plus new 
data  
01/11/2011 - 
31/10/2014 
20 Predictive 
toxicology of 
engineered 
nanoparticles 
PreNanoTox FP7 Rafi 
Korenstein 
Tel-Aviv 
University 
http://prenanotox.
tau.ac.il/ 
Development of a database of in vitro and 
in vivo studies; development, adaptation 
and validation of novel methodologies for 
establishing QNAR modeling as a tool for 
predicting biological effects of selected  
NMs 
01/01/2013 - 
31/12/2015 
21 Development of a 
web based REACH 
Toolkit to support 
the chemical safety 
assessment of 
nanomaterials 
REACHnano LIFE+ Carlos Fito 
ITENE, Spain 
http://www.liferea
chnano.eu/  
Provide the industry and stakeholders with 
easy-to-use tools to support the risk 
assessment of nanomaterials along their 
lifecycle. 
01/10/2012 
– 
30/09/2015 
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Appendix V. US EPA and OECD projects including aspects of modelling and grouping 
 Project Title Contact 
(coordinator) 
Project website Topics directly related 
to NanoComput 
Duration 
1 Genomics-based 
Determination of 
Nanoparticle Toxicity: 
Structure-function 
Analysis* 
Bakalinsky, 
Alan T.
Li, Qilin 
http://cfpub.epa.gov/ncer_abstracts/index.cfm/fu
seaction/display.abstractDetail/abstract/8449/rep
ort/0 
Determination of the 
mechanisms by which 
manufactured 
nanomaterials cause 
cytotoxicity in realistic 
environments of 
exposure.  
Ended (05/2007 – 
05/2009) 
2 Structure-function 
Relationships in 
Engineered Nanomaterial 
Toxicity* 
Colvin, Vicki L. 
Rice University 
http://cfpub.epa.gov/ncer_abstracts/index.cfm/fu
seaction/display.abstractDetail/abstract/7888/rep
ort/0 
 
Links to publications at:  
 
https://cfpub.epa.gov/ncer_abstracts/index.cfm/f
useaction/display.publications/abstract/7888 
 
This project aimed to 
provide structure-
function relationships 
for nanoparticle 
toxicology for the 
benefit of industry and 
regulators 
Ended (12/2005 – 
11/2008) 
3 OECD Working Party on 
Manufactured 
Nanomaterials (WPMN) to 
promote international co-
operation in human health 
and environmental safety 
aspects of manufactured 
nanomaterials.  
Steering groups (SGs): SG 
347 (Testing and 
Assessment = TA); SG 56 
Mar Gonzales 
(OECD 
secretariat) 
Jenny 
Holmqvist 
(chair SG TA) 
www.oecd.org/env/nanosafety 
 
 
Link to OECD publication series on the Safety of 
Manufactured Nanomaterials: 
 
http://www.oecd.org/env/ehs/nanosafety/publica
tions-series-safety-manufactured-
nanomaterials.htm 
 
Sponsorship 
Programme for the 
Testing of 
Manufactured 
Nanomaterial: 
Fullerenes (C60), 
SWCNTs, MWCNTs, 
Silver nanoparticles, 
TiO2, CeO, ZnO, SiO2, 
Dendrimers, Nanoclays 
and Gold nanoparticles 
Since 2006 
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(Risk Assessment and 
Regulatory Program), SG8 
(Exposure Measurement 
and Exposure Mitigation) 
SG 9: Environmentally 
Sustainable Use of 
Manufactured 
Nanomaterials 
are tested for their 
physical chemicals 
properties, 
environmental fate and 
behaviour, ecotoxicity 
and toxicity 
using appropriate 
testing methods  
* Projects funded by the US EPA under the Extramural Nanotechnology Research http://www2.epa.gov/chemical-research/research-
evaluating-nanomaterials-chemical-safety  
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Appendix VI. The revised QMRF 
 
 
 
1.1. QSAR identifier (title): 
Oxidative stress caused by metal oxides nanoparticles  
1.2. Other related models: 
None 
1.3. Software coding the model: 
None  
 
 
2.1. Date of QMRF: 
November 2015 
2.2. QMRF author(s) and contact details: 
David Asturiol. David.asturiol-bofill@ec.europa.eu 
2.3. Date of QMRF update(s): 
2.4. QMRF update(s): 
2.5. Model developer(s) and contact details: 
Enrico Burello and Andrew Worth Joint Research Centre,Via Enrico Fermi 2749, Ispra, Varese, 
21027 Italy 
2.6. Date of model development and/or publication: 
2011 
2.7. Reference(s) to main scientific papers and/or software package:  Burello, E., Worth, A.P., 
2011. A theoretical framework for predicting the oxidative stress potential of oxide nanoparticles. 
Nanotoxicology 5, 228–35. doi:10.3109/17435390.2010.502980 
2.8. Availability of information about the model: 
The model is free 
2.9. Availability of another QMRF for exactly the same model: 
None to date 
 
 
3.1.Species: 
Various cell lines 
 
 
3.Defining the endpoint - OECD Principle 1
2.General information 
1.QSAR identifier 
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3.2.Endpoint: 
Reactive Oxygen Species (ROS) generation 
3.3. Comment on endpoint: 
Metal oxides affecting relevant intracellular reactions. 
3.4. Endpoint units: 
Not applicable 
3.5. Dependent variable: 
Heat of formation (∆Hf).which is obtained from ionization potential and electron affinity 
3.6. Experimental protocol: 
The model is a theoretical framework based on a chemical hypothesis and confirmed with in vitro 
data from various sources. 
3.7. Endpoint data quality and variability: 
No information available 
 
 
4.1. Type of model: 
Classification QSAR 
4.2. Explicit algorithm: 
Is a parametric model defined by the value of the band gap energy (Eg).  
Eg=A·exp(0.34 ∆Hº). 
Eg<-4.84 Æ non ROS generator 
-4.84eV<=Eg<=-4.12 Æ ROS generator 
Eg>-4.12 Æ non ROS generator 
4.3. Descriptors in the model: 
The model uses reactivity descriptors to build the energy band structure of oxide nanoparticles, 
assuming a particle diameter larger than 20–30 nm and no surface states in the band gap, and 
predicts their ability to induce an oxidative stress by comparing the redox potentials of relevant 
intracellular reactions with the oxides’ energy structure 
4.4. Descriptor selection: 
Band gap energy of bulk material (obtained from ∆Hf, enthalpy of formation, ionization potential, 
and electron affinity). See pag. 230 of Burello & Worth 2011 for further details. 
4.5. Algorithm and descriptor generation: 
No information available 
4.6. Software name and version for descriptor generation: 
No information available 
4.7. Chemicals/Descriptors ratio: 
6/1=6 
 
 
5.1. Description of the applicability domain of the model: 
Metal oxides of sizes >20-30nm 
5.2. Method used to assess the applicability domain: 
Not applicable 
5.3. Software name and version for applicability domain assessment: 
5.Defining the applicability domain - OECD Principle 3
4.Defining the algorithm - OECD Principle 2
 393 
 
Not applicable 
5.4. Limits of applicability: 
No information available 
 
 
6.1. Availability of the training set: 
Yes 
6.2. Available information for the training set: 
CAS: No 
Chemical Name: not applicable 
SMILES: not applicable 
Formula: not applicable 
INChI: not applicable 
MOL file: not applicable 
Part extended for NPs. 
NP composition: Yes 
NP size: Yes 
NP surface chemistry: No 
6.3. Data for each descriptor variable for the training set: 
Yes 
6.4. Data for the dependent variable for the training set: 
Yes 
6.5. Other information about the training set: 
The training set consists of 6 metal oxides of sizes 20-30nm. 
6.6. Pre-processing of data before modelling: 
No information available 
6.7. Statistics for goodness-of-fit: 
R2=0.84 
6.8. Robustness - Statistics obtained by leave-one-out cross-validation: 
No information available 
6.9. Robustness - Statistics obtained by leave-many-out cross-validation: 
No information available 
6.10. Robustness - Statistics obtained by Y-scrambling: 
No information available 
6.11. Robustness - Statistics obtained by bootstrap: 
No information available 
6.12. Robustness - Statistics obtained by other methods: 
No information available 
 
 
7.1. Availability of the external validation set: 
Yes 
7.2. Available information for the external validation set: 
7.External validation - OECD Principle 4
6.Internal validation - OECD Principle 4
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CAS: No 
Chemical Name: not applicable 
SMILES: not applicable 
Formula: not applicable 
INChI: not applicable 
MOL file: not applicable 
Part extended for NPs. 
NP composition: Yes 
NP size: Yes 
NP surface chemistry: No 
7.3. Data for each descriptor variable for the external validation set: 
No 
7.4. Data for the dependent variable for the external validation set: 
Yes 
7.5. Other information about the external validation set: 
No information available 
7.6. Experimental design of test set: 
No information available 
7.7. Predictivity - Statistics obtained by external validation: 
No information available 
7.8. Predictivity - Assessment of the external validation set: 
No information available 
7.9. Comments on the external validation of the model: 
Band gaps of 64 untested metal oxides were predicted 
 
 
8.1. Mechanistic basis of the model: 
The model uses reactivity descriptors to build the energy band structure of oxide nanoparticles, 
assuming a particle diameter larger than 20–30 nm and no surface states in the band gap, and 
predicts their ability to induce an oxidative stress by comparing the redox potentials of relevant 
intracellular reactions with the oxides’ energy structure. 
8.2. A priori or a posteriori mechanistic interpretation: 
A priori  
8.3. Other information about the mechanistic interpretation: 
No additional information available 
 
 
9.1. Comments: 
No additional information available. 
9.2. Bibliography: 
[1] Burello, E., Worth, A.P., 2011. A theoretical framework for predicting the oxidative stress 
potential of oxide nanoparticles. Nanotoxicology 5, 228–35 
 
 
9.Miscellaneous information 
8.Providing a mechanistic interpretation - OECD Principle 5
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10.1. QMRF number: 
To be entered by JRC 
10.2. Publication date: 
To be entered by JRC 
10.3.Keywords: 
Oxidative stress, ROS, metal oxides, nanoparticle, nanomaterial, NM, QSAR, prediction, band 
gap energy.  
10.4.Comments: 
 
10.Summary (JRC QSAR Model Database)
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Appendix VII. The TK/TD/dosimetry/environmental  fate model reporting template 
List of the information collected in the model reporting template for toxicokinetic (TK), 
toxicodynamic (TD) and environmental fate models.  
M
od
el
 M
et
ad
at
a 
Model 
Model name 
Version 
Homepage 
Owner 
Model ownership 
contact point 
email address 
License 
Reference 
References associated 
DOI 
M
od
el
 d
es
cr
ip
tio
n 
Characteristics 
Model output(s) (generic description) 
Level of organisation (cell, human body, organelle, 
environment, etc) 
Level of organisation (specific details) 
Time span 
Model type 
General description 
Description (free text) 
Is a conceptual model (compartment diagram) given in the 
original reference? 
Process info 
Processes considered 
Symbol (if applicable) 
Units 
Is a set of equations given corresponding to the process? 
Are the parameters relating to the model processes provided 
and defined? 
Assumptions/approximations related to the processes 
Other Free Text 
I/
O
 
Information on NP (or chemical) 
dependent input parameters 
NP (or chemical) dependent input parameters 
Symbol (if applicable) 
Units 
Protocol/assumptions 
Information on NP (or chemical)-
independent input parameters 
NP (or chemical)-independent input parameters 
Symbol (if applicable) 
Units  
Information on utput parameters 
Output parameters 
Symbol (if applicable) 
Units  
NPs description 
Type NP 
Shape 
Coating 
Size (nm) 
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Other/info on measured properties 
Used in reference 
Model domain 
General model assumptions 
Is the model nanospecific, i.e. capture proprties unique to the 
nano size range? 
Applicability domain 
Sources of uncertainty 
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Structure of the reporting template for the PBTK and environmental fate models. 
Model reference  
Ref Model name Version Homepage
Model 
ownership
contact 
point
email 
address
License
References 
associated
DOI
Ref. 
number 
given by 
compi lers
If the model  has  a  
name, report i t, 
otherwise give a  
comprehens ible one. 
Report a lso the 
acronym, i f ava i lable.
If 
ava i lable
If 
ava i lable
If 
ava i lable
Related to 
the emai l  
address
Indicated 
on the 
webs i te 
as  contact 
point or in 
the 
publ icatio
ns  as  
correspon
ding 
author
Is  i t free? 
Is  there 
any 
informatio
n on the 
access?
Scienti fic 
publ icatio
ns  or 
reports  
des cribing 
the model  
deta i l s
Index
Model  Metadata
Model Owner Reference
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Model description: characteristics, general description, process information, other. 
Model output(s) 
(generic 
description)
Level of 
organisation (cell, 
human body, 
organelle, 
Level of 
organisatio
n (specific 
details)
Time span Model type
Description 
(free text)
Is a conceptual model 
(compartment 
diagram) given in the 
original reference?
Lis t of the 
model  outputs
Lis t of generic 
compartments : 
envi ronment, 
biota , human 
body
Lis t of 
speci fi c 
ompartme
nts/units/
organs  
cons idere
d 
Refers  to 
the input 
or output 
time 
scale; i t 
can be 
dynamic or 
at s teady 
s tate
Pos s ible model  
types :
multimedia  mass  
ba lance model
mass  flow 
ana lys is
Phys ica l  
quanti tative 
model
…
Report a  
short text 
describing 
the model  -
what i t 
does , how 
i t works , 
hbow i t 
can be 
used
Y/N 
Characteri s tics Genera l  description
 
Other
Processes 
considered
Symbol (if 
applicable)
Units
Is a set of equations given 
corresponding to the 
model processes?
Are the parameters 
relating to the model 
processes provided and 
defined?
Assumptions/approximation
s related to the processes
Free Text
Lis t the 
process es  
cons idere
d in the 
model
Symbol  
related to 
the 
proces s
measure 
unit 
related to 
the 
process
Indicate i f equation(s ) 
are identi fied for the 
des cription of the 
process .
Indicate i f the model  
code i s  ava i lable.
Indicate here the 
parameters  necessary 
to describe the process
Lis t the as sumptions  
related to the proces s  (i f 
the assumption made is  
not related to the 
identi fied processes , 
shi ft the information to 
the last column "genera l  
assumptions")
Any 
relevant 
comment
Process  info
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Inputs and outputs of the models 
NP (or 
chemical) 
dependent input 
parameters
Symbol (if 
applicable)
Units
Protocol/as
sumption
NP (or chemical)-
independent input 
parameters
Symbol (if 
applicable)
Units 
Output 
parameters
Units 
In these cel l s  information on the (nano)particle-
speci fi c or chemica l -speci fic parameters  should 
be reported (parameter, symbol , uni ts , protocol  
for measured va lues). Are the parameters  
mesaured or ca lculated? If there are assumptions  
on the NMs these should go under 
protocol/assumptions
In these cel l s  information on the 
(nano)particle-independent or chemica l -
independent input parameters  s hould be 
reported.
Model  outputs  should 
be reported here 
including units
I/O
 
 
 
 
 
 
 
Nanomaterials description and considerations on model domain 
Type NP Shape Coating Size (n
Here input information on the (nano)parti
the model  s imulation i s  reported. Please f
adapt the l i s t of properties  included here 
Are the parameters  mesaured or ca lculate
If measured deta i l s  are reported but are n
as  input parameters , then these should be
under other/information on measured pro
thid column a lso other properties  reported
shuld be reported (e.g. crysta l l ini ty, solubi
NPs description
General model assumptions
Is the model 
nanospecific, i.e. 
capture properties 
unique to the nano 
Applicability dom
Here general  assumptions  
on the model  set up are 
reported
Are (nano)particle-
speci fic parameters  
included in the 
model? Or i s  the 
model  s imply 
partci le-speci fic 
(i rrespective of 
partci le s i ze). 
Model domain
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Appendix VIII. TiO2 case study - physicochemical data analysis 
Physicochemical data collected from different sources (OECD dossiers, Nanogenotox 
deliverables, JRC repository) were analysed to build the data matrix for grouping and read-
across (step 4 of the ECHA draft workflow for grouping and read-across) ad to support 
evaluation of uncertainty.  
The properties that populate our dataset and that are analysed in this Annex are:  
Total non-TiO2 content including coating and impurities: property corresponding to the 
%w/w of impurities and coating. This property was defined so as to include the large amount 
of impurities found in NM-101, which probably corresponded to coating, at the same level as 
the coating of NM-103 and NM-104. 
Particle size distribution: the data represent the diameter of a sphere having the same 
physical property. This is known as the equivalent spherical diameter (ISO 9276-1). The 
measures reported under this property come from dynamic light scattering (DLS). 
Zeta potential: the charge at the particles interfaces, measured by DLS. 
Polydispersity index: measure done with the z-average instrument and gives the idea of a 
monomodal/bimodal distribution. According to NanoGenotox deliverable 4.5 (Guiot et al. 
2012) when the PdI<0.25 then the size distribution is monomodal and z-average is 
calculated. When the PdI<0.8 then we have a bimodal distribution and we should take the 
Intensity main peak.  
Solubility (dissolution) and biodurability: 0.05% BSA batch dispersion medium, low-Ca 
Gamble’s solution, and in Caco 2 cell medium by 24-hour incubation at 37 °C and 5% CO2 air 
at 95% RH in a cell incubator. Solubility was assessed from elemental analyses of the solute 
adjusted for background concentrations in the three test media, and biodurability is also 
determined according to elemental analysis in the media after 24 h. 
Dustiness: propensity of a material to generate airborne dust during its handling. Two 
different methods were available and reported in our dataset.  
Primary particle size: this is the size of the particles, measured by Transmission Electron 
Microscope (TEM).  
Specific surface area: surface area of the particle SA [m2] per unit mass m [g] SSA=SA/m 
[m2/g] and can be measured by Small-Angle X-Ray Scattering (SAXS) or by the Brünauer, 
Emmett And Teller (BET) method. 
Crystallite size: Size of the crystal or grain. 
Porosity: an indication of the fraction of the particle that is devoid of material (ISO, 2011e). 
Isoelectric point: pH at which the NM has no net surface charge. 
 
Data on particle size distribution 
Figure A7.1 shows the average of all modes obtained for the size (in nm) per nanoform, 
treatment (sonication time and type) and method (biological medium). MQ stands for milli-Q 
water, DMEM for Dulbecco's modified eagle medium, PBS is phosphate-buffered saline 
medium, FBS stands for fetal bovine serum. 
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Figure A7.2 gives an overview of the data collected for each NM, treatment and medium. 
The different modes are also included.  
 
Figure A7.1. Average size distribution of different modes reported for the different 
nanoforms measured via dynamic light scattering (DLS). 
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a) 
 
 
 
 
 
b) 
 
 
 
 
 
c) 
 
 
 
 
 
d) 
 
 
 
 
e) 
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  f) 
Figure A7.2. Modes 1 to 3 of the particle size distribution per mode 1 to 3 of NM-100 to NM-
105 in different media: a) DMEM + 1% FBS; b) DMEM + 10% FBS; c) DMEM + 5% FBS; d) 
DMEM + L glutamate; e) in MQ water; f) in PBS  
 
Figure A7.3 shows the presence of agglomerates in different dispersions and with different 
treatments. Data show that the different treatments (untreated or 1 min probe sonication 
and 20 min batch sonication) do not have a significant and equal impact on the measured 
size in the dispersion. In general it can be observed that the 20 min sonication treatment 
usually tends to correspond with large agglomerates.  
 a) 
 b) 
 405 
 
 c) 
 d) 
 e) 
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 f) 
Figure A7.3. DLS measurements for the different NM at different sonication conditions and 
in different culture media; a) data for NM-100, b) data for NM-101; c) data for NM-102; d) 
reports data for NM-103; e) data for NM-104; f) data for NM-105. 
 
Figure A7.4 shows the overall variability across the Zeta size of the different nanoforms (NM-
102-105) in the different tested dispersion protocols. The plot corresponds to the mean 
values with the standard deviations obtained in each study, and shows that there is almost 
an overlap between them.  
A measure based on the standard deviation shall capture the variance within a method over 
the Z-size. Whereas the between St.Dev (standard deviation of the averages) shall capture 
the variance between methods.  
Since the average across studies may be used, the interesting measure to keep is the one 
describing the difference between methods to describe the uncertainty of the measure 
used. 
 
 
Figure A7.4. Plot of the overall variability in the size (nm) measured with different 
treatments and for different nanomaterials. Each measurement corresponds to an item of 
the x axis. 
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Data on zeta potential 
Figure A7.5. shows the average of all modes of the Zeta potential per nanoform, per medium 
treatment (sonication time and type, exposure medium). 
 
Figure A7.5. Zeta potential values collected from the OECD dossiers on the six nanoforms 
considered in the read-across case study (average of modes) 
Figure A7.6 shows an overview of the Zeta potential modes for each nanoform, for each 
exposure medium. It is observed that when only one mode is reported, all nanoforms look 
alike, but when the solution is polydispersed, their behaviour is unpredictable as some 
modes are positive and some are negative; some are around ±20 mV (indicator of stability) 
and some are lower in modulus, what indicates low stability of the dispersion.  
 
 a) 
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  b) 
 
 
c) 
 
 
 
d)
 
 
 
 
 
e) 
Figure A7.6. Zeta potential modes are reported per medium; different treatments 
(sonication times and types) are reported for each nanoform. 
 
Figure A7.7 shows the modes reported for each nanoform, medium, and sonication 
treatment. 
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    a) 
 
 
 
b) 
 
 
 
c) 
 
 
d) 
 
 
 
 
 
 
e) 
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   f) 
Figure A7.7. from a) to f) the modes are reported for each nanoform (NM-100 to NM-105) 
and for the different exposure media and tratments. 
 
Figure A7.6 and Figure A7.7 shows that Zeta potential measures are not highly affected by 
treatment, medium or NM type. It is observed, though, that the Zeta potential measured in 
Milli-Q water is less stable (outside the stability interval -20<ζ<20) compared to the 
biological media. 
 
Data on polydispersity index – PdI  
PdI is a measure linked with the z-average measurement and it gives the idea of a 
monomodal/bimodal distribution. When the PdI<0.25 the size distribution is considered 
monomodal and z-average is calculated. When the PdI<0.8 the size distribution is considered  
bimodal and the Intensity main peak should be considered (Guiot et al., 2012). Figure A7.8 
shows the values reported in the OECD dossier for this property. Considering the variability 
and the relevant range for identification of mono- or poly- dispersion, the resulting PdI per 
nanoform is too dependent on the media and treatments and, therefore, is not considered a 
reliable measure. 
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Figure A7.8. PdI for the NMs in different media and treatment (untreated, 1 min sonication, 
20min sonication). 
 
Data on biodurability  
Biodurability of NMs is measured as the fraction of elements found in the media after 24h of 
incubation. Solubility of different elements in different media are reported below. Al 
concentration in NM-101 is due to the impurities (or not declared coating) whereas on NM-
103-104 it is due to the coating. Si is also due to impurities in NM-105 and coating (NM-104). 
 
a) 
b) 
c) 
Figure A7.9. Elemental biodurability in different biological media; BSA: bovine serum 
albumin; Gambles solution:  lung fluid; Caco2:  Caco2 cell medium (acidic medium). 
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Data on dustiness 
Figure A7.10 shows two methods to report for dustiness, the small rotating drum (SD) and the vortex 
shaker (VS). Respirable and inhalable indexes45 are measured. Only SD was considered for the 
respirable fraction as a measure for this property as it is given for all nanoforms. The other methods 
are lacking data for some of the NMs.  
 
Figure A7.10. Dustiness measurement with vortex shaker (VS) and small rotating drum (SD). 
 
Data on primary particle size 
Figure A7.11 shows that the different methods used to measure primary particle size (TEM 
and USAX) give similar values for the small NMs. It shows that their values can be averaged. 
                                                      
4545 Inhalable index approximates to the fraction of airborne material which enters the nose 
and mouth during breathing and is therefore available for deposition in the respiratory tract; 
respirable index approximates to that fraction which penetrates to the gas exchange region 
of the lung (ISO 1995 Air Quality - Particle Size Fraction Definitions for Health-related 
Sampling ISO Standard 7708. International Organization for Standardization (ISO), Geneva.) 
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Figure A7.11. Primary particle size is measured through transmission electron microscopy 
(TEM) and ultra-small angle X-ray scattering (USAX). 
Data on specific surface area (SSA) 
Figure A7.12 shows that SSA measures with BET and USAX are in general similar, and 
therefore could be comparable. The smallest NM, NM-101, instead shows a higher 
variability. 
 
Figure A7.12. SSA measures with ultra-small angle X-ray scattering (USAX) and the Brunauer, 
Emmett and Teller method (BET) 
Data on solubility 
Solubility, intended as metal dissolved in media was considered as biodurability.  
 
Data on total non-TiO2 content including coating and impurities 
Figure A7.13 shows the elemental analysis (%w/w) of the NMs. These values correspond to 
impurities and coating, as they cannot be distinguished in the elemental analysis. The 
amounts of coating declared by the manufacturers (NM-103 and NM-104) are indicated in 
light blue.  
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The graph in Figure A7.13 is driven by the total amount of impurities, yielding the NM 
without coating at nearly 0. Only the amount of Al is significant with respect to other 
impurities and for NM-103 and NM-104. 
 
Figure A7.13. Elemental impurities for the different nanoforms (%w/w) 
 
Data on crystallite size 
Crystallite size is always measured with x-ray diffraction (XRD) and the measurements are 
not very variable, as shown in 
Fi
gure A7.14. The mean will be considered in the data analysis. 
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Figure A7.14. Crystallite size measured by XRD. 
 
Data on porosity 
Values for mean total pore volumes are presented in Figure A7.15.  
 
Figure A7.15. Porosity in the dataset is represented by mean of total pore volume. 
 
Data on isoelectric point 
Mean, maximum (max), and minimum (min) values are reported for isoelectric point in 
Figure A7.16. The measurement is not available for NM-100. 
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Figure A7.16. Isoelectric point. 
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Appendix IX. TiO2 case study - data treatment 
Two main problems arise when gathering data from already available sources: a) lack of data 
and b) availability of data generated with different methods, labs, technicians, or 
techniques. The latter situation is mitigated by the use of standard or guideline methods, 
which assures the comparability of the data and the mutual acceptance of data between 
administrations. In the case of nanomaterials, the reality is that there is lack of data and lack 
of guidelines and standards. This leads to a situation like the one that was encountered for 
nano-TiO2, in which data obtained with two or more methods (e.g. EDS or ICP-OES for 
impurities, DLS and TEM for particle size), or data measured in different solvents (e.g. MQ 
water, DMEM + 1% FBS, DMEM + 5% FBS, DMEM + 10% FBS, PBS), or with different pre-
treatments (e.g. not sonicated, 1min sonication with tip sonication, 20min bath sonication) 
are found and need to be merged. In such a situation, two options can be considered: a) 
each technique, instrument, media, and pre-treatment is considered as a different property 
or b) data from different origins is merged into a common value. Both options present 
advantages and disadvantages. Keeping each value as a different measure leads to a dataset 
plenty of data gaps that becomes unusable for modelling or read-across as the properties 
are not considered comparable and it becomes impossible to compare two substances. 
Instead, merging data from different techniques, studies, or pre-treatments enables the 
comparison of different substances but raises questions like: what is the best way to 
combine the data? ( e.g. average, median, selection of a representative value), and more 
importantly how much will variability be affected by the inclusion of these data? 
These questions do not have an easy answer and especially in a situation with a relatively 
low number of values (<5), as is the case of nano-TiO2. Moreover, in many situations there 
are not right or wrong options.  
In this section the way in which the nano-TiO2 data that was obtained from different sources 
was merged into single values will be explained. This section is not intended to provide 
guidance on how to merge data from different sources, but rather to show the problems 
one may encounter when building a matrix of data to read-across and also to show how this 
step was carried out in the present report in order to render the read-across case study 
more transparent.  
Compilation of the initial dataset 
In order to compile all the available data for the case study a dataset for each nanoform 
(NM-100 –> NM-105) was created. The data was gathered in an excel file with columns 
defining properties (see Figure 17) such as impurities (Al, Si, P, etc.), crystal type, crystal size, 
surface coating, primary particle diameter, particle size distribution, etc., and rows 
corresponding to different entries of data. 
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Figure 17. Example of the dataset created for NM-102. The first columns (pink) correspond 
to metadata and linkers to the data source, and the rest of columns to the data obtained.  
The columns of the dataset were defined on-the-fly as the data was being processed, and 
the data type was defined by the type of data that was available in the sources. For instance, 
since the particle size diameter section was obtained from SAXS/USAXS data, the following 
columns were registered: 
• Mean particle diameter (nm) 
• Gyration radius of primaries (nm) 
• Gyration radius of aggregates(nm) 
• Fractal dimension 
• Number particles/aggregate 
• Aggregated diameter  
 
Similarly, the particle size distribution section contained columns for the measures in each 
media, e.g. PBS, DMEM + X% FBS, MQ Water, etc.  
Each row of the dataset corresponded to data obtained from one test. For instance, all 
impurities measured with EDS were inputted in the first row under the corresponding 
columns. Each new source of data was inputted as a new row. In case the same type of data 
was found in a different source, the data was inputted in a new row but under the same 
column that was created previously. In order to keep track of the sources of the data, the 
first columns of the dataset were dedicated to store metadata (see Figure 17) such as the 
test method (e.g. EDS, DLS, XRD, BET), source of data (e.g. Nanogenotox deliverable D4.3), 
units of the data (e.g. nm, %, ppm, µg/g), guideline used, or remarks.  
This task yielded a dataset that was mostly empty as each new entry added a new row but 
only the property of interest was filled with data and the rest are left blank. The initial 
dataset of NM-102 was comprised of 7260 cells (44 rows x 165 columns), 464 of which 
contained some data, i.e. 6%.  
Reducing the initial dataset to a single row of data 
The next step to obtain a dataset for read-across that could be used, consisted of merging 
the data available in the columns into a row of data, which means that each column was 
reduced to a single value.  
Impurities 
Data on impurities was obtained from two different instruments, EDS and ICP-OES. In most 
cases, both instruments detected different atoms and there was no need to merge the data. 
However, for some cases like Impurity of K of NM-100 two values were present, 2500ppm 
(EDS) and 1000 µg/g (ICP-OES). In this case, the different precision of the instruments was 
not considered. Instead, the conservative principle was applied and only the largest value 
was considered, i.e. 2500ppm. 
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The same strategy was used for all impurities. 
Crystal type 
This data corresponded to the percentage of crystal. The decision for most of the NMs was 
not complicated as they were measured as 100% anatase or 100% rutile. Only for NM-105 
two measures from different labs using the same technique were obtained, one with 86% 
anatase and the other one 81% anatase. It was decided to average the two values giving a 
final value of 83.68% of anatase and 16.32% of rutile. 
Crystallite size 
Crystallite size is one of the problematic measures because crystallite sizes are measured 
with XRD but different algorithms can be used to determine the sizes (see Nanogenotox 4.3 
pag. 14 for further information), e.g. Scherrer equation, Peak fit FWHM, Topas, Fullprof. In 
addition, measures from three different labs were obtained for this property. The measures 
obtained by the different groups and algorithms are shown in Figure 18. 
 
Figure 18. Crystallite size measures obtained from the Nanogenotox report for TiO2 
The crystallite size measures for the small NMs, i.e. NM-101 - NM-105 showed a rather low 
variability independently of the laboratory or methods used to determine it.  But some cases 
showed unexpected differences: For instance the laboratories IMC-BAS and NRCWE used the 
same algorithms and instrument to measure the “same” NMs, but the measures obtained by 
NRCWE were systematically larger than those of IMC-BAS, ~25% larger. The case of NM-102 
is significant as although the larger size difference is only of 12nm, it is with respect to a 
measure of 18-30nm, which represents more than 50% variation. The authors acknowledge 
these differences and state that most of them can be explained by the differences of 
instrumental performance, which has an estimated standard deviation of 5 nm. 
Different is the case of NM-100, whose values were rather variable (from 57-168 nm). The 
reason for this is probably the fact that XRD is not suitable to measure crystals of more than 
100 nm as the authors stated in the report. In addition, the producers indicate a size of 200-
220 nm, but one of the measures determined a crystal size of 57 nm. Therefore, it was 
difficult to determine what value was the right one. Like in most cases, the truth probably 
was somewhere in between the extremes. It is worth mentioning that NM-100 
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corresponded to a dry milled NM what could explain the presence of particles of different 
sizes.  
When dealing with samples with large variability or having extreme values, it is usually 
advisable to use the median of these values. The median of the measures obtained for NM-
100 was 120 nm. However, since the average was 117 nm and the average was used for the 
rest of NMs, it was considered appropriate to use for NM-100 the average value of 117 nm.  
Surface chemistry 
Surface chemistry is per se a difficult category because of the “legal” definition of surface 
chemistry and coating and the tests that are used to determine it. Surface chemistry and 
coating are defined as substances that were intentionally added to the surface of the 
nanomaterial and therefore it depends on the declaration of the manufacturer (see Figure 
19). NM surface chemistry is usually determined by the w/w percentage of each of the 
constituents of the NM. The method used to determine the surface chemistry of NMs is 
usually Thermogravimetric analysis, which consists of the monitoring of the weight of the 
sample while increasing the temperature up to 1000 ºC. The thermogravimetric analysis is 
usually complemented with an elemental composition analysis that is carried out after 
calcination. As it stands, the thermogravimetric analysis cannot distinguish between 
substances that were intentionally added to the surface and those that were not 
intentionally added. 
 
Figure 19. Impurities/coating of nano-TiO2 as declared by manufacturers. * Indicates 
measures not declared by the producer 
In the current case study, 2 NMs (NM-103 and NM-104) were declared as coated with Al2O3 
and silicon dimethicone, and the rest of NMs were declared uncoated by the manufacturers. 
As expected, the thermogravimetric analysis of NM-103 and NM-104 showed a mass loss 
that matched the declaration of coating by the producer, but NM-101 showed an 
unexpected similar mass loss (~8%) at the same temperature and of the same composition 
as NM-103 and NM-104. Since the raising of the temperature calcinates both surface coating 
and impurities, it is impossible to know if the mass loss of NM-101 corresponded to 
impurities or to undeclared coating. Therefore, since NM-101 was declared uncoated, the 
mass loss cannot be considered as surface chemistry but has to be considered as impurities.  
In order to indicate this difference, a row consisting of “organic matter” impurities was 
added to the data matrix (see Table 5). Similarly, a row consisting of the sum of all non-TiO2 
content, which corresponded to the sum of surface chemistry and impurities was also added 
to the matrix.  
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Table 5 Data used in the grouping hypothesis and read-across of comet assay results of nano-
TiO2. 
Name NM-100 NM-101 NM-102 NM-103 NM-104 NM-105 
In vitro comet assay 1 0 1 0 0 1 
Total non-TiO2 content including coating and 
impurities (% w/w) 1.5 9 5 11 11 0.11 
Surface coating (declared) (%) 0 0 0 8 8 0 
Organic matter (%) 0 8 0 2 2 0 
Impurity(% w/w Fe) 0.49 0 0.07 0.06 0 0.06 
Impurity(% w/w Si) 0.28 0.29 0.08 0.68 0.018 0.07 
Impurity(% w/w K) 0.25 0 0.001 0.001 0.001 0 
Impurity(% w/w P) 0.21 0.27 0.001 0 0 0 
Impurity – coating (% w/w Al) 0.09 0.09 0.05 3.4 3.2 0.04 
Impurity(% w/w  Cr) 0.03 0 0 0 0 0 
Impurity(% w/w Zr) 0.005 0.01 0.005 0.001 0.001 0 
Impurity(% w/w Ca) 0.001 0 0.005 0.005 0.01 0 
Impurity(% w/w Na) 0.001 0.1 0.001 0.01 0 0.001 
Impurity(% w/w S) 0 0.22 0.001 0.01 0.01 0.26 
Impurity(% w/w Mg) 0 0 0 0.001 0.001 0 
 
Primary particle diameter 
Data from different sources and methods were obtained for the primary particle diameter. 
The most common technique to determine the primary particle size is TEM. In case different 
values from TEM were obtained, the average value was considered. In the present case 
study, however, data from SAXS/USAXS corresponding to the radius of gyration of primary 
particles was also found. But since data for NM-100 and NM-101 were missing, it was 
decided not to consider the data from SAXS/USAXS due to data gaps and keep only the TEM 
related data as data was available for all NMs. 
Particle size distribution 
Data on the particle size distribution and aggregation/agglomeration was gathered for the 
NMs from: a) different sources, b) different methods (DLS and PCS), c) different media (e.g. 
MQ Water, PBS, DMEM + 1-10% FBS, DMEM + L-Glutamine), d) different treatments 
(unsonicated, 1min probe-sonication, 20min bath sonication). In addition, different 
measures (e.g. Zeta-size, Intensity distribution main peak, and FWHM main peak) were 
obtained for some of the NMs, only.  
Since NM-100 and NM-101 were missing data for the Intensity distribution main peak and 
FWHM main peak, these parameters were not considered in the analysis.  
Data in different media and treatment 
Data for DLS measured as Z average was averaged between the different sources. Instead, 
the data obtained from PCS in different solvents and treatments was treated individually. 
Figure 20 shows a snapshot of the data that was obtained for NM-102 from the OECD 
dossiers. The table contains different measures of particle size distribution, size, and Z-
average with different solvents and treatments. Additionally, the data shows that measures 
such as the untreated sample in MQ water are bimodal as it contains sizes of 1115nm and 
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5170nm. In some cases, 3 modes were detected. This problem is reproduced in the 
corresponding measures of PdI and Zeta Potential. The differences of particle sizes indicate 
that the NMs agglomerate in a different way depending on the media and sonication 
treatment. In general they cannot be averaged between them unless a common behavior is 
observed. For instance, NM-102 shows very similar sizes in DMEM + 1,5,10% FBS as they 
correspond to 1415, 1414 and 1521 nm. However, NM-101 shows a bimodal of 1201/5232 
for DMEM + 1% FBS, 1272 and 1406 for DMEM + 5 and 10% FBS, respectively. This shows 
that it is impossible to use a common merging technique and that the data needs to be 
treated individually.  
 
Figure 20. Particle size distribution data obtained for NM-102 from the OECD Dossiers.  
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An additional problem is the fact that not all media and treatments show bimodal or 
trimodal distributions. In order for the computer to be able to process the data, it was 
decided to include a row of data for each mode. In order to avoid blanks for the modes 2 
and 3 of the monomodal cases, the value obtained was copied to mode 2 and mode 3. An 
example of the final data matrix is shown in Table 6 
 
Table 6 Particle size distribution data in different media and treatments. Values in red indicate 
that the distribution was monomodal and that the same value was used for mode 1 and mode 
2. 
Name NM-100 NM-101 NM-102 NM-103 NM-104 NM-105 
Particle size distribution in MQ Water, untreated, Mode 
#1 (nm) 
391.2 1609 115 973.2 727.8 1102 
Particle size distribution in MQ Water, untreated, Mode 
#2 (nm) 
4862 1609 5170 973.2 727.8 204.7 
Particle size distribution in PBS, untreated, Mode #1 
(nm) 
1440 1188 1528 1977 1817 4526 
Particle size distribution in PBS, untreated, Mode #2 
(nm) 
5236 5148 5330 1977 5194 1150 
Particle size distribution in DMEM + Lglutamate, 
untreated, Mode #1 (nm) 
995.5 1438 2745 2255 3059 1881 
Particle size distribution in DMEM + Lglutamate, 
untreated, Mode #2 (nm) 
995.5 5560 2745 2255 3059 5372 
Particle size distribution in DMEM + 1% FBS, untreated,
Mode #1 (nm) 
736 1201 1415 1040 1156 2454 
Particle size distribution in DMEM + 1% FBS, untreated,
Mode #2 (nm) 
736 5232 1415 4593 5211 626.5 
 
This strategy allowed the inclusion of all data but rendered a dataset with a number of 
particle size distribution values (54 for each NM). It is obvious that having 54 values for the 
particle size distribution of a NM is unnecessary and does not provide relevant information. 
In addition, it highly biases the dataset towards particle size distribution as it corresponds to 
more than 1/3 of the total number of physicochemical variables. In order to reduce the 
dimensionality of the particle size distribution part of the dataset, hierarchical clustering of 
the transposed dataset was used to find “similar” combinations of media-treatments. Figure 
21 shows the resulting clustering with the values that were randomly selected from each 
cluster.  
Such a dimensionality reduction is not expected to be representative of the original data or 
an example to follow to reduce the dimensionality. Since it was deemed necessary to reduce 
the weight of the particle size distribution part of dataset and there was no apparent 
rational, the solution of the hierarchical clustering and random selection was chosen as an 
objective way of doing it. The use of the hierarchical clustering assured that the measures 
chosen did not show similar behavior and contributed to capture differences between NMs.   
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Figure 21. Hierarchical clustering of the transposed matrix of particle size distribution 
measures obtained for the nano-TiO2. Arrows indicate the medium-treatment properties 
that were randomly selected from each cluster as representative. 
Zeta Potential 
Since the Zeta Potential data is obtained with the same instrument and test as the particle 
size distribution and PdI, the reader is referred to the particle size distribution section for 
further details. The hierarchical clustering of the transposed matrix of Zeta Potential with 
the randomly selected properties for each cluster is shown below. 
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Figure 22. Hierarchical clustering of the transposed matrix of Zeta Potential measures 
obtained for the nano-TiO2. Arrows indicate the medium-treatment values that were 
randomly selected for each cluster as representative. 
 
Polydispersibility Index (PdI) 
Since the PdI data is obtained with the same instrument and test as the particle size 
distribution, the reader is referred to the particle size distribution section for further details. 
The hierarchical clustering of the transposed matrix of PdI with the randomly selected 
properties for each cluster is shown below. 
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Figure 23. Hierarchical clustering of the transposed matrix of polidispersibility index 
measures obtained for the nano-TiO2. Arrows indicate the medium-treatment values that 
were randomly selected for each cluster as representative. 
 
Isoelectric point 
Isoelectric point corresponds to the pH-value at which the charge on the surface of the NM, 
i.e. Zeta Potential, is reversed.  The data gathered was generated in different media (water 
and 0.1mM CaCl2), different conditions (acid-to-basic and basic-to-acid) and was found in 
three different sources (Nanogenotox, OECD dossiers, and in Cotogno et al. 2014). Some 
sources provided the exact values while in others the isoelectric point was given as an 
interval. In addition, no isoelectric point data could be found for NM-100. In order to take 
into account all these variations it was decided to consider the mean, minimum, and 
maximum isoelectric point data found for the NMs. This way, 3 rows with data relative to 
isoelectric point were added to the data matrix (see Table 7). 
 
Table 7. Isoelectric point data included in the final dataset 
Name NM-100 NM-101 NM-102 NM-103 NM-104 NM-105
Isoelectric Point (Mean) (pH) NA 5.5 6.0 8.3 8.5 6.8 
Isoelectric Point (Min) (pH) NA 5.3 6.0 8.2 8.2 6.6 
Isoelectric Point (Max) (pH) NA 5.7 6 8.5 8.8 6.9 
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The fact that the nano-TiO2 dispersions appear to be unstable at pH 5-9 and that in vitro 
experiments are generally carried out at pH 7.4 indicate that the dispersions will tend to 
sediment, which might affect the results.  
Density 
Density data was obtained from the OECD dossiers and the Nanogenotox project. Different 
methods were used to measure the density. Some of them declared the temperature at 
which the measure was carried out while others did not. Most of the methods rendered 
values of the order of 4.1 g/cm3 but two measures corresponded to 0.5-1.2 g/cm3 and 0.500-
0.75 g/cm3, the latter corresponding to bulk density. Since these two values were considered 
to correspond to “bulk density”, they were discarded and the rest of the data was averaged.  
Porosity 
Data on porosity was obtained solely from a single source and, therefore, there was no 
problem with the data treatment. Three different measures were found: total pore volume 
(ml/g), micro surface area (m2/g), and micropore volume (ml/g). 
Specific surface area 
The data gathered for specific surface area corresponded to two different methods, SAXS 
and BET. The authors of Nanogenotox compared the two methods and observed a good 
agreement for values up to 130 m2/g. The values obtained for the same NM that were 
smaller than 130 m2/g were averaged. In the current dataset, only NM-101 was found to 
have values larger than 130 m2/g (316 and 169.5 m2/g for BET and SAXS, respectively). In 
such a situation, it is not recommended to average the values as they are not comparable, 
and the BET should be preferred. 
Dustiness (respirable) 
Data on dustiness was obtained from the Nanogenotox project. Two methods, small rotating 
drum and the vortex shaker, were used and different parameters were measured, e.g. 
number of particles in 180s or 3600s, inhalable dustiness index, and respirable dustiness 
index. The authors compared the two methods and observed no significant correlation 
between them. In addition, they acknowledged that dustiness values depended on the 
characteristic properties of the powders and the activation energy in the simulated handling. 
Therefore different values may be obtained by the different test methods (test apparatus, 
operation procedure, sampling and measurement strategy, etc.). In the current case, only 
respirable dustiness index measured by small rotating drum was considered in the read-
across because it was found to be the only method with data for all NMs. 
Biodurability 
Data on biodurability corresponds to the amount of Ti, Al, and Si present in media after 24h 
of incubation of the NMs. Data on different media, i.e. water, bovine serum albumin 0.05%, 
Gambles solution, and Caco2 media was collected; but the data on water was discarded 
because all values were considered insoluble and data was not available for NM-100. The 
measures that were below the detection limit of the instrument were considered to be 0. 
Redox potential 
The redox potential of NMs corresponds to the variation of O2 in the media during 
incubation. The data obtained from Nanogenotox was mainly qualitative and was 
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transformed into 1 for oxidative behavior, -1 for reductive behavior, and 0 for neutral. Data 
in 3 different media (BSA, Gambles, and Caco2) was obtained.  
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Appendix X. TiO2 case study. Dataset for clustering, PCA, and variable selection 
(random forest) 
 
Table A8.1 reports the full dataset considered in the data treatment (clustering, principal 
component analysis, random forest reported in paragraph 4.4.5). 
 
Table A8.1. The full dataset. Data analysis is reported in Appendix VIII. TiO2 case study - 
physicochemical data analysisError! Reference source not found.. 
Name NM-100 NM-101 NM-102 NM-103 NM-104 NM-105 
In vitro comet assay 1 0 1 0 0 1 
Total non-TiO2 content including coating and 
impurities (% w/w) 1.5 9 5 11 11 0.11 
Impurity (% w/w Fe) 0.49 0 0.07 0.06 0 0.06 
Impurity (% w/w Si) 0.28 0.29 0.08 0.68 0.018 0.07 
Impurity (% w/w K) 0.25 0 0.001 0.001 0.001 0 
Impurity (% w/w P) 0.21 0.27 0.001 0 0 0 
Impurity – coating (% w/w Al) 0.09 0.09 0.05 3.4 3.2 0.04 
Impurity (% w/w  Cr) 0.03 0 0 0 0 0 
Impurity (% w/w Zr) 0.005 0.01 0.005 0.001 0.001 0 
Impurity (% w/w Ca) 0.001 0 0.005 0.005 0.01 0 
Impurity (% w/w Na) 0.001 0.1 0.001 0.01 0 0.001 
Impurity (% w/w S) 0 0.22 0.001 0.01 0.01 0.26 
Impurity (% w/w Mg) 0 0 0 0.001 0.001 0 
Organic matter (% w/w) 0 8 0 2 2 0 
Crystal type (Anatase) 1 1 1 0 0 0.84 
Crystal type (Rutile) 0 0 0 1 1 0.16 
Crystal type (Cubic) 0 0 0 0 0 0 
Crystallite size (mean) 117.81 7.69 23.93 24.32 24.71 22.44 
Surface coating (declared) (%) 0 0 0 8 8 0 
Specific surface area (m2/g) 9.23 316.07 77.86 53.98 54.33 47.00 
Shape (elongated=1, spherical=0) 0 0 0 1 0 1 
Aspect ratio 1.53 1.53 1.53 1.70 1.53 1.36 
Primary particle diameter (mean) 93.45 5.25 22.00 24.00 24.50 20.13 
Particle size distribution (Z-average) (nm) 210 278 439.8 135.11 144.47 176.78 
Particle size distribution-SD (Z-average) (nm) 10 0 36.66 25.27 35.21 38.99 
Particle size distribution (Intensity distribution peak 
(nm)) 
NA NA 685.55 146.62 193.94 180.75 
Particle size distribution-SD (Intensity distribution peak
(nm)) 
NA NA 30.8 21.46 48.36 17.98 
Particle size distribution (FWHM main peak) NA NA 444.5 82.36 100.52 75.47 
Particle size distribution-SD (FWHM main peak) NA NA 94.9 12.74 31.37 10.20 
Particle size distribution (after 24h) (nm) NA NA 969 198 NA 214 
Particle size distribution-SD (after 24h) (nm) NA NA 7.65 NA NA NA 
Particle size distribution in MQ Water, untreated, Mode 
#1 (nm) 
391.2 1609 115 973.2 727.8 1102 
Particle size distribution in MQ Water, untreated, Mode 
#2 (nm) 
4862 1609 5170 973.2 727.8 204.7 
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Name NM-100 NM-101 NM-102 NM-103 NM-104 NM-105 
Particle size distribution in PBS, untreated, Mode #1 
(nm) 
1440 1188 1528 1977 1817 4526 
Particle size distribution in PBS, untreated, Mode #2 
(nm) 
5236 5148 5330 1977 5194 1150 
Particle size distribution in DMEM + Lglutamate, 
untreated, Mode #1 (nm) 
995.5 1438 2745 2255 3059 1881 
Particle size distribution in DMEM + Lglutamate, 
untreated, Mode #2 (nm) 
995.5 5560 2745 2255 3059 5372 
Particle size distribution in DMEM + 1% FBS, untreated,
Mode #1 (nm) 
736 1201 1415 1040 1156 2454 
Particle size distribution in DMEM + 1% FBS, untreated,
Mode #2 (nm) 
736 5232 1415 4593 5211 626.5 
Particle size distribution in DMEM + 5% FBS, untreated,
Mode #1 (nm) 
845.4 1278 1414 991.1 719.3 1709 
Particle size distribution in DMEM + 5% FBS, untreated,
Mode #2 (nm) 
845.4 1278 1414 991.1 5375 1709 
Particle size distribution in DMEM + 10%FBS, untreated,
Mode #1 (nm) 
639.1 1406 1521 1156 711.2 1030 
Particle size distribution in DMEM + 10%FBS, untreated,
Mode #2 (nm) 
4793 1406 1521 1156 711.2 4731 
Particle size distribution in MQ water, untreated (Z-
average) (nm) 
343 1746 1062 671.6 367.8 720 
Particle size distribution in PBS , untreated (Z-average)
(nm) 
2289 1229 1579 1397 1600 3342 
Particle size distribution in DMEM + Lglutamine 
untreated (Z-average) (nm) 
2129 1954 2427 1665 2869 2868 
Particle size distribution in DMEM + 1% FBS,  untreated
(Z-average) (nm) 
606.8 1166 1295 828.8 1111 1599 
Particle size distribution in) DMEM + 5% FBS, untreated 
(Z-average) (nm) 
621.3 1039 1234 653.2 657.5 1116 
Particle size distribution in DMEM + 10% FBS, untreated 
(Z-average) (nm) 
582.4 1127 1227 683.3 617.8 937.3 
Particle size distribution in MQ Water, 1min sonication,
Mode #1 (nm) 
259.3 719.5 703 2649 207.7 352.6 
Particle size distribution in MQ Water, 1min sonication,
Mode #2 (nm) 
259.3 719.5 703 2649 207.7 352.6 
Particle size distribution in PBS, 1min sonication, Mode 
#1 (nm), Mode #1 
2116 2254 2525 1629 4031 1682 
Particle size distribution in PBS,  1min sonication, Mode 
#2 (nm)  
2116 2254 2525 4619 465.2 5108 
Particle size distribution in DMEM + Lglutamate, 1min 
sonication, Mode #1 (nm)  
2973 2854 3488 4043 1701 4673 
Particle size distribution in DMEM + Lglutamate, 1min 
sonication, Mode #2 (nm) 
2973 2854 3488 4043 5560 1995 
Particle size distribution in DMEM + 1% FBS , 1min 
sonication, Mode #1 (nm) 
405.3 678.5 837.5 275.6 333.6 306.8 
Particle size distribution in DMEM + 1% FBS, 1min 
sonication, Mode #2 (nm) 
405.3 678.5 189.8 4344 4670 4755 
Particle size distribution in DMEM + 5% FBS , 1min 
sonication, Mode #1 (nm) 
408.8 755.5 901.8 432.4 278.2 336.9 
Particle size distribution in DMEM + 5% , 1min 
sonication, Mode #2 (nm) 
408.8 755.5 115.6 4881 278.2 4755 
Particle size distribution in DMEM + 10%FBS, 1min 
sonication, Mode #1 (nm) 
345.8 823.6 1077 370.9 334.4 349.8 
Particle size distribution in DMEM + 10%FBS, 1min 
sonication, Mode #2 (nm) 
345.8 823.6 1077 370.9 334.4 349.8 
Particle size distribution in MQ water, 1min sonication
(Z-average) (nm) 
201.3 500.9 505.7 1977 194.3 227.5 
Particle size distribution in PBS, 1min sonication (Z-
average) (nm) 
1624 1827 2079 2275 3197 3585 
Particle size distribution in DMEM + , 1min sonication
(Z-average) (nm) 
2514 2350 2701 3551 3306 3507 
Particle size distribution in DMEM + 1% FBS - 1min 
sonication) (Z-average) (nm) 
310.4 521.2 590 263.5 278.5 265.3 
Particle size distribution in DMEM + 5% FBS - 1min 
sonication) (Z-average) (nm) 
315.2 569.2 617.3 345.8 225.8 286.3 
Particle size distribution in DMEM + 10% FBS - 1min 
sonication) (Z-average) (nm) 
283.9 623.4 732.2 286.9 267.8 281.2 
Particle size distribution in MQ Water, 20min 378.8 1111 1103 765.3 344.5 902 
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Name NM-100 NM-101 NM-102 NM-103 NM-104 NM-105 
sonication, Mode #1 (nm) 
Particle size distribution in MQ Water , 20min 
sonication, Mode #2 (nm) 
378.8 4077 193.6 5041 4638 243.9 
Particle size distribution in PBS , 20min sonication, 
Mode #1 (nm) 
1042 1265 1789 1449 2779 4437 
Particle size distribution in PBS Mode #2, 20min 
sonication, Mode #2 (nm) 
5236 4976 4988 5037 2779 4437 
Particle size distribution in DMEM + Lglutamate, 20min 
sonication, Mode #1 (nm) 
1059 1974 2001 2916 3207 1956 
Particle size distribution in DMEM + Lglutamate, 20min 
sonication, Mode #2 (nm) 
1059 4881 5517 2916 3207 5290 
Particle size distribution in DMEM + 1% FBS, 20min 
sonication, Mode #1 (nm) 
631.9 1368 1063 684.1 975.4 969.6 
Particle size distribution in DMEM + 1% FBS, 20min 
sonication, Mode #2 (nm) 
5059 420.5 1063 4946 286.9 226.6 
Particle size distribution in DMEM + 5% FBS, 20min 
sonication, Mode #1 (nm) 
522.7 1073 1487 1079 925 848.3 
Particle size distribution in DMEM + 5% FBS, 20min 
sonication, Mode #2 (nm) 
5017 5046 1487 1079 925 4864 
Particle size distribution in DMEM + 10%FBS, 20min 
sonication, Mode #1 (nm) 
565.7 1255 1228 1155 605.2 1110 
Particle size distribution in DMEM + 10%FBS, 20min 
sonication, Mode #2 (nm) 
565.7 5222 1228 262.3 4991 1110 
Particle size distribution in MQ water - 20min 
sonication) 
307.6 1130 794.1 596.9 290.8 474.4 
Particle size distribution in PBS,- 20min sonication (Z-
average) (nm) 
1217 1276 1809 1350 2284 4514 
Particle size distribution in DMEM + Lglutamine, 20min 
sonication (Z-average) (nm) 
1754 1992 1997 2268 2636 2938 
Particle size distribution in DMEM + 1% FBS, 20min 
sonication (Z-average) (nm) 
540.2 668.7 975.4 526.8 520.4 743.9 
Particle size distribution in DMEM + 5% FBS, 20min 
sonication (Z-average) (nm) 
450.4 1065 1197 656.9 696.2 921.8 
Particle size distribution in DMEM + 10% FBS, 20min 
sonication (Z-average) (nm) 
473.1 957.9 874.8 570.3 480.8 619.8 
Zeta Potential in MQ Water, 1min sonication (mV) -24.5 -27.2 -27.1 39.1 -23.4 -23.8 
Zeta Potential in PBS, 1min sonication (mV) -26.7 -19.7 -25.1 -20.8 -16.9 -20.5 
Zeta Potential in DMEM + Lglutamate, 1min sonication, 
Mode #1 (mV) 
20.5 22.3 -3.14 -8.44 -7.29 -2.55 
Zeta Potential in DMEM + Lglutamate, 1min sonication, 
Mode #2 (mV) 
-26 -34.3 -3.14 -8.44 -7.29 -2.55 
Zeta Potential in DMEM + Lglutamate, 1min sonication, 
Mode #3 (mV) 
95.4 -92 -3.14 -8.44 -7.29 -2.55 
Zeta Potential in DMEM + 1% FBS, 1min sonication, 
Mode #1 (mV) 
-9.14 -11.8 -13.6 -9.98 -8.88 -9.37 
Zeta Potential in DMEM + 1% FBS, 1min sonication, 
Mode #2 (mV) 
140 -11.8 -13.6 -9.98 -8.88 -9.37 
Zeta Potential in DMEM + 5% FBS, 1min sonication, 
Mode #1 (mV) 
107 -15 -13.4 -12 15.1 9.43 
Zeta Potential in DMEM + 5% FBS, 1min sonication, 
Mode #2 (mV) 
35.4 -15 -13.4 -12 -43.7 -47.9 
Zeta Potential in DMEM + 5% FBS, 1min sonication, 
Mode #3 (mV) 
-21.2 -15 -13.4 -12 -43.7 -47.9 
Zeta Potential in DMEM + 10%FBS, 1min sonication, 
Mode #1 (mV) 
78.4 0.13 -10.5 -12.4 -9.38 -9.92 
Zeta Potential in DMEM + 10%FBS, 1min sonication, 
Mode #2 (mV) 
12.2 0.13 -10.5 -12.4 129 -9.92 
Zeta Potential in DMEM + 10%FBS, 1min sonication, 
Mode #3 (mV) 
-27.1 0.13 -10.5 -12.4 129 -9.92 
Zeta Potential in MQ Water - 20min sonication (mV) -40.6 -27.5 30.3 39.1 24.6 -32.6 
Zeta Potential in PBS - 20min sonication (mV) -20.2 -21.7 -18.5 -20.9 -20.3 -33.2 
Zeta Potential in DMEM + Lglutamate, 20min 
sonication, Mode #1 (mV) 
-1.55 3.6 -3.46 -8.76 -9.98 -8.55 
Zeta Potential in DMEM + Lglutamate, 20min 
sonication, Mode #2 (mV) 
-1.55 -42.5 -3.46 -8.76 -9.98 -8.55 
Zeta Potential in DMEM + 1% FBS, 20min sonication 
(mV) 
-11.4 -12 -12.4 -10 -10.2 -7.76 
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Name NM-100 NM-101 NM-102 NM-103 NM-104 NM-105 
Zeta Potential in DMEM + 5% FBS, 20min sonication 
(mV) 
-10.4 -11.3 -9.47 -13.7 -9.38 -11.9 
Zeta Potential in DMEM + 10%FBS, 20min sonication, 
Mode #1 (mV) 
-11.3 -11.5 -10.4 -11.8 -10.5 -5.43 
Zeta Potential in DMEM + 10%FBS, 20min sonication, 
Mode #2 (mV) 
-11.3 -11.5 -10.4 -11.8 -10.5 -74 
Polydispersity Index in MQ water - untreated 0.205 0.264 0.187 0.287 0.376 0.376 
Polydispersity Index in PBS - untreated 0.219 0.239 0.769 0.255 0.232 0.232 
Polydispersity Index in DMEM + Lglutamine – untreated 0.332 0.359 0.181 0.256 0.247 0.247 
Polydispersity Index in DMEM + 1% FBS - untreated 0.207 0.201 0.081 0.269 0.208 0.208 
Polydispersity Index in DMEM + 5% FBS - untreated 0.194 0.232 0.139 0.293 0.22 0.22 
Polydispersity Index in DMEM + 10% FBS - untreated 0.176 0.194 0.182 0.369 0.201 0.201 
Polydispersity Index in MQ water - 1min sonication 0.205 0.274 0.248 0.393 0.236 0.211 
Polydispersity Index in PBS - 1min sonication 0.219 0.283 0.188 0.442 0.334 0.443 
Polydispersity Index in DMEM + Lglutamine - 1min 
sonication 
0.332 0.217 0.268 0.279 0.434 0.395 
Polydispersity Index in DMEM + 1% FBS - 1min 
sonication 
0.207 0.232 0.243 0.243 0.194 0.177 
Polydispersity Index in DMEM + 5% FBS - 1min 
sonication 
0.194 0.232 0.27 0.25 0.161 0.207 
Polydispersity Index in DMEM + 10% FBS - 1min 
sonication 
0.176 0.24 0.27 0.196 0.178 0.196 
Polydispersity Index in MQ water - 20min sonication 0.199 0.351 0.254 0.393 0.306 0.443 
Polydispersity Index in PBS - 20min sonication 0.317 0.238 0.231 0.25 0.227 0.274 
Polydispersity Index in DMEM + Lglutamine - 20min 
sonication 
0.515 0.247 0.227 0.264 0.209 0.341 
Polydispersibility Index in DMEM + 1% FBS - 20min 
sonication 
0.195 0.282 0.054 0.317 0.282 0.48 
Polydispersibility Index in DMEM + 5% FBS - 20min 
sonication 
0.223 0.302 0.179 0.367 0.221 0.456 
Polydispersibility Index in DMEM + 10% FBS - 20min 
sonication 
0.204 0.234 0.235 0.417 0.239 0.391 
Polydispersity Index (PdI) NA 0.323 0.427 0.292 0.227 0.245 
IsoelectricPoint (Mean) NA 5.5 6 8.3 8.5 6.8 
IsoelectricPoint (Min) NA 5.3 6 8.2 8.2 6.6 
IsoelectricPoint (Max) NA 5.7 6 8.5 8.8 6.9 
Density (g/mL) 3.84 3.99 3.84 4.015 4.09 4.052 
Mean of total pore volume (mL/g) 0.0324 0.319 0.2996 0.2616 0.1935 0.1937 
Micro surface area (m2/g) 0 13.625 1.108 0 0 0 
Micropore volume (mL/g) 0 0.00179 0.00034 0 0 0 
Specific surface area (mean) 9.23 242.785 77.864 53.983 54.331 47 
Dustiness-Respirable(mg/kg) 1500 5600 9200 19000 6400 11000 
Biodurability 24h 0.05% BSA (Ti content) (µg/l) 5.2 0 0 0 0 0 
Biodurability 24h Gambles solution (Ti content) 
(µg/l) 0 0 3388 0 0 0 
Biodurability 24h Caco2 (Ti content) (µg/l) 796 3414 1741 222 3386 2724 
Biodurability 24h 0.05% BSA (Al content) (µg/l) 0 175 0 198 137 0 
Biodurability 24h Gambles solution (Al content) 
(µg/l) 0 177 0 868 413 0 
Biodurability 24h Caco2 (Al content) (µg/l) 24 252 0 182 413 0 
Biodurability 24h 0.05% BSA (Si content) (mg/l) 0 0 0 0.9 0 0 
Biodurability 24h Gambles solution (Si content) 0 0 0 2.0 0 0 
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Name NM-100 NM-101 NM-102 NM-103 NM-104 NM-105 
(µg/l) 
Biodurability 24h Caco2 (Si content) (µg/l) 0 0 0 1.7 0 0 
Redox Caco2 medium Ω 1 -1 -1 1 -1 -1 
Redox Gamble's solution Ω 1 0 -1 1 -1 -1 
Redox BSA Ω 0 0 0 0 0 0 
Ω values obtained from Nanogenotox 4.7 determined by measuring the content of O2. Oxidising properties (1), neutral (0), reducing (-1) 
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Appendix XI. Literature search on genotoxicity studies 
Our initial dataset on toxicological endpoints was collected from the OECD dossier on TiO2 
(OECD, 2015) that, although not aimed specifically at hazard assessment, is considered an 
updated NMs data repository. This starting toxicological dataset which content is reported in 
Table 4. was expanded for the selected endpoint to be read-across (genotoxicity) by 
searching available studies in the literature. 
A bibliographic search was done in August 2016 in Scopus using the keywords genotox*, 
nano*, TiO2. It resulted in 152 review and research papers. A first selection done depending 
on title and abstract contents: if it was not about genotoxicity testing, the papers were not 
included. Also, only toxicity studies relevant for human health hazard assessment were 
considered (studies on bacteria, plants, mussels, fish were excluded). 
 
Table A9.1 reports the list of papers containing genotoxicity studies that were taken into 
consideration for the selection of the genotoxicity tests to read-across. According to the first 
criteria, related to NMs characterisation, the information necessary for identification was 
available in the reliable studies, hence the studied NM could be assigned to the 
corresponding analogue in our case study. The results coming from the reliable studies 
reported in the table are accounted for in Table 4.. 
 
Table A9.1. List of genotoxicity studies found in the literature search to extend the 
number of studies for building our grouping hypothesis for our set of source NMs. 
 
 Assay type Reference Reliability 
In vivo Comet  (Dobrzyńska et al., 2014) Unreliable 
(Trouiller et al., 2009) Unreliable 
(Suzuki et al., 2016) Unreliable 
(Louro et al., 2014) Reliable 
Micronucleus  (Dobrzyńska et al., 2014) Unreliable 
(Trouiller et al., 2009) Unreliable 
(Suzuki et al., 2016) Unreliable 
(Louro et al., 2014) Reliable 
Chromosome aberration (Louro et al., 2014) Reliable 
In vitro Comet  (Prasad, Wallace, Daniel, 
Tennant, Zucker, 
Strickland, Dreher, 
Kligerman, Blackman, & 
Demarini, 2013) 
Reliable 
(Vales et al., 2014) Reliable 
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 Assay type Reference Reliability 
(Kansara et al., 2015) Reliable 
(Armand et al., 2016) Reliable 
(Jugan et al., 2012) Reliable 
(Gerloff et al., 2012b) Reliable 
(A Kermanizadeh et al., 
2012) 
Reliable 
(Ali Kermanizadeh et al., 
2013) 
Reliable 
(Stoccoro et al., 2016) Unreliable 
(Guichard et al., 2012) Reliable  
(Barillet et al., 2010) Reliable 
(Guichard et al., 2012) Reliable 
Micronucleus  (Prasad, Wallace, Daniel, 
Tennant, Zucker, 
Strickland, Dreher, 
Kligerman, Blackman, & 
Demarini, 2013) 
Reliable 
(Prasad et al., 2014) Reliable 
(Vales et al., 2014) Reliable 
(Kansara et al., 2015) Reliable 
(Jugan et al., 2012) Reliable 
(Armand et al., 2016) Reliable 
(Tavares et al., 2014a) Reliable 
(Stoccoro et al., 2016) Unreliable 
(Guichard et al., 2012) Reliable  
Chromosome aberration (L Browning et al., 2014) Reliable 
 
Reliability of the studies was assessed following the criteria reported in paragraph 4.4.3.2. 
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